<html class="gs_el_sm gs_pfcs"><head><title>‪Ghulam Mufti‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.co.uk/citations?user=gZU2Ie8AAAAJ&amp;hl=en"><meta name="description" content="‪Professor of Haemato-Oncology, King's College‬ - ‪‪Cited by 40,118‬‬"><meta property="og:description" content="‪Professor of Haemato-Oncology, King's College‬ - ‪‪Cited by 40,118‬‬"><meta property="og:title" content="Ghulam Mufti"><meta property="og:image" content="https://scholar.google.com/citations/images/avatar_scholar_256.png"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"SM89Yfa_MYnwmgGHsJCwCQ"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=gZU2Ie8AAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=gZU2Ie8AAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=gZU2Ie8AAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=gZU2Ie8AAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYT8gyBvtjDXysXflXt-rQCjNRJcBnXWQ"><input type="hidden" name="user" value="gZU2Ie8AAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">40118</td><td class="gsc_rsb_std">14868</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">101</td><td class="gsc_rsb_std">58</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">427</td><td class="gsc_rsb_std">234</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:1126px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:1080px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">2800</div><div class="gsc_g_xtl" style="top:73px;">1400</div><div class="gsc_g_xtl" style="top:113px;">700</div><div class="gsc_g_xtl" style="top:33px;">2100</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:1027px">1989</span><span class="gsc_g_t" style="right:995px">1990</span><span class="gsc_g_t" style="right:963px">1991</span><span class="gsc_g_t" style="right:931px">1992</span><span class="gsc_g_t" style="right:899px">1993</span><span class="gsc_g_t" style="right:867px">1994</span><span class="gsc_g_t" style="right:835px">1995</span><span class="gsc_g_t" style="right:803px">1996</span><span class="gsc_g_t" style="right:771px">1997</span><span class="gsc_g_t" style="right:739px">1998</span><span class="gsc_g_t" style="right:707px">1999</span><span class="gsc_g_t" style="right:675px">2000</span><span class="gsc_g_t" style="right:643px">2001</span><span class="gsc_g_t" style="right:611px">2002</span><span class="gsc_g_t" style="right:579px">2003</span><span class="gsc_g_t" style="right:547px">2004</span><span class="gsc_g_t" style="right:515px">2005</span><span class="gsc_g_t" style="right:483px">2006</span><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:1032px;top:152px;height:8px;z-index:33"><span class="gsc_g_al">143</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:1000px;top:151px;height:9px;z-index:32"><span class="gsc_g_al">169</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:968px;top:152px;height:8px;z-index:31"><span class="gsc_g_al">153</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:936px;top:142px;height:18px;z-index:30"><span class="gsc_g_al">326</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:904px;top:149px;height:11px;z-index:29"><span class="gsc_g_al">195</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:872px;top:148px;height:12px;z-index:28"><span class="gsc_g_al">214</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:840px;top:148px;height:12px;z-index:27"><span class="gsc_g_al">221</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:808px;top:145px;height:15px;z-index:26"><span class="gsc_g_al">271</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:776px;top:146px;height:14px;z-index:25"><span class="gsc_g_al">247</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:744px;top:140px;height:20px;z-index:24"><span class="gsc_g_al">354</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:712px;top:140px;height:20px;z-index:23"><span class="gsc_g_al">351</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:680px;top:137px;height:23px;z-index:22"><span class="gsc_g_al">408</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:648px;top:134px;height:26px;z-index:21"><span class="gsc_g_al">467</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:616px;top:126px;height:34px;z-index:20"><span class="gsc_g_al">598</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:584px;top:126px;height:34px;z-index:19"><span class="gsc_g_al">608</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:552px;top:118px;height:42px;z-index:18"><span class="gsc_g_al">736</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:520px;top:113px;height:47px;z-index:17"><span class="gsc_g_al">828</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:488px;top:106px;height:54px;z-index:16"><span class="gsc_g_al">962</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:100px;height:60px;z-index:15"><span class="gsc_g_al">1057</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:84px;height:76px;z-index:14"><span class="gsc_g_al">1341</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:82px;height:78px;z-index:13"><span class="gsc_g_al">1376</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:56px;height:104px;z-index:12"><span class="gsc_g_al">1834</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:48px;height:112px;z-index:11"><span class="gsc_g_al">1962</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:40px;height:120px;z-index:10"><span class="gsc_g_al">2101</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:22px;height:138px;z-index:9"><span class="gsc_g_al">2423</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:25px;height:135px;z-index:8"><span class="gsc_g_al">2363</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:15px;height:145px;z-index:7"><span class="gsc_g_al">2546</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:15px;height:145px;z-index:6"><span class="gsc_g_al">2540</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:22px;height:138px;z-index:5"><span class="gsc_g_al">2427</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:21px;height:139px;z-index:4"><span class="gsc_g_al">2447</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:26px;height:134px;z-index:3"><span class="gsc_g_al">2346</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:3px;height:157px;z-index:2"><span class="gsc_g_al">2762</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:30px;height:130px;z-index:1"><span class="gsc_g_al">2284</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=gZU2Ie8AAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3dgZU2Ie8AAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>48 articles</span></div><div class="gsc_rsb_m_na"><div>5 articles</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:9%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span>not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:128px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:80pt;height:80pt;}}</style><img alt="Ghulam Mufti" sizes="print 80px,128px" src="/citations/images/avatar_scholar_128.png" id="gsc_prf_pup-img" srcset="/citations/images/avatar_scholar_128.png 128w,/citations/images/avatar_scholar_256.png 256w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">Ghulam Mufti</div><div class="gsc_prf_il">Professor of Haemato-Oncology, <a href="/citations?view_op=view_org&amp;hl=en&amp;org=1087198676816281164" class="gsc_prf_ila">King's College</a></div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at kcl.ac.uk</div><div class="gsc_prf_il" id="gsc_prf_int"></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=gZU2Ie8AAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYT8gyBvtjDXysXflXt-rQCjNRJcBnXWQ"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=gZU2Ie8AAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=gZU2Ie8AAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=gZU2Ie8AAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=gZU2Ie8AAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=gZU2Ie8AAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:u5HHmVD_uO8C" class="gsc_a_at">International scoring system for evaluating prognosis in myelodysplastic syndromes</a><div class="gs_gray">P Greenberg, C Cox, MM LeBeau, P Fenaux, P Morel, G Sanz, M Sanz, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 89 (6), 2079-2088<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1290306343803917719" class="gsc_a_ac gs_ibl">5007</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:u-x6o8ySG0sC" class="gsc_a_at">Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study</a><div class="gs_gray">P Fenaux, GJ Mufti, E Hellstrom-Lindberg, V Santini, C Finelli, ...</div><div class="gs_gray">The lancet oncology 10 (3), 223-232<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2224262189970279185" class="gsc_a_ac gs_ibl">2456</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:d1gkVwhDpl0C" class="gsc_a_at">Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia</a><div class="gs_gray">P Fenaux, GJ Mufti, E Hellström-Lindberg, V Santini, N Gattermann, ...</div><div class="gs_gray">Journal of clinical oncology 28 (4), 562-569<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12891453452691702473" class="gsc_a_ac gs_ibl">1003</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:9yKSN-GCB0IC" class="gsc_a_at">Myelodysplastic syndromes: a scoring system with prognostic significance</a><div class="gs_gray">GJ Mufti, JR Stevens, DG Oscier, TJ Hamblin, D Machin</div><div class="gs_gray">British Journal of Haematology 59 (3), 425-433<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2162818984556606511" class="gsc_a_ac gs_ibl">631</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:_FxGoFyzp5QC" class="gsc_a_at">Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet</a><div class="gs_gray">L Malcovati, E Hellström-Lindberg, D Bowen, L Ades, J Cermak, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (17), 2943-2964<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10952127596705054304" class="gsc_a_ac gs_ibl">622</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:Y0pCki6q_DkC" class="gsc_a_at"><i>TP53</i> Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression</a><div class="gs_gray">M Jädersten, L Saft, A Smith, A Kulasekararaj, S Pomplun, G Göhring, ...</div><div class="gs_gray">Journal of clinical oncology 29 (15), 1971-1979<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12977487730435632117" class="gsc_a_ac gs_ibl">470</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:W7OEmFMy1HYC" class="gsc_a_at">A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q</a><div class="gs_gray">P Fenaux, A Giagounidis, D Selleslag, O Beyne-Rauzy, G Mufti, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (14), 3765-3776<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12182646009083211070" class="gsc_a_ac gs_ibl">451</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:qjMakFHDy7sC" class="gsc_a_at">The role of apoptosis, proliferation, and the Bcl-2–related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS</a><div class="gs_gray">JE Parker, GJ Mufti, F Rasool, A Mijovic, S Devereux, A Pagliuca</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 96 (12), 3932-3938<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8075687489354074157,1336379263953992489" class="gsc_a_ac gs_ibl">423</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:43bX7VzcjpAC" class="gsc_a_at">Guidelines for the diagnosis and management of adult aplastic anaemia</a><div class="gs_gray">SB Killick, N Bown, J Cavenagh, I Dokal, T Foukaneli, A Hill, P Hillmen, ...</div><div class="gs_gray">British journal of haematology 172 (2), 187-207<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14074061925572298696" class="gsc_a_ac gs_ibl">420</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:2osOgNQ5qMEC" class="gsc_a_at">Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes</a><div class="gs_gray">D Bowen, D Culligan, S Jowitt, S Kelsey, G Mufti, D Oscier, J Parker</div><div class="gs_gray">British journal of haematology 120 (2), 187-200<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13033111934309251731" class="gsc_a_ac gs_ibl">406</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:IjCSPb-OGe4C" class="gsc_a_at">Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical&nbsp;…</a><div class="gs_gray">R Martino, S Iacobelli, R Brand, T Jansen, A Van Biezen, J Finke, ...</div><div class="gs_gray">Blood 108 (3), 836-846<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1518790126837644521" class="gsc_a_ac gs_ibl">393</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:UeHWp8X0CEIC" class="gsc_a_at">Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin</a><div class="gs_gray">JW Janssen, M Buschle, M Layton, HG Drexler, J Lyons, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11360424743596337242" class="gsc_a_ac gs_ibl">384</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:YsMSGLbcyi4C" class="gsc_a_at">Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the&nbsp;…</a><div class="gs_gray">GJ Mufti, JM Bennett, J Goasguen, BJ Bain, I Baumann, R Brunning, ...</div><div class="gs_gray">haematologica 93 (11), 1712-1717<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13728072243647294408" class="gsc_a_ac gs_ibl">357</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:zYLM7Y9cAGgC" class="gsc_a_at">Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells</a><div class="gs_gray">A Essafi, SF de Mattos, YAM Hassen, I Soeiro, GJ Mufti, NSB Thomas, ...</div><div class="gs_gray">Oncogene 24 (14), 2317-2329<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17908825144776717178" class="gsc_a_ac gs_ibl">334</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:UebtZRa9Y70C" class="gsc_a_at">Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia</a><div class="gs_gray">ZY Lim, R Brand, R Martino, A Van Biezen, J Finke, A Bacigalupo, ...</div><div class="gs_gray">Journal of Clinical Oncology 28 (3), 405-411<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14976586242715855215" class="gsc_a_ac gs_ibl">310</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd–Chiari syndrome</a><div class="gs_gray">RK Patel, NC Lea, MA Heneghan, NB Westwood, D Milojkovic, ...</div><div class="gs_gray">Gastroenterology 130 (7), 2031-2038<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3274392030270170358,6930212072904162730" class="gsc_a_ac gs_ibl">308</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:yNlG6JgpFqoC" class="gsc_a_at">Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia&nbsp;…</a><div class="gs_gray">J Donadieu, T Leblanc, BB Meunier, M Barkaoui, O Fenneteau, ...</div><div class="gs_gray">haematologica 90 (1), 45-53<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11631774142063382722,11123812854966518981" class="gsc_a_ac gs_ibl">303</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:LkGwnXOMwfcC" class="gsc_a_at">CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment</a><div class="gs_gray">PEM Patten, AGS Buggins, J Richards, A Wotherspoon, J Salisbury, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 111 (10), 5173-5181<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4045231422761762743" class="gsc_a_ac gs_ibl">270</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:Se3iqnhoufwC" class="gsc_a_at">Next-generation sequencing of the <i>TET2</i> gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite&nbsp;…</a><div class="gs_gray">AE Smith, AM Mohamedali, A Kulasekararaj, ZY Lim, J Gäken, NC Lea, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 116 (19), 3923-3932<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9090118702588764360" class="gsc_a_ac gs_ibl">261</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;citation_for_view=gZU2Ie8AAAAJ:MXK_kJrjxJIC" class="gsc_a_at">CD4<sup>+</sup>CD25<sup>high</sup> Foxp3<sup>+</sup> regulatory T cells in myelodysplastic syndrome (MDS)</a><div class="gs_gray">SY Kordasti, W Ingram, J Hayden, D Darling, L Barber, B Afzali, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (3), 847-850<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=894061227017724219" class="gsc_a_ac gs_ibl">260</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:0EnyYjriUFMC" class="gsc_a_at">Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes</a><div class="gs_gray">AA Van De Loosdrecht, C Alhan, MC Béné, MG Della Porta, AM Dräger, ...</div><div class="gs_gray">haematologica 94 (8), 1124<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12476312732439196946" class="gsc_a_ac gs_ibl">257</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:WF5omc3nYNoC" class="gsc_a_at">Immunological abnormalities in myelodysplastic syndromes I. Serum immunoglobulins and autoantibodies</a><div class="gs_gray">GJ Mufti, A Figes, TJ Hamblin, DG Oscier, JA Copplestoni</div><div class="gs_gray">British journal of haematology 63 (1), 143-147<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11910078303279896083" class="gsc_a_ac gs_ibl">252</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:KlAtU1dfN6UC" class="gsc_a_at">Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres</a><div class="gs_gray">DJ Kuter, B Bain, G Mufti, A Bagg, RP Hasserjian</div><div class="gs_gray">British journal of haematology 139 (3), 351-362<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5817110214662705530" class="gsc_a_ac gs_ibl">251</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:4JMBOYKVnBMC" class="gsc_a_at"><i>TP53</i> mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis</a><div class="gs_gray">AG Kulasekararaj, AE Smith, SA Mian, AM Mohamedali, P Krishnamurthy, ...</div><div class="gs_gray">British journal of haematology 160 (5), 660-672<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10525058653642040496" class="gsc_a_ac gs_ibl">245</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:Wp0gIr-vW9MC" class="gsc_a_at">Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group</a><div class="gs_gray">TM Westers, R Ireland, W Kern, C Alhan, JS Balleisen, P Bettelheim, ...</div><div class="gs_gray">Leukemia 26 (7), 1730-1741<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3709156773700715639" class="gsc_a_ac gs_ibl">245</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:nb7KW1ujOQ8C" class="gsc_a_at">Applying synthetic lethality for the selective targeting of cancer</a><div class="gs_gray">DP McLornan, A List, GJ Mufti</div><div class="gs_gray">New England Journal of Medicine 371 (18), 1725-1735<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8686016626492980232" class="gsc_a_ac gs_ibl">242</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:eQOLeE2rZwMC" class="gsc_a_at">Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine&nbsp;…</a><div class="gs_gray">AYL Ho, A Pagliuca, M Kenyon, JE Parker, A Mijovic, S Devereux, ...</div><div class="gs_gray">Blood 104 (6), 1616-1623<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4585457276683597302" class="gsc_a_ac gs_ibl">240</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:ufrVoPGSRksC" class="gsc_a_at">Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes</a><div class="gs_gray">A Mohamedali, J Gäken, NA Twine, W Ingram, N Westwood, NC Lea, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (9), 3365-3373<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7606277880007071413" class="gsc_a_ac gs_ibl">233</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:TewouNez5YAC" class="gsc_a_at">Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel</a><div class="gs_gray">T De Witte, D Bowen, M Robin, L Malcovati, D Niederwieser, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 129 (13), 1753-1762<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8925322390385068203" class="gsc_a_ac gs_ibl">217</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:Zph67rFs4hoC" class="gsc_a_at">Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies</a><div class="gs_gray">RV Tiu, LP Gondek, CL O'Keefe, P Elson, J Huh, A Mohamedali, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 117 (17), 4552-4560<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16819668761253175505" class="gsc_a_ac gs_ibl">213</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:hqOjcs7Dif8C" class="gsc_a_at">Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study</a><div class="gs_gray">SM Kelsey, JM Goldman, S McCann, AC Newland, JH Scarffe, ...</div><div class="gs_gray">Bone marrow transplantation 23 (2), 163-168<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8289856132664401488" class="gsc_a_ac gs_ibl">208</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:roLk4NBRz8UC" class="gsc_a_at">BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients</a><div class="gs_gray">RD Faulkner, C Craddock, JL Byrne, P Mahendra, AP Haynes, ...</div><div class="gs_gray">Blood 103 (2), 428-434<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8136321362732348722" class="gsc_a_ac gs_ibl">205</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:fQNAKQ3IYiAC" class="gsc_a_at">Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome</a><div class="gs_gray">AG Kulasekararaj, J Jiang, AE Smith, AM Mohamedali, S Mian, S Gandhi, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (17), 2698-2704<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14540010155739751334" class="gsc_a_ac gs_ibl">196</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:9ZlFYXVOiuMC" class="gsc_a_at">Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher‐risk myelodysplastic syndromes</a><div class="gs_gray">LR Silverman, P Fenaux, GJ Mufti, V Santini, E Hellström‐Lindberg, ...</div><div class="gs_gray">Cancer 117 (12), 2697-2702<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6512775453245928161" class="gsc_a_ac gs_ibl">192</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:-f6ydRqryjwC" class="gsc_a_at">Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim</a><div class="gs_gray">DJ Kuter, GJ Mufti, BJ Bain, RP Hasserjian, W Davis, M Rutstein</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 114 (18), 3748-3756<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7812458448350210446" class="gsc_a_ac gs_ibl">186</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:TQgYirikUcIC" class="gsc_a_at">IL‐17‐producing CD4<sup>+</sup> T cells, pro‐inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome</a><div class="gs_gray">SY Kordasti, B Afzali, Z Lim, W Ingram, J Hayden, L Barber, K Matthews, ...</div><div class="gs_gray">British journal of haematology 145 (1), 64-72<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15424706606262168201" class="gsc_a_ac gs_ibl">184</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:8k81kl-MbHgC" class="gsc_a_at">Nonmyeloablative stem cell transplantation for congenital immunodeficiencies</a><div class="gs_gray">P Amrolia, HB Gaspar, A Hassan, D Webb, A Jones, N Sturt, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 96 (4), 1239-1246<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8064520978668535090" class="gsc_a_ac gs_ibl">183</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:esGtpfCv0y8C" class="gsc_a_at">‘Off-the-shelf’allogeneic CAR T cells: development and challenges</a><div class="gs_gray">S Depil, P Duchateau, SA Grupp, G Mufti, L Poirot</div><div class="gs_gray">Nature reviews Drug discovery 19 (3), 185-199<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=405761622619271365" class="gsc_a_ac gs_ibl">182</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:m8MyhXdlT-4C" class="gsc_a_at">Luspatercept in patients with lower-risk myelodysplastic syndromes</a><div class="gs_gray">P Fenaux, U Platzbecker, GJ Mufti, G Garcia-Manero, R Buckstein, ...</div><div class="gs_gray">New England Journal of Medicine 382 (2), 140-151<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10043304288617157426" class="gsc_a_ac gs_ibl">181</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:E10ZYwHxBI8C" class="gsc_a_at">Myelodysplastic syndromes</a><div class="gs_gray">G Mufti, AF List, SD Gore, AY Ho</div><div class="gs_gray">Palliative Care Consultations in Haemato-oncology, 43<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16574628940417376121,10586047747267430978,3639386272536171308" class="gsc_a_ac gs_ibl">179</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:L8Ckcad2t8MC" class="gsc_a_at">Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia?</a><div class="gs_gray">FV Rassool, TJ Gaymes, N Omidvar, N Brady, S Beurlet, M Pla, M Reboul, ...</div><div class="gs_gray">Cancer research 67 (18), 8762-8771<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11336523353505987519" class="gsc_a_ac gs_ibl">178</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:M3ejUd6NZC8C" class="gsc_a_at">Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival</a><div class="gs_gray">A Worsley, DG Oscier, J Stevens, S Darlow, A Figes, GJ Mufti, TJ Hamblin</div><div class="gs_gray">British journal of haematology 68 (1), 17-21<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=967606719981474336" class="gsc_a_ac gs_ibl">174</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:4TOpqqG69KYC" class="gsc_a_at">Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin</a><div class="gs_gray">ZY Lim, S Killick, U Germing, J Cavenagh, D Culligan, A Bacigalupo, ...</div><div class="gs_gray">Leukemia 21 (7), 1436-1441<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7860575786920210602" class="gsc_a_ac gs_ibl">173</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:rbm3iO8VlycC" class="gsc_a_at">Randomized phase III study of lenalidomide versus placebo in RBC transfusion-dependent patients with lower-risk non-del (5q) myelodysplastic syndromes and ineligible for or&nbsp;…</a><div class="gs_gray">V Santini, A Almeida, A Giagounidis, S Gröpper, A Jonasova, N Vey, ...</div><div class="gs_gray">Journal of Clinical Oncology 34 (25), 2988-2996<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2592251256898433951" class="gsc_a_ac gs_ibl">169</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:hFOr9nPyWt4C" class="gsc_a_at">A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Francais des Myelodysplasies and European CMML Group</a><div class="gs_gray">E Wattel, A Guerci, B Hecquet, T Economopoulos, A Copplestone, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14585546971331539421" class="gsc_a_ac gs_ibl">169</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:ns9cj8rnVeAC" class="gsc_a_at">Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party</a><div class="gs_gray">JC Marsh, A Bacigalupo, H Schrezenmeier, A Tichelli, AM Risitano, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 119 (23), 5391-5396<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4262270287467458099" class="gsc_a_ac gs_ibl">168</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:YOwf2qJgpHMC" class="gsc_a_at">CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine</a><div class="gs_gray">K Raj, A John, A Ho, C Chronis, S Khan, J Samuel, S Pomplun, ...</div><div class="gs_gray">Leukemia 21 (9), 1937-1944<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9714694241554910882" class="gsc_a_ac gs_ibl">168</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:kNdYIx-mwKoC" class="gsc_a_at">A pilot study of antithymocyte globulin (ATG) in the treatment of patients with ‘low‐risk’myelodysplasia</a><div class="gs_gray">SB Killick, G Mufti, JD Cavenagh, A Mijovic, JL Peacock, ...</div><div class="gs_gray">British journal of haematology 120 (4), 679-684<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6546736723197140952" class="gsc_a_ac gs_ibl">168</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:TFP_iSt0sucC" class="gsc_a_at">Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia</a><div class="gs_gray">JC Marsh, V Gupta, ZY Lim, AY Ho, RM Ireland, J Hayden, V Potter, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (8), 2351-2357<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7233777959754632557" class="gsc_a_ac gs_ibl">167</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:4DMP91E08xMC" class="gsc_a_at">Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell&nbsp;…</a><div class="gs_gray">R Martino, R Parody, T Fukuda, J Maertens, K Theunissen, A Ho, GJ Mufti, ...</div><div class="gs_gray">Blood 108 (9), 2928-2936<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7328534696886152904" class="gsc_a_ac gs_ibl">165</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:3fE2CSJIrl8C" class="gsc_a_at">Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell–leukemia cell hybrids and other antigen-loading strategies for&nbsp;…</a><div class="gs_gray">J Galea-Lauri, D Darling, G Mufti, P Harrison, F Farzaneh</div><div class="gs_gray">Cancer Immunology, Immunotherapy 51 (6), 299-310<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4971733734672368721" class="gsc_a_ac gs_ibl">165</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:IWHjjKOFINEC" class="gsc_a_at">Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-κB, c-Myc, and pRb pathways</a><div class="gs_gray">AGS Buggins, D Milojkovic, MJ Arno, NC Lea, GJ Mufti, NSB Thomas, ...</div><div class="gs_gray">The Journal of Immunology 167 (10), 6021-6030<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9160686426511342822" class="gsc_a_ac gs_ibl">164</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:M05iB0D1s5AC" class="gsc_a_at">Functional characterization of CD4<sup>+</sup> T cells in aplastic anemia</a><div class="gs_gray">S Kordasti, J Marsh, S Al-Khan, J Jiang, A Smith, A Mohamedali, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 119 (9), 2033-2043<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2283964279620216723" class="gsc_a_ac gs_ibl">161</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:ULOm3_A8WrAC" class="gsc_a_at">Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromes</a><div class="gs_gray">J Lyons, JW Janssen, C Bartram, M Layton, GJ Mufti</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15525370536101489022" class="gsc_a_ac gs_ibl">161</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:7PzlFSSx8tAC" class="gsc_a_at">Myeloid leukemias have increased activity of the nonhomologous end-joining pathway and concomitant DNA misrepair that is dependent on the Ku70/86 heterodimer</a><div class="gs_gray">TJ Gaymes, GJ Mufti, FV Rassool</div><div class="gs_gray">Cancer research 62 (10), 2791-2797<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10809347754573782042" class="gsc_a_ac gs_ibl">158</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:aqlVkmm33-oC" class="gsc_a_at">'Low-risk'myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro-versus anti-apoptotic bcl-2-related proteins.</a><div class="gs_gray">JE Parker, KL Fishlock, A Mijovic, B Czepulkowski, A Pagliuca, GJ Mufti</div><div class="gs_gray">British journal of haematology 103 (4), 1075-1082<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18146763850885955990" class="gsc_a_ac gs_ibl">156</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:vV6vV6tmYwMC" class="gsc_a_at">B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease</a><div class="gs_gray">T Satoh, A Smith, A Sarde, H Lu, S Mian, C Trouillet, G Mufti, JF Emile, ...</div><div class="gs_gray">PloS one 7 (4), e33891<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18181591215263661367" class="gsc_a_ac gs_ibl">154</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:dhFuZR0502QC" class="gsc_a_at">Fludarabine, cytarabine, G‐CSF and idarubicin (FLAG‐IDA) for the treatment of poor‐risk myelodysplastic syndromes and acute myeloid leukaemia</a><div class="gs_gray">JE Parker, A Pagliuca, A Mijovic, JO Cullis, B Czepulkowski, ...</div><div class="gs_gray">British journal of haematology 99 (4), 939-944<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=803135778142644409" class="gsc_a_ac gs_ibl">153</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:_kc_bZDykSQC" class="gsc_a_at">Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes</a><div class="gs_gray">JE Parker, GJ Mufti</div><div class="gs_gray">British journal of haematology 101 (2), 220-230<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2155961965171563679" class="gsc_a_ac gs_ibl">151</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:mVmsd5A6BfQC" class="gsc_a_at">Whole genome scanning as a cytogenetic tool in hematologic malignancies</a><div class="gs_gray">JP Maciejewski, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (4), 965-974<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2131377760426616711" class="gsc_a_ac gs_ibl">150</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:ZeXyd9-uunAC" class="gsc_a_at">Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab</a><div class="gs_gray">AGS Buggins, GJ Mufti, J Salisbury, J Codd, N Westwood, M Arno, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 100 (5), 1715-1720<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4005707235138332275" class="gsc_a_ac gs_ibl">150</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:mB3voiENLucC" class="gsc_a_at">Role of 4-1BB: 4-1BB ligand in cancer immunotherapy</a><div class="gs_gray">ATC Cheuk, GJ Mufti, B Guinn</div><div class="gs_gray">Cancer gene therapy 11 (3), 215-226<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13437970479949367343" class="gsc_a_ac gs_ibl">148</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:SdhP9T11ey4C" class="gsc_a_at">p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del (5q)</a><div class="gs_gray">L Saft, M Karimi, M Ghaderi, A Matolcsy, GJ Mufti, A Kulasekararaj, ...</div><div class="gs_gray">haematologica 99 (6), 1041<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9101198046214338951" class="gsc_a_ac gs_ibl">141</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:uQdrZ3qaPmcC" class="gsc_a_at">Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells</a><div class="gs_gray">NR Mathew, F Baumgartner, L Braun, D O'Sullivan, S Thomas, ...</div><div class="gs_gray">Nature medicine 24 (3), 282-291<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1565074704917195683" class="gsc_a_ac gs_ibl">140</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:1qzjygNMrQYC" class="gsc_a_at">Results of a randomized, double‐blind study of romiplostim versus placebo in patients with low/intermediate‐1–risk myelodysplastic syndrome and thrombocytopenia</a><div class="gs_gray">A Giagounidis, GJ Mufti, P Fenaux, MA Sekeres, J Szer, U Platzbecker, ...</div><div class="gs_gray">Cancer 120 (12), 1838-1846<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12569922298960735569" class="gsc_a_ac gs_ibl">140</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:_Qo2XoVZTnwC" class="gsc_a_at">Pathobiology, classification, and diagnosis of myelodysplastic syndrome</a><div class="gs_gray">GJ Mufti</div><div class="gs_gray">Best Practice &amp; Research Clinical Haematology 17 (4), 543-557<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14830812799168717972" class="gsc_a_ac gs_ibl">137</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:HDshCWvjkbEC" class="gsc_a_at">Increased error-prone non homologous DNA end-joining–a proposed mechanism of chromosomal instability in Bloom's syndrome</a><div class="gs_gray">TJ Gaymes, PS North, N Brady, ID Hickson, GJ Mufti, FV Rassool</div><div class="gs_gray">Oncogene 21 (16), 2525-2533<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3805997366911063246" class="gsc_a_ac gs_ibl">135</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:R3hNpaxXUhUC" class="gsc_a_at">Immunological abnormalities in myelodysplastic syndromes II. Coexistent lymphoid or plasma cell neoplasms: a report of 20 cases unrelated to chemotherapy</a><div class="gs_gray">JA Copplestone, GJ Mufti, TJ Hamblin, DG Oscier</div><div class="gs_gray">British journal of haematology 63 (1), 149-159<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2735831674667134109" class="gsc_a_ac gs_ibl">133</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:pyW8ca7W8N0C" class="gsc_a_at">Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning</a><div class="gs_gray">K Raj, A Pagliuca, K Bradstock, V Noriega, V Potter, M Streetly, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 20 (6), 890-895<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11946404875754696621" class="gsc_a_ac gs_ibl">132</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:qUcmZB5y_30C" class="gsc_a_at">Clinical-cytogenetic correlations in myelodysplasia (preleukemia)</a><div class="gs_gray">RV Pierre, D Catovsky, GJ Mufti, GJ Swansbury, C Mecucci, GW Dewald, ...</div><div class="gs_gray">Cancer Genetics and Cytogenetics 40 (2), 149-161<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10916067475309241942" class="gsc_a_ac gs_ibl">130</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:plAW456RD7MC" class="gsc_a_at">Liver transplantation for Budd-Chiari syndrome</a><div class="gs_gray">P Srinivasan, M Rela, A Prachalias, P Muiesan, B Portmann, GJ Mufti, ...</div><div class="gs_gray">Transplantation 73 (6), 973-977<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12886085708451887514" class="gsc_a_ac gs_ibl">129</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:hC7cP41nSMkC" class="gsc_a_at">Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia</a><div class="gs_gray">JN Philpott-Howard, JJ Wade, GJ Mufti, KW Brammer, G Ehniniger, ...</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 31 (6), 973-984<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15652324038961282780" class="gsc_a_ac gs_ibl">129</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:e5wmG9Sq2KIC" class="gsc_a_at">A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate-to high-risk myelodysplastic syndrome</a><div class="gs_gray">P Fenaux, A Raza, GJ Mufti, C Aul, U Germing, H Kantarjian, L Cripe, ...</div><div class="gs_gray">Blood 109 (10), 4158-4163<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11659393462599767398" class="gsc_a_ac gs_ibl">128</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:owLR8QvbtFgC" class="gsc_a_at">Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes</a><div class="gs_gray">DA Sallman, R Komrokji, C Vaupel, T Cluzeau, SM Geyer, KL McGraw, ...</div><div class="gs_gray">Leukemia 30 (3), 666-673<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14672478637317094784" class="gsc_a_ac gs_ibl">126</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:CHSYGLWDkRkC" class="gsc_a_at">Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS</a><div class="gs_gray">P Valent, BJ Bain, JM Bennett, F Wimazal, WR Sperr, G Mufti, HP Horny</div><div class="gs_gray">Leukemia research 36 (1), 1-5<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15569688026234800453" class="gsc_a_ac gs_ibl">123</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:JV2RwH3_ST0C" class="gsc_a_at">Effects of azacitidine compared with conventional care regimens in elderly (≥ 75 years) patients with higher-risk myelodysplastic syndromes</a><div class="gs_gray">JF Seymour, P Fenaux, LR Silverman, GJ Mufti, E Hellström-Lindberg, ...</div><div class="gs_gray">Critical reviews in oncology/hematology 76 (3), 218-227<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12464901229824723780" class="gsc_a_ac gs_ibl">123</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:NMxIlDl6LWMC" class="gsc_a_at">Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine</a><div class="gs_gray">V Santini, P Fenaux, GJ Mufti, E Hellström‐Lindberg, LR Silverman, A List, ...</div><div class="gs_gray">European journal of haematology 85 (2), 130-138<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3803534430750706178" class="gsc_a_ac gs_ibl">123</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:bEWYMUwI8FkC" class="gsc_a_at">Commitment Point during G<sub>0</sub>→G<sub>1</sub> That Controls Entry into the Cell Cycle</a><div class="gs_gray">NC Lea, SJ Orr, K Stoeber, GH Williams, EWF Lam, MAA Ibrahim, GJ Mufti, ...</div><div class="gs_gray">Molecular and Cellular Biology 23 (7), 2351-2361<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1022190764616908573" class="gsc_a_ac gs_ibl">122</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:maZDTaKrznsC" class="gsc_a_at">The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow</a><div class="gs_gray">W Ingram, NC Lea, J Cervera, U Germing, P Fenaux, B Cassinat, ...</div><div class="gs_gray">Leukemia 20 (7), 1319-1321<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3582882561975964581" class="gsc_a_ac gs_ibl">119</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:4OULZ7Gr8RgC" class="gsc_a_at">Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis</a><div class="gs_gray">A Jerez, Y Sugimoto, H Makishima, A Verma, AM Jankowska, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 119 (25), 6109-6117<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13824798627966818171" class="gsc_a_ac gs_ibl">118</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:RHpTSmoSYBkC" class="gsc_a_at">Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies</a><div class="gs_gray">MH Mangi, GJ Mufti</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16737549306112555575" class="gsc_a_ac gs_ibl">117</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:LPZeul_q3PIC" class="gsc_a_at">STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients</a><div class="gs_gray">A Jerez, MJ Clemente, H Makishima, H Rajala, I Gómez-Seguí, T Olson, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (14), 2453-2459<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12244752158236464922" class="gsc_a_ac gs_ibl">116</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:NaGl4SEjCO4C" class="gsc_a_at">Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-κB activation and de novo gene transcription</a><div class="gs_gray">AGS Buggins, C Pepper, PEM Patten, S Hewamana, S Gohil, J Moorhead, ...</div><div class="gs_gray">Cancer research 70 (19), 7523-7533<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9468972020447972110" class="gsc_a_ac gs_ibl">113</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:JQOojiI6XY0C" class="gsc_a_at">Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia</a><div class="gs_gray">J Clay, AG Kulasekararaj, V Potter, F Grimaldi, D McLornan, K Raj, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 20 (11), 1711-1716<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9857396719966440283" class="gsc_a_ac gs_ibl">112</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:j3f4tGmQtD8C" class="gsc_a_at">Chromosomal deletions in the myelodysplastic syndrome</a><div class="gs_gray">GJ Mufti</div><div class="gs_gray">Leukemia research 16 (1), 35-41<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12621696979812481516" class="gsc_a_ac gs_ibl">112</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:a0OBvERweLwC" class="gsc_a_at">Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited</a><div class="gs_gray">A Jerez, LP Gondek, AM Jankowska, H Makishima, B Przychodzen, ...</div><div class="gs_gray">Journal of clinical oncology 30 (12), 1343<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=402301322420244827" class="gsc_a_ac gs_ibl">111</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:GnPB-g6toBAC" class="gsc_a_at">Increased error-prone NHEJ activity in myeloid leukemias is associated with DNA damage at sites that recruit key nonhomologous end-joining proteins</a><div class="gs_gray">N Brady, TJ Gaymes, M Cheung, GJ Mufti, FV Rassool</div><div class="gs_gray">Cancer research 63 (8), 1798-1805<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6030432850641353829" class="gsc_a_ac gs_ibl">111</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:isC4tDSrTZIC" class="gsc_a_at">Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia.</a><div class="gs_gray">K Tobal, A Pagliuca, B Bhatt, N Bailey, DM Layton, GJ Mufti</div><div class="gs_gray">Leukemia 4 (7), 486-489<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12513900932607592381" class="gsc_a_ac gs_ibl">110</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:AXPGKjj_ei8C" class="gsc_a_at">Morphological evaluation of monocytes and their precursors</a><div class="gs_gray">JE Goasguen, JM Bennett, BJ Bain, T Vallespi, R Brunning, GJ Mufti</div><div class="gs_gray">haematologica 94 (7), 994<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5577664200696898338" class="gsc_a_ac gs_ibl">109</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:yD5IFk8b50cC" class="gsc_a_at">Internation-al Vidaza High-Risk MDS Survival Study Group. Efficacy ofzacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic&nbsp;…</a><div class="gs_gray">P Fenaux</div><div class="gs_gray">Lancet Oncol. 10, 223-232<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16972502290683043295" class="gsc_a_ac gs_ibl">109</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:iH-uZ7U-co4C" class="gsc_a_at">Myelodysplastic syndrome</a><div class="gs_gray">G Mufti, AF List, SD Gore, AYL Ho</div><div class="gs_gray">ASH Education Program Book 2003 (1), 176-199<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10635880880654311974" class="gsc_a_ac gs_ibl">108</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:M3NEmzRMIkIC" class="gsc_a_at">Correction of the hyper-IgM syndrome after liver and bone marrow transplantation</a><div class="gs_gray">N Hadžić, A Pagliuca, M Rela, B Portmann, A Jones, P Veys, ND Heaton, ...</div><div class="gs_gray">New England Journal of Medicine 342 (5), 320-324<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1482498526306622098" class="gsc_a_ac gs_ibl">107</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:X1xEhyGaivYC" class="gsc_a_at">Clinical utilization of chimeric antigen receptor T cells in B cell acute lymphoblastic leukemia: an expert opinion from the european society for blood and marrow&nbsp;…</a><div class="gs_gray">AJ Kansagra, NV Frey, M Bar, TW Laetsch, PA Carpenter, BN Savani, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 25 (3), e76-e85<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15079936038593919732,4978912465247931518" class="gsc_a_ac gs_ibl">106</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="gZU2Ie8AAAAJ:X1xEhyGaivYC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:XvxMoLDsR5gC" class="gsc_a_at">An International MDS/MPN Working Group’s perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic&nbsp;…</a><div class="gs_gray">TI Mughal, NCP Cross, E Padron, RV Tiu, M Savona, L Malcovati, R Tibes, ...</div><div class="gs_gray">haematologica 100 (9), 1117<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9829604340089756976" class="gsc_a_ac gs_ibl">106</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:SeFeTyx0c_EC" class="gsc_a_at">Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant</a><div class="gs_gray">BE Shaw, GJ Mufti, S Mackinnon, JD Cavenagh, RM Pearce, KE Towlson, ...</div><div class="gs_gray">Bone marrow transplantation 42 (12), 783-789<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14786900869642404912" class="gsc_a_ac gs_ibl">106</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:O3NaXMp0MMsC" class="gsc_a_at">Myelofibrosis in primary myelodysplastic syndromes: a clinico‐morphological study of 10 cases</a><div class="gs_gray">A Pagliuca, DM Layton, A Manoharan, S Gordon, PJ Green, GJ Mufti</div><div class="gs_gray">British Journal of Haematology 71 (4), 499-504<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16932575369762421915" class="gsc_a_ac gs_ibl">106</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:RGFaLdJalmkC" class="gsc_a_at">Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis?</a><div class="gs_gray">TJ Gaymes, RA Padua, M Pla, S Orr, N Omidvar, C Chomienne, GJ Mufti, ...</div><div class="gs_gray">Molecular cancer research 4 (8), 563-573<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8925260612852510759" class="gsc_a_ac gs_ibl">105</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:BqipwSGYUEgC" class="gsc_a_at">Changes in antigen expression on differentiating HL60 cells treated with dimethylsulphoxide, all-trans retinoic acid, α1, 25-dihydroxyvitamin D3 or 12-O-tetradecanoyl phorbol&nbsp;…</a><div class="gs_gray">ID Trayner, T Bustorff, AE Etches, GJ Mufti, Y Foss, F Farzaneh</div><div class="gs_gray">Leukemia research 22 (6), 537-547<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4615784156747644714" class="gsc_a_ac gs_ibl">105</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:k_IJM867U9cC" class="gsc_a_at">Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced‐intensity conditioning compared with standard preparative&nbsp;…</a><div class="gs_gray">JE Parker, T Shafi, A Pagliuca, A Mijovic, S Devereux, M Potter, ...</div><div class="gs_gray">British journal of haematology 119 (1), 144-154<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16750576901029621779" class="gsc_a_ac gs_ibl">104</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=gZU2Ie8AAAAJ:epqYDVWIO7EC" class="gsc_a_at">Guidelines for the diagnosis and management of adult myelodysplastic syndromes</a><div class="gs_gray">SB Killick, C Carter, D Culligan, C Dalley, E Das‐Gupta, M Drummond, ...</div><div class="gs_gray">British journal of haematology 164 (4), 503-525<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16535886189603507573" class="gsc_a_ac gs_ibl">102</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:lSLTfruPkqcC" class="gsc_a_at">Prolonged survival with improved tolerability in higher‐risk myelodysplastic syndromes: azacitidine compared with low dose ara‐C</a><div class="gs_gray">P Fenaux, N Gattermann, JF Seymour, E Hellström‐Lindberg, GJ Mufti, ...</div><div class="gs_gray">British journal of haematology 149 (2), 244-249<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7301960461821621039" class="gsc_a_ac gs_ibl">101</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QIV2ME_5wuYC" class="gsc_a_at">Azacitidine (AZA) treatment prolongs overall survival (OS) in higher-risk MDS patients compared with conventional care regimens (CCR): results of the AZA-001 phase III study.</a><div class="gs_gray">P Fenaux, GJ Mufti, V Santini, C Finelli, A Giagounidis, R Schoch, AF List, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 817-817<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14763952736477507579" class="gsc_a_ac gs_ibl">101</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:RYcK_YlVTxYC" class="gsc_a_at">Frequent expression of HAGE in presentation chronic myeloid leukaemias</a><div class="gs_gray">SP Adams, SS Sahota, A Mijovic, B Czepulkowski, RA Padua, GJ Mufti, ...</div><div class="gs_gray">Leukemia 16 (11), 2238-2242<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5831911559030810921" class="gsc_a_ac gs_ibl">99</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:_xSYboBqXhAC" class="gsc_a_at">Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes</a><div class="gs_gray">TJ Gaymes, S Shall, LJ MacPherson, NA Twine, NC Lea, F Farzaneh, ...</div><div class="gs_gray">haematologica 94 (5), 638<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13469284959603615202" class="gsc_a_ac gs_ibl">95</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:u_35RYKgDlwC" class="gsc_a_at">Spectrum of clinical presentation, treatment and prognosis in a series of eight patients with leukaemia cutis</a><div class="gs_gray">KMT Watson, G Mufti, JR Salisbury, AWP Du Vivier, D Creamer</div><div class="gs_gray">Clinical and Experimental Dermatology: Clinical Dermatology 31 (2), 218-221<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9512077946367359968" class="gsc_a_ac gs_ibl">95</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:r0BpntZqJG4C" class="gsc_a_at">Bleomycin‐detectable iron in serum from leukaemic patients before and after chemotherapy Therapeutic implications for treatment with oxidant‐generating drugs</a><div class="gs_gray">B Halliwell, OI Aruoma, G Mufti, A Bomford</div><div class="gs_gray">FEBS letters 241 (1-2), 202-204<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16672309268695484849" class="gsc_a_ac gs_ibl">95</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:YFjsv_pBGBYC" class="gsc_a_at">Common ALL with pre-B-cell features showing (8; 14) and (14; 18) chromosome translocations</a><div class="gs_gray">GJ Mufti, TJ Hamblin, DG Oscier, S Johnson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12086344544858596728" class="gsc_a_ac gs_ibl">95</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:hMod-77fHWUC" class="gsc_a_at">Novel <i>TET2</i> Mutations Associated With UPD4q24 in Myelodysplastic Syndrome</a><div class="gs_gray">AM Mohamedali, AE Smith, J Gaken, NC Lea, SA Mian, NB Westwood, ...</div><div class="gs_gray">Journal of clinical oncology 27 (24), 4002-4006<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16163441003309541480" class="gsc_a_ac gs_ibl">93</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ybfzIt2tCtgC" class="gsc_a_at">Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment</a><div class="gs_gray">S Kordasti, B Costantini, T Seidl, P Perez Abellan, M Martinez Llordella, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 128 (9), 1193-1205<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9935128087695494726" class="gsc_a_ac gs_ibl">91</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:5awf1xo2G04C" class="gsc_a_at">Aetiology and management of extrahepatic portal vein obstruction in children: King's College Hospital experience</a><div class="gs_gray">N Abd El-hamid, RM Taylor, D Marinello, GJ Mufti, R Patel, ...</div><div class="gs_gray">Journal of pediatric gastroenterology and nutrition 47 (5), 630-634<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14862008309855091472" class="gsc_a_ac gs_ibl">91</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:70eg2SAEIzsC" class="gsc_a_at">The JAK2 V617F mutation is rare in RARS but common in RARS-T</a><div class="gs_gray">MM Ceesay, NC Lea, W Ingram, NB Westwood, J Gäken, A Mohamedali, ...</div><div class="gs_gray">Leukemia 20 (11), 2060-2061<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16067553337147405104" class="gsc_a_ac gs_ibl">91</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:blknAaTinKkC" class="gsc_a_at">Cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients age 60 years or older with previously untreated acute myeloid leukemia</a><div class="gs_gray">F Giles, D Rizzieri, J Karp, N Vey, F Ravandi, S Faderl, KD Khan, ...</div><div class="gs_gray">Journal of clinical oncology 25 (1), 25-31<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3137575472220366157" class="gsc_a_ac gs_ibl">88</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:D_sINldO8mEC" class="gsc_a_at">Complement abnormalities in acquired lipodystrophy revisited</a><div class="gs_gray">DB Savage, RK Semple, MR Clatworthy, PA Lyons, BP Morgan, ...</div><div class="gs_gray">The Journal of Clinical Endocrinology &amp; Metabolism 94 (1), 10-16<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4764492860640172564" class="gsc_a_ac gs_ibl">87</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:35N4QoGY0k4C" class="gsc_a_at">Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia</a><div class="gs_gray">B Guinn, EA Bland, U Lodi, AP Liggins, K Tobal, S Petters, JW Wells, ...</div><div class="gs_gray">Biochemical and biophysical research communications 335 (4), 1293-1304<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7131657382558691201" class="gsc_a_ac gs_ibl">87</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:J_g5lzvAfSwC" class="gsc_a_at">Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study Group</a><div class="gs_gray">P Greenberg, J Anderson, T De Witte, E Estey, P Fenaux, P Gupta, ...</div><div class="gs_gray">Journal of clinical oncology: official journal of the American Society of&nbsp;…<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7649912447708689540" class="gsc_a_ac gs_ibl">87</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:pqnbT2bcN3wC" class="gsc_a_at">Lead poisoning: clinical, biochemical, and haematological aspects of a recent outbreak.</a><div class="gs_gray">A Pagliuca, GJ Mufti, D Baldwin, AN Lestas, RM Wallis, AJ Bellingham</div><div class="gs_gray">Journal of clinical pathology 43 (4), 277-281<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13355722909404230026" class="gsc_a_ac gs_ibl">87</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:dfsIfKJdRG4C" class="gsc_a_at">Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be?</a><div class="gs_gray">S Querol, GJ Mufti, SGE Marsh, A Pagliuca, AM Little, BE Shaw, R Jeffery, ...</div><div class="gs_gray">haematologica 94 (4), 536<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15106173907100402491" class="gsc_a_ac gs_ibl">86</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:XiVPGOgt02cC" class="gsc_a_at">Azacytidine (Vidaza®) in the treatment of myelodysplastic syndromes</a><div class="gs_gray">K Raj, GJ Mufti</div><div class="gs_gray">Therapeutics and clinical risk management 2 (4), 377<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14092679617547712047" class="gsc_a_ac gs_ibl">86</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ZuybSZzF8UAC" class="gsc_a_at">SnapShot: acute myeloid leukemia</a><div class="gs_gray">BB Zeisig, AG Kulasekararaj, GJ Mufti, CWE So</div><div class="gs_gray">Cancer cell 22 (5), 698-698. e1<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17379638369454442935" class="gsc_a_ac gs_ibl">85</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:g5m5HwL7SMYC" class="gsc_a_at">Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes</a><div class="gs_gray">A Giagounidis, P Fenaux, GJ Mufti, P Muus, U Platzbecker, G Sanz, ...</div><div class="gs_gray">Annals of hematology 87 (5), 345-352<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13507033006618063716" class="gsc_a_ac gs_ibl">85</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:NhqRSupF_l8C" class="gsc_a_at">Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning&nbsp;…</a><div class="gs_gray">ZY Lim, V Fiaccadori, S Gandhi, J Hayden, M Kenyon, R Ireland, J Marsh, ...</div><div class="gs_gray">Leukemia research 34 (6), 723-727<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13451925016267501346" class="gsc_a_ac gs_ibl">84</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:2P1L_qKh6hAC" class="gsc_a_at">Effect of costimulation and the microenvironment on antigen presentation by leukemic cells</a><div class="gs_gray">AGS Buggins, N Lea, J Gäken, D Darling, F Farzaneh, GJ Mufti, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 94 (10), 3479-3490<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17118703332961721180" class="gsc_a_ac gs_ibl">84</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wKETBy42zhYC" class="gsc_a_at">Autoimmune diseases and myelodysplastic syndromes</a><div class="gs_gray">RS Komrokji, A Kulasekararaj, NH Al Ali, S Kordasti, E Bart‐Smith, ...</div><div class="gs_gray">American journal of hematology 91 (5), E280-E283<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12536679938963485998" class="gsc_a_ac gs_ibl">83</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ldfaerwXgEUC" class="gsc_a_at">Primary myelodysplastic syndrome in children: the clinical experience in 33 cases</a><div class="gs_gray">MA Tuncer, A Pagliuca, G Hicsonmez, S Yetgin, S Ozsoylu, GJ Mufti</div><div class="gs_gray">British journal of haematology 82 (2), 347-353<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6192709558572009668" class="gsc_a_ac gs_ibl">83</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:mvPsJ3kp5DgC" class="gsc_a_at">Spliceosome mutations exhibit specific associations with epigenetic modifiers and proto-oncogenes mutated in myelodysplastic syndrome</a><div class="gs_gray">SA Mian, AE Smith, AG Kulasekararaj, A Kizilors, AM Mohamedali, ...</div><div class="gs_gray">haematologica 98 (7), 1058<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3021128140099389831" class="gsc_a_ac gs_ibl">82</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:5nxA0vEk-isC" class="gsc_a_at">Methylation inhibitor therapy in the treatment of myelodysplastic syndrome</a><div class="gs_gray">LR Silverman, GJ Mufti</div><div class="gs_gray">Nature Clinical Practice Oncology 2 (1), S12-S23<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14048185842841672383" class="gsc_a_ac gs_ibl">82</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Z5m8FVwuT1cC" class="gsc_a_at">The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome</a><div class="gs_gray">B Costantini, SY Kordasti, AG Kulasekararaj, J Jiang, T Seidl, PP Abellan, ...</div><div class="gs_gray">Haematologica 98 (8), 1196<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5209173573490317927" class="gsc_a_ac gs_ibl">81</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:f13iAvnbnnYC" class="gsc_a_at">Integrative genomics identifies the molecular basis of resistance to azacitidine therapy in myelodysplastic syndromes</a><div class="gs_gray">A Unnikrishnan, E Papaemmanuil, D Beck, NP Deshpande, A Verma, ...</div><div class="gs_gray">Cell reports 20 (3), 572-585<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11567842292219034799" class="gsc_a_ac gs_ibl">74</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:8xutWZnSdmoC" class="gsc_a_at">Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the&nbsp;…</a><div class="gs_gray">A Symeonidis, A Van Biezen, L de Wreede, A Piciocchi, J Finke, D Beelen, ...</div><div class="gs_gray">British journal of haematology 171 (2), 239-246<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13445835751933596168" class="gsc_a_ac gs_ibl">73</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:D03iK_w7-QYC" class="gsc_a_at">BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia</a><div class="gs_gray">N Omidvar, S Kogan, S Beurlet, C le Pogam, A Janin, R West, ...</div><div class="gs_gray">Cancer research 67 (24), 11657-11667<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8122589723340528433" class="gsc_a_ac gs_ibl">73</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4MWp96NkSFoC" class="gsc_a_at">Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study&nbsp;…</a><div class="gs_gray">JC Marsh, RM Pearce, MBC Koh, Z Lim, A Pagliuca, GJ Mufti, J Perry, ...</div><div class="gs_gray">Bone marrow transplantation 49 (1), 42-48<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10724695112631765047" class="gsc_a_ac gs_ibl">72</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:W5xh706n7nkC" class="gsc_a_at">Outcome of donor lymphocyte infusion after T cell–depleted allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromes</a><div class="gs_gray">P Krishnamurthy, VT Potter, LD Barber, AG Kulasekararaj, ZY Lim, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 19 (4), 562-568<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5458275841040457921" class="gsc_a_ac gs_ibl">72</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:EUQCXRtRnyEC" class="gsc_a_at">Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors: delay of the transplant is associated with inferior survival</a><div class="gs_gray">T De Witte, R Brand, A Van Biezen, G Mufti, T Ruutu, J Finke, ...</div><div class="gs_gray">British journal of haematology 146 (6), 627-636<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13553225326847314199" class="gsc_a_ac gs_ibl">72</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:w5CyTnyFq80C" class="gsc_a_at">A novel erythroid anion exchange variant (Gly796Arg) of hereditary stomatocytosis associated with dyserythropoiesis</a><div class="gs_gray">A Iolascon, L De Falco, F Borgese, MR Esposito, RA Avvisati, P Izzo, ...</div><div class="gs_gray">haematologica 94 (8), 1049<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14158459747897288516" class="gsc_a_ac gs_ibl">71</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ZHo1McVdvXMC" class="gsc_a_at"><i>In Vitro</i> Colony Culture and Chromosomal Studies in Hepatic and Portal Vein Thrombosis—Possible Evidence of an Occult Myeloproliferative State</a><div class="gs_gray">A Pagliuca, GJ Mufti, M Janossa-Tahernia, S Eridani, NB Westwood, ...</div><div class="gs_gray">QJM: An International Journal of Medicine 76 (3), 981-989<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4132145351123940838" class="gsc_a_ac gs_ibl">71</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PELIpwtuRlgC" class="gsc_a_at">Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromes</a><div class="gs_gray">AG Kulasekararaj, AM Mohamedali, GJ Mufti</div><div class="gs_gray">British journal of haematology 162 (5), 587-605<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1119489730568230405" class="gsc_a_ac gs_ibl">70</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:sSrBHYA8nusC" class="gsc_a_at">Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet&nbsp;…</a><div class="gs_gray">AA Van De Loosdrecht, R Ireland, W Kern, MG Della Porta, C Alhan, ...</div><div class="gs_gray">Leukemia &amp; lymphoma 54 (3), 472-475<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7692043867211413217" class="gsc_a_ac gs_ibl">70</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:3s1wT3WcHBgC" class="gsc_a_at">Variable expression of CD3-zeta and associated protein tyrosine kinases in lymphocytes from patients with myeloid malignancies</a><div class="gs_gray">AGS Buggins, WJR Hirst, A Pagliuca, GJ Mufti</div><div class="gs_gray">British journal of haematology 100 (4), 784-792<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16891512756815714732" class="gsc_a_ac gs_ibl">69</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:t6usbXjVLHcC" class="gsc_a_at">Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD</a><div class="gs_gray">FL Dignan, D Greenblatt, M Cox, J Cavenagh, H Oakervee, JF Apperley, ...</div><div class="gs_gray">Bone marrow transplantation 47 (6), 824-830<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4068919386362977430" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:B3FOqHPlNUQC" class="gsc_a_at">Cutaneous manifestations of granulocyte colony‐stimulating factor</a><div class="gs_gray">JML White, GJ Mufti, JR Salisbury, AWP Du Vivier</div><div class="gs_gray">Clinical and Experimental Dermatology: Clinical dermatology 31 (2), 206-207<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=476380258119918694" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:HoB7MX3m0LUC" class="gsc_a_at">Targeted therapies in myeloid leukemia</a><div class="gs_gray">AM John, NSB Thomas, GJ Mufti, RA Padua</div><div class="gs_gray">Seminars in cancer biology 14 (1), 41-62<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=399345080516731391" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:bnK-pcrLprsC" class="gsc_a_at">Emberger syndrome—Primary lymphedema with myelodysplasia: Report of seven new cases</a><div class="gs_gray">S Mansour, F Connell, C Steward, P Ostergaard, G Brice, S Smithson, ...</div><div class="gs_gray">American Journal of Medical Genetics Part A 152 (9), 2287-2296<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2930564034151148011" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:NJ774b8OgUMC" class="gsc_a_at">Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies</a><div class="gs_gray">TJ Gaymes, AM Mohamedali, M Patterson, N Matto, A Smith, ...</div><div class="gs_gray">Haematologica 98 (9), 1397<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2379915599743812059" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:K3LRdlH-MEoC" class="gsc_a_at">Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen–UV-A therapy</a><div class="gs_gray">D Creamer, CL Martyn-Simmons, G Osborne, M Kenyon, JR Salisbury, ...</div><div class="gs_gray">Archives of dermatology 143 (9), 1157-1162<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16751806824225002404" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:rO6llkc54NcC" class="gsc_a_at">Enhanced immune costimulatory activity of primary acute myeloid leukaemia blasts after retrovirus-mediated gene transfer of B7. 1</a><div class="gs_gray">WJR Hirst, A Buggins, D Darling, J Gäken, F Farzaneh, GJ Mufti</div><div class="gs_gray">Gene therapy 4 (7), 691-699<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7136375077822803051" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:v6i8RKmR8ToC" class="gsc_a_at">Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome</a><div class="gs_gray">AO Kittang, S Kordasti, KE Sand, B Costantini, AM Kramer, ...</div><div class="gs_gray">Oncoimmunology 5 (2), e1062208<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7360279768828465694" class="gsc_a_ac gs_ibl">65</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:f2IySw72cVMC" class="gsc_a_at">The myelodysplastic syndromes: a matter of life or death</a><div class="gs_gray">JE Parker, GJ Mufti</div><div class="gs_gray">Acta haematologica 111 (1-2), 78-99<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=115239866107843610" class="gsc_a_ac gs_ibl">65</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:djcsc3XHdKAC" class="gsc_a_at">The Medalist trial: results of a phase 3, randomized, double-blind, placebo-controlled study of luspatercept to treat anemia in patients with very low-, low-, or intermediate&nbsp;…</a><div class="gs_gray">P Fenaux, U Platzbecker, GJ Mufti, G Garcia-Manero, R Buckstein, ...</div><div class="gs_gray">Blood 132, 1<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4182254340157220750" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:b0M2c_1WBrUC" class="gsc_a_at">Outcome of BEAM‐autologous and BEAM‐alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma</a><div class="gs_gray">W Ingram, S Devereux, EP Das‐Gupta, NH Russell, AP Haynes, JL Byrne, ...</div><div class="gs_gray">British journal of haematology 141 (2), 235-243<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16581683866111832752" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:a3BOlSfXSfwC" class="gsc_a_at">JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells</a><div class="gs_gray">C Keohane, S Kordasti, T Seidl, P Perez Abellan, NSB Thomas, ...</div><div class="gs_gray">British journal of haematology 171 (1), 60-73<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5734886279704868396" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:zA6iFVUQeVQC" class="gsc_a_at">Myelodysplastic syndromes: from morphology to molecular biology. Part I. Classification, natural history and cell biology of myelodysplasia.</a><div class="gs_gray">Y Yoshida, J Stephenson, GJ Mufti</div><div class="gs_gray">International journal of hematology 57 (2), 87-97<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1726217874030337132" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:fPk4N6BV_jEC" class="gsc_a_at">Low doses of cytarabine in the treatment of myelodysplastic syndrome and acute myeloid leukemia.</a><div class="gs_gray">GJ Mufti, DG Oscier, TJ Hamblin, AJ Bell</div><div class="gs_gray">The New England journal of medicine 309 (26), 1653-1654<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13279143348808805230" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:cFHS6HbyZ2cC" class="gsc_a_at">The role of apoptosis in the pathogenesis of the myelodysplastic syndromes</a><div class="gs_gray">JE Parker, GJ Mufti</div><div class="gs_gray">International journal of hematology 73 (4), 416-428<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4448107820217710766" class="gsc_a_ac gs_ibl">62</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:bFI3QPDXJZMC" class="gsc_a_at">Deletion of the acetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML)</a><div class="gs_gray">J Stephenson, B Czepulkowski, W Hirst, GJ Mufti</div><div class="gs_gray">Leukemia research 20 (3), 235-241<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8351176194831258109" class="gsc_a_ac gs_ibl">61</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:zGWyAL6qfKUC" class="gsc_a_at">Versatile humanized niche model enables study of normal and malignant human hematopoiesis</a><div class="gs_gray">A Abarrategi, K Foster, A Hamilton, SA Mian, D Passaro, J Gribben, ...</div><div class="gs_gray">The Journal of clinical investigation 127 (2), 543-548<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16914660009948366769" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:1DsIQWDZLl8C" class="gsc_a_at">SF3B1 mutant MDS-initiating cells may arise from the haematopoietic stem cell compartment</a><div class="gs_gray">SA Mian, K Rouault-Pierre, AE Smith, T Seidl, I Pizzitola, A Kizilors, ...</div><div class="gs_gray">Nature communications 6 (1), 1-14<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4052037466302833756" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:_FM0Bhl9EiAC" class="gsc_a_at">Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at King's College Hospital</a><div class="gs_gray">M Wang, W Wang, A Abeywardane, M Adikarama, D McLornan, K Raj, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 21 (1), 60-66<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7074453647806359270" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:xtRiw3GOFMkC" class="gsc_a_at">Apoptosis and its significance in MDS: controversies revisited</a><div class="gs_gray">Y Yoshida, GJ Mufti</div><div class="gs_gray">Leukemia research 23 (9), 777-785<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14365089039458905971" class="gsc_a_ac gs_ibl">59</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:P5F9QuxV20EC" class="gsc_a_at">A guide to risk assessment in the primary myelodysplastic syndrome</a><div class="gs_gray">GJ Mufti</div><div class="gs_gray">Hematology/oncology clinics of North America 6 (3), 587-606<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=642835370699090081" class="gsc_a_ac gs_ibl">59</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:uWQEDVKXjbEC" class="gsc_a_at">The cytokine receptor superfamily</a><div class="gs_gray">RS Kaczmarski, GJ Mufti</div><div class="gs_gray">Blood reviews 5 (3), 193-203<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8242304167422273245" class="gsc_a_ac gs_ibl">59</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:1yQoGdGgb4wC" class="gsc_a_at">Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience</a><div class="gs_gray">P Krishnamurthy, ZY Lim, W Nagi, M Kenyon, A Mijovic, R Ireland, ...</div><div class="gs_gray">Bone marrow transplantation 45 (10), 1502-1507<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14968320017915093373" class="gsc_a_ac gs_ibl">57</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:AubyX3KqGToC" class="gsc_a_at">Heterogeneous breakpoints in patients with acute lymphoblastic leukemia and the dic (9; 20)(p11~ 13; q11) show recurrent involvement of genes at 20q11. 21</a><div class="gs_gray">Q An, SL Wright, AV Moorman, H Parker, M Griffiths, FM Ross, T Davies, ...</div><div class="gs_gray">Haematologica 94 (8), 1164<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8499998061193099840" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:dshw04ExmUIC" class="gsc_a_at">Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation</a><div class="gs_gray">K Raj, S Narayanan, B Augustson, A Ho, P Mehta, N Duncan, S Tauro, ...</div><div class="gs_gray">Bone marrow transplantation 35 (3), 299-301<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5660456930814586526" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:d6JCS5z0ckYC" class="gsc_a_at">July 2017 ENCALS statement on edaravone</a><div class="gs_gray">A Al-Chalabi, PM Andersen, S Chandran, A Chio, P Corcia, P Couratier, ...</div><div class="gs_gray">Amyotrophic lateral sclerosis and frontotemporal degeneration 18 (7-8), 471-474<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8078595188265051294,4963515684906519430" class="gsc_a_ac gs_ibl">55</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="gZU2Ie8AAAAJ:d6JCS5z0ckYC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:eMMeJKvmdy0C" class="gsc_a_at">Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in&nbsp;…</a><div class="gs_gray">A Nagler, M Labopin, A Shimoni, D Niederwieser, GJ Mufti, AR Zander, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 18 (9), 1422-1429<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11299573944008450861" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:OU6Ihb5iCvQC" class="gsc_a_at">IL-2/B7. 1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines&nbsp;…</a><div class="gs_gray">L Chan, N Hardwick, D Darling, J Galea-Lauri, J Gäken, S Devereux, ...</div><div class="gs_gray">Molecular Therapy 11 (1), 120-131<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10536455463412215433" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:1sJd4Hv_s6UC" class="gsc_a_at">Excessive apoptosis in low risk myelodysplastic syndromes (MDS)</a><div class="gs_gray">JE Parker, GJ Mufti</div><div class="gs_gray">Leukemia &amp; lymphoma 40 (1-2), 1-24<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1873391360536007039" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:738O_yMBCRsC" class="gsc_a_at">Lamivudine prophylaxis and treatment of hepatitis B Virus‐exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab</a><div class="gs_gray">SE Moses, ZY Lim, M Sudhanva, S Devereux, AYL Ho, A Pagliuca, ...</div><div class="gs_gray">Journal of medical virology 78 (12), 1560-1563<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15327086648497130870" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4X0JR2_MtJMC" class="gsc_a_at">A multicentre UK study of GVHD following DLI: rates of GVHD are high but mortality from GVHD is infrequent</a><div class="gs_gray">JJ Scarisbrick, FL Dignan, S Tulpule, ED Gupta, S Kolade, B Shaw, ...</div><div class="gs_gray">Bone marrow transplantation 50 (1), 62-67<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11325210524069732959" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:BrmTIyaxlBUC" class="gsc_a_at">Sclerodermatous graft‐versus‐host disease: clinical spectrum and therapeutic challenges</a><div class="gs_gray">JML White, D Creamer, AWP Du Vivier, A Pagliuca, AY Ho, S Devereux, ...</div><div class="gs_gray">British Journal of Dermatology 156 (5), 1032-1038<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16618232942394156462" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:SP6oXDckpogC" class="gsc_a_at">Outcomes of alemtuzumab‐based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes</a><div class="gs_gray">ZY Lim, AYL Ho, W Ingram, M Kenyon, L Pearce, B Czepulkowski, ...</div><div class="gs_gray">British journal of haematology 135 (2), 201-209<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13220997647288620598" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:08ZZubdj9fEC" class="gsc_a_at">Detection of HIV in haemopoietic progenitors</a><div class="gs_gray">RS Kaczmarski, F Davison, E Blair, S Sutherland, J Moxham, T McManus, ...</div><div class="gs_gray">British journal of haematology 82 (4), 764-769<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5152748388375119010" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:eflP2zaiRacC" class="gsc_a_at">Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow&nbsp;…</a><div class="gs_gray">I Avivi, S Montoto, C Canals, J Maertens, H Al‐Ali, GJ Mufti, J Finke, ...</div><div class="gs_gray">British journal of haematology 147 (5), 719-728<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8159941447458131414" class="gsc_a_ac gs_ibl">51</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:l7t_Zn2s7bgC" class="gsc_a_at">Phenotypic and functional characteristics of monocyte‐derived dendritic cells from patients with myelodysplastic syndromes</a><div class="gs_gray">G Matteo Rigolin, J Howard, A Buggins, C Sneddon, G Castoldi, ...</div><div class="gs_gray">British journal of haematology 107 (4), 844-850<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1927698021336288080" class="gsc_a_ac gs_ibl">51</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:p2g8aNsByqUC" class="gsc_a_at">Irradiated NC adenocarcinoma cells transduced with both B7. 1 and interleukin-2 induce CD4+-mediated rejection of established tumors</a><div class="gs_gray">JA Gäken, SJ Hollingsworth, WJR Hirst, AGS Buggins, J Galea-Lauri, ...</div><div class="gs_gray">Human gene therapy 8 (4), 477-488<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14130217225109820403" class="gsc_a_ac gs_ibl">51</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:eJjLl3UG7CkC" class="gsc_a_at">Rituximab therapy for the type B syndrome of severe insulin resistance</a><div class="gs_gray">AP Coll, S Thomas, GJ Mufti</div><div class="gs_gray">New England Journal of Medicine 350 (3), 310-311<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3013360184046741677" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:uWiczbcajpAC" class="gsc_a_at">John Hughes Bennett, Rudolph Virchow... and Alfred Donné: the first description of leukemia.</a><div class="gs_gray">L Degos</div><div class="gs_gray">The Hematology Journal: the Official Journal of the European Haematology&nbsp;…<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3465067722319148096,12749057234206871632" class="gsc_a_ac gs_ibl">50</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="gZU2Ie8AAAAJ:uWiczbcajpAC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:6MVT8mER-OMC" class="gsc_a_at">Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King’s College Hospital experience</a><div class="gs_gray">V Shah, T Ko Ko, M Zuckerman, J Vidler, S Sharif, V Mehra, S Gandhi, ...</div><div class="gs_gray">Br J Haematol 190 (5), e279-e282<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16596985191203584929" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:olpn-zPbct0C" class="gsc_a_at">Successful pregnancies involving men with chronic myeloid leukaemia on imatinib therapy</a><div class="gs_gray">K Ramasamy, J Hayden, ZY Lim, GJ Mufti, AYL Ho</div><div class="gs_gray">British journal of haematology 137 (4), 374-375<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17607486398353831494" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:eJXPG6dFmWUC" class="gsc_a_at">Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cells</a><div class="gs_gray">L Chan, D Nesbeth, T MacKey, J Galea-Lauri, J Gäken, F Martin, ...</div><div class="gs_gray">Journal of virology 79 (20), 13190-13194<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1593277798814311291" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:F9fV5C73w3QC" class="gsc_a_at">A comprehensive diagnostic approach using galactomannan, targeted β‐<span class="gs_fscp">d</span>‐glucan, baseline computerized tomography and biopsy yields a significant burden of&nbsp;…</a><div class="gs_gray">MM Ceesay, SR Desai, L Berry, J Cleverley, CC Kibbler, S Pomplun, ...</div><div class="gs_gray">British journal of haematology 168 (2), 219-229<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6103263213014548815" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:kRWSkSYxWN8C" class="gsc_a_at">Granulocyte colony-stimulating factor improves function of neutrophils from patients with acute liver failure.</a><div class="gs_gray">N Rolando, M Clapperton, J Wade, G Panetsos, G Mufti, R Williams</div><div class="gs_gray">European journal of gastroenterology &amp; hepatology 12 (10), 1135-1140<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8796743757581693526" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:abG-DnoFyZgC" class="gsc_a_at">Effect of azacitidine (AZA) on overall survival in higher-risk myelodysplastic syndromes (MDS) without complete remission</a><div class="gs_gray">AF List, P Fenaux, GJ Mufti, E Hellstrom-Lindberg, S Gore, JM Bennett, ...</div><div class="gs_gray">Journal of Clinical Oncology 26 (15_suppl), 7006-7006<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12156630198600899635" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:UxriW0iASnsC" class="gsc_a_at">Management of adult T‐cell leukaemia/lymphoma</a><div class="gs_gray">R Pawson, GJ Mufti, A Pagliuca</div><div class="gs_gray">British journal of haematology 100 (3), 453-458<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7130761418289616764" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:8AbLer7MMksC" class="gsc_a_at">Prognostic implication and characterization of the blast cell population in the myelodysplastic syndrome</a><div class="gs_gray">JE Goasguen, JM Bennett, C Cox, H Hambley, G Mufti, G Flandrin</div><div class="gs_gray">Leukemia research 15 (12), 1159-1165<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8256811304218166557" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:EkHepimYqZsC" class="gsc_a_at">Valuation of transfusion-free living in MDS: results of health utility interviews with patients</a><div class="gs_gray">A Szende, C Schaefer, TF Goss, K Heptinstall, R Knight, M Lübbert, ...</div><div class="gs_gray">Health and quality of life outcomes 7 (1), 1-8<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14088920257537327240" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:XiSMed-E-HIC" class="gsc_a_at">Successful treatment of refractory angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasone</a><div class="gs_gray">K Ramasamy, Z Lim, A Pagliuca, GJ Mufti, S Devereux</div><div class="gs_gray">Haematologica 91 (8_Suppl), ECR44-ECR44<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4028785048331335253" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:VOx2b1Wkg3QC" class="gsc_a_at">Antigen gene transfer to cultured human dendritic cells using recombinant avipoxvirus vectors</a><div class="gs_gray">M Brown, DH Davies, MA Skinner, G Bowen, SJ Hollingsworth, GJ Mufti, ...</div><div class="gs_gray">Cancer gene therapy 6 (3), 238-245<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17409659522825131337" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:_Ybze24A_UAC" class="gsc_a_at">Lead poisoning: an age old problem.</a><div class="gs_gray">A Pagliuca, GJ Mufti</div><div class="gs_gray">BMJ: British Medical Journal 300 (6728), 830<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2432027052483536861" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:u9iWguZQMMsC" class="gsc_a_at">Coexistent myelodysplasia and plasma cell neoplasia</a><div class="gs_gray">GJ Mufti, TJ Hamblin, GP Clein, C Race</div><div class="gs_gray">British journal of haematology 54 (1), 91-96<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17343509920520774162" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Tiz5es2fbqcC" class="gsc_a_at">Ras and myelodysplasia: lessons from the last decade</a><div class="gs_gray">J Parker, GJ Mufti</div><div class="gs_gray">Seminars in hematology 33 (3), 206-224<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6563775334684352399" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Dip1O2bNi0gC" class="gsc_a_at">Lenalidomide as a disease-modifying agent in patients with del (5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes</a><div class="gs_gray">A Giagounidis, GJ Mufti, P Fenaux, U Germing, A List, KJ MacBeth</div><div class="gs_gray">Annals of hematology 93 (1), 1-11<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13049941436001432101" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4fGpz3EwCPoC" class="gsc_a_at">Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions</a><div class="gs_gray">A Aziz, EJ Baxter, C Edwards, CY Cheong, M Ito, A Bench, R Kelley, ...</div><div class="gs_gray">The Journal of clinical investigation 123 (5), 2169-2182<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16093381791288931846" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4fKUyHm3Qg0C" class="gsc_a_at">Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML</a><div class="gs_gray">ZY Lim, W Ingram, R Brand, A Ho, M Kenyon, S Devereux, J Marsh, ...</div><div class="gs_gray">Bone marrow transplantation 45 (4), 633-639<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6816540831743592187" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:WA5NYHcadZ8C" class="gsc_a_at">Delayed attainment of full donor chimaerism following alemtuzumab‐based reduced‐intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and&nbsp;…</a><div class="gs_gray">ZY Lim, L Pearce, AY Ho, L Barber, W Ingram, M Usai, K Tobal, ...</div><div class="gs_gray">British journal of haematology 138 (4), 517-526<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10419812596991457910" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:AvfA0Oy_GE0C" class="gsc_a_at">Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity&nbsp;…</a><div class="gs_gray">K Matthews, ZY Lim, B Afzali, L Pearce, A Abdallah, S Kordasti, ...</div><div class="gs_gray">haematologica 94 (7), 956<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=985904607723915764" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:vRqMK49ujn8C" class="gsc_a_at">An immune edited tumour versus a tumour edited immune system: prospects for immune therapy of acute myeloid leukaemia</a><div class="gs_gray">L Chan, NR Hardwick, B Guinn, D Darling, J Gäken, J Galea-Lauri, AY Ho, ...</div><div class="gs_gray">Cancer Immunology, Immunotherapy 55 (8), 1017<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9494749701895423567" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:tOudhMTPpwUC" class="gsc_a_at">Idiopathic CD4+ T-lymphocytopenia</a><div class="gs_gray">V Soriano, I Hewlett, A Heredia, J Pedreira, M Gutierrez, R Bravo, ...</div><div class="gs_gray">The Lancet 340 (8819), 607-609<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2492023884422445473" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:WbkHhVStYXYC" class="gsc_a_at">The insertion of chronic indwelling central venous catheters (Hickman lines) in interventional radiology suites</a><div class="gs_gray">AC Page, RA Evans, R Kaczmarski, GJ Mufti, P Gishen</div><div class="gs_gray">Clinical radiology 42 (2), 105-109<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13212877166646684698" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:5ugPr518TE4C" class="gsc_a_at">Multicentric reticulohistiocytosis. Detailed immunophenotyping confirms macrophage origin.</a><div class="gs_gray">JR Salisbury, PA Hall, HC Williams, MH Mangi, GJ Mufti</div><div class="gs_gray">The American journal of surgical pathology 14 (7), 687-693<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17811793029275352251" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:V3AGJWp-ZtQC" class="gsc_a_at">Myelodysplastic syndromes: their history, evolution and relation to acute myeloid leukaemia</a><div class="gs_gray">DM Layton, GJ Mufti</div><div class="gs_gray">Blut 53 (6), 423-436<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15972818914186249502" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LjlpjdlvIbIC" class="gsc_a_at">Crucial roles for protein kinase C isoforms in tumor-specific killing by apoptin</a><div class="gs_gray">J Jiang, D Cole, N Westwood, L Macpherson, F Farzaneh, G Mufti, ...</div><div class="gs_gray">Cancer research 70 (18), 7242-7252<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12095081996685745302" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:j8SEvjWlNXcC" class="gsc_a_at">Reducing MCM levels in human primary T cells during the G 0→ G 1 transition causes genomic instability during the first cell cycle</a><div class="gs_gray">SJ Orr, T Gaymes, D Ladon, C Chronis, B Czepulkowski, R Wang, ...</div><div class="gs_gray">Oncogene 29 (26), 3803-3814<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15396089234874628958" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:KxtntwgDAa4C" class="gsc_a_at">RBC Transfusion Independence and Safety Profile of Lenalidomide 5 or 10 mg in Pts with Low-or Int-1-Risk MDS with Del5q: Results From a Randomized Phase III Trial (MDS-004).</a><div class="gs_gray">P Fenaux, A Giagounidis, D Selleslag, O Beyne-Rauzy, GJ Mufti, ...</div><div class="gs_gray">Blood 114 (22), 944<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3329905622910915993" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:5Ul4iDaHHb8C" class="gsc_a_at">Constitutive DNA damage is linked to DNA replication abnormalities in Bloom's syndrome cells</a><div class="gs_gray">FV Rassool, PS North, GJ Mufti, ID Hickson</div><div class="gs_gray">Oncogene 22 (54), 8749-8757<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11200767561589391904" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:S16KYo8Pm5AC" class="gsc_a_at">Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris</a><div class="gs_gray">EE Craythorne, G Mufti</div><div class="gs_gray">Journal of the American Academy of Dermatology 65 (5), 1064-1065<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10559691036905431853" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:hkOj_22Ku90C" class="gsc_a_at">Tumor-derived IL-6 may contribute to the immunological defect in CLL</a><div class="gs_gray">AGS Buggins, PEM Patten, J Richards, NSB Thomas, GJ Mufti, ...</div><div class="gs_gray">Leukemia 22 (5), 1084-1087<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16785219467439991558" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:geHnlv5EZngC" class="gsc_a_at">The clinical diversity and role of chemotherapy in lymphoproliferative disorder in liver transplant recipients</a><div class="gs_gray">M McCarthy, J Ramage, A McNair, E Gane, B Portmann, A Pagliuca, ...</div><div class="gs_gray">Journal of hepatology 27 (6), 1015-1021<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7781786010584214671" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:WqliGbK-hY8C" class="gsc_a_at">Severe deafness in systemic lupus erythematosus: its immediate relief by plasma exchange.</a><div class="gs_gray">TJ Hamblin, GJ Mufti, A Bracewell</div><div class="gs_gray">British medical journal (Clinical research ed.) 284 (6326), 1374<span class="gs_oph">, 1982</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8799701146300249719" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1982</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:tS2w5q8j5-wC" class="gsc_a_at">Microarray analysis of tumour antigen expression in presentation acute myeloid leukaemia</a><div class="gs_gray">B Guinn, AF Gilkes, E Woodward, NB Westwood, GJ Mufti, D Linch, ...</div><div class="gs_gray">Biochemical and biophysical research communications 333 (3), 703-713<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1405174456856011617" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Mojj43d5GZwC" class="gsc_a_at">Serous effusions in monocytic leukaemias</a><div class="gs_gray">GJ Mufti, DG Oscier, TJ Hamblin, A Nightingale, S Darlow</div><div class="gs_gray">British journal of haematology 58 (3), 547-552<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13475544971728606287" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:HE397vMXCloC" class="gsc_a_at">Possible co-existence of RAS activation and monosomy 7 in the leukaemic transformation of myelodysplastic syndromes</a><div class="gs_gray">J Stephenson, H Lizhen, GJ Mufti</div><div class="gs_gray">Leukemia research 19 (10), 741-748<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4195296918462914754" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:dTyEYWd-f8wC" class="gsc_a_at">Abnormal localization of immature precursors (ALIP) in the bone marrow of myelodysplastic syndromes: current state of knowledge and future directions</a><div class="gs_gray">MH Mangi, JR Salisbury, GJ Mufti</div><div class="gs_gray">Leukemia research 15 (7), 627-639<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4284038327762636984" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:FiDNX6EVdGUC" class="gsc_a_at">Chronic relapsing remitting Sweet syndrome–a harbinger of myelodysplastic syndrome</a><div class="gs_gray">AG Kulasekararaj, S Kordasti, T Basu, JR Salisbury, GJ Mufti, ...</div><div class="gs_gray">British journal of haematology 170 (5), 649-656<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8283794987627646330" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:fEOibwPWpKIC" class="gsc_a_at">Treatment with the thrombopoietin (TPO)-receptor agonist romiplostim in thrombocytopenic patients (Pts) with low or intermediate-1 (int-1) risk myelodysplastic syndrome (MDS&nbsp;…</a><div class="gs_gray">HM Kantarjian, GJ Mufti, P Fenaux, MA Sekeres, J Szer, U Platzbecker, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 421-421<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14623299289986977349" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:9Nmd_mFXekcC" class="gsc_a_at">Long-term transfusion independence in del (5q) MDS patients who discontinue lenalidomide</a><div class="gs_gray">AAN Giagounidis, A Kulasekararaj, U Germing, R Radkowski, S Haase, ...</div><div class="gs_gray">Leukemia 26 (4), 855-858<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17381548791536020799" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:gsN89kCJA0AC" class="gsc_a_at">Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe disease</a><div class="gs_gray">ZY Lim, AYL Ho, S Abrahams, A Fensom, M Aldouri, A Pagliuca, C Shaw, ...</div><div class="gs_gray">Bone marrow transplantation 41 (9), 831-832<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17621925745984724048" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wbdj-CoPYUoC" class="gsc_a_at">Treatment of chronic myelomonocytic leukaemia with low dose etoposide</a><div class="gs_gray">DG Oscier, A Worsley, TJ Hamblin, GJ Mufti</div><div class="gs_gray">British journal of haematology 72 (3), 468-471<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15387907057240887503" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:v1_lew4L6wgC" class="gsc_a_at">Outcomes in RBC transfusion‐dependent patients with L ow‐/I ntermediate‐1‐risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis&nbsp;…</a><div class="gs_gray">A Giagounidis, GJ Mufti, M Mittelman, G Sanz, U Platzbecker, P Muus, ...</div><div class="gs_gray">European journal of haematology 93 (5), 429-438<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17724847717546367848" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:UHK10RUVsp4C" class="gsc_a_at">Van‐den Berghe’s 5q‐syndrome in 2008</a><div class="gs_gray">A Mohamedali, GJ Mufti</div><div class="gs_gray">British journal of haematology 144 (2), 157-168<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6418133901424614036" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Y5dfb0dijaUC" class="gsc_a_at">Bilateral adrenal lymphoma presenting as Addison's disease.</a><div class="gs_gray">A Pagliuca, DS Gillett, JR Salisbury, RN Basu, GJ Mufti</div><div class="gs_gray">Postgraduate medical journal 65 (767), 684-686<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13064329853212983329" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:MvIMIWP2nqIC" class="gsc_a_at">Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698&nbsp;…</a><div class="gs_gray">C Schmid, LC De Wreede, A Van Biezen, J Finke, G Ehninger, A Ganser, ...</div><div class="gs_gray">haematologica 103 (2), 237<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4865942775393166690" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:q3oQSFYPqjQC" class="gsc_a_at">The effects of continued azacitidine (AZA) treatment cycles on response in higher-risk patients (Pts) with myelodysplastic syndromes (MDS)</a><div class="gs_gray">LR Silverman, P Fenaux, GJ Mufti, V Santini, E Hellström-Lindberg, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 227-227<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=497354397066075671" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:J-pR_7NvFogC" class="gsc_a_at">High-Risk Myelodysplastic Syndrome (MDS): First Results of International Phase 2 Study with Oral Farnesyltransferase Inhibitor R115777 (ZARNESTRA<sup>TM</sup>).</a><div class="gs_gray">R Kurzrock, P Fenaux, A Raza, G Mufti, C Aul, U Germing, R Kerstens, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 68-68<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13886661605397920446" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Q3-QASNKTMEC" class="gsc_a_at">Comparison of intensive chemotherapy and hypomethylating agents before allogeneic stem cell transplantation for advanced myelodysplastic syndromes: a study of the&nbsp;…</a><div class="gs_gray">VT Potter, S Iacobelli, A van Biezen, J Maertens, JH Bourhis, JR Passweg, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 22 (9), 1615-1620<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=450882205711497074,8906551760777821494" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:S0CDQJw8Yr4C" class="gsc_a_at">Mutations in histone modulators are associated with prolonged survival during azacitidine therapy</a><div class="gs_gray">M Tobiasson, DP McLornan, M Karimi, M Dimitriou, M Jansson, ...</div><div class="gs_gray">Oncotarget 7 (16), 22103<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13505403185209502577" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:tkaPQYYpVKoC" class="gsc_a_at">Very-low-dose cytarabine for myelodysplastic syndromes and acute myeloid leukaemia in the elderly.</a><div class="gs_gray">A Worsley, GJ Mufti, JA Copplestone, DG Oscier, TJ Hamblin</div><div class="gs_gray">Lancet (London, England) 1 (8487), 966-966<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14949115979583017652" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:N5tVd3kTz84C" class="gsc_a_at">Myelodysplastic syndromes: from morphology to molecular biology. Part II. The molecular genetics of myelodysplasia.</a><div class="gs_gray">J Stephenson, GJ Mufti, Y Yoshida</div><div class="gs_gray">International journal of hematology 57 (2), 99-112<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5313862535800144214" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Ug5p-4gJ2f0C" class="gsc_a_at">Human CD80/IL2 lentivirus‐transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: implications for a phase I clinical&nbsp;…</a><div class="gs_gray">W Ingram, L Chan, H Guven, D Darling, S Kordasti, N Hardwick, L Barber, ...</div><div class="gs_gray">British journal of haematology 145 (6), 749-760<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15700296301713892831" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:7T2F9Uy0os0C" class="gsc_a_at">Life-threatening motor neurotoxicity in association with bortezomib</a><div class="gs_gray">S Gupta, A Pagliuca, S Devereux, GJ Mufti, S Schey</div><div class="gs_gray">Haematologica 91 (7), 1001-1001<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12961724241735988546" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ye4kPcJQO24C" class="gsc_a_at">Apoptosis in the myelodysplastic syndromes.</a><div class="gs_gray">NB Westwood, GJ Mufti</div><div class="gs_gray">Current hematology reports 2 (3), 186-192<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17017290306065831471" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:kuK5TVdYjLIC" class="gsc_a_at">Acquired sideroblastic anaemia induced by a copper-chelating agent.</a><div class="gs_gray">AR Perry, A Pagliuca, EJ Fitzsimons, GJ Mufti, R Williams</div><div class="gs_gray">International journal of hematology 64 (1), 69-72<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=53724597812274281" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:JoZmwDi-zQgC" class="gsc_a_at">Hyperinfection with strongyloides after treatment for adult T cell leukaemia-lymphoma in an African immigrant.</a><div class="gs_gray">A Pagliuca, DM Layton, S Allen, GJ Mufti</div><div class="gs_gray">BMJ: British Medical Journal 297 (6661), 1456<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1762949566907503332" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:8d8msizDQcsC" class="gsc_a_at">Prevalence and clinical outcomes of the 46/1 haplotype, Janus kinase 2 mutations, and ten‐eleven translocation 2 mutations in budd‐chiari syndrome and their impact on&nbsp;…</a><div class="gs_gray">RH Westbrook, NC Lea, AM Mohamedali, AE Smith, DW Orr, LN Roberts, ...</div><div class="gs_gray">Liver transplantation 18 (7), 819-827<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8629888668455008861" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:nrtMV_XWKgEC" class="gsc_a_at">Treatment with the thrombopoietin (TPO)-receptor agonist romiplostim in thrombocytopenic patients (Pts) with low or intermediate-1 (Int-1) risk myelodysplastic syndrome (MDS&nbsp;…</a><div class="gs_gray">A Giagounidis, GJ Mufti, HM Kantarjian, P Fenaux, MA Sekeres, J Szer, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 117-117<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1923092903679224583" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:eq2jaN3J8jMC" class="gsc_a_at">The prevalence of the activating <i>JAK</i>2 tyrosine kinase mutation in chronic porto‐splenomesenteric venous thrombosis</a><div class="gs_gray">DW Orr, RK Patel, NC Lea, RH Westbrook, JG O’GRADY, ND Heaton, ...</div><div class="gs_gray">Alimentary pharmacology &amp; therapeutics 31 (12), 1330-1336<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9131918602009900734" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:xEMdJR0kL_sC" class="gsc_a_at">Transplant outcomes for secondary acute myeloid leukemia: acute leukemia working party of the European society for blood and bone marrow transplantation study</a><div class="gs_gray">S Sengsayadeth, M Labopin, A Boumendil, J Finke, A Ganser, M Stelljes, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 24 (7), 1406-1414<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14987472848279930380" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:rAN7mHg6NlYC" class="gsc_a_at">Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission</a><div class="gs_gray">F Saraceni, M Labopin, RM Hamladji, G Mufti, G Socié, A Shimoni, ...</div><div class="gs_gray">Oncotarget 9 (3), 3379<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8339859213358995601" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Ehil0879vHcC" class="gsc_a_at">Long-term outcomes of alemtuzumab-based reduced-intensity conditioned hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myelogenous leukemia&nbsp;…</a><div class="gs_gray">VT Potter, P Krishnamurthy, LD Barber, ZY Lim, M Kenyon, RM Ireland, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 20 (1), 111-117<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11081898502911252280" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:DUooU5lO8OsC" class="gsc_a_at">Epigenetics in focus: pathogenesis of myelodysplastic syndromes and the role of hypomethylating agents</a><div class="gs_gray">V Santini, A Melnick, JP Maciejewski, E Duprez, C Nervi, L Cocco, ...</div><div class="gs_gray">Critical reviews in oncology/hematology 88 (2), 231-245<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15784764729109751348" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:YohjEiUPhakC" class="gsc_a_at">Utility of peripheral blood for cytogenetic and mutation analysis in myelodysplastic syndrome</a><div class="gs_gray">AM Mohamedali, H Alkhatabi, A Kulasekararaj, S Shinde, S Mian, F Malik, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (4), 567-570<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9028404389871279664" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:hMsQuOkrut0C" class="gsc_a_at">Myelodysplastic syndromes: who and when in the course of disease to transplant</a><div class="gs_gray">GJ Mufti, V Potter</div><div class="gs_gray">Hematology 2010, the American Society of Hematology Education Program Book&nbsp;…<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6676728866561847806" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ruyezt5ZtCIC" class="gsc_a_at">A functional assay for microRNA target identification and validation</a><div class="gs_gray">J Gäken, AM Mohamedali, J Jiang, F Malik, D Stangl, AE Smith, C Chronis, ...</div><div class="gs_gray">Nucleic acids research 40 (10), e75-e75<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10958837690669705071" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:xXdmTUQ9lisC" class="gsc_a_at">Hydroxyurea treatment of meningiomas: a pilot study</a><div class="gs_gray">GJ Weston, AJ Martin, GJ Mufti, AJ Strong, MJ Gleeson</div><div class="gs_gray">Skull Base 16 (03), 157-160<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13926221093498451913" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:dQ2og3OwTAUC" class="gsc_a_at">Development of a whole cell vaccine for acute myeloid leukaemia</a><div class="gs_gray">ATC Cheuk, L Chan, B Czepulkowski, SA Berger, H Yagita, K Okumura, ...</div><div class="gs_gray">Cancer Immunology, Immunotherapy 55 (1), 68-75<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17088840588495947218" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:uLbwQdceFCQC" class="gsc_a_at">Differentially expressed genes in adult familial myelodysplastic syndromes</a><div class="gs_gray">A Pradhan, A Mijovic, K Mills, P Cumber, N Westwood, GJ Mufti, ...</div><div class="gs_gray">Leukemia 18 (3), 449-459<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13054054371486710425" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:9vf0nzSNQJEC" class="gsc_a_at">The myelodysplastic syndromes: towards a functional classification</a><div class="gs_gray">A Mijović, GJ Mufti</div><div class="gs_gray">Blood reviews 12 (2), 73-83<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6243982898605443118" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PR6Y55bgFSsC" class="gsc_a_at">Adult T-cell leukemia/lymphoma in London: clinical experience of 21 cases</a><div class="gs_gray">R Pawson, DS Richardson, A Pagliuca, SM Kelsey, S Hoque, J Breuer, ...</div><div class="gs_gray">Leukemia &amp; lymphoma 31 (1-2), 177-185<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15697460921981710484" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:VL0QpB8kHFEC" class="gsc_a_at">Parvovirus B19-induced red cell aplasia treated with plasmapheresis and immunoglobulin.</a><div class="gs_gray">JK Ramage, A Hale, E Gane, B Cohen, M Boyle, G Mufti, R Williams</div><div class="gs_gray">Lancet (London, England) 343 (8898), 667-668<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17252239005312589183" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:35r97b3x0nAC" class="gsc_a_at">Clinicopathological features of acute undifferentiated leukaemia with a stem cell phenotype</a><div class="gs_gray">F Brito‐Babapulle, H Pullon, DM Layton, A Etches, A Huxtable, M Mangi, ...</div><div class="gs_gray">British journal of haematology 76 (2), 210-214<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12657476300462981851" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Fu2w8maKXqMC" class="gsc_a_at">Differentiation induction in myelodysplasia and acute myeloid leukaemia: use of synergistic drug combinations</a><div class="gs_gray">GE Francis, GJ Mufti, SM Knowles, JJ Berney, JET Guimaraes, ...</div><div class="gs_gray">Leukemia research 11 (11), 971-977<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=176179104068733515" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:_B80troHkn4C" class="gsc_a_at">Successful treatment of post‐transfusion purpura with high dose immunoglobulins after lack of response to plasma exchange</a><div class="gs_gray">TJ Hamblin, SMN Abidi, PA Nee, A Copplestone, GJ Mufti, DG Oscier</div><div class="gs_gray">Vox sanguinis 49 (2), 164-167<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3995036636445761193" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:b2kfBsK7yCQC" class="gsc_a_at">Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome</a><div class="gs_gray">E Bono, D McLornan, E Travaglino, S Gandhi, A Gallì, AA Khan, ...</div><div class="gs_gray">Leukemia 33 (10), 2495-2505<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10865085355800492248" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:kzcSZmkxUKAC" class="gsc_a_at">High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS)</a><div class="gs_gray">AM Mohamedali, J Gäken, M Ahmed, F Malik, AE Smith, S Best, S Mian, ...</div><div class="gs_gray">Leukemia 29 (9), 1928-1938<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13840372660492379396" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-FonjvnnhkoC" class="gsc_a_at">Proteomic and protein interaction network analysis of human T lymphocytes during cell‐cycle entry</a><div class="gs_gray">SJ Orr, DR Boutz, R Wang, C Chronis, NC Lea, T Thayaparan, E Hamilton, ...</div><div class="gs_gray">Molecular systems biology 8 (1), 573<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6232035654414426384" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:evX43VCCuoAC" class="gsc_a_at">Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data</a><div class="gs_gray">ZY Lim, A Pagliuca, S Simpson, S Cottam, M Ervine, AYL Ho, S Devereux, ...</div><div class="gs_gray">British journal of haematology 136 (3), 448-450<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10993363254963122082" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Ui_nyea79ooC" class="gsc_a_at">An atlas of malignant haematology: cytology, histology, and cytogenetics</a><div class="gs_gray">GJ Mufti</div><div class="gs_gray">Lippincott Williams &amp; Wilkins<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4564177745449136361" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:tzM49s52ZIMC" class="gsc_a_at">Loss of ras oncogene mutation in a myelodysplastic syndrome after low-dose cytarabine therapy.</a><div class="gs_gray">DM Layton, GJ Mufti, J Lyons, JW Janssen, CR Bartram</div><div class="gs_gray">The New England journal of medicine 318 (22), 1468-1469<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10338794430777646032" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:VLnqNzywnoUC" class="gsc_a_at">Reciprocal translocation between chromosomes 8 and 9 in atypical chronic myeloid leukaemia.</a><div class="gs_gray">DG Oscier, GJ Mufti, A Gardiner, TJ Hamblin</div><div class="gs_gray">Journal of medical genetics 22 (5), 398-401<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3926672489189803743" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ILKRHgRFtOwC" class="gsc_a_at">Acute myeloid leukaemia presenting with mediastinal myeloid sarcoma: report of three cases and review of literature</a><div class="gs_gray">K Ramasamy, Z Lim, A Pagliuca, S Devereux, AY Ho, GJ Mufti</div><div class="gs_gray">Leukemia &amp; lymphoma 48 (2), 290-294<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2029837326721331316" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:_Re3VWB3Y0AC" class="gsc_a_at">Incidence and management of hepatic venoocclusive disease in 237 patients undergoing reduced-intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT)</a><div class="gs_gray">K Ramasamy, ZY Lim, A Pagliuca, R Grundy, S Devereux, AYL Ho, ...</div><div class="gs_gray">Bone marrow transplantation 38 (12), 823-824<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9131874565518286484" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:t7zJ5fGR-2UC" class="gsc_a_at">Antiapoptotic microenvironment of acute myeloid leukemia</a><div class="gs_gray">D Milojković, S Devereux, NB Westwood, GJ Mufti, NSB Thomas, ...</div><div class="gs_gray">The Journal of Immunology 173 (11), 6745-6752<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6788241982321137093" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ZfRJV9d4-WMC" class="gsc_a_at">Methylation status within exon 3 of the c-myc gene as a prognostic marker in myeloma and leukaemia</a><div class="gs_gray">J Stephenson, R Akdag, N Ozbek, GJ Mufti</div><div class="gs_gray">Leukemia research 17 (3), 291-293<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17520250600529497987" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ipzZ9siozwsC" class="gsc_a_at">Monocytic skin infiltration in chronic myelomonocytic leukaemia</a><div class="gs_gray">JA Copplestone, DG Oscier, GJ Mufti, TJ Hamblin</div><div class="gs_gray">Clinical &amp; Laboratory Haematology 8 (2), 115-119<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11760505854120715520" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:AmQcmOVUwm0C" class="gsc_a_at">Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies</a><div class="gs_gray">R Benjamin, C Graham, D Yallop, A Jozwik, OC Mirci-Danicar, G Lucchini, ...</div><div class="gs_gray">The Lancet 396 (10266), 1885-1894<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4680949699471310170" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:tBp-nognM3UC" class="gsc_a_at">Intravenous busulfan compared with treosulfan-based conditioning for allogeneic stem cell transplantation in acute myeloid leukemia: a study on behalf of the Acute Leukemia&nbsp;…</a><div class="gs_gray">A Shimoni, M Labopin, B Savani, RM Hamladji, D Beelen, G Mufti, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 24 (4), 751-757<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6288152832284432899" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Gs1AF5H0x94C" class="gsc_a_at">Heterozygous <i>RTEL1</i> variants in bone marrow failure and myeloid neoplasms</a><div class="gs_gray">JCW Marsh, F Gutierrez-Rodrigues, J Cooper, J Jiang, S Gandhi, ...</div><div class="gs_gray">Blood advances 2 (1), 36-48<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=348828565162452881" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:WZBGuue-350C" class="gsc_a_at">Update on developments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS): consensus statements and report from an expert workshop</a><div class="gs_gray">U Platzbecker, V Santini, GJ Mufti, C Haferlach, JP Maciejewski, S Park, ...</div><div class="gs_gray">Leukemia research 36 (3), 264-270<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3621733911685625993" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:EYYDruWGBe4C" class="gsc_a_at">Rituximab for the treatment of corticosteroid–refractory pemphigus vulgaris with oral and skin manifestations</a><div class="gs_gray">E Craythorne, A du Viver, GJ Mufti, S Warnakulasuriya</div><div class="gs_gray">Journal of oral pathology &amp; medicine 40 (8), 616-620<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16029743254553935147" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:URolC5Kub84C" class="gsc_a_at">Epigenetics of human T cells during the G0→ G1 transition</a><div class="gs_gray">AE Smith, C Chronis, M Christodoulakis, SJ Orr, NC Lea, NA Twine, ...</div><div class="gs_gray">Genome research 19 (8), 1325-1337<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=438313439989416821" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:pe4chHNxNLUC" class="gsc_a_at">EVI1 overexpression in t (3; 17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22</a><div class="gs_gray">A De Weer, F Speleman, B Cauwelier, N Van Roy, N Yigit, B Verhasselt, ...</div><div class="gs_gray">haematologica 93 (12), 1903-1907<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=477749417643633705,276962988711843035" class="gsc_a_ac gs_ibl">28</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="gZU2Ie8AAAAJ:pe4chHNxNLUC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:MLfJN-KU85MC" class="gsc_a_at">High incidence of therapy‐related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent&nbsp;…</a><div class="gs_gray">SJ Bowcock, SMB Rassam, Z Lim, SM Ward, MM Ryali, GJ Mufti</div><div class="gs_gray">British journal of haematology 134 (2), 242-243<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5171835390744708815" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-_dYPAW6P2MC" class="gsc_a_at">Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (±fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion</a><div class="gs_gray">RJ Lush, AP Haynes, JL Byrne, GM Cull, GI Carter, A Pagliuca, JE Parker, ...</div><div class="gs_gray">Cytotherapy 3 (3), 203-210<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13224095591295832366" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:gYnLYBw1zZMC" class="gsc_a_at">An atlas of malignant haematology</a><div class="gs_gray">GJ Mufti, G Flandrin, HE Schaefer, M Uhr</div><div class="gs_gray">Annals of Oncology 7 (9), 980-980<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10136541891723070214" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:0KyAp5RtaNEC" class="gsc_a_at">HTLV-I screening in Britain</a><div class="gs_gray">A Pagliuca, R Pawson, GJ Mufti</div><div class="gs_gray">BMJ 311 (7016), 1313-1314<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6428314178286728415" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:F0CZgh39Fi0C" class="gsc_a_at">Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based study</a><div class="gs_gray">A Kizilors, E Crisà, N Lea, R Passera, S Mian, J Anwar, S Best, FE Nicolini, ...</div><div class="gs_gray">The Lancet Haematology 6 (5), e276-e284<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13179646252612602168" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:JoHZYnTS1h4C" class="gsc_a_at">Preclinical modeling of myelodysplastic syndromes</a><div class="gs_gray">K Rouault-Pierre, SA Mian, M Goulard, A Abarrategi, A Di Tulio, AE Smith, ...</div><div class="gs_gray">Leukemia 31 (12), 2702-2708<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16917830152216651013" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:jtOrAYjvdewC" class="gsc_a_at">Molecular Mechanisms in Malignant Lymphomas Network Project. Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular&nbsp;…</a><div class="gs_gray">SM Aukema, M Kreuz, CW Kohler, M Rosolowski, D Hasenclever, ...</div><div class="gs_gray">Haematologica 99 (4), 726-735<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4709151406265123076" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Vch7EZszQGgC" class="gsc_a_at">GRAFT-VERSUS-LEUKEMIA REACTIONS-EXPERIMENTAL-MODELS AND CLINICAL-TRIALS</a><div class="gs_gray">RL Truitt, AV Lefever, CCY SHIH</div><div class="gs_gray">JOURNAL OF CELLULAR BIOCHEMISTRY, 207-207<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1326745621743944901" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Z7R3Ocg27JUC" class="gsc_a_at">Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis</a><div class="gs_gray">J Canaani, E Beohou, M Labopin, A Ghavamzadeh, D Beelen, ...</div><div class="gs_gray">Journal of internal medicine 285 (4), 407-418<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3968790581303442677" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:9pM33mqn1YgC" class="gsc_a_at">Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and&nbsp;…</a><div class="gs_gray">R Brand, H Putter, A van Biezen, D Niederwieser, R Martino, G Mufti, ...</div><div class="gs_gray">PLoS One 8 (10), e74368<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=486632803134117871" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:MSzX15-gZgkC" class="gsc_a_at">Cost-effectiveness of early assisted discharge for COPD exacerbations in the Netherlands</a><div class="gs_gray">LMA Goossens, CMA Utens, FWJM Smeenk, OCP van Schayck, ...</div><div class="gs_gray">Value in health 16 (4), 517-528<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3772606523904943211" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:hCrLmN-GePgC" class="gsc_a_at">Mobilized peripheral blood stem cells compared with bone marrow from HLA‐identical siblings for reduced‐intensity conditioning transplantation in acute myeloid leukemia in&nbsp;…</a><div class="gs_gray">A Nagler, M Labopin, A Shimoni, GJ Mufti, JJ Cornelissen, D Blaise, ...</div><div class="gs_gray">European journal of haematology 89 (3), 206-213<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3434914616830771868" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:BUYA1_V_uYcC" class="gsc_a_at">PNP with Waldenström's macroglobulinaemia</a><div class="gs_gray">GK Perera, S Devereux, G Mufti, J Salisbury, D Creamer</div><div class="gs_gray">Clinical and Experimental Dermatology: Clinical dermatology 30 (1), 27-29<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4520767954435515069" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:tKAzc9rXhukC" class="gsc_a_at">Non-invasive isolation of constitutional DNA for genetic analysis</a><div class="gs_gray">K Tobal, DM Layton, GJ Mufti</div><div class="gs_gray">Lancet (British edition) 2 (8674), 1281-1282<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13763955688120520594" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:EcS_2O1c4Q0C" class="gsc_a_at">Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study</a><div class="gs_gray">S Sengsayadeth, KS Gatwood, A Boumendil, M Labopin, J Finke, ...</div><div class="gs_gray">Blood advances 2 (16), 2127-2135<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3905726264321294317" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:jMZTt8odoasC" class="gsc_a_at">Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party&nbsp;…</a><div class="gs_gray">M Robin, R Porcher, W Zinke-Cerwenka, A Van Biezen, L Volin, G Mufti, ...</div><div class="gs_gray">Bone marrow transplantation 52 (2), 209-215<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9703216126278742499" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4hFrxpcac9AC" class="gsc_a_at">Allogeneic stem cell transplantation in MDS: how? When?</a><div class="gs_gray">U Platzbecker, G Mufti</div><div class="gs_gray">Best Practice &amp; Research Clinical Haematology 26 (4), 421-429<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8954709493058932499" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:TIZ-Mc8IlK0C" class="gsc_a_at">The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT</a><div class="gs_gray">S Giebel, M Labopin, M Mohty, GJ Mufti, D Niederwieser, JJ Cornelissen, ...</div><div class="gs_gray">Bone marrow transplantation 48 (2), 238-242<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16289565915819679021" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LI9QrySNdTsC" class="gsc_a_at">Allogeneic transplantation for myelodysplastic syndrome (MDS)</a><div class="gs_gray">W Ingram, ZY Lim, GJ Mufti</div><div class="gs_gray">Blood reviews 21 (2), 61-71<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11802895197442651763" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:uJ-U7cs_P_0C" class="gsc_a_at">Presence of JAK2 V617F tyrosine kinase mutation as a myeloid-lineage-specific mutation in chronic neutrophilic leukaemia</a><div class="gs_gray">NC Lea, Z Lim, NB Westwood, MJ Arno, J Gäken, A Mohamedali, GJ Mufti</div><div class="gs_gray">Leukemia 20 (7), 1324-1326<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2597122623111725448" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:BwyfMAYsbu0C" class="gsc_a_at"><i>Cyclin D2</i> controls B cell progenitor numbers</a><div class="gs_gray">A Mohamedali, I Soeiro, NC Lea, J Glassford, L Banerji, GJ Mufti, ...</div><div class="gs_gray">Journal of leukocyte biology 74 (6), 1139-1143<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12340549257768759223" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:z_wVstp3MssC" class="gsc_a_at">Reduced-intensity rituximab-BEAM-CAMPATH allogeneic haematopoietic stem cell transplantation for follicular lymphoma is feasible and induces durable molecular remissions</a><div class="gs_gray">AYL Ho, S Devereux, GJ Mufti, A Pagliuca</div><div class="gs_gray">Bone marrow transplantation 31 (7), 551-557<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6459477777810266744" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:uc_IGeMz5qoC" class="gsc_a_at">Positron emission scanning with 18-FDG in the diagnosis of deep fungal infections.</a><div class="gs_gray">AY Ho, A Pagliuca, MN Maisey, GJ Mufti</div><div class="gs_gray">British journal of haematology 101 (2), 392-393<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10245177277072616053" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:cTy_cm4PQvYC" class="gsc_a_at">Mixed T cell chimerism after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia using an alemtuzumab-containing regimen is shaped by persistence of&nbsp;…</a><div class="gs_gray">F Grimaldi, V Potter, P Perez-Abellan, JP Veluchamy, M Atif, R Grain, ...</div><div class="gs_gray">Biology of blood and marrow transplantation 23 (2), 293-299<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3171510110444395360" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:p__nRnzSRKYC" class="gsc_a_at">Detection and clinical significance of bone marrow micrometastases in patients undergoing liver transplantation for hepatocellular carcinoma</a><div class="gs_gray">R Sutcliffe, D Maguire, P Murphy, B Portmann, M Rela, G O’Sullivan, ...</div><div class="gs_gray">Transplantation 80 (1), 88-94<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13651149007460140133" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:kz9GbA2Ns4gC" class="gsc_a_at">The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors</a><div class="gs_gray">BE Shaw, NH Russell, S Devereux, E Das-Gupta, S Mackinnon, ...</div><div class="gs_gray">Haematologica 90 (11), 1562-1569<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14999309750325813725" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:2KloaMYe4IUC" class="gsc_a_at">Fatal donor-derived Epstein–Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for&nbsp;…</a><div class="gs_gray">AYL Ho, S Adams, H Shaikh, A Pagliuca, S Devereux, GJ Mufti</div><div class="gs_gray">Bone marrow transplantation 29 (10), 867-869<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10496978774590248708" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:k8Z6L05lTy4C" class="gsc_a_at">Idiopathic hyperammonaemia syndrome following allogeneic peripheral blood progenitor cell transplantation (allo-PBPCT)</a><div class="gs_gray">AYL Ho, A Mijovic, A Pagliuca, GJ Mufti</div><div class="gs_gray">Bone marrow transplantation 20 (11), 1007-1008<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15586293263114599343" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:XD-gHx7UXLsC" class="gsc_a_at">The effect of combined expression of interleukin 2 and interleukin 4 on the tumorigenicity and treatment of B16F10 melanoma</a><div class="gs_gray">SJ Hollingsworth, D Darling, J Gäken, W Hirst, P Patel, M Kuiper, ...</div><div class="gs_gray">British journal of cancer 74 (1), 6-15<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7149935505834931604" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:2u1QkWOsl3MC" class="gsc_a_at">Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia&nbsp;…</a><div class="gs_gray">R Devillier, M Labopin, P Chevallier, MP Ledoux, G Socie, A Huynh, ...</div><div class="gs_gray">Bone marrow transplantation 53 (4), 431-437<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5375834563960926474" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:P7Ujq4OLJYoC" class="gsc_a_at">Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL)</a><div class="gs_gray">MM Ceesay, E Matutes, GP Taylor, P Fields, J Cavenagh, S Simpson, ...</div><div class="gs_gray">Leukemia research 36 (7), 857-861<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10405136567259252774" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:kh2fBNsKQNwC" class="gsc_a_at">Lytic activity against primary AML cells is stimulated in vitro by an autologous whole cell vaccine expressing IL-2 and CD80</a><div class="gs_gray">N Hardwick, L Chan, W Ingram, G Mufti, F Farzaneh</div><div class="gs_gray">Cancer immunology, immunotherapy 59 (3), 379-388<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15087606103610537326" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:edDO8Oi4QzsC" class="gsc_a_at"><i>Saccharomyces cerevisiae</i> emboli in an immunocompromised patient with relapsed acute myeloid leukaemia</a><div class="gs_gray">JS Williams, GJ Mufti, S Powell, JR Salisbury, EM Higgins</div><div class="gs_gray">Clinical and Experimental Dermatology: Clinical dermatology 32 (4), 395-397<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18407221966422564812" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:yB1At4FlUx8C" class="gsc_a_at">Bone marrow reticulin in patients with immune thrombocytopenic purpura.</a><div class="gs_gray">G Mufti, A Bagg, R Hasserjian, B Bain, D Kuter, L Dreiling, J Nichol</div><div class="gs_gray">Blood 108 (11), 3982<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5530955449275353689" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:KUbvn5osdkgC" class="gsc_a_at">Cardiac presentation of ALK positive anaplastic large cell lymphoma</a><div class="gs_gray">ZY Lim, R Grace, JR Salisbury, D Creamer, A Jayaprakasam, AYL Ho, ...</div><div class="gs_gray">European journal of haematology 75 (6), 511-514<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11791879473366649252" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:foquWX3nUaYC" class="gsc_a_at">CD4+ lymphocytopenia due to common variable immunodeficiency mimicking AIDS.</a><div class="gs_gray">RS Kaczmarski, AD Webster, J Moxham, F Davison, S Sutherland, ...</div><div class="gs_gray">Journal of clinical pathology 47 (4), 364-366<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1722819651364459942" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:kzcrU_BdoSEC" class="gsc_a_at">Randomized multicentre study of ciprofloxacin and azlocillin versus gentamicin and azlocillin in the treatment of febrile neutropenic patients</a><div class="gs_gray">JN Philpott-Howard, KF Barker, JJ Wade, RS Kaczmarski, JC Smedley, ...</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 26 (suppl_F), 89-99<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2041874024091254968" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:vDZJ-YLwNdEC" class="gsc_a_at">Haematopoietic stem cell transplantation for acquired aplastic anaemia</a><div class="gs_gray">ME Young, V Potter, AG Kulasekararaj, GJ Mufti, JC Marsh</div><div class="gs_gray">Current opinion in hematology 20 (6), 515-520<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13402954625526433793" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:FPJr55Dyh1AC" class="gsc_a_at">Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell&nbsp;…</a><div class="gs_gray">K Matthews, ZY Lim, L Pearce, A Pagliuca, J Alejandro Madrigal, GJ Mufti, ...</div><div class="gs_gray">British journal of haematology 149 (6), 879-889<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9483134437414557142" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:HbR8gkJAVGIC" class="gsc_a_at">Familial MDS with 5q—abnormality</a><div class="gs_gray">DJ Grimwade, J Stephenson, C De Silva, RG Dalton, GJ Mufti</div><div class="gs_gray">British journal of haematology 84 (3), 536-538<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15087236492903211983" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:1YatL4jblGcC" class="gsc_a_at">Somatic mutations and clonal hematopoiesis in aplastic anemia</a><div class="gs_gray">DV Babushok, TS Olson, M Bessler</div><div class="gs_gray">The New England journal of medicine 373 (17), 1673<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9194151676098855376,1117290001416990413" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:dBIO0h50nwkC" class="gsc_a_at">Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantation</a><div class="gs_gray">ZY Lim, B Baker, M Zuckermann, JJ Wade, M Ceesay, AYL Ho, ...</div><div class="gs_gray">Journal of Infection 54 (2), e83-e86<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9629773621215116227" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:tuHXwOkdijsC" class="gsc_a_at">Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes</a><div class="gs_gray">K Saunders, B Czepulkowski, R Sivalingam, J Hayes, M Aldouri, ...</div><div class="gs_gray">Cancer genetics and cytogenetics 156 (2), 154-157<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4558553981055448816" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:vDijr-p_gm4C" class="gsc_a_at">Non-myeloablative stem cell transplantation for congenital immunodeficiencies</a><div class="gs_gray">HB Gaspar, P Amrolia, A Hassan, D Webb, A Jones, N Sturt, G Vergani, ...</div><div class="gs_gray">Immunosurveillance, Immunodeficiencies and Lymphoproliferations, 134-142<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17281414531866013702" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:5qfkUJPXOUwC" class="gsc_a_at">Neutrophilic eccrine hidradenitis in two neutropaenic patients</a><div class="gs_gray">FM Keane, SE Munn, DA Buckley, D Hopster, GJ Mufti, AWP Du Vivier</div><div class="gs_gray">Clinical and experimental dermatology 26 (2), 162-165<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3536359919194570524" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:vbGhcppDl1QC" class="gsc_a_at">In vitro immune modulation by antibodies coupled to tumour cells</a><div class="gs_gray">D Darling, J Galea-Lauri, J Gäken, P Towner, M Kuiper, S Hollingsworth, ...</div><div class="gs_gray">Gene therapy 4 (12), 1350-1360<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15186062666136218062" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:tYavs44e6CUC" class="gsc_a_at">Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemia.</a><div class="gs_gray">J Mehta, A Mijović, R Powles, A Pagliuca, S Singhal, B Czepulkowski, ...</div><div class="gs_gray">Bone marrow transplantation 17 (1), 25-29<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13909292167232385748" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:e_rmSamDkqQC" class="gsc_a_at">Management of myelodysplastic syndromes</a><div class="gs_gray">WJR Hirst, GJ Mufti</div><div class="gs_gray">British journal of haematology 84 (2), 191-196<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6509698186409198824" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:xtoqd-5pKcoC" class="gsc_a_at">Prodromal cutaneous vasculitis in myelodysplastic syndromes</a><div class="gs_gray">A Pagliuca, E Higgins, D Samson, S Humphries, GJ Mufti</div><div class="gs_gray">British journal of haematology 75 (3), 444-446<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13806680361672681185" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:q-HalDI95KYC" class="gsc_a_at">Azacitidine treatment for patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 3q abnormalities</a><div class="gs_gray">A Wanquet, T Prebet, C Berthon, M Sebert, C Roux, A Kulasekararaj, ...</div><div class="gs_gray">American journal of hematology 90 (10), 859-863<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12401148272727191646" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:w1MjKQ0l0TYC" class="gsc_a_at">CSNK1A1 mutations and isolated del (5q) abnormality in myelodysplastic syndrome: a retrospective mutational analysis</a><div class="gs_gray">AE Smith, AG Kulasekararaj, J Jiang, S Mian, A Mohamedali, J Gaken, ...</div><div class="gs_gray">The Lancet Haematology 2 (5), e212-e221<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11933820567016848167" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:WJVC3Jt7v1AC" class="gsc_a_at">Efficacy and safety of lenalidomide (LEN) versus placebo (PBO) in RBC-transfusion dependent (TD) patients (Pts) with IPSS low/intermediate (Int-1)-risk myelodysplastic&nbsp;…</a><div class="gs_gray">V Santini, A Almeida, A Giagounidis, S Gröpper, A Jonasova, N Vey, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 409-409<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1669586705147242335" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:uDGL6kOW6j0C" class="gsc_a_at">Development and validation of a model to predict platelet response to romiplostim in patients with lower‐risk myelodysplastic syndromes</a><div class="gs_gray">MA Sekeres, A Giagounidis, H Kantarjian, GJ Mufti, P Fenaux, C Jia, ...</div><div class="gs_gray">British journal of haematology 167 (3), 337-345<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14746821579385919860" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:zLWjf1WUPmwC" class="gsc_a_at">Polycomb complex group gene mutations and their prognostic relevance in 5-azacitidine treated myelodysplastic syndrome patients</a><div class="gs_gray">AG Kulasekararaj, AM Mohamedali, AE Smith, NC Lea, A Kizilors, ...</div><div class="gs_gray">Blood 116 (21), 125<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15400817687858945209" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:M7yex6snE4oC" class="gsc_a_at"><i>AKT1</i> (E17K) Mutation in Pancreatic Cancer</a><div class="gs_gray">A Mohamedali, NC Lea, RM Feakins, K Raj, GJ Mufti, HM Kocher</div><div class="gs_gray">Technology in cancer research &amp; treatment 7 (5), 407-408<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18214425584060727329" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:86PQX7AUzd4C" class="gsc_a_at">A novel MHC-associated proteinase 3 peptide isolated from primary chronic myeloid leukaemia cells further supports the significance of this antigen for the immunotherapy of&nbsp;…</a><div class="gs_gray">AJ Knights, AO Weinzierl, T Flad, BA Guinn, L Mueller, GJ Mufti, ...</div><div class="gs_gray">Leukemia 20 (6), 1067-1072<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6065041814138198584" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:b1wdh0AR-JQC" class="gsc_a_at">The tumour antigens RAGE-1 and MGEA6 are expressed more frequently in the less lineage restricted subgroups of presentation acute myeloid leukaemia</a><div class="gs_gray">B Guinn, AF Gilkes, GI Mufti, AK Burnett, KI Mills</div><div class="gs_gray">British journal of haematology 134 (2), 238-239<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4465140984875995113" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:g3aElNc5_aQC" class="gsc_a_at">Analysis of CHK2 in patients with myelodysplastic syndromes</a><div class="gs_gray">D Aktas, MJ Arno, F Rassool, GJ Mufti</div><div class="gs_gray">Leukemia research 26 (11), 985-987<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10471384665875716647" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:XoXfffV-tXoC" class="gsc_a_at">High-dose methylprednisolone, low-dose cytosine arabinoside, and mitoxantrone in children with myelodysplastic syndromes.</a><div class="gs_gray">G Hiçsönmez, AM Tuncer, T Sayli, E Güler, M Cetin, N Ozbek, GJ Mufti</div><div class="gs_gray">Hematologic pathology 9 (3-4), 185-193<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6667479367309932339" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:VaXvl8Fpj5cC" class="gsc_a_at">Quantification of HIV by PCR in monocytes and lymphocytes in patients receiving antiviral treatment and low dose recombinant human granulocyte macrophage colony stimulating factor.</a><div class="gs_gray">FD Davison, RS Kaczmarski, A Pozniak, GJ Mufti, S Sutherland</div><div class="gs_gray">Journal of clinical pathology 47 (9), 855-857<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12236888545584799182" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:L7CI7m0gUJcC" class="gsc_a_at">Myelodysplasia syndromes during pregnancy</a><div class="gs_gray">A Pagliuca, GJ Mufti, P Fenaux, C De Silva, I Samaratunga</div><div class="gs_gray">European journal of haematology 47 (4), 310-312<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1367636510392214460" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ve7iT2ZEuL4C" class="gsc_a_at">Transplant results in adults with Fanconi anaemia</a><div class="gs_gray">M Bierings, C Bonfim, R Peffault De Latour, M Aljurf, PA Mehta, C Knol, ...</div><div class="gs_gray">British journal of haematology 180 (1), 100-109<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15109971175479337373" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:2SFquFhkCoYC" class="gsc_a_at">FLT3 and JAK2 mutations in acute myeloid leukemia promote interchromosomal homologous recombination and the potential for copy neutral loss of heterozygosity</a><div class="gs_gray">TJ Gaymes, A Mohamedali, AL Eiliazadeh, D Darling, GJ Mufti</div><div class="gs_gray">Cancer Research 77 (7), 1697-1708<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3290975975422173389" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:bz8QjSJIRt4C" class="gsc_a_at">An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide</a><div class="gs_gray">N Hardwick, S Buchan, W Ingram, G Khan, G Vittes, J Rice, K Pulford, ...</div><div class="gs_gray">Cancer Immunity Archive 13 (3)<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15927289994281910864" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ClCfbGk0d_YC" class="gsc_a_at">Chromosomal instability syndromes are sensitive to poly ADP-ribose polymerase inhibitors</a><div class="gs_gray">TJ Gaymes, S Shall, F Farzaneh, GJ Mufti</div><div class="gs_gray">haematologica 93 (12), 1886-1889<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=107534884793945670" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ML0RJ9NH7IQC" class="gsc_a_at">Changing the treatment paradigm in myelodysplastic syndromes</a><div class="gs_gray">GJ Mufti, TL Chen</div><div class="gs_gray">Cancer Control 15 (4_suppl), 14-28<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7401314680615594203" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Ri6SYOTghG4C" class="gsc_a_at">Chimerism does not predict for outcome after alemtuzumab-based conditioning: lineage-specific analysis of chimerism of specific diseases may be more informative</a><div class="gs_gray">ZY Lim, L Pearce, W Ingram, AYL Ho, GJ Mufti, A Pagliuca</div><div class="gs_gray">Bone marrow transplantation 41 (6), 587-588<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12472728835767270034" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:lmc2jWPfTJgC" class="gsc_a_at">Precipitation of porphyria cutanea tarda by imatinib mesylate?</a><div class="gs_gray">AYL Ho, A Deacon, G Osborne, GJ Mufti</div><div class="gs_gray">British journal of haematology 121 (2), 375-375<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9512309487156475395" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:oYLFIHfuHKwC" class="gsc_a_at">Application of the pMHC array to characterise tumour antigen specific T cell populations in leukaemia patients at disease diagnosis</a><div class="gs_gray">SE Brooks, SA Bonney, C Lee, A Publicover, G Khan, EL Smits, ...</div><div class="gs_gray">PLoS One 10 (10), e0140483<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7651213174627553023" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:nVrZBo8bIpAC" class="gsc_a_at">Eltrombopag: a stem cell cookie?</a><div class="gs_gray">JCW Marsh, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 123 (12), 1774-1775<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5001274765651260185" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:GtLg2Ama23sC" class="gsc_a_at">The leukaemia‐associated antigen, SSX2IP, is expressed during mitosis on the surface of myeloid leukaemia cells</a><div class="gs_gray">FAK Denniss, A Breslin, W Ingram, NR Hardwick, GJ Mufti, BA Guinn</div><div class="gs_gray">British journal of haematology 138 (5), 668-669<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=926429961804919981" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Lpa4s8qvUTIC" class="gsc_a_at">Reactivation of hepatitis B virus infection in patients with hematologic disorders</a><div class="gs_gray">B Wang, G Mufti, K Agarwal</div><div class="gs_gray">Haematologica 104 (3), 435<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1589174906103038708" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QlnOKEPDpKwC" class="gsc_a_at">Allogeneic hematopoietic cell transplantation in patients aged 50years or older with severe aplastic anemia</a><div class="gs_gray">C Rice, DJ Eikema, JCW Marsh, C Knol, K Hebert, H Putter, E Peterson, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 25 (3), 488-495<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18321994258040766839" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:H_jBuBxbQIAC" class="gsc_a_at">The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes</a><div class="gs_gray">KL McGraw, LM Zhang, DE Rollison, AA Basiorka, W Fulp, B Rawal, ...</div><div class="gs_gray">Blood cancer journal 5 (3), e291-e291<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14253239601558424430" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:OP4eGU-M3BUC" class="gsc_a_at">Eculizumab in paroxysmal nocturnal hemoglobinuria (PNH): a report of all 153 patients treated in the UK</a><div class="gs_gray">A Hill, RJ Kelly, AG Kulasekararaj, SA Gandhi, LD Mitchell, M Elebute, ...</div><div class="gs_gray">Blood 120 (21), 3472<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6849442063856574803,14183136075124696572" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:yMeIxYmEMEAC" class="gsc_a_at">Erythropoietic uroporphyria associated with myeloid malignancy is likely distinct from autosomal recessive congenital erythropoietic porphyria</a><div class="gs_gray">RPE Sarkany, SH Ibbotson, SD Whatley, CM Lawrence, P COVER</div><div class="gs_gray">Journal of investigative dermatology 131 (5), 1172-1175<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12949823174923254334" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:IUKN3-7HHlwC" class="gsc_a_at">Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and&nbsp;…</a><div class="gs_gray">ZY Lim, W Ingram, R Brand, M Akthari, D Milojkovic, AYL Ho, S Devereux, ...</div><div class="gs_gray">Bone marrow transplantation 40 (8), 747-752<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6471386445209487010" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:OR75R8vi5nAC" class="gsc_a_at">Reduced-intensity conditioned allogeneic haematopoietic transplantation in an adult with Langerhans’ cell histiocytosis and thrombocytopenia with absent radii</a><div class="gs_gray">W Ingram, SR Desai, JSR Gibbs, G Mufti</div><div class="gs_gray">Bone marrow transplantation 37 (7), 713-715<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9172248308606652178" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:rmuvC79q63oC" class="gsc_a_at">High efficiency protein transduction of quiescent and proliferating primary hematopoietic cells</a><div class="gs_gray">NC Lea, AGS Buggins, SJ Orr, GJ Mufti, NSB Thomas</div><div class="gs_gray">Journal of biochemical and biophysical methods 55 (3), 251-258<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8916302839868403550" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:SpbeaW3--B0C" class="gsc_a_at">Optimised SEREX technique for the identification of leukaemia-associated antigens</a><div class="gs_gray">B Guinn, JF Collin, G Li, RC Rees, GJ Mufti</div><div class="gs_gray">Journal of immunological methods 264 (1-2), 207-214<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12231217899015294054" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:i2xiXl-TujoC" class="gsc_a_at">A pilot study of low‐dose recombinant human granulocyte‐macrophage colony‐stimulating factor in chronic neutropenia</a><div class="gs_gray">RS Kaczmarski, A Pozniak, A Lakhani, E Harvey, GJ Mufti</div><div class="gs_gray">British journal of haematology 84 (2), 338-340<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11816177602830171922" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PoWvk5oyLR8C" class="gsc_a_at">Sweet's syndrome and myelodysplasia</a><div class="gs_gray">DK Knight, DM Layton, GJ Mufti, H Williams</div><div class="gs_gray">Blut 56 (1), 47-48<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13036519610365218293" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:uGrg30pLAbkC" class="gsc_a_at">Preliminary Results of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a First-in-Human Trial (CALM) in Adult Patients with CD19<sup>+</sup> Relapsed/Refractory&nbsp;…</a><div class="gs_gray">C Graham, D Yallop, A Jozwik, P Patten, A Dunlop, R Ellard, O Stewart, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 887-887<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4850867135985567354" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:_axFR9aDTf0C" class="gsc_a_at">Outcomes of MDS Patients with Chromosome 7 Abnormalities Treated with 5-Azacytidine.</a><div class="gs_gray">ZY Lim, AYL Ho, J Samuel, J Hayden, G Garcia-Manero, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 1449-1449<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8111329578442961951" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:48xauSegjOkC" class="gsc_a_at">Complete response of deep neutrophilic dermatosis associated with myelodysplastic syndrome to 5‐azacytidine</a><div class="gs_gray">K Raj, A Ho, JD Creamer, AWP Du Vivier, JR Salisbury, GJ Mufti</div><div class="gs_gray">British Journal of Dermatology 156 (5), 1039-1041<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6162267979485284782" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:anf4URPfarAC" class="gsc_a_at">Intraperitoneal rituximab: an effective measure to control recurrent abdominal ascites due to non-Hodgkin's lymphoma</a><div class="gs_gray">T Ng, A Pagliuca, G Mufti</div><div class="gs_gray">Annals of hematology 81 (7), 405-406<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15155459889668396204" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:FAceZFleit8C" class="gsc_a_at">Consistent interstitial chromosomal deletions in myeloid malignancies and their correlation with fragile sites</a><div class="gs_gray">WJR Hirst, B Czepulkowski, GJ Mufti</div><div class="gs_gray">Cancer genetics and cytogenetics 65 (1), 51-57<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7658278636879445581" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:HIFyuExEbWQC" class="gsc_a_at">Prodromal cutaneous lesions in adult T-cell leukaemia/lymphoma.</a><div class="gs_gray">A Pagliuca, H Williams, J Salisbury, GJ Mufti</div><div class="gs_gray">Lancet (London, England) 335 (8691), 733-734<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10693220008181012227" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4vMrXwiscB8C" class="gsc_a_at">Pyogenic abscesses in the myelodysplastic syndrome.</a><div class="gs_gray">PJ Williamson, DG Oscier, GJ Mufti, TJ Hamblin</div><div class="gs_gray">BMJ: British Medical Journal 299 (6695), 375<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10905081253184459666" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:v7LLNfYe7h0C" class="gsc_a_at">Reduced relapse incidence with FLAMSA–RIC compared with Busulfan/Fludarabine for acute myelogenous leukemia patients in first or second complete remission: a study from the&nbsp;…</a><div class="gs_gray">T Heinicke, M Labopin, C Schmid, E Polge, G Socié, D Blaise, GJ Mufti, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 24 (11), 2224-2232<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8084238821749092818" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-qpA3cGbmHsC" class="gsc_a_at">Myelodysplastic syndrome can propagate from the multipotent progenitor compartment</a><div class="gs_gray">K Rouault-Pierre, AE Smith, SA Mian, I Pizzitola, AG Kulasekararaj, ...</div><div class="gs_gray">haematologica 102 (1), e7<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9422341158491066554" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:7Hz3ACDFbsoC" class="gsc_a_at">Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia</a><div class="gs_gray">S Gandhi, AG Kulasekararaj, GJ Mufti, JCW Marsh</div><div class="gs_gray">International journal of hematology 97 (5), 573-580<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18171857412831323095" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:0izLItjtcgwC" class="gsc_a_at">Azacitidine prolongs overall survival (OS) and reduces infections and hospitalizations in patients (Pts) with WHO-defined acute myeloid leukemia (AML) compared with&nbsp;…</a><div class="gs_gray">P Fenaux, GJ Mufti, E Hellström-Lindberg, V Santini, N Gattermann, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 3636-3636<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16836237395505207989" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:q3CdL3IzO_QC" class="gsc_a_at">Effects of azacitidine (AZA) vs conventional care regimens (CCR) in elderly (≥ 75 years) patients (pts) with myelodysplastic syndromes (MDS) from the AZA-001 survival trial</a><div class="gs_gray">JF Seymour, P Fenaux, LB Silverman, GJ Mufti, E Hellström-Lindberg, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 3629-3629<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2190981696915852700" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:DJbcl8HfkQkC" class="gsc_a_at">Mixed donor chimaerism in recipient fingernails following reduced-intensity conditioning haematopoietic SCT</a><div class="gs_gray">L Pearce, ZY Lim, M Usai, AYL Ho, GJ Mufti, A Pagliuca</div><div class="gs_gray">Bone marrow transplantation 42 (5), 361-362<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16466694817820352259" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:IRz6iEL74y4C" class="gsc_a_at">JAK V617F missense mutation is absent in pancreatic cancer</a><div class="gs_gray">HM Kocher, L Mears, NC Lea, K Raj, GJ Mufti</div><div class="gs_gray">Gut 56 (8), 1174-1175<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2533877488420306058" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:lgwcVrK6X84C" class="gsc_a_at">Disseminated herpes virus (HSV-2) infection with rhabdomyolysis and hemophagocytic lymphohistiocytosis in a patient with bone marrow failure syndrome</a><div class="gs_gray">K Ramasamy, ZY Lim, M Savvas, JR Salisbury, I Dokal, GJ Mufti, ...</div><div class="gs_gray">Annals of hematology 85 (9), 629-630<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6888503702830276029" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PVjk1bu6vJQC" class="gsc_a_at">Early and Sustained Response to Azacytidine in High-Risk MDS Patients with Monosomy 7 Correlates with Increased Apoptosis and Not <i>CDKN2B</i> Demethylation.</a><div class="gs_gray">KK Raj, AM John, A Ho, NSB Thomas, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 2530-2530<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5321123775937276014" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:0N-VGjzr574C" class="gsc_a_at">Thalidomide therapy for low-risk myelodysplasia.</a><div class="gs_gray">D Bowen, L MacIlwaine, J Cavanagh, S Killick, D Culligan, E Thomson, ...</div><div class="gs_gray">Leukemia research 29 (2), 235-236<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6682579616281658285" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:mlAyqtXpCwEC" class="gsc_a_at">The aplasia-leukaemia syndrome</a><div class="gs_gray">GJ Mufti, TJ Hamblin, JP Lee-Potter</div><div class="gs_gray">Acta haematologica 69 (5), 349-352<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3504954439664616539" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:fbc8zXXH2BUC" class="gsc_a_at">Plasmapheresis and a placebo procedure in autoerythrocyte sensitisation.</a><div class="gs_gray">TJ Hamblin, S Hart, GJ Mufti</div><div class="gs_gray">British medical journal (Clinical research ed.) 283 (6306), 1575<span class="gs_oph">, 1981</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17302470686775999747" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1981</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:EmjvLWWcsQIC" class="gsc_a_at">Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia</a><div class="gs_gray">J Schetelig, LC De Wreede, M Van Gelder, L Koster, J Finke, ...</div><div class="gs_gray">Leukemia 33 (3), 686-695<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15563123106441653064" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:VRfTbSk87rEC" class="gsc_a_at">Clinical significance of acquired somatic mutations in aplastic anaemia</a><div class="gs_gray">JCW Marsh, GJ Mufti</div><div class="gs_gray">International journal of hematology 104 (2), 159-167<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3697605166221533079" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:buQ7SEKw-1sC" class="gsc_a_at">Bilateral retinal vasculopathy associated with autosomal dominant dyskeratosis congenita</a><div class="gs_gray">S Vaz-Pereira, PA Pacheco, S Gandhi, AG Kulasekararaj, JC Marsh, ...</div><div class="gs_gray">European journal of ophthalmology 23 (5), 772-775<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14326756503057447767" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:0CzhzZyukY4C" class="gsc_a_at">Fluorescence‐based experimental model to evaluate the concomitant effect of drugs on the tumour microenvironment and cancer cells</a><div class="gs_gray">K Ramasamy, H Khatun, L Macpherson, MP Caley, J Sturge, GJ Mufti, ...</div><div class="gs_gray">British journal of haematology 157 (5), 564-579<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13782676964813423066" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:umqufdRvDiIC" class="gsc_a_at">Allogeneic stem cell transplantation in patients with chronic myelomonocytic leukaemia: the impact of WHO classification and of the conditioning regimen on the transplantation&nbsp;…</a><div class="gs_gray">A Symeonidis, A Van Biezen, G Mufti, J Finke, D Beelen, M Bornhauser, ...</div><div class="gs_gray">Bone Marrow Transplant 45 (Suppl 2), S241<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12644117881364425484" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:yqoGN6RLRZoC" class="gsc_a_at">Results of a phase I/II British Society of Bone Marrow Transplantation study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection&nbsp;…</a><div class="gs_gray">ZY Lim, G Cook, PR Johnson, A Parker, M Zuckerman, D Marks, ...</div><div class="gs_gray">Leukemia research 33 (2), 244-249<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16390358724070109362" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QYdC8u9Cj1oC" class="gsc_a_at">Sarcoidosis as an unusual cause of hepatic dysfunction following reduced intensity conditioned allogeneic stem cell transplantation</a><div class="gs_gray">L Gooneratne, ZY Lim, A du Vivier, JR Salisbury, AS Knisely, AYL Ho, ...</div><div class="gs_gray">Bone marrow transplantation 39 (8), 511-512<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8743017924749828122" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:sNmaIFBj_lkC" class="gsc_a_at">Central role of leukemia-derived factors in the development of leukemia-associated immune dysfunction.</a><div class="gs_gray">W Hirst, A Buggins, G Mufti</div><div class="gs_gray">The hematology journal: the official journal of the European Haematology&nbsp;…<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15524408548944247046" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:GYcXSSpN504C" class="gsc_a_at">The myelodysplastic syndromes.</a><div class="gs_gray">JA Masey</div><div class="gs_gray">British journal of biomedical science 54 (1), 65-70<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1781720971366621833,5203115405582838331" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:HtEfBTGE9r8C" class="gsc_a_at">Fulminant fungal sinusitis following intensive chemotherapy</a><div class="gs_gray">R Kaczmarski, A Pagliuca, H Pullon, J Philpott-Howard, J Salisbury, ...</div><div class="gs_gray">QJM: An International Journal of Medicine 75 (1), 365-370<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4050771858063747421" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:NXb4pA-qfm4C" class="gsc_a_at">Basic isoferritin and hypercalcaemia in renal cell carcinoma</a><div class="gs_gray">GJ Mufti, TJ Hamblin, J Stevens</div><div class="gs_gray">Journal of clinical pathology 35 (9), 1008-1010<span class="gs_oph">, 1982</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17010113075170705192" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1982</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QxlgOPrhsAcC" class="gsc_a_at">Assessment of longer-term efficacy and safety in the phase 3, randomized, double-blind, placebo-controlled medalist trial of luspatercept to treat anemia in patients (pts) with&nbsp;…</a><div class="gs_gray">P Fenaux, GJ Mufti, R Buckstein, V Santini, M Díez-Campelo, C Finelli, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16984174791203448432" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:fixghrsIJ_wC" class="gsc_a_at">Somatic mutations in aplastic anemia</a><div class="gs_gray">GJ Mufti, JCW Marsh</div><div class="gs_gray">Hematology/Oncology Clinics 32 (4), 595-607<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3543457685409089231" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:yBJCJstOu-sC" class="gsc_a_at">Somatic mutations and clonal hematopoiesis in aplastic anemia</a><div class="gs_gray">GJ Mufti, AG Kulasekararaj, JCW Marsh</div><div class="gs_gray">The New England journal of medicine 373 (17), 1674-1675<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8823752089953419618" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:N4u4nq0IxgcC" class="gsc_a_at">Autologous stem cell transplantation (ASCT) for the treatment of patients with Waldenstrom’s macroglobulinemia/lymphoplasmacytic lymphoma (WM/LPL). a risk factor analysis by&nbsp;…</a><div class="gs_gray">C Kyriakou, A Boumendil, H Finel, JP Vernant, JJ Cornelissen, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 678-678<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2413085644175899613" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:6ZxmRoH8BuwC" class="gsc_a_at">Treatment of high-risk MDS patients (pts) with-7/del (7q) with azacitidine (AZA) versus conventional care regimens (CCR): Effects on overall survival (OS)</a><div class="gs_gray">GJ Mufti, P Fenaux, E Hellstrom-Lindberg, V Santini, AF List, S Gore, ...</div><div class="gs_gray">Journal of Clinical Oncology 26 (15_suppl), 7033-7033<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17228498612678074412" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:cWzG1nlazyYC" class="gsc_a_at">European multi-centre study on the use of anti-thymocyte globulin in the treatment of myelodysplastic syndromes.</a><div class="gs_gray">ZY Lim, S Killick, J Cavenagh, D Bowen, D Culligan, A Bacigalupo, ...</div><div class="gs_gray">Blood 106 (11), 2518<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15928209627790248486" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:OTTXONDVkokC" class="gsc_a_at">Liver transplantation for HCV‐related cirrhosis in a patient with gastric mucosa‐associated lymphoma (MALToma) pretreated with rituximab</a><div class="gs_gray">MR Foxton, L Knight, AS Knisely, GJ Mufti, J O'Grady, P Muiesan, S Norris</div><div class="gs_gray">Liver transplantation 11 (7), 839-842<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5046251396916906142" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:a9-T7VOCCH8C" class="gsc_a_at">Low-dose filgrastim therapy for chronic neutropenia</a><div class="gs_gray">RS Kaczmarski, GJ Mufti</div><div class="gs_gray">New England Journal of Medicine 329 (17), 1280-1281<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8284470382001271599" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:TEVcCiyi8yIC" class="gsc_a_at">COINFECTION WITH HTLV-IIII AND HIV-1</a><div class="gs_gray">A Pagliuca, GJ Mufti</div><div class="gs_gray">Lancet 336 (8711), 383-383<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8400218681334280636" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:r_AWSJRzSzQC" class="gsc_a_at">Polycythaemia rubra vera and hairy cell leukaemia in the same patient: studies on the spleen</a><div class="gs_gray">GJ Mufti, TJ Hamblin, FK Stevenson, M Fitchett</div><div class="gs_gray">Journal of clinical pathology 35 (12), 1312-1315<span class="gs_oph">, 1982</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14933252917955147846" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1982</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:AbQWx2m_oG8C" class="gsc_a_at">Clinical and morphological predictors of outcome in older aplastic anemia patients treated with eltrombopag</a><div class="gs_gray">B Fattizzo, AG Kulasekararaj, A Hill, N Benson-Quarm, M Griffin, T Munir, ...</div><div class="gs_gray">haematologica 104 (11), e494<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17272282595391488704" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:_u2aKJ9e-CoC" class="gsc_a_at">Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation</a><div class="gs_gray">N Gagelmann, DJ Eikema, M Stelljes, D Beelen, L de Wreede, G Mufti, ...</div><div class="gs_gray">haematologica 104 (5), 929<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6003165374746429319" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:P-MJmu9ZMwQC" class="gsc_a_at">Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a&nbsp;…</a><div class="gs_gray">C Scheid, L De Wreede, A van Biezen, C Koenecke, G Göhring, L Volin, ...</div><div class="gs_gray">Bone marrow transplantation 52 (11), 1519-1525<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12698559925694576496" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:pYRxIbzCxX0C" class="gsc_a_at">Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related&nbsp;…</a><div class="gs_gray">R Martino, A Henseler, M Van Lint, N Schaap, J Finke, D Beelen, ...</div><div class="gs_gray">Bone marrow transplantation 52 (8), 1107-1112<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10414909918010995032" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:HtS1dXgVpQUC" class="gsc_a_at">Influence of Karyotype On Overall Survival in Patients with Higher-Risk Myelodysplastic Syndrome Treated with Azacitidine or a Conventional Care Regimen.</a><div class="gs_gray">GJ Mufti, SD Gore, V Santini, P Fenaux, LR Silverman, A Hagemeijer, ...</div><div class="gs_gray">Blood 114 (22), 1755<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=933809816788048890" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:KbBQZpvPDL4C" class="gsc_a_at">Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4+ T cells in a subset of cultures</a><div class="gs_gray">W Ingram, S Kordasti, L Chan, LD Barber, GJ Tye, N Hardwick, GJ Mufti, ...</div><div class="gs_gray">Cancer immunology, immunotherapy 58 (10), 1679-1690<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11703808985519186819" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:1taIhTC69MYC" class="gsc_a_at">Azacitidine prolongs overall survival and reduces infections and hospitalisations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens&nbsp;…</a><div class="gs_gray">P Fenaux, GJ Mufti, E Hellström-Lindberg, V Santini, N Gattermann, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=284609982845550692" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:yFnVuubrUp4C" class="gsc_a_at">Sarcoidosis and haematological malignancies: is there an association?</a><div class="gs_gray">L Gooneratne, W Nagi, Z Lim, AYL Ho, S Devereux, A Pagliuca, GJ Mufti</div><div class="gs_gray">British journal of haematology 141 (2), 260-262<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6896936721754065347" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:GFxP56DSvIMC" class="gsc_a_at">Dose-limiting dermatological toxicity secondary to imatinib mesylate (STI571) in chronic myeloid leukaemia</a><div class="gs_gray">D Milojkovic, K Short, JR Salisbury, D Creamer, AWP Du Vivier, GJ Mufti</div><div class="gs_gray">Leukemia 17 (7), 1414-1416<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13816620815808256127" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:9c2xU6iGI7YC" class="gsc_a_at">Reduced-intensity allogeneic hematopoietic stem cell transplantation with alemtuzumab conditioning regimens: survival does not plateau until after day 200</a><div class="gs_gray">AYL Ho, M Kenyon, I El-Hemaidi, S Devereux, A Pagliuca, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 101 (2), 779-780<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7662539939050467402" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ODE9OILHJdcC" class="gsc_a_at">Pre-ALL and non-A, non-B hepatitis infection</a><div class="gs_gray">R Ireland, D Gillett, G Mieli-Vergani, G Mufti</div><div class="gs_gray">Leukemia research 12 (10), 795-797<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6978356023239978909" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:_cFkbNEifk0C" class="gsc_a_at">Human erythroid progenitors are directly infected by SARS-CoV-2: Implications for emerging erythropoiesis in severe COVID-19 patients</a><div class="gs_gray">HH Encabo, W Grey, M Garcia-Albornoz, H Wood, R Ulferts, IV Aramburu, ...</div><div class="gs_gray">Stem cell reports 16 (3), 428-436<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14050210858079196611" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:yL7DKRohVA8C" class="gsc_a_at">Use of hematopoietic cell transplantation for patients with myelodysplastic syndrome and chronic myelomonocytic leukemia</a><div class="gs_gray">T de Witte, D Bowen, M Robin, L Malcovati, D Niederwieser, ...</div><div class="gs_gray">Blood 129, 1753-62<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9059049758380712189" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:5AT-p8ixKR4C" class="gsc_a_at">British Society for Standards in Haematology</a><div class="gs_gray">SB Killick, N Bown, J Cavenagh, I Dokal, T Foukaneli, A Hill, P Hillmen, ...</div><div class="gs_gray">Guidelines for the diagnosis and management of adult aplastic anaemia. Br J&nbsp;…<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10119558162778464992" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ZYLUaBFA95QC" class="gsc_a_at">International Working Group on Morphology of Myelodysplastic Syndrome. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of&nbsp;…</a><div class="gs_gray">GJ Mufti</div><div class="gs_gray">Haematologica 93, 1713-1718<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15449790179909173539" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:O0MA3yP7Y3UC" class="gsc_a_at">Trisomy 10 and acute myeloid leukemia</a><div class="gs_gray">B Czepulkowski, AR Powell, A Pagliuca, GJ Mufti</div><div class="gs_gray">Cancer genetics and cytogenetics 134 (1), 81-83<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18092406300056495316" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:2VqYfGB8ITEC" class="gsc_a_at">Peripheral blood dendritic cells express CD52 and are depleted in-vivo by treatment with CAMPATH-1H.</a><div class="gs_gray">AGS Buggins, GJ Mufti, K Fishlock, M Arno, G Hale, H Waldmann, ...</div><div class="gs_gray">Blood 98 (11), 366A-367A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17862279095505843886" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LO7wyVUgiFcC" class="gsc_a_at">The “G-CSF test”: The response to a single dose of granulocyte colony-stimulating factor predicts mobilization of hemopoietic progenitors in patients with hematologic malignancies</a><div class="gs_gray">A Mijovic, A Pagliuca, GJ Mufti</div><div class="gs_gray">Experimental hematology 27 (7), 1204-1209<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10683378431665795018" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:6yz0xqPARnAC" class="gsc_a_at">Hemophagocytosis: a potential complication in small bowel transplantation</a><div class="gs_gray">P Muiesan, A Dhawan, J Wendon, GJ Mufti, J O'Grady, M Rela, ...</div><div class="gs_gray">Transplantation 66 (6), 794-796<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13128936359233631903" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:bKqednn6t2AC" class="gsc_a_at">Hypoalbuminaemia after prolonged treatment with recombinant granulocyte macrophage colony stimulating factor.</a><div class="gs_gray">RS Kaczmarski, GJ Mufti</div><div class="gs_gray">BMJ: British Medical Journal 301 (6764), 1312<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3582366430971323637" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:mNrWkgRL2YcC" class="gsc_a_at">Acute transformation of a myeloproliferative state in sideroblastic anaemia with abnormal karyotype.</a><div class="gs_gray">GJ Mufti, TJ Hamblin, M Seabright</div><div class="gs_gray">Journal of medical genetics 19 (6), 478<span class="gs_oph">, 1982</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14591840952392575403" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1982</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:hXkWDDAEazwC" class="gsc_a_at">Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European&nbsp;…</a><div class="gs_gray">K Halaburda, M Labopin, A Mailhol, G Socié, C Craddock, M Aljurf, ...</div><div class="gs_gray">haematologica 105 (6), 1723<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15458889415878605214" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:pxLfhFzThFYC" class="gsc_a_at">Hematologic improvement-neutrophil and-platelet in the MEDALIST Trial: Multilineage data from a phase 3, randomized, double-blind, placebo-controlled study of luspatercept to&nbsp;…</a><div class="gs_gray">G Garcia-Manero, GJ Mufti, P Fenaux, R Buckstein, V Santini, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17775769343962866191" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:KEtq3P1Vf8oC" class="gsc_a_at">Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation</a><div class="gs_gray">S Chitre, F Stölzel, K Cuthill, M Streetly, C Graham, C Dill, A Mohamedali, ...</div><div class="gs_gray">Leukemia 32 (9), 2020-2024<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12785558239806061750" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-uzm3Y7AvW0C" class="gsc_a_at">Life coaching following haematopoietic stem cell transplantation: a mixed‐method investigation of feasibility and acceptability</a><div class="gs_gray">M Kenyon, F Young, GJ Mufti, A Pagliuca, Z Lim, E Ream</div><div class="gs_gray">European journal of cancer care 24 (4), 531-541<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15071080050822932268" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:5MTHONV0fEkC" class="gsc_a_at">JAK Inhibition Reduces CD25 <sup>high</sup> CD27<sup>+</sup> FOXp3<sup>+</sup> T Regulatory Cells and Causes a Silencing Of T Effector Cells In Patients With Myeloproliferative Neoplasms&nbsp;…</a><div class="gs_gray">C Keohane, SY Kordasti, T Seidl, PP Abellan, NSB Thomas, GJ Mufti, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 4092-4092<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4238969700845623121" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:artPoR2Yc-kC" class="gsc_a_at">Effects on erythropoiesis of alemtuzumab‐containing reduced intensity and standard conditioning regimens</a><div class="gs_gray">A Mijovic, A Abdallah, L Pearce, K Tobal, GJ Mufti</div><div class="gs_gray">British journal of haematology 142 (3), 444-452<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11769688074585946622" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:3htObqc8RwsC" class="gsc_a_at">Cloretazine is an effective induction therapy in elderly patients (pts) with poor-risk de novo AML</a><div class="gs_gray">JE Karp, D Rizzieri, N Vey, G Mufti, R Geller, S O’Brien, F Giles</div><div class="gs_gray">Journal of Clinical Oncology 24 (18_suppl), 6512-6512<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9620704432146616043" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Bg7qf7VwUHIC" class="gsc_a_at">Epstein-Barr virus–related post-transplant lymphoproliferative disorder with t (9; 14)(p11∼ 12; q32)</a><div class="gs_gray">O Fasan, C Willmott, B Czepulkowski, A Baker, D Rees, J Salisbury, ...</div><div class="gs_gray">Cancer genetics and cytogenetics 142 (2), 134-136<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16916527927593629861" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:_5tno0g5mFcC" class="gsc_a_at">Allogeneic stem cell transplantation (SCT) in MDS: interim results of outcome following nonmyeloablative conditioning compared to standard preparative regimens</a><div class="gs_gray">JE Parker</div><div class="gs_gray">Blood 96 (1), 554a<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17349231243585766960" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Aul-kAQHnToC" class="gsc_a_at">The rate of disease progression predicts the quality of remissions following intensive chemotherapy for myelodysplastic syndromes</a><div class="gs_gray">WJR Hirst, GJ Mufti</div><div class="gs_gray">Leukemia research 18 (11), 797-804<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16036905847153061324" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LhH-TYMQEocC" class="gsc_a_at">Modification of standard proteinase K/phenol method for extraction of DNA from small tumour biopsies</a><div class="gs_gray">R Pitera, JE Pitera, GJ Mufti, JR Salisbury</div><div class="gs_gray">Pathology-Research and Practice 189 (8), 882-887<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4461611703118054004" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:fc7zyzPI2QAC" class="gsc_a_at">Erythropoietin: an old friend revisited.</a><div class="gs_gray">H Hambley, GJ Mufti</div><div class="gs_gray">BMJ: British Medical Journal 300 (6725), 621<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10145020673594675657" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:XR3BWSlh_xcC" class="gsc_a_at">Cytarabine in Pre-Leukaemia</a><div class="gs_gray">GT Mufti, DG Oscier, TJ Hamblin, A Copplestone, SMN Abidi</div><div class="gs_gray">The Lancet 323 (8387), 1187<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13762050562099311420" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:2MdNiwGT7yoC" class="gsc_a_at">The case for upfront HLA-matched unrelated donor hematopoietic stem cell transplantation as a curative option for adult acquired severe aplastic anemia</a><div class="gs_gray">JCW Marsh, AM Risitano, GJ Mufti</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 25 (9), e277-e284<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6700920022213518648" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:6xXPb0EiZccC" class="gsc_a_at">Novel ADA2 mutation presenting with neutropenia, lymphopenia and bone marrow failure in patients with deficiency in adenosine deaminase 2 (DADA2)</a><div class="gs_gray">RR Ghurye, K Sundaram, F Smith, B Clark, MA Simpson, L Fairbanks, ...</div><div class="gs_gray">British journal of haematology 186 (3), e60-e64<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=686660259811030964" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:u1IMlZnpNFQC" class="gsc_a_at">Impact of T‐cell depletion strategies on outcomes following hematopoietic stem cell transplantation for idiopathic aplastic anemia: A study on behalf of the European blood and&nbsp;…</a><div class="gs_gray">S Samarasinghe, K Clesham, S Iacobelli, G Sbianchi, C Knol, ...</div><div class="gs_gray">American journal of hematology 94 (1), 80-86<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=450793752911333653" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ojlX30-wUrgC" class="gsc_a_at">Baseline cytokine profiling identifies novel risk factors for invasive fungal disease among haematology patients undergoing intensive chemotherapy or haematopoietic stem cell&nbsp;…</a><div class="gs_gray">MM Ceesay, S Kordasti, E Rufaie, N Lea, M Smith, J Wade, A Douiri, ...</div><div class="gs_gray">Journal of Infection 73 (3), 280-288<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7678779627685031955" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Zh0EY9V9P6UC" class="gsc_a_at">Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial</a><div class="gs_gray">U Platzbecker, MA Sekeres, H Kantarjian, A Giagounidis, GJ Mufti, C Jia, ...</div><div class="gs_gray">Leukemia 28 (12), 2418-2421<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16019176059972083411" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:O0nohqN1r9EC" class="gsc_a_at">Transplant-acquired food allergy (TAFA) following cord blood stem cell transplantation in two adult patients with haematological malignancies</a><div class="gs_gray">J Feliu, J Clay, K Raj, L Barber, V Devlia, B Shaw, T Pagliuca, G Mufti</div><div class="gs_gray">British journal of haematology 167 (3), 426-428<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4759552156817948680" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:IaI1MmNe2tcC" class="gsc_a_at">Drug rash with eosinophilia and systemic symptoms and graft‐versus‐host disease developing sequentially in a patient</a><div class="gs_gray">J Natkunarajah, K Watson, S Diaz‐Cano, G Mufti, A Du Vivier, D Creamer</div><div class="gs_gray">Clinical and Experimental Dermatology: Clinical dermatology 34 (2), 199-201<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4913058014504330164" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:fFSKOagxvKUC" class="gsc_a_at">False positive results of galactomannan ELISA assay in haemato-oncology patients: a single centre experience.</a><div class="gs_gray">ZY Lim, AY Ho, S Devereux, GJ Mufti, A Pagliuca, J Wade, M Smith</div><div class="gs_gray">The Journal of infection 55 (2), 201-202<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10341405686694473832" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:_OXeSy2IsFwC" class="gsc_a_at">Rituximab salvage following relapse after allogeneic bone marrow transplantation for non‐hodgkin's lymphoma</a><div class="gs_gray">D Milojkovic, A Mijovic, CG Taylor, GJ Mufti, A Pagliuca</div><div class="gs_gray">British journal of haematology 110 (4), 1013-1014<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14365619733972626082" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:j7_hQOaDUrUC" class="gsc_a_at">Colchicine: an effective treatment for refractory malignant pericardial effusion</a><div class="gs_gray">T Ng, A Gatt, A Pagliuca, GJ Mufti</div><div class="gs_gray">Acta haematologica 104 (4), 217-219<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1683767474591138151" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:NyGDZy8z5eUC" class="gsc_a_at">Familial myelodysplastic syndromes: a key to understanding leukaemogenesis?</a><div class="gs_gray">A Mijovic, P Antunovic, A Pagliuca, G Mufti</div><div class="gs_gray">Leukemia Research 21 (S1), S6-S6<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14127163767356058093" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:HeT0ZceujKMC" class="gsc_a_at">Palmar-plantar erythema associated with combination chemotherapy.</a><div class="gs_gray">A Pagliuca, R Kaczmarski, GJ Mufti</div><div class="gs_gray">Postgraduate medical journal 66 (773), 242-243<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14691710847513158507" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:lvd772isFD0C" class="gsc_a_at">Primary myelodysplastic syndrome with complex chromosomal rearrangements in a patient with Klinefelter's syndrome.</a><div class="gs_gray">SM Abidi, M Griffiths, DG Oscier, GJ Mufti, TJ Hamblin</div><div class="gs_gray">Journal of medical genetics 23 (2), 183-185<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2468449654938077389" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:dBzKUGQurMsC" class="gsc_a_at">Diagnostic algorithm for lower-risk myelodysplastic syndromes</a><div class="gs_gray">GJ Mufti, DP McLornan, AA van de Loosdrecht, U Germing, ...</div><div class="gs_gray">Leukemia 32 (8), 1679-1696<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5384806192653403154" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:rqnDXT1GswoC" class="gsc_a_at">GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways</a><div class="gs_gray">L Guerenne, S Beurlet, M Said, P Gorombei, C Le Pogam, F Guidez, ...</div><div class="gs_gray">Journal of hematology &amp; oncology 9 (1), 1-20<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6375796546981306014" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:_mQi-xiA4oYC" class="gsc_a_at">Romiplostim in thrombocytopenic patients (Pts) with low-risk or intermediate-1 (Int-1)-risk myelodysplastic syndrome (MDS) results in reduced bleeding without impacting&nbsp;…</a><div class="gs_gray">H Kantarjian, GJ Mufti, P Fenaux, MA Sekeres, J Szer, U Platzbecker, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 2863-2863<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8698846816356871145" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:AYInfyleIOsC" class="gsc_a_at">Successful treatment of aplastic anaemia associated with HIV infection with eltrombopag: implications for a possible immunomodulatory role</a><div class="gs_gray">EE Bart-Smith, S Kordasti, AG Kulasekararaj, D Richardson, GJ Mufti, ...</div><div class="gs_gray">Aids 28 (18), 2786-2788<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10104040039427752646" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:2ywjKiB__4kC" class="gsc_a_at">Bone marrow hypocellularity does not affect tolerance or efficacy of azacitidine in patients with higher‐risk myelodysplastic syndromes</a><div class="gs_gray">JF Seymour, JM Bennett, AF List, GJ Mufti, SD Gore, P Fenaux, V Santini, ...</div><div class="gs_gray">British journal of haematology 165 (1), 49-56<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9300591493241560918" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Ei5r6KrKXVQC" class="gsc_a_at">Myelodysplastic syndrome</a><div class="gs_gray">MM Ceesay, W Ingram, GJ Mufti</div><div class="gs_gray">Dalam: Provan D, Gribben JG, editor (penyunting). Molecular Hematology&nbsp;…<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3551468270335491222" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:G887dSk7Sz8C" class="gsc_a_at">Relationship among gene methylation, azacitidine treatment, and survival in patients with higher-risk myelodysplastic syndromes (MDS): results from the AZA-001 trial</a><div class="gs_gray">JG Herman, S Gore, G Mufti, P Fenaux, V Santini, L Silverman, J Seymour, ...</div><div class="gs_gray">CANCER RESEARCH 69<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1714424070183344906" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ZzlSgRqYykMC" class="gsc_a_at">Serum profiling reveals distinctive proteomic markers in chronic myeloid leukaemia patients</a><div class="gs_gray">A Mohamedali, B Guinn, S Sahu, NS Thomas, GJ Mufti</div><div class="gs_gray">British journal of haematology 144 (2), 263-265<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15455666889577830747" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:F1b5ZUV5XREC" class="gsc_a_at">The effects of continued azacitidine treatment cycles on response in higher risk patients with myelodysplastic syndromes: an update</a><div class="gs_gray">LR Silverman, P Fenaux, GJ Mufti, V Santini, E Hellström-Lindberg, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3377419730758964416" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:5icHVeHT4IsC" class="gsc_a_at">Imatinib mesylate in myelofibrosis: Preliminary results show early sustained improvements in platelet counts and splenomegaly.</a><div class="gs_gray">AYL Ho, S Lim, K Fishlock, TH Yang, N Westwood, S Devereux, ...</div><div class="gs_gray">Blood 100 (11), 3155<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6589529945726553346" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:2tRrZ1ZAMYUC" class="gsc_a_at">Hairy cell leukaemia and Legionnaires' disease</a><div class="gs_gray">VJ Chowdhury, DG Oscier, GJ Mufti, TJ Hamblin</div><div class="gs_gray">British journal of diseases of the chest 79, 393-395<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4050887549923922884" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:OcBU2YAGkTUC" class="gsc_a_at">Exercise-induced urticaria and angio-oedema with relief from cromoglycate insufflation.</a><div class="gs_gray">S Hatty, GJ Mufti, TJ Hamblin</div><div class="gs_gray">Postgraduate medical journal 59 (695), 586-587<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9107234087240011128" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:fMcxjvj1mj8C" class="gsc_a_at">Epstein-Barr virus and monoclonal gammopathy of clinical significance in autologous stem cell transplantation for multiple sclerosis</a><div class="gs_gray">V Mehra, E Rhone, S Widya, M Zuckerman, V Potter, K Raj, ...</div><div class="gs_gray">Clinical Infectious Diseases 69 (10), 1757-1763<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3234589195443642368" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:9shLKfS_uJEC" class="gsc_a_at">Should patients with high-risk or transformed myelodysplastic syndrome proceed directly to allogeneic transplant without prior cytoreduction by remission-induction chemotherapy&nbsp;…</a><div class="gs_gray">TM De Witte, D Bowen, M Robin, L Malcovati, G Mufti, D Niederwieser, ...</div><div class="gs_gray">Clinical Lymphoma Myeloma and Leukemia 14, S42-S45<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3595901632270410537" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:WC23djZS0W4C" class="gsc_a_at">Challenges of phase III trial design for novel treatments in diseases with no standard treatment: the AZA-001 myelodysplasia study model</a><div class="gs_gray">P Fenaux, JF Seymour, V Santini, L Silverman, S Gore, A List, G Sanz, ...</div><div class="gs_gray">Leukemia research 38 (2), 258-262<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9791557346256627632" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:HGTzPopzzJcC" class="gsc_a_at">Primary effusion lymphoma in an HIV‐negative man</a><div class="gs_gray">SA Gandhi, G Mufti, S Devereux, R Ireland</div><div class="gs_gray">British journal of haematology 155 (4), 411-411<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17564239343995029588" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:BJbdYPG6LGMC" class="gsc_a_at">Anti-tumor immunity in a model of acute myeloid leukemia</a><div class="gs_gray">ATC Cheuk, JW Wells, L Chan, NB Westwood, SA Berger, H Yagita, ...</div><div class="gs_gray">Leukemia &amp; lymphoma 50 (3), 447-454<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15637505474604586411" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:jU7OWUQzBzMC" class="gsc_a_at">Leucoderma and leucotrichia in association with chronic cutaneous graft‐versus‐host disease</a><div class="gs_gray">JS Williams, GJ Mufti, AWP Du Vivier, JR Salisbury, D Creamer</div><div class="gs_gray">British Journal of Dermatology 158 (1), 172-174<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18429757305555782918" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:kWvqk_afx_IC" class="gsc_a_at">Acquired factor V inhibitor after haematopoietic stem cell transplantation</a><div class="gs_gray">D Milojkovic, R Patel, E Ford, R Arya, G Mufti</div><div class="gs_gray">Thrombosis and haemostasis 98 (09), 685-687<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3472571336911344495" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Ak0FvsSvgGUC" class="gsc_a_at">Extending the role of allogeneic stem-cell transplantion</a><div class="gs_gray">D Milojkovic, GJ Mufti</div><div class="gs_gray">The Lancet 357 (9257), 652-654<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=520516525169110870" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QD3KBmkZPeQC" class="gsc_a_at">Cutaneous presentation of Fusarium solani infection in a bone marrow transplant recipient</a><div class="gs_gray">FJ Child, LC Fuller, EM Higgins, AWP Du Vivier, GJ Mufti</div><div class="gs_gray">Journal of the Royal Society of Medicine 89 (11), 647-648<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=950891617101373458" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wMgC3FpKEyYC" class="gsc_a_at">Primary myelodysplastic syndrome: Prognostic value of FAB classification, scoring systems, bone marrow histology and karyotypic analysis</a><div class="gs_gray">GJ Mufti</div><div class="gs_gray">The Myelodysplastic Syndromes. Churchill Livingstone: London, 207-23<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3425339714001425512" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PVgj2kMGcgYC" class="gsc_a_at">Coulter S Plus STKR histograms detect spurious elevation of leucocyte and platelet counts associated with cryoglobulinaemia</a><div class="gs_gray">A Pagliuca, H Hambley, GJ Mufti</div><div class="gs_gray">Blut 59 (4), 396-397<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14221547792404190946" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4xDN1ZYqzskC" class="gsc_a_at">Acute vincristine neurotoxicity</a><div class="gs_gray">S Jalihal, N Roebuck, CE Davies, JA Copplestone, DG Oscier, GJ Mufti, ...</div><div class="gs_gray">The Lancet 325 (8429), 637-638<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16827481690879170889" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:gKiMpY-AVTkC" class="gsc_a_at">Melphalan-induced pulmonary fibrosis in osteosclerotic myeloma</a><div class="gs_gray">GJ Mufti, TJ Hamblin, J Gordon</div><div class="gs_gray">Acta haematologica 69 (2), 140-141<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7671063473620463163" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:eP5N1itS6b0C" class="gsc_a_at">Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia</a><div class="gs_gray">B Fattizzo, R Ireland, A Dunlop, D Yallop, S Kassam, J Large, S Gandhi, ...</div><div class="gs_gray">Leukemia, 1-9<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5241927868207395308" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:H8haQKU-3ZsC" class="gsc_a_at">Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7</a><div class="gs_gray">E Crisà, AG Kulasekararaj, V Adema, E Such, J Schanz, D Haase, ...</div><div class="gs_gray">Leukemia 34 (9), 2441-2450<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10290495590805937084" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:zaHkCSmj5XkC" class="gsc_a_at">The use of PARP inhibitors in cancer therapy: use as adjuvant with chemotherapy or radiotherapy, use as a single agent in susceptible patients, and techniques used to identify&nbsp;…</a><div class="gs_gray">S Shall, T Gaymes, F Farzaneh, NJ Curtin, GJ Mufti</div><div class="gs_gray">Poly (ADP-Ribose) Polymerase, 343-370<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5021073301222745842" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:M0leSnx2MbUC" class="gsc_a_at">Hypoplastic MDS is a distinct clinico-pathological entity with somatic mutations frequent in patients with prior aplastic anaemia with favorable clinical outcome</a><div class="gs_gray">AA Hunt, AB Khan, VT Potter, D McLornan, K Raj, H de Lavallade, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 3269-3269<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2233204102873114241" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:mWEH9CqjF64C" class="gsc_a_at">Treatment with romiplostim, a thrombopoietin-receptor agonist, in thrombocytopenic patients with low or intermediate-1 risk myelodysplastic syndrome: Updated follow-up results&nbsp;…</a><div class="gs_gray">HM Kantarjian, GJ Mufti, P Fenaux, MA Sekeres, J Szer, U Platzbecker, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 1553-1553<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18354019176011155944" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:6YFk0eKgftsC" class="gsc_a_at">Advances in malignant hematology</a><div class="gs_gray">HI Saba, G Mufti</div><div class="gs_gray">John Wiley &amp; Sons<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8107407367530726040" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LdasjJ6CEcoC" class="gsc_a_at">Evaluation of Bone Marrow Reticulin Formation in Romiplostim-Treated Adult Patients with Chronic Immune Thrombocytopenic Purpura (ITP).</a><div class="gs_gray">DJ Kuter, G Mufti, B Bain, R Hasserjian, M Rutstein</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 3416-3416<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17794832756607077883" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:u-coK7KVo8oC" class="gsc_a_at">Impact of the intensity of conditioning regimen in 144 patients with follicular lymphoma (FL) receiving a matched unrelated donor stem cell transplant (MUD-SCT): an analysis&nbsp;…</a><div class="gs_gray">A Sureda, I Avivi, C Canals, J Maertens, D Niederwieser, GJ Mufti, J Finke, ...</div><div class="gs_gray">Journal of Clinical Oncology 26 (15_suppl), 7036-7036<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16807772594296637026" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:7wO8s98CvbsC" class="gsc_a_at">Therapeutic strategies in the care of patients with myelodysplastic syndromes</a><div class="gs_gray">D Milojkovic, GJ Mufti</div><div class="gs_gray">BASIC AND CLINICAL ONCOLOGY 27, 465-516<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9082187585938565404" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:otzGkya1bYkC" class="gsc_a_at">Blast counts in blood progenitor cell (BPC) collections correlate with CD34+ cells and CFU-GM and are a useful predictor of haemopoietic recovery after autologous BPC&nbsp;…</a><div class="gs_gray">A Mijovic, K Fishlock, A Pagliuca, GJ Mufti</div><div class="gs_gray">Bone marrow transplantation 21 (9), 869-872<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10535945237228554578" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ALROH1vI_8AC" class="gsc_a_at">Application of the international scoring system for myelodysplasia to MD Anderson patients-Response</a><div class="gs_gray">P Greenberg, MM LeBeau, P Fenaux, P Morel, G Sanz, M Sanz, ...</div><div class="gs_gray">Blood 90 (7), 2844-2846<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7226474474049960335" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:K-tzbvM8PMoC" class="gsc_a_at">Biological significance of chromosomal abnormalities in the myelodysplastic syndromes</a><div class="gs_gray">M Thangabelu</div><div class="gs_gray">The Myelodysplastic Syndrome<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15925237228464491372" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:gVv57TyPmFsC" class="gsc_a_at">The myelodysplastic syndromes.</a><div class="gs_gray">DM Layton, GJ Mufti</div><div class="gs_gray">British medical journal (Clinical research ed.) 295 (6592), 227<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6494537938970823831" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:7LLGAk_PBK4C" class="gsc_a_at">Ectopic humanized mesenchymal niche in mice enables robust engraftment of myelodysplastic stem cells</a><div class="gs_gray">SA Mian, A Abarrategi, KL Kong, K Rouault-Pierre, H Wood, ...</div><div class="gs_gray">Blood cancer discovery 2 (2), 135<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9744944304086676957" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:7uOkfv6XYJ4C" class="gsc_a_at">An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial</a><div class="gs_gray">JC Marsh, SJ Stanworth, LA Pankhurst, D Kallon, AZ Gilbertson, C Pigden, ...</div><div class="gs_gray">Blood 137 (3), 310-322<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=851590653828735361" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ThYxFsVAhEkC" class="gsc_a_at">Treg sensitivity to FasL and relative IL-2 deprivation drive idiopathic aplastic anemia immune dysfunction</a><div class="gs_gray">SP Lim, B Costantini, SA Mian, P Perez Abellan, S Gandhi, ...</div><div class="gs_gray">blood 136 (7), 885-897<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15630594923856853584" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ZbXHRDTBJTgC" class="gsc_a_at">Luspatercept significantly reduces red blood cell (RBC) transfusion burden, regardless of gene mutation frequency, spectrum, and prognostic significance, among patients (pts&nbsp;…</a><div class="gs_gray">U Platzbecker, D Dunshee, RS Komrokji, GJ Mufti, G Garcia-Manero, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5461763372598760338" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:e0CZ6poB34oC" class="gsc_a_at">Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years</a><div class="gs_gray">VS Sheth, V Potter, SA Gandhi, AG Kulasekararaj, H de Lavallade, ...</div><div class="gs_gray">Blood advances 3 (20), 3070-3079<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16507952175383933567" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:gxb_f1p9zx4C" class="gsc_a_at"><i>miR‐181c</i>‐BRK1 axis plays a key role in actin cytoskeleton‐dependent T cell function</a><div class="gs_gray">SP Lim, N Ioannou, AG Ramsay, D Darling, J Gäken, GJ Mufti</div><div class="gs_gray">Journal of leukocyte biology 103 (5), 855-866<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9011001688073705232" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:NObE97JSLecC" class="gsc_a_at">Allogeneic stem cell transplantation for myelodysplastic syndrome patients with a 5q deletion</a><div class="gs_gray">L Garderet, D Ziagkos, A Van Biezen, S Iacobelli, J Finke, J Maertens, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 24 (3), 507-513<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12615637557626691346,1205256934285708407" class="gsc_a_ac gs_ibl">5</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="gZU2Ie8AAAAJ:NObE97JSLecC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:FtNbRaqWXr4C" class="gsc_a_at">Women administered standard dose imatinib for chronic myeloid leukemia have higher dose-adjusted plasma imatinib and norimatinib concentrations than men</a><div class="gs_gray">SL Belsey, R Ireland, K Lang, A Kizilors, A Ho, GJ Mufti, A Bisquera, ...</div><div class="gs_gray">Therapeutic drug monitoring 39 (5), 499-504<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11950000172119831393" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:YGhAHpnIhDoC" class="gsc_a_at">Impact of finding of low level kinase domain mutations using ultra deep next generation sequencing in patients with chronic phase CML</a><div class="gs_gray">A Kizilors, E Crisa, N Lea, S Best, M Syed, RM Ireland, M Aldouri, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 347-347<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13131214442519989924" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:GiYFt9mpioMC" class="gsc_a_at">Safety of lenalidomide (LEN) 10mg in non-del (5q) versus del (5q) in the treatment of patients (Pts) with lower-risk myelodysplastic syndromes (MDS): Pooled analysis of&nbsp;…</a><div class="gs_gray">A Almeida, V Santini, S Gröpper, A Jonasova, N Vey, A Giagounidis, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 2880-2880<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9014995028450473674" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:tHtfpZlB6tUC" class="gsc_a_at">Impact of different in vivo T cell depletion strategies on outcomes following hematopoietic stem cell transplantation for idiopathic aplastic anaemia: a study on behalf of the&nbsp;…</a><div class="gs_gray">S Samarasinghe, S Iacobelli, C Knol, RM Hamladji, G Socie, M Aljurf, ...</div><div class="gs_gray">Blood 126 (23), 1210<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10414751005157459088" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LPtt_HFRSbwC" class="gsc_a_at">Long term follow-up of BEAM-autologous and BEAM-alemtuzumab allogeneic stem cell transplantation in relapsed advanced stage follicular lymphoma</a><div class="gs_gray">V Noriega, H Kaur, S Devereux, J Byrne, R Marcus, A Haynes, D Yallop, ...</div><div class="gs_gray">Leukemia research 38 (7), 737-743<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5419471861702309628" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:DBa1UEJaJKAC" class="gsc_a_at">Development and Validation of a Model to Predict Response to Romiplostim in Patients with Lower-Risk Myelodysplastic Syndromes (MDS).</a><div class="gs_gray">MA Sekeres, A Giagounidis, HM Kantarjian, GJ Mufti, P Fenaux, C Jia, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 2801-2801<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11989695434242347768" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:7H_MAutzIkAC" class="gsc_a_at">Analysis of second primary malignancies in lenalidomide-treated patients with IPSS Low-or Int-1-Risk myelodysplastic syndromes</a><div class="gs_gray">A Giagounidis, A Raza, AF List, P Fenaux, B Benettaib, B Brown, J Zhong, ...</div><div class="gs_gray">Blood 118 (21), 1704<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11123521209514299834" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ziOE8S1-AIUC" class="gsc_a_at">The use of PARP inhibitors in cancer therapy: use as adjuvant with chemotherapy or radiotherapy; use as a single agent in susceptible patients; techniques used to identify&nbsp;…</a><div class="gs_gray">S Shall, T Gaymes, F Farzaneh, N Curtin, GJ Mufti</div><div class="gs_gray">Poly (ADP-ribose) Polymerase, 239-266<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12440736395303718744" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:DkZNVXde3BIC" class="gsc_a_at">MicroRNA expression profiling of high and low risk MDS</a><div class="gs_gray">J Gaken, A Mohamedali, N Twine, N Westwood, B Czepulkowski, ...</div><div class="gs_gray">Leukemia Research 33 (SUPPL. 1), S90-S91<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1222986586049836608,14579621932169832772" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:jL-93Qbq4QoC" class="gsc_a_at">Management and Supportive Care Measures of Adverse Events (AEs) in Higher-Risk MDS Patients (Pts) Treated with Azacitidine (AZA).</a><div class="gs_gray">V Santini, P Fenaux, GJ Mufti, E Hellström-Lindberg, LB Silverman, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 1653-1653<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=133882008536896068" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PaBasH6fAo0C" class="gsc_a_at">CD38 Expression in B-CLL Is Dynamic and Changes Due to Contact with Activating Stimuli Found within the Leukaemic Microenvironment.</a><div class="gs_gray">PEM Patten, AGS Buggins, J Richards, A Wotherspoon, TJ Hamblin, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 108 (11), 2798-2798<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2288443119930178276" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:1Ye0OR6EYb4C" class="gsc_a_at">Prolonged remission in a case of Richter's transformation of B-cell chronic lymphocytic leukaemia following adoptive immunotherapy</a><div class="gs_gray">D Milojković, M Aldouri, A Pagliuca, GJ Mufti, S Devereux</div><div class="gs_gray">Bone marrow transplantation 38 (6), 461-462<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15357266253066440858" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:jgBuDB5drN8C" class="gsc_a_at">Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London–2005</a><div class="gs_gray">RF Duarte, D Pamphilon, J Cornish, BE Shaw, D Samson, C Craddock, ...</div><div class="gs_gray">Bone marrow transplantation 37 (10), 901-908<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11159155879944972736" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:pS0ncopqnHgC" class="gsc_a_at">T-cell lymphoblastic lymphoma presenting as an intra-muscular mass</a><div class="gs_gray">ZY Lim, S Gupta, JR Salisbury, D Elias, NK Venkatram, GJ Mufti, ...</div><div class="gs_gray">Br J Haematol 132 (5), 537<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15616905141191174886" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ubry08Y2EpUC" class="gsc_a_at">Ancestim associated with Filgrastim and/or chemotherapy can improve blood progenitor yields in patients who previously failed mobilisation</a><div class="gs_gray">A Mijovic, N Russell, RE Clark, TCM Morris, P Browne, J Crown, M Potter, ...</div><div class="gs_gray">Bone marrow transplantation 35 (10), 1019-1019<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9803618279059749945" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:AHdEip9mkN0C" class="gsc_a_at">Reduced-intensity allogeneic haematopoietic stem cell transplantation (HSCT) in 75 patients with myelodysplastic syndromes following conditioning with fludarabine, busulphan&nbsp;…</a><div class="gs_gray">AYL Ho, M Kenyon, I El-Hemaidi, A Mijovic, S Devereux, A Pagliuca, ...</div><div class="gs_gray">Blood 102 (11), 263<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3999002054828351630" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:1yWc8FF-_SYC" class="gsc_a_at">Characterization of an AML-derived immunomodulatory factor (s) that inhibit T cell activation and the signal transduction pathways involved.</a><div class="gs_gray">AGS Buggins, MJ Arno, A Milojkovic, A Pagliuca, GJ Mufti, NSB Thomas, ...</div><div class="gs_gray">Blood 96 (11), 501A-501A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4689678360496172249" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:6_hjMsCP8ZoC" class="gsc_a_at">ANTITHYMOCYTE GLOBULIN FOR THE TREATMENT OF PATIENTS WITH'LOW RISK'MYELODYSPLASTIC SYNDROMES</a><div class="gs_gray">S Killick, JCW Marsh, J Cavenagh, A Mijovic, G Mufti, EC Gordon-Smith, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 105 (1S)<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13234827194293533943" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:BzfGm06jWhQC" class="gsc_a_at">The role of apoptosis, proliferation and amifostine in the myelodysplastic syndromes (MDS) and AML secondary to MDS.</a><div class="gs_gray">JE Parker, KL Fishlock, A Pagliuca, GJ Mufti</div><div class="gs_gray">Blood 92 (10), 418A-419A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14477926854932261240" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QVtou7C4vgoC" class="gsc_a_at">The pathophysiology and management of HIV-associated haematological abnormalities</a><div class="gs_gray">RS Kaczmarski, GJ Mufti</div><div class="gs_gray">Haematologia 25 (1), 1-17<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11090891295024858461" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:zCSUwVk65WsC" class="gsc_a_at">BEAM regimen and G-CSF in HTLV-I-associated T-cell lymphoma</a><div class="gs_gray">F Brito-Babapulle, R Arya, T Griffiths, A Pagliuca, GJ Mufti</div><div class="gs_gray">Lancet (British edition) 339 (8785), 133-134<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13642072518464838425" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:cK4Rrx0J3m0C" class="gsc_a_at">Development of polycythaemia vera in a patient with myelofibrosis</a><div class="gs_gray">I Dokal, A Pagliuca, M Deenmamode, GJ Mufti, SM Lewis</div><div class="gs_gray">European journal of haematology 42 (1), 96-98<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17015987961631180381" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Dem6FJhTUoYC" class="gsc_a_at">Coexistent lymphoid or plasma cell neoplasms</a><div class="gs_gray">AN Stark, CS Scott, BE Roberts, TJ HAMBLIN, JA COPPLESTONE</div><div class="gs_gray">British journal of haematology 65 (3), 376-377<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16464958906507700089" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:1lhNe0rCu4AC" class="gsc_a_at">LOW-DOSE CYTARABINE (ARA-C) IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML)</a><div class="gs_gray">GJ Mufti, DG Oscier, TJ Hamblin</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 61 (3), 571-571<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8018329986997574355" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:sJsF-0ZLhtgC" class="gsc_a_at">Delayed hemolytic transfusion reaction caused by anti-Fyb in a splenectomized patient.</a><div class="gs_gray">IP Boyland, GJ Mufti, TJ Hamblin</div><div class="gs_gray">Transfusion 22 (5), 402-402<span class="gs_oph">, 1982</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4206377071034609152" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1982</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:EVUe1p4rgj0C" class="gsc_a_at">Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European&nbsp;…</a><div class="gs_gray">E Domingo-Domenech, RF Duarte, A Boumedil, F Onida, I Gabriel, ...</div><div class="gs_gray">Bone marrow transplantation 56 (6), 1391-1401<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17245798441980596850" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:dYRx7efp7U0C" class="gsc_a_at">Health-related quality of life outcomes in patients with myelodysplastic syndromes with ring sideroblasts treated with luspatercept in the MEDALIST study</a><div class="gs_gray">EN Oliva, U Platzbecker, G Garcia-Manero, GJ Mufti, V Santini, ...</div><div class="gs_gray">Blood 136 (Supplement 1), 10-12<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6928647287131828563" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:irE4lMk4wWMC" class="gsc_a_at">Impact of Human Leucocyte Antigen epitope matched platelet transfusions in alloimmunised aplastic anaemia patients</a><div class="gs_gray">D Kallon, CV Navarrete, DA Sage, S Stanworth, GJ Mufti, JCW Marsh, ...</div><div class="gs_gray">Transfusion Medicine 30 (1), 23-29<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4638361255494342149" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wE8AsS3ykUMC" class="gsc_a_at">Neoantigens in MDS are associated with two novel CD4+ T cell subsets and improved overall survival</a><div class="gs_gray">T Coats, AE Smith, A Mourikis, T Shahin, AG Kulasekararaj, S Best, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 2958&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17107157986956285579" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:g9YHGIZn7mcC" class="gsc_a_at">Clinical efficacy of rituximab in the treatment of pemphigus vulgaris: A 10-year follow-up</a><div class="gs_gray">Z Laftah, E Craythorne, G Mufti, A du Vivier</div><div class="gs_gray">British Journal of Dermatology 177, 62-62<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3115035978411200578,9011186177115048647" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:fGk8ZXjgAbkC" class="gsc_a_at">Comparison of allogeneic stem cell transplantation for transformed acute myeloid leukemia derived from MDS, CMML or MPN. A report of the Chronic Malignancies Working Party of EBMT</a><div class="gs_gray">N Kröger, DJ Eikema, L De Wreede, A van Biezen, DW Beelen, J Finke, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 128 (22), 3499-3499<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5776120772702954726" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:nj26e0utjpAC" class="gsc_a_at">Mass cytometry reveals PD1 upregulation is an early step in MDS disease progression</a><div class="gs_gray">T Coats, A e Smith, TP Mourikis, JM Irish, S Kordasti, GJ Mufti</div><div class="gs_gray">Blood 128 (22), 4296<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3308927953297687640" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:_n8fIOMweQoC" class="gsc_a_at">The EBMT score predicts transplant related mortality and overall survival after allogeneic stem cell transplantation for myelodysplastic syndromes</a><div class="gs_gray">S Lozano, E Olavarria, S Iacobelli, A van Biezen, DW Beelen, J Finke, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 3223-3223<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16590172163808856814" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:oYwriLWYh5YC" class="gsc_a_at">NLRP3 Inflammosome polymorphisms are enriched in Myelodysplastic syndrome patients with autoimmune disorders</a><div class="gs_gray">SA Mian, AG Kulasekararaj, A Kizilors, KL McGraw, S Kordasti, S Menzel, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 1659-1659<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16119930409670624146" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:NXYAu82O0W8C" class="gsc_a_at">Treatment with Romiplostim, a thrombopoietin-receptor agonist, in thrombocytopenic patients (pts) with low or intermediate-1 (Int-1) risk myelodysplastic syndrome (MDS&nbsp;…</a><div class="gs_gray">HM Kantarjian, G Mufti, P Fenaux, M Sekeres, J Szer, U Platzbecker, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 3276-3276<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9971475659108024183" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:NDuN12AVoxsC" class="gsc_a_at">Allogeneic haematopoietic stem cell transplantation in myelodysplastic syndromes</a><div class="gs_gray">E Bart-Smith, GJ Mufti</div><div class="gs_gray">Current opinion in oncology 26 (6), 642-649<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1369137908077886986" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:3NQIlFlcGxIC" class="gsc_a_at">Azacitidine treatment for patients with myelodysplastic syndromes and acute myeloid leukemia harboring chromosome 3q abnormalities</a><div class="gs_gray">A Wanquet, C Berthon, M Sebert, C Roux, A Kulasekararaj, JB Micol, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 1512-1512<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5369084350196045987" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:CB2v5VPnA5kC" class="gsc_a_at">Myelodysplastic Syndromes</a><div class="gs_gray">F Schmalzl, GJ Mufti</div><div class="gs_gray">Springer Science &amp; Business Media<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16967742189212731032" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-mN3Mh-tlDkC" class="gsc_a_at">5-azacytidine specifically depletes regulatory t cells (tregs) in myelodysplastic syndrome (mds) patients</a><div class="gs_gray">B Costantini, SY Kordasti, AG Kulasekararaj, J Jiang, T Seidl, PP Abellan, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 787-787<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1667457048605721009" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:rTD5ala9j4wC" class="gsc_a_at">Alemtuzumab-based reduced-intensity conditioning allogeneic transplantation for myeloma and plasma cell leukemia–a single-institution experience</a><div class="gs_gray">K Ramasamy, S Mahmood, ZY Lim, S Corderoy, S Devereux, GJ Mufti, ...</div><div class="gs_gray">Clinical Lymphoma Myeloma and Leukemia 11 (2), 242-245<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16519550830776023273" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Ade32sEp0pkC" class="gsc_a_at">Prognostic factors of long-term outcomes in low-or int-1-risk MDS with del5q treated with lenalidomide (LEN): results from a randomized phase 3 trial (MDS-004)</a><div class="gs_gray">P Fenaux, A Giagounidis, O Beyne-Rauzy, G Mufti, M Mittelman, P Muus, ...</div><div class="gs_gray">Blood 116 (21), 4027<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9275079080358861490" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:2l5NCbZemmgC" class="gsc_a_at">Comparison of Low Dose Total Body Irradiation (TBI)-Based Reduced Intensity Conditioning (RIC) Vs. Chemotherapy-Based RIC Prior to Allogeneic Stem Cell Transplantation (allo&nbsp;…</a><div class="gs_gray">M Mohty, M Labopin, JJWM Janssen, GJ Mufti, JJ Cornelissen, NJ Milpied, ...</div><div class="gs_gray">Blood 114 (22), 1190<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14563413572452387856" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:kVjdVfd2voEC" class="gsc_a_at">Patient outcome measures during prolonged survival in patients (Pts) with high-risk myelodysplastic syndromes (MDS) treated with azacitidine (AZA)</a><div class="gs_gray">V Santini, P Fenaux, GJ Mufti, E Hellström-Lindberg, AF List, ...</div><div class="gs_gray">Journal of Clinical Oncology 26 (15_suppl), 7028-7028<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16465240892502920357" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:prdVHNxh-e8C" class="gsc_a_at">Prolonged survival in higher-risk myelodysplastic syndrome (MDS) patients (PTS) with-7/del (7Q) treated with azacitidine (AZA)</a><div class="gs_gray">GJ Mufti, G Garcia-Manero, N Hovarth, Z Lim, B Quesnel, G Leone, ...</div><div class="gs_gray">Haematologica 93, 369-370<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1002405939835206710" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:oi2SiIJ9l4AC" class="gsc_a_at">Combination Chemotherapy with CHOP-Daclizumab in HTLV-I Associated Adult T-Cell Leukaemia/Lymphoma.</a><div class="gs_gray">S Simpson, M Thanigaikumar, G Taylor, E Matutes, P Fields, S Devereux, ...</div><div class="gs_gray">Blood 108 (11), 2750<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12274704085795977690" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:jODAHDUrbwUC" class="gsc_a_at">Myelodysplastic syndromes (MDSs) and acute myelogenous leukemia (AML) comprise a closely linked continuum of malignant hematologic diseases. Introduction.</a><div class="gs_gray">SB Baylin, GJ Mufti</div><div class="gs_gray">Nature clinical practice. Oncology 2, S1-3<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12477822183647372061" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:CaZNVDsoPx4C" class="gsc_a_at">Reduced intensity conditioned allografts for chronic myeloid leukaemia: A study from the chronic leukaemia working party of the EBMT.</a><div class="gs_gray">CR Crawley, M Lalancette, R Szydlo, A Bacigalupo, A Lange, G Juliusson, ...</div><div class="gs_gray">Blood 100 (11), 3089<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5029181771831121616" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:BrOSOlqYqPUC" class="gsc_a_at">Non-caseating granulomata associated with hypocellular myelodysplastic syndrome</a><div class="gs_gray">T Ng, T Yeghen, A Pagliuca, DS Gillett, GJ Mufti</div><div class="gs_gray">Leukemia &amp; lymphoma 39 (3-4), 397-403<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14320153379350565825" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:jFemdcug13IC" class="gsc_a_at">AML-derived immunomodulatory factor (s) inhibit T cell cytokine secretion and proliferation via inhibition of NF-ATc activation and failure to upregulate C-MYC.</a><div class="gs_gray">AGS Buggins, N Lea, D Milojkovic, A Pagliuca, GJ Mufti, WJR Hirst</div><div class="gs_gray">Blood 94 (10), 596A-596A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13761677945441431281" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ON9TkA72AHEC" class="gsc_a_at">Opiates for sickle-cell crisis?</a><div class="gs_gray">DH Bevan</div><div class="gs_gray">The Lancet 351 (9120), 1965<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8695722013062755954" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:MAUkC_7iAq8C" class="gsc_a_at">Opiates for sickle-cell crisis?</a><div class="gs_gray">DM Layton, GJ Mufti</div><div class="gs_gray">The Lancet 351 (9120), 1964-1965<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16736739563723786507" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:kw52XkFRtyQC" class="gsc_a_at">Leukemic progression in myelodysplastic syndromes (MDS) is associated with decreased apoptosis and a reduced ratio of proversus anti-apoptotic Bcl-2 related proteins.</a><div class="gs_gray">JE Parker</div><div class="gs_gray">Blood 90, 520a<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6658025865263457430" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:FiytvqdAVhgC" class="gsc_a_at">Idarubicin, fludarabine, cytarabine and G-CSF (FLAG-IDA) for the treatment of high risk myeloid malignancies</a><div class="gs_gray">JE Parker, JO Cullis, A Mijovic, A Pagliuca, GJ Mufti</div><div class="gs_gray">Blood 88 (10), 1803-1803<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5595552749344640141" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:raTqNPD5sRQC" class="gsc_a_at">Myelodysplastic relapse of de-novo AML: a heterogeneous entity?</a><div class="gs_gray">DM Layton, RM Ireland, GJ Mufti, AJ Bellingham</div><div class="gs_gray">Leukemia research 11 (11), 1055-1056<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13017177722095796677" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:InLRhUNj-rwC" class="gsc_a_at">Results of the Ebmt Saawp Phase III Prospective Randomized Multicenter Race Study of Horse Atg and Ciclosporin with or Without Eltrombopag in Naive Saa Patients</a><div class="gs_gray">RP de Latour, J Marsh, S Iacobelli, S Terwel, A Hill, CJM Halkes, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 55 (SUPPL 1), 12-13<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16867040646571189973" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:HKuYlFsi-qEC" class="gsc_a_at">Efficacy and safety of Luspatercept treatment in patients with Myelodysplastic syndrome/Myeloproliferative neoplasm with ring Sideroblasts and thrombocytosis (MDS/MPN-RS-T): a&nbsp;…</a><div class="gs_gray">RS Komrokji, U Platzbecker, P Fenaux, G Garcia-Manero, GJ Mufti, ...</div><div class="gs_gray">Blood 136, 13-15<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1686536651755470954" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:vrnMIr82eJkC" class="gsc_a_at">Prognostic and predictive impact of small pnh clones in a large cohort of patients with myelodysplastic syndromes and aplastic anemia: a single-center experience</a><div class="gs_gray">B Fattizzo, A Dunlop, RM Ireland, S Kassam, D Consonni, D Yallop, ...</div><div class="gs_gray">Blood 132, 3870<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8584075562973724693" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:3wLP7v6BnpwC" class="gsc_a_at">Alemtuzumab vs anti‐thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioning</a><div class="gs_gray">M Robin, K Raj, S Chevret, J Gauthier, H De Lavallade, D Michonneau, ...</div><div class="gs_gray">European journal of haematology 101 (4), 466-474<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3024359756421979478" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:DrOLxFoABAwC" class="gsc_a_at">Hypoplastic Myelodysplastic Syndrome: Clinical, Histopathological and Molecular Characterization</a><div class="gs_gray">E Bono, D McLornan, E Travaglino, S Gandhi, A Gallì, AA Khan, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 588-588<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10759960343051796698" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:P2d6BWbXU0IC" class="gsc_a_at">Comparison of haematopoietic stem cell transplantation approaches in primary plasma cell leukaemia</a><div class="gs_gray">S Lawless, S Iacobelli, A van Biezen, L Koster, P Chevallier, D Blaise, ...</div><div class="gs_gray">Clinical Lymphoma, Myeloma and Leukemia 17 (1), e23<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1562300668176055369" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QYmifXMdJWgC" class="gsc_a_at">Allogeneic hematopoietic cell transplantation in elderly patients aged 65 and older: a retrospective analysis by the complications and quality of life working party of the EBMT</a><div class="gs_gray">GW Basak, I Sánchez-Ortega, E Beohou, S van der Werf, M Labopin, ...</div><div class="gs_gray">Blood 128 (22), 681<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9931355772251184618" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:0aBXIfxlw9sC" class="gsc_a_at">The safety and tolerability of azacitidine (AZA) are comparable in patients with acute myeloid leukemia (AML) or higher-risk myelodysplastic syndromes (MDS)</a><div class="gs_gray">JF Seymour, LR Silverman, H Döhner, P Fenaux, GJ Mufti, V Santini, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 3754-3754<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8873946495881021445" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:qwy9JoKyICEC" class="gsc_a_at">Clinical Characteristics and Treatment Allocations in Patients with Myelodysplastic Syndromes and Monosomy 7: Results from an International Multicenter Study Suggest That&nbsp;…</a><div class="gs_gray">J Schanz, F Braulke, GJ Mufti, E Crisà, A Kulasekararaj, K Nachtkamp, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 4656-4656<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7239375772008274244" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:CLhUwle04lcC" class="gsc_a_at">Results of a phase 1 study of BMN 673, a potent and specific PARP-1/2 inhibitor, in patients with advanced hematological malignancies</a><div class="gs_gray">GJ Mufti, E Estey, R Popat, R Mattison, T Menne, J Azar, A Bloor, ...</div><div class="gs_gray">Haematologica 99, 33-34<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18376633240504207915" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:eGYfIraVYiQC" class="gsc_a_at">Comprehensive Mutational Screening Of 5-Azacitidne Treated Myelodysplastic Syndrome (MDS) Patients Fails To Identify a Specific Mutational Profile Predicting Response To Therapy</a><div class="gs_gray">AG Kulasekararaj, AM Mohamedali, AE Smith, SA Mian, N Matto, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 2792-2792<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8823941471040825330" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:YsrPvlHIBpEC" class="gsc_a_at">Somatic mutations implicated in myeloid malignancies are frequent in idiopathic aplastic anaemia and its relevance to disease classification and treatment-a comprehensive&nbsp;…</a><div class="gs_gray">J Jiang, AG Kulasekararaj, AE Smith, AM Mohamedali, SA Gandhi, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 803-803<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12766454883248430396" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ZysSsiWj_g4C" class="gsc_a_at">O-016 Relationship of different platelet response criteria and patient outcomes in a Romiplostim MDS trial</a><div class="gs_gray">U Platzbecker, MA Sekeres, H Kantarjian, A Giagounidis, G Mufti, C Jia, ...</div><div class="gs_gray">Leukemia Research, S15-S16<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10175400879192647079" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:uVUOdF_882EC" class="gsc_a_at">National, retrospective, multi-centre comparison of alemtuzumab-versus ATG-based conditioning regimens in hematopoietic stem cell transplantation for aplastic anemia: a study&nbsp;…</a><div class="gs_gray">JCW Marsh, RM Pearce, MB Koh, D Tang, ZY Lim, A Pagliuca, GJ Mufti, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 52-52<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4821242725463231262" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:nRpfm8aw39MC" class="gsc_a_at">Telomere length in MDS patients bone marrow is highly correlated with complex cytogenetics, IPSS risk groups and transfusion dependency</a><div class="gs_gray">J Jiang, AG Kulasekararaj, P Krishnamurthy, AE Smith, SA Mian, ...</div><div class="gs_gray">Blood 118 (21), 3826<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3063671957438254366" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QyXJ3EUuO1IC" class="gsc_a_at">Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis</a><div class="gs_gray">W Nagi, ZY Lim, P Krishnamurthy, V Potter, V Tindell, L Reiff-Zall, ...</div><div class="gs_gray">Leukemia research 35 (8), 998-1000<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=888960888783926205" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QsaTk4IG4EwC" class="gsc_a_at">Mucous membrane pemphigoid following reduced intensity conditioning allogeneic haematopoietic SCT for biphenotypic leukaemia</a><div class="gs_gray">S Mahmood, ZY Lim, E Benton, A du Vivier, B Bhogal, GJ Mufti, ...</div><div class="gs_gray">Bone marrow transplantation 45 (1), 195-196<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4104720684950664642" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:L1USKYWJimsC" class="gsc_a_at">Contrasting Roles of Th1 and Th17 Cells in Aplastic Anaemia (AA) and Myelodysplastic Syndrome (MDS).</a><div class="gs_gray">SY Kordasti, SM AlKhan, Z Lim, PP Abellan, JCW Marsh, GJ Mufti</div><div class="gs_gray">Blood 114 (22), 1090<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=714313769740885564" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:rHJHxKgnXwkC" class="gsc_a_at">Azacitidine (AZA) improves overall survival (OS) in WHO acute myeloid leukemia (AML) in elderly patients with low bone marrow blast counts</a><div class="gs_gray">PF Fenaux, LR Silverman, GJ Mufti, E Hellstrom-Lindberg, V Santini, ...</div><div class="gs_gray">Haematologica 94, 430-431<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11552070665241883204" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:OlbiQ0ttILcC" class="gsc_a_at">C005 New definitions for blast cells in AML and MDS with validation by virtual microscopy</a><div class="gs_gray">JE Goasguen, JM Bennett, B Bain, R Brunning, MT Vallespi, C Cox, ...</div><div class="gs_gray">Leukemia Research, S25<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15243345129543320837" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:mKu_rENv82IC" class="gsc_a_at">Kinesin family member 20A (KIF20A) is specifically down regulated in 5q-CD34+ and CD61+ cells and uniparental disomy is not a feature of 5q-syndrome.</a><div class="gs_gray">NC Lea, A Mohamedali, N Twine, J Gaken, N Westwood, W Ingram, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 108 (11), 2611-2611<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1966708039020947945" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:7BrZ7Jt4UNcC" class="gsc_a_at">Real-time detection of PML-RARA and RARA-PML fusion transcripts in high risk acute promyelocytic leukemia (APL) treated with arsenic trioxide (ATO): Implications for&nbsp;…</a><div class="gs_gray">D Grimwade, JV Jovanovic, D Diverio, E Nugent, AY Ho, GJ Mufti, ...</div><div class="gs_gray">Blood 108 (11), 493<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3268074631871104409" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:WC9gN4BGCRcC" class="gsc_a_at">Reduced Intensity Allogeneic Transplantation Using BEAM-Alemtuzumab in Patients with Lymphoid Malignancy: Long Term Results and Impact of Intervention with DLI.</a><div class="gs_gray">EP Das-Gupta, JL Byrne, C Craddock, S Robinson, S Devereux, ...</div><div class="gs_gray">Blood 106 (11), 2890<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8072718332382976169" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-7ulzOJl1JYC" class="gsc_a_at">Phase II study of VNP40101M in patients (pts) with acute myelogenous leukemia (AML) and high-risk myelodysplasia (MDS)</a><div class="gs_gray">FJ Giles, S O’Brien, N Vey, E Feldman, D Rizzieri, KD Khan, SF Bilgrami, ...</div><div class="gs_gray">Journal of Clinical Oncology 23 (16_suppl), 6541-6541<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16058315896536702681,11748074165565741873" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:AXkvAH5U_nMC" class="gsc_a_at">Reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation with or without alemtuzumab in acute myelogenous leukaemia and myelodysplastic syndromes&nbsp;…</a><div class="gs_gray">R Martino, A Ho, J Sierra, M Caballero, J Pérez-Simón, A Pagliuca, ...</div><div class="gs_gray">Bone Marrow Transplantation 33<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12712844886884675358" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:UY3hNwcQ290C" class="gsc_a_at">Reduced-intensity allogeneic haematopoietic stem cell transplantation (HSCT) using fludarabine, busulphan and alemtuzumab conditioning in 63 patients with myelodysplastic&nbsp;…</a><div class="gs_gray">A Ho, M Kenyon, B Czepulkowski, R Padua, N Westwood, I El-Hemaidi, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3001021881554185640" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:jE2MZjpN3IcC" class="gsc_a_at">Allogeneic stem cell transplantation with matched related and unrelated donors for patients with refractory anemia: T-cell depletion and reduced intensity regimens are&nbsp;…</a><div class="gs_gray">TM De Witte, R Brand, A Van Biezen, P Guardiola, R Barge, T Ruutu, ...</div><div class="gs_gray">Blood 102 (11), 422<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16069789525571428925" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:qe6vwMD2xtsC" class="gsc_a_at">Reduced-intensity allogeneic haematopoietic stem cell transplantation for poor prognosis myelodysplastic syndromes using fludarabine, busulphan and CAMPATH-1H (alemtuzumab&nbsp;…</a><div class="gs_gray">AYL Ho, I El-Hemaidi, M Kenyon, A Pagliuca, S Devereux, G Mufti</div><div class="gs_gray">Blood 100 (11), 621A-621A<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6222994902375746813" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:SjuI4pbJlxcC" class="gsc_a_at">P15 (INK4B) is not mutated in adult familial myelodysplastic syndromes</a><div class="gs_gray">E Cameron, A Mijovic, JG Herman, SB Baylin, A Pradhan, GJ Mufti, ...</div><div class="gs_gray">British journal of haematology 119 (1), 277-279<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10945731368023145844" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:MIg0yeAD4ggC" class="gsc_a_at">Liver transplantation in children with primary immunodeficiencies</a><div class="gs_gray">N Hadzic, G Davies, M Rela, A Pagliuca, G Mufti, P Veys, A Jones, ...</div><div class="gs_gray">Hepatology 30 (4), 182A-182A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12170048068430396551" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:6bLC7aUMtPcC" class="gsc_a_at">Autologous blood or bone marrow transplantation for relapsed and partially responding low-grade non-Hodgkin's lymphoma.</a><div class="gs_gray">A Mijovic, J Parker, J Salisbury, A Pagliuca, GJ Mufti</div><div class="gs_gray">CANCER RESEARCH THERAPY &amp; CONTROL 5 (4), 253-260<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7660245491697091057" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:27LrP4qxOz0C" class="gsc_a_at">RAS gene mutations in Chinese leukaemia patients and members of a family with high incidence of leukaemia</a><div class="gs_gray">LZ He, J Stephenson, GY He, GJ Mufti</div><div class="gs_gray">Leukemia research 20 (11-12), 901-903<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7667255841805704668" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-jrNzM816MMC" class="gsc_a_at">Genotype study of non-Hodgkin's lymphoma</a><div class="gs_gray">R Pitera, JE Pitera, GJ Mufti, JR Salisbury</div><div class="gs_gray">Pathology-Research and Practice 191 (5), 444-455<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1174152789116828033" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Br1UauaknNIC" class="gsc_a_at">DO CD34<sup>+</sup> CELL COUNTS PREDICT HAEMOPOIETIC RECOVERY AFTER AUTOLOGOUS BLOOD STEM CELL TRANSPLANTATION (ABSCT)?</a><div class="gs_gray">A Mijovic, GJ Mufti, WI Bensinger</div><div class="gs_gray">British journal of haematology 89 (1), 226-227<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3043373131701685139" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:WHdLCjDvYFkC" class="gsc_a_at">Autologous blood stem cell transplantation in hematological malignancies</a><div class="gs_gray">A Mijovic, A Pagliuca, GJ Mufti</div><div class="gs_gray">Leukemia &amp; lymphoma 13 (1-2), 33-40<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8752747139060022330" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:3bvyWxjaHKcC" class="gsc_a_at">Evolution of a terminal deoxynucleotidyl transferase‐positive lymphoma from a chronic T cell lymphocytosis</a><div class="gs_gray">DG Oscier, GJ Mufti, TJ Hamblin, DB Jones, JL Smith</div><div class="gs_gray">Scandinavian journal of haematology 36 (2), 221-228<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10855039374386931143" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:RuPIJ_LgqDgC" class="gsc_a_at">Polycythemia rubra vera and Hairy Cell Leukaemia/Reply</a><div class="gs_gray">GJ Mufti, TJ Hamblin, FK Stevenson, M Fitchett</div><div class="gs_gray">Acta haematologica 73 (3), 189-189<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16520798988041696173" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LgRImbQfgY4C" class="gsc_a_at">Angiodysplasia of the colon in patients with hemostatic defects: risk of secondary hemorrhage after electrocoagulation treatment</a><div class="gs_gray">AJ Bell, GJ Mufti, DG Oscier, TJ Hamblin, DFC Shepherd</div><div class="gs_gray">Angiology 35 (8), 511-514<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2349070141579620476" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:vYYylRVofzEC" class="gsc_a_at">Patients with triple-negative, <i>JAK2</i>V617F- and <i>CALR</i>-mutated essential thrombocythemia share a unique gene expression signature</a><div class="gs_gray">S Alimam, W Villiers, R Dillon, M Simpson, M Runglall, A Smith, ...</div><div class="gs_gray">Blood advances 5 (4), 1059-1068<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2563153534421334715" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:U_h31ocWZrQC" class="gsc_a_at">Effects of luspatercept on serum ferritin in patients with lower-risk myelodysplastic syndromes with ring sideroblasts in the phase 3 MEDALIST trial</a><div class="gs_gray">P Fenaux, V Santini, GJ Mufti, M Diez-Campelo, C Finelli, MA Sekeres, ...</div><div class="gs_gray">Abstract presented at: the 25th European Hematology Association Congress<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16953791174517477259" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QC-2xSqExF4C" class="gsc_a_at">Assessment of dose-dependent response to luspatercept in patients with lower-risk myelodysplastic syndromes with ring sideroblasts in the phase 3 MEDALIST trial</a><div class="gs_gray">U Platzbecker, P Fenaux, GJ Mufti, G Garcia-Manero, RS Komrokji, ...</div><div class="gs_gray">Abstract presented at: the 25th European Hematology Association Congress<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1638001606594664402" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:8moDcb_GFzgC" class="gsc_a_at">Clinical benefit of luspatercept in patients (pts) with lower-risk MDS (LR-MDS) and high transfusion burden in the phase III MEDALIST study.</a><div class="gs_gray">AM Zeidan, G Garcia-Manero, AE Dezern, P Fenaux, PL Greenberg, ...</div><div class="gs_gray">Journal of Clinical Oncology 38 (15_suppl), 7554-7554<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17447302195374084893" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:BSZS1fLCB98C" class="gsc_a_at">Longer-term RBC transfusion reduction in the phase III MEDALIST study of luspatercept in patients (pts) with lower-risk MDS with ring sideroblasts (RS).</a><div class="gs_gray">RS Komrokji, MA Sekeres, AM Zeidan, P Fenaux, AF List, AE Dezern, ...</div><div class="gs_gray">Journal of Clinical Oncology 38 (15_suppl), 7518-7518<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=66596484240019252" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:AFXcoJnoRH0C" class="gsc_a_at">Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI)</a><div class="gs_gray">J Feliu, V Potter, F Grimaldi, J Clay, L Floro, C Saha, L Barber, G Orti, ...</div><div class="gs_gray">Bone marrow transplantation 55 (3), 562-569<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7588913619391679164" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Ltc9rfRcsxEC" class="gsc_a_at">The role of a critical care outreach service in the management of patients with haematological malignancy</a><div class="gs_gray">L Taheri, R Anandanadesan, H de Lavallade, E Pagkalidou, A Pagliuca, ...</div><div class="gs_gray">Journal of the Intensive Care Society 20 (4), 327-334<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15969896767189148958" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:kOdZbmsmKqcC" class="gsc_a_at">Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemia</a><div class="gs_gray">RS Sellar, V Mehra, TA Fox, A Grigg, A Kulasekararaj, A Sarma, ...</div><div class="gs_gray">British journal of haematology<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6281040958618394600" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:AeM5kdmBKVwC" class="gsc_a_at">Prevalence of small PNH clones and their prognostic significance in patients tested for unusual indications: A single center experience</a><div class="gs_gray">B Fattizzo, A Dunlop, R Ireland, S Kassam, D Yallop, G Mufti, J Marsh, ...</div><div class="gs_gray">Br. J. Haematol 185, 125<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6543841584499895489" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:kcGNQN_anIUC" class="gsc_a_at">Clinical intervention using NGS-based kinase domain mutation testing in CML Patients</a><div class="gs_gray">A Kizilors, P Harrington, S Jackson, N Lea, J Newman, R Gale, S Hassan, ...</div><div class="gs_gray">Blood 132, 3025<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15092206645624352681" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ExNiBuTMO9IC" class="gsc_a_at">Pre-symptomatic (Baseline) computed tomography predicts invasive pulmonary aspergillosis in high-risk adult haemato-oncology patients.</a><div class="gs_gray">MM Ceesay, SR Desai, J Cleverley, L Berry, M Smith, J Wade, GJ Mufti, ...</div><div class="gs_gray">British journal of haematology 182 (5), 723-727<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2251744307100125811" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wH03y5nBhxsC" class="gsc_a_at">British Committee for Standards in Haematology guidelines for aplastic anaemia: single centre retrospective review finds no compelling evidence for the recommended higher&nbsp;…</a><div class="gs_gray">M Yan, Y Lin, J Callum</div><div class="gs_gray">British journal of haematology 182 (2), 284-286<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17305100947487950034,5780988903390876442" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:o0eFlWRwRSUC" class="gsc_a_at">A randomized, open-label, phase II study of azacitidine (AZA) in combination with durvalumab in patients (pts) with previously untreated higher-risk myelodysplastic syndromes&nbsp;…</a><div class="gs_gray">LR Silverman, H Dohner, H Dombret, GJ Mufti, RM Stone, S Rose, ...</div><div class="gs_gray">Journal of Clinical Oncology 35 (15_suppl), TPS7074-TPS7074<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15500583444509278589" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:o-PowTg_VKEC" class="gsc_a_at">Pre-emptive donor lymphocyte infusion corrects deficiencies in the T-Cell repertoire after allogeneic haematopoietic stem cell transplantation with lymphocyte-depletion for&nbsp;…</a><div class="gs_gray">LD Barber, M Al Rakhayes, J Golding, J Feliu, P Perez-Abellan, L Floro, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 22 (3), S150<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13472411141244072049" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:yKzB5RS27GgC" class="gsc_a_at">Comparison of haematopoietic stem cell transplantation approaches in primary plasma cell leukaemia</a><div class="gs_gray">S Lawless, I Simona, A van Biezen, L Koster, P Chevallier, D Blaise, ...</div><div class="gs_gray">Blood 128 (22), 2293<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14505138218747887589" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:E2bRg1zSkIsC" class="gsc_a_at">Mutations in cohesin complex as potential targets for therapeutic intervention by PARP (Poly ADP ribose polymerase) Inhibitors in myelodysplastic syndrome</a><div class="gs_gray">N Matto, TJ Gaymes, AG Kulasekararaj, SA Mian, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 1221-1221<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18093540397964583350" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:BFa5h04uPMwC" class="gsc_a_at">The proinflammatory protein S100A9 suppresses erythropoietin elaboration in patients with myelodysplastic syndromes</a><div class="gs_gray">T Cluzeau, KL McGraw, B Irvine, E Masala, L Ades, AA Basiorka, GJ Mufti, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 355-355<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13382883507599524717" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:mUJArPsKIAAC" class="gsc_a_at">High resolution mass cytometry (CyTOF) in aplastic anaemia (AA) can identify an aberrant Treg subset with pro-inflammatory properties, predicting poor response to&nbsp;…</a><div class="gs_gray">S Kordasti, T Seidl, RJ Ellis, A Kulasekararaj, X Feng, DM Townsley, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 1600-1600<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12382684376090516282" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:EBV337fEn3EC" class="gsc_a_at">Feasibility and optimal schedule of using Eculizumab in patients with hemolytic Paroxysmal Nocturnal Hemoglobinuria (hPNH) with Severe Aplastic Anemia (SAA) prior to&nbsp;…</a><div class="gs_gray">AG Kulasekararaj, VT Potter, SA Gandhi, N Benson-Quarm, J Large, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 2482-2482<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2083219953721480519,1509955679129010237" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:s85pQhAUCrAC" class="gsc_a_at">Internal tandem duplication mutation of FLT3 (FLT3/ITD) induces increased homologous recombination DNA repair activity, drug resistance and sister chromatid exchanges in acute&nbsp;…</a><div class="gs_gray">TJ Gaymes, DC Darling, GJ Mufti</div><div class="gs_gray">Blood 122 (21), 1244<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16866554967095690353" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:X9ykpCP0fEIC" class="gsc_a_at">Outcomes in RBC transfusion-dependent patients (Pts) with low-/intermediate (Int)-1-risk myelodysplastic syndromes (MDS) with isolated deletion 5q treated with lenalidomide&nbsp;…</a><div class="gs_gray">A Giagounidis, GJ Mufti, M Mittelman, G Sanz, U Platzbecker, P Muus, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 2753-2753<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13070650323988208523" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:HJSXoJQnj-YC" class="gsc_a_at">SF3B1 mutant clones from patients with refractory anaemia with ringed sideroblasts (RARS) originate from the early haematopoietic stem cells and maintain their engraftment&nbsp;…</a><div class="gs_gray">SA Mian, K Rouault-Pierre, AE Smith, T Seidl, AG Kulasekararaj, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 262-262<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3695525583030513859" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:XUvXOeBm_78C" class="gsc_a_at">Characteristics and outcome of myelodysplastic syndromes (MDS) patients with autoimmune diseases</a><div class="gs_gray">RS Komrokji, AG Kulasekararaj, NH Al Ali, SY Kordasti, E Bart-smith, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 746-746<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11746887084012863973" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:uEM9VtRl8xsC" class="gsc_a_at">Bone marrow failure–causes and complications</a><div class="gs_gray">AG Kulasekararaj, GJ Mufti, JCW Marsh</div><div class="gs_gray">Medicine 41 (5), 257-260<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3076976690563960532,13298283261132949082" class="gsc_a_ac gs_ibl">2</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="gZU2Ie8AAAAJ:uEM9VtRl8xsC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-DxkuPiZhfEC" class="gsc_a_at">HCT-CI Is not a useful predictor for non relapse mortality in older patients (&gt; 60 years old) receiving RIC transplant for AML or MDS</a><div class="gs_gray">V Noriega, H de Lavallade, VT Potter, P Krishnamurthy, JCW Marsh, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 4158-4158<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7414404221467613703" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:VN7nJs4JPk0C" class="gsc_a_at">STAT3-Mutations indicate the presence of subclinical self-reactive cytotoxic T cell clones in aplastic anemia and myelodysplastic syndromes</a><div class="gs_gray">A Jerez, MJ Clemente, H Makishima, HLM Koskela, I Gómez-Seguí, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 646-646<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7842900996086918356" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:aU4yMueWZ3QC" class="gsc_a_at">A comprehensive diagnostic approach improves the diagnostic accuracy of invasive fungal disease in adult haemato-oncology patients undergoing HSCT or high-dose chemotherapy&nbsp;…</a><div class="gs_gray">M Ceesay, L Berry, S Desai, J Cleverly, C Kibbler, J Wade, M Smith, ...</div><div class="gs_gray">Bone Marrow Transplantation 47<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16685708901707601425" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:c1e4I3QdEKYC" class="gsc_a_at">Prospective Phase II Pilot Study of Rabbit Antithymocyte Globulin (ATG, Thymoglobuline) with Ciclosporin for Patients with Acquired Aplastic Anemia and Matched Pair Analysis&nbsp;…</a><div class="gs_gray">JC Marsh, G Socié, H Schrezenmeier, A Tichelli, AM Risitano, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 2408-2408<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12310459659827299770,13206260178262617578" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:DyXnQzXoVgIC" class="gsc_a_at">Investigation of the impact of myelodysplasia (MDS) from the patients' perspective</a><div class="gs_gray">SP McKenna, J Twiss, JN Wilburn, SR Crawford, K Loth, GJ Mufti</div><div class="gs_gray">Blood 118 (21), 5049<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5217748961041830927" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:aIdbFUkbNIkC" class="gsc_a_at">UK Estimates of Burden of Disease Associated with Management of Intermediate-2 or High-Risk Myelodysplastic Syndromes</a><div class="gs_gray">N Brereton, L Nicklasson, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 4749-4749<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4694831858775173579" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:pAkWuXOU-OoC" class="gsc_a_at">Whole exome sequencing reveals acquired SF3B1 mutations defining patients with acquired idiopathic sideroblastic anaemia</a><div class="gs_gray">AE Smith, SA Mian, AG Kulasekararaj, AM Mohamedali, GJ Mufti</div><div class="gs_gray">Blood 118 (21), 2793<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6547440542980078694" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:zdjWy_NXXwUC" class="gsc_a_at">The myelodysplastic syndromes</a><div class="gs_gray">TJT Chevassut, GJ Mufti</div><div class="gs_gray">Postgraduate Haematology, 503-529<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1978528707559438213" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:U_HPUtbDl20C" class="gsc_a_at">Comparison of low-dose TBI-Based reduced-intensity conditioning (RIC) vs. chemotherapy-based RIC prior to allogeneic stem cell transplantation from an HLA identical sibling&nbsp;…</a><div class="gs_gray">M Mohty, M Labopin, J Janssen, G Mufti, JJ Cornelissen, N Milpied, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 45, S38-S39<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1428061533328230555" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:OBSaB-F7qqsC" class="gsc_a_at">Predicting thrombotic complications after liver transplantation in patients with Budd Chiari syndrome</a><div class="gs_gray">R Westbrook, D Orr, N Heaton, J O'Grady, R Patel, N Lea, A Smith, ...</div><div class="gs_gray">Liver Transplantation 16 (6), S72-S72<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=63771091467515150" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:__bU50VfleQC" class="gsc_a_at">Abstract# 4746: Relationship among gene methylation, azacitidine treatment, and survival in patients with higher-risk myelodysplastic syndromes (MDS): results from the AZA-001&nbsp;…</a><div class="gs_gray">JG Herman, S Gore, G Mufti, P Fenaux, V Santini, L Silverman, J Seymour, ...</div><div class="gs_gray">Cancer Research 69 (9 Supplement), 4746-4746<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12297406577839062073" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:SAZ1SQo2q1kC" class="gsc_a_at">A review of 100 consecutive cases of myelodysplastic syndrome with skin disorders: O-13</a><div class="gs_gray">E Benton, E Craythorne, Z Lim, G Mufti, A du Vivier</div><div class="gs_gray">British Journal of Dermatology 159<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14518588817188319403" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:RtRctb2lSbAC" class="gsc_a_at">Relationship of progression to acute myeloid leukemia (AML) from myelodysplastic syndrome (MDS) and cytogenetic status</a><div class="gs_gray">E Hellstrom-Lindberg, P Fenaux, GJ Mufti, AF List, V Santini, S Gore, ...</div><div class="gs_gray">Journal of Clinical Oncology 26 (15_suppl), 7089-7089<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18323202621464911909" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LNjCCq68lIgC" class="gsc_a_at">Large Field Virtual Microscopy as a Tool for Quality Control and Blast Definitions in MDS and Leukemia. From the International Working Group on MDS.</a><div class="gs_gray">JE Goasguen, JM Bennett, B Bain, R Brunning, MT Vallespi, C Cox, ...</div><div class="gs_gray">Blood 108 (11), 2616<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5270281137169299334" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:F2UWTTQJPOcC" class="gsc_a_at">Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Myelodysplastic Syndromes 50 Years or Older. A Retrospective Survey from the EBMT.</a><div class="gs_gray">ZY Lim, R Brand, A van Biezen, J Finke, DW Niederwieser, T Ruutu, ...</div><div class="gs_gray">Blood 108 (11), 520<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11689334652694495359" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:5bg8sr1QxYwC" class="gsc_a_at">Reduced intensity conditioned volunteer unrelated donor transplants using alemtuzumab are safe and effective in older patients with myelodysplastic syndromes.</a><div class="gs_gray">ZY Lim, A Ho, M Kenyon, S Devereux, R Duarte, A Pagliuca, G Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 444-444<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14298546245554581803,4910930923326253333" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ce2CqMG-AY4C" class="gsc_a_at">Use of a Disease-Specific Comorbidity Index To Describe Elderly Patients with Acute Myelogenous Leukemia (AML) and High Risk Myelodysplasia (MDS) Enrolled in a Phase II Study&nbsp;…</a><div class="gs_gray">F Giles, D Rizzieri, J Karp, N Vey, K Khan, G Mufti, D Hudak, V Karsten, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 2787-2787<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2845704737558069135" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:hGdtkIFZdKAC" class="gsc_a_at">CD38 expression in B-CLL is not fixed and may change due to contact with activating stimuli found within the leukaemic microenvironment</a><div class="gs_gray">PEM Patten, AGS Buggins, J Richards, GJ Mufti, S Devereux</div><div class="gs_gray">British Journal of Haematology 129, 79<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=102439514079179677" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:w0F2JDEymm0C" class="gsc_a_at">Emerging therapeutic and supportive care approaches for the myelodisplastic syndromes</a><div class="gs_gray">GJ Mufti</div><div class="gs_gray">Reviews in clinical and experimental hematology 8 (2), E4<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8768978166511220802" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-95Q15plzcUC" class="gsc_a_at">Analysis of Beam (Carmustine, Etoposide, Cytosine Arabinoside, Melphalan) Versus High Dose Melphalan (HDM) with Autologous Rescue in Multiple Myeloma (MM).</a><div class="gs_gray">KA Ramasamy, R Branford, R Selvaratnam, AYL Ho, R Duarte, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 5227-5227<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4233342309720786198" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:CdxZDUztZiMC" class="gsc_a_at">5-azacytidine in the treatment of high risk myelodysplastic syndromes: Clinical response can occur without demethylation of the CDKN2B, CDKN1A or TP73 gene promoters.</a><div class="gs_gray">K Raj, A John, A Ho, NSB Thomas, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 2369-2369<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7370346398602270927" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:KNjnJ3z-R6IC" class="gsc_a_at">Comparative trial of aazacitidine versus conventional care in high risk MDS patients: Methodologic challenges in designing an international survival trial.</a><div class="gs_gray">AF List, JC Byrd, P Fenaux, SD Gore, E Hellstrom-Lindberg, GJ Mufti, ...</div><div class="gs_gray">Blood 102 (11), 5056<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5572878640530036494" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:SZzxPo9m4nkC" class="gsc_a_at">Acute lymphoblastic leukemia</a><div class="gs_gray">WA Bleyer</div><div class="gs_gray">Therapy of Cancer in Children. New York, Clinical Insights, 8-10<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11721941017828814019" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wuD5JclIwkYC" class="gsc_a_at">MDS DENDRITIC CELLS ARE PHENOTYPICALLY AND FUNCTIONALLLY DIFFERENT FROM THOSE OBTAINED IN HEALTHY SUBJECTS</a><div class="gs_gray">GM Rigolin, W HIRST, A BUGGINS, C SNEDDON, G CASTOLDI, ...</div><div class="gs_gray">HAEMATOLOGICA-PAVIA THEN ROMA- 84 (9; SUPP/1), 275-275<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7235952614758385382" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:WAzi4Gm8nLoC" class="gsc_a_at">Induction of human T cell responses to tumour-associated neoantigens and virus antigens using cultured dendritic cells</a><div class="gs_gray">JIN LI, G BOWEN, JJ MURPHY, HUW DAVIES, S HOLLINGSWORTH, ...</div><div class="gs_gray">Biochemical Society Transactions 25 (2), 204S-204S<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13080733343123262467" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:HhcuHIWmDEUC" class="gsc_a_at">International workshop consensus risk analysis system for myelodysplastic syndromes (MDS).</a><div class="gs_gray">P Greenberg, P Fenaux, P Morel, G Sanz, M Sanz, T Vallespi, T Hamblin, ...</div><div class="gs_gray">Blood 86 (10), 1065-1065<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7950227525665113503" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:EPG8bYD4jVwC" class="gsc_a_at">TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE-EXPERIENCE IN A SINGLE-CENTER</a><div class="gs_gray">R JANMOHAMED, H Hambley, H Gamsu, GJ Mufti</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 84, 10-10<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14425380418338311976" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:RoXSNcbkSzsC" class="gsc_a_at">Therapy of myelodysplastic syndromes: advances and perspectives. Innsbruck, Austria, October 7-10, 1990.</a><div class="gs_gray">H Zwierzina, GJ Mufti, F Schmalzl</div><div class="gs_gray">Leukemia 5 (2), 166-185<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2155212529214122376" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:yxmsSjX2EkcC" class="gsc_a_at">Human cancer DNA fingerprint analysis.</a><div class="gs_gray">DM Layton, GJ Mufti</div><div class="gs_gray">British journal of cancer 56 (3), 381<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1697362219692142766" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:An6A6Jpfc1oC" class="gsc_a_at">COEXISTENT LYMPHOID OR PLASMA-CELL NEOPLASMS</a><div class="gs_gray">TJ Hamblin, JA Copplestone, GJ Mufti, DG Oscier</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 65 (3), 377-377<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14503785568769504418" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-nhnvRiOwuoC" class="gsc_a_at">Angio-immunoblastic lymphadenopathy with hypogammaglobulinaemia complicated by miliary tuberculosis</a><div class="gs_gray">S Hatty, GJ Mufti, TJ Hamblin</div><div class="gs_gray">Acta haematologica 73 (1), 37-39<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11698240023638288649" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PyEswDtIyv0C" class="gsc_a_at">CHROMOSOMAL ANALYSES IN 52 CASES OF B-CLL</a><div class="gs_gray">DG Oscier, GJ Mufti, M Fitchett, TJ Hamblin, M Seabright</div><div class="gs_gray">British Journal of Haematology 61 (3), 573-573<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1237599609009885098" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PYBJJbyH-FwC" class="gsc_a_at">Cytogenetic analysis of 113 patients with myelodysplastic syndrome</a><div class="gs_gray">M Fitchett, MJ Griffiths, GJ Mufti, TJ Hamblin, DG Oscier, M Seabright</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 61 (3), 571-571<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12907166685439269511" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LGh1lRt-7sUC" class="gsc_a_at">Mixed T cell lineage chimerism in acute leukemia/MDS using pre-emptive donor lymphocyte infusion strategy—Is it prognostic?—a single-center retrospective study</a><div class="gs_gray">V Sheth, V Potter, H de Lavallade, S Gandhi, A Kulasekararaj, ...</div><div class="gs_gray">Blood Cancer Journal 11 (7), 1-6<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11286565287913025703" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:W91e3rS6dHEC" class="gsc_a_at">Guidelines for the diagnosis and evaluation of prognosis of adult myelodysplastic syndromes</a><div class="gs_gray">SB Killick, DH Wiseman, L Quek, C Cargo, D Culligan, H Enright, S Green, ...</div><div class="gs_gray">British journal of haematology<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17619363368408123043" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LZ55yeyZZb4C" class="gsc_a_at">Guidelines for the management of adult myelodysplastic syndromes</a><div class="gs_gray">SB Killick, W Ingram, D Culligan, H Enright, J Kell, EM Payne, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1443672554747451489" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:rsrKZ8bNWIsC" class="gsc_a_at">Single and dual targeting chimeric antigen receptor T-cell therapy in acute myeloid leukemia</a><div class="gs_gray">S Chitre, J Gaken, A Venuso, GJ Mufti</div><div class="gs_gray">Blood 136, 25<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16002227305265755930" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:o0tJHVzi6PsC" class="gsc_a_at">Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipients</a><div class="gs_gray">V Anton-Vazquez, V Mehra, JL Mbisa, D Bradshaw, TN Basu, ML Daly, ...</div><div class="gs_gray">Journal of Clinical Virology 128, 104421<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17422180537958993168" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:52neCvzbxIwC" class="gsc_a_at">Non-del (5q) myelodysplastic syndromes–associated loci detected by SNP-array genome-wide association meta-analysis</a><div class="gs_gray">KL McGraw, CH Cheng, YA Chen, HA Hou, B Nilsson, G Genovese, ...</div><div class="gs_gray">Blood advances 3 (22), 3579-3589<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2515615109172508498" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:SC9kKMAi-DoC" class="gsc_a_at">Pacritinib demonstrates efficacy versus best available therapy in myelofibrosis patients with severe thrombocytopenia in two phase 3 studies</a><div class="gs_gray">RA Mesa, M Talpaz, JJ Kiladjian, CN Harrison, S Verstovsek, SA Buckley, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15569448682961325133" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:oMtqKo3K3HAC" class="gsc_a_at">Intractable pruritus in chronic myelomonocytic leukaemia and myelodysplastic syndromes: a case series</a><div class="gs_gray">MM Ceesay, TN Basu, A du Vivier, GJ Mufti</div><div class="gs_gray">BMJ Case Reports CP 12 (10), e232480<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14488810304580873580" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:AzjrKLz9U9oC" class="gsc_a_at">Clinical Intervention Using NGS-Based Kinase Domain Mutation Testing in CML Patients</a><div class="gs_gray">P Harrington, S Jackson, A Kizilors, N Lea, J Newman, R Gale, S Hassan, ...</div><div class="gs_gray">Clinical Lymphoma, Myeloma and Leukemia 19, S293-S294<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6395531232328347984" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wuYnf3tzzDUC" class="gsc_a_at">Differential interaction of peripheral blood lymphocyte counts (ALC) with different in vivo depletion strategies in predicting outcomes of allogeneic transplant: an&nbsp;…</a><div class="gs_gray">V Sheth, V Kennedy, H de Lavallade, D Mclornan, V Potter, ...</div><div class="gs_gray">Frontiers in oncology 9, 623<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8540649244162395910" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:hZ5_QnqxF7AC" class="gsc_a_at">THE EFFICACY OF IBRUTINIB IN PATIENTS WITH RELAPSED MANTLE CELL LYMPHOMA AFTER FIRST LINE INTENSIVE CHEMO‐IMMUNOTHERAPY AND ASCT–A RETROSPECTIVE STUDY FROM THE LWP‐EBMT</a><div class="gs_gray">CN Burney, S Robinson, A Boumendil, H Finel, I Khvedelidze, H Hunter, ...</div><div class="gs_gray">Hematological Oncology 37, 243-244<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1876884983436590921" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:0kLwNjf3oFwC" class="gsc_a_at">Shortened telomeres in essential thrombocythemia: clinicopathological and treatment correlations</a><div class="gs_gray">S Alimam, DP McLornan, J Jiang, D Radia, GJ Mufti, CN Harrison</div><div class="gs_gray">haematologica 103 (6), e234<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8214906010794657977" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:9fRKRCJz75UC" class="gsc_a_at">Eltrombopag in a real world cohort of aplastic anemia patients: large retrospective analysis of two UK centers</a><div class="gs_gray">B Fattizzo, N Benson-Quarm, A Hill, L Arnold, K Riley, T Munir, M Griffin, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 181, 9-9<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10188126912546643698" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:pcWPcJyQGiUC" class="gsc_a_at">Diagnosis and Prognosis: Molecular</a><div class="gs_gray">AG Kulasekararaj, O Kosmider, GJ Mufti</div><div class="gs_gray">Myelodysplastic Syndromes, 15-37<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17351251548326919483" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:2mikiJ1VBVsC" class="gsc_a_at">Allogeneic hematopoietic stem cell transplantation in older patients aged 50 years or older with severe aplastic anaemia: Results from the European Society for Blood and Marrow&nbsp;…</a><div class="gs_gray">C Rice, DJ Eikema, J Marsh, C Knol, K Hebert, E Petersen, HJ Deeg, ...</div><div class="gs_gray">Blood 130, 2446<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5728488029573779302" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:0iM-huCvmk0C" class="gsc_a_at">Outcomes of Patients with Pre-Existing Invasive Fungal Disease Undergoing Allogeneic Haematopoietic Stem Cell Transplantation—5 Years Single Centre Experience</a><div class="gs_gray">V Mehra, E Barnwell, U Boczek, S Widya, K Raj, H De Lavallade, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 3216&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17362578965783625426" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PQY3Tb_h0-cC" class="gsc_a_at">CD123-Specific Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukaemia</a><div class="gs_gray">S Chitre, J Gaken, A Venuso, G Mufti</div><div class="gs_gray">HAEMATOLOGICA 102, 207-207<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6344717728679139006" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Qh5Z_vBjo80C" class="gsc_a_at">Immunosuppressive therapy for aplastic anemia</a><div class="gs_gray">JCW Marsh, S Gandhi, GJ Mufti</div><div class="gs_gray">Congenital and Acquired Bone Marrow Failure, 73-89<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1149881088568940408" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:654Jc7Ppz2kC" class="gsc_a_at">Guidelines for the diagnosis and management of adult aplastic anaemia (vol 172, pg 187, 2016)</a><div class="gs_gray">SB Killick, N Bown, J Cavenagh, I Dokal, T Foukaneli, A Hill, P Hillmen, ...</div><div class="gs_gray">British Journal of Haematology 175 (3), 546-546<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11032770187233918793" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ZZwcLRaXOV4C" class="gsc_a_at">Treatment-emergent adverse events (TEAEs) in lenalidomide (LEN)-treated Low-/Int-1-risk myelodysplastic syndromes (MDS) patients (pts) without del (5q) ineligible for or&nbsp;…</a><div class="gs_gray">AM Almeida, P Fenaux, G Garcia-Manero, A Giagounidis, S Goldberg, ...</div><div class="gs_gray">Journal of Clinical Oncology 34 (15_suppl), 7061-7061<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2802747290506975226" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:mnAcAzq93VMC" class="gsc_a_at">A randomized, open-label, phase II study of CC-486 (oral azacitidine), alone or in combination with durvalumab (MEDI4736), in patients (pts) with myelodysplastic syndromes (MDS&nbsp;…</a><div class="gs_gray">P Fenaux, LR Silverman, GJ Mufti, JF Seymour, RS Komrokji, S Faderl, ...</div><div class="gs_gray">Journal of Clinical Oncology 34 (15_suppl), TPS7078-TPS7078<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13616666939175751009" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:43LB_KcVqeAC" class="gsc_a_at">A phase 3, randomized, double-blind study of luspatercept (ACE-536) in patients (pts) with Revised International Prognostic Scoring System (IPSS-R) very low-to intermediate&nbsp;…</a><div class="gs_gray">U Platzbecker, RS Komrokji, P Fenaux, G Garcia-Manero, GJ Mufti, ...</div><div class="gs_gray">Journal of Clinical Oncology 34 (15_suppl), TPS7076-TPS7076<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6035913359000446264" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:oFn-K-OQSCAC" class="gsc_a_at">Feasibility and optimal schedule of eculizumab in patients with haemolytic paroxysmal nocturnal hemoglobinuria (hPNH) with severe aplastic anaemia (SAA) prior to haemopoietic&nbsp;…</a><div class="gs_gray">A Kulasekararaj, A Hill, I Farmer, K Riley, L Arnold, R Allam, S Gandhi, ...</div><div class="gs_gray">British Journal of Haematology 173<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1858495811937454078" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:RdUpO4xyVKMC" class="gsc_a_at">Mir-181c modulates T cell function by regulating the expression of BRK1</a><div class="gs_gray">SP Lim, D McLornan, N Ioannou, D Darling, AG Ramsay, J Gäken, ...</div><div class="gs_gray">Blood 128 (22), 132<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11939989755944057412" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-BKJ5vZJwzMC" class="gsc_a_at">Reduced Levels of mTOR and TGF-β Signaling Pathway-Associated Proteins in Patients with High Risk MDSsamia AL-Shouli., Pilar Perezabellan, Frederic Toulza. Shahram Kordasti&nbsp;…</a><div class="gs_gray">ST Al-Shouli, GJ Mufti</div><div class="gs_gray">Blood 128 (22), 5501<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4113841209124513561" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:rzmi0EmCOGEC" class="gsc_a_at">Novel Findings for the Role of Microenvironment and Heat Shock Proteins (HSP) in B-Cell Recptor (BCR) Activation, Disease Progression and Transformation of Follicular Non&nbsp;…</a><div class="gs_gray">SMB Rassam, J Schofield, F Malik, AM Mohamedali, B Przychodzen, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 3897-3897<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11552299185221271342" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QoJ_w57xiyAC" class="gsc_a_at">Pathology of bone marrow failure syndromes</a><div class="gs_gray">S Gandhi, H Abuarqoub, S Kordasti, J Jiang, A Kulasekararaj, G Mufti, ...</div><div class="gs_gray">Diagnostic Histopathology 21 (5), 174-180<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2933337635873566912" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:DwWRdx-KAo4C" class="gsc_a_at">134 ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN LOWER RISK MDS PATIENTS: A RETROSPECTIVE STUDY ON BEHALF OF THE CMWP OF THE EBMT</a><div class="gs_gray">M Robin, R Porcher, W Zinke, A Van Biezen, L Volin, G Mufti, C Craddock, ...</div><div class="gs_gray">Leukemia Research, S68-S69<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17837751087092170704" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ZYsTHYU9jrMC" class="gsc_a_at">Prevalence and clinical impact of additional cytogenetic abnormalities in patients (Pts) with myelodysplastic syndromes (MDS) and deletion 5q from the MDS-003 and MDS-004 studies</a><div class="gs_gray">A Giagounidis, AF List, E Hellstrom-Lindberg, GJ Mufti, B Schlegelberger, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 3270-3270<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15117417113229674379" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ghEM2AJqZyQC" class="gsc_a_at">Telomerase gene complex mutations are common in myelodysplastic syndromes patients</a><div class="gs_gray">M Ibañez, J Jiang, S Gandhi, M Syed, AE Smith, S Best, N Lea, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 1899-1899<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8582326949074160966" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:B2rIPIGFPLEC" class="gsc_a_at">Comparison of peripheral blood and bone marrow molecular profiling in primary myelodysplastic syndromes (MDS)</a><div class="gs_gray">AM Mohamedali, J Gaken, M Ahmed, A Kulasekararaj, AE Smith, F Malik, ...</div><div class="gs_gray">Blood 124 (21), 4655<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9299304726430739024" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:XeErXHja3Z8C" class="gsc_a_at">Impact of the proportion of metaphases with isolated del (5Q) on clinical outcomes in lenalidomide (LEN)-treated patients with IPSS low-/INT-1-risk myelodysplastic syndromes&nbsp;…</a><div class="gs_gray">A Giagounidis, A List, E Hellström-Lindberg, MA Sekeres, GJ Mufti, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 1538-1538<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14505595844034688880" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:qCpRzq7zkD8C" class="gsc_a_at">Chronic Relapsing Remitting Sweet’s Syndrome-a Harbinger Of Myelodysplastic Syndrome (MDS), Single Centre Analysis Of 31 Patients</a><div class="gs_gray">AG Kulasekararaj, SY Kordasti, T Basu, J Salisbury, A du Vivier, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 2793-2793<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12270122504482119705" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:kxd3qP2_5uAC" class="gsc_a_at">Impact of 5q breakpoints on clinical outcomes in patients with ipss low-/int-1-risk myelodysplastic syndromes (MDS) and isolated del (5q) treated with lenalidomide in the MDS&nbsp;…</a><div class="gs_gray">G Gohring, A Giagounidis, A List, E Hellstrom-Lindberg, M Sekeres, ...</div><div class="gs_gray">Haematologica 98, 80-80<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12627829872065001953" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:A8cqit5AE6sC" class="gsc_a_at">Mitoxanthrone-induced acute myeloid leukaemia presenting with leukaemia cutis</a><div class="gs_gray">JD Fleming, S Walsh, J Salisbury, AWP Du-Vivier, G Mufti</div><div class="gs_gray">European Journal of Dermatology 23 (3), 419-420<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12211516842501441996" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:_tF6a-HnqWAC" class="gsc_a_at">P-058 Implementation of an extended Ogata Flow Cytometry Myelodysplasia Score at King's College Hospital</a><div class="gs_gray">V Tindell, T Milne, A Douri, GJ Mufti, RM Ireland</div><div class="gs_gray">Leukemia Research, S48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2648889632413913381" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:s9ia6_kGH2AC" class="gsc_a_at">P-248 Dendritic cell subsets in myelodysplastic syndromes</a><div class="gs_gray">N Kerkhoff, S Kordasti, T Seidl, TM Westers, HJ Bontkes, GJ Mufti, ...</div><div class="gs_gray">Leukemia Research, S134-S135<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17962074677019530674" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4aZ_i-5WJEQC" class="gsc_a_at">Autoimmune haemolytic anaemia after allogeneic haematopoietic stem cell transplantation: analysis of 555 transplant patients at King’s College Hospital</a><div class="gs_gray">M Wang, W Wang, A Abeywardane</div><div class="gs_gray">The 53rd Annual Scientific Meeting of the British Society for Haematology<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15884128902158667695" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:mVC4hKzE2FoC" class="gsc_a_at">The Non-transplant Treatment of Myelodysplastic Syndromes—What's on the Horizon?</a><div class="gs_gray">AG Kulasekararaj, GJ Mufti</div><div class="gs_gray">Seminars in hematology 49 (4), 350-360<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9180447651355520146" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:SIv7DqKytYAC" class="gsc_a_at">Impact of alemtuzumab versus anti-thymocyte globulin after unrelated allogeneic stem cell transplantation with reduced-intensity conditioning as treatment for AML in CR1: a&nbsp;…</a><div class="gs_gray">F Baron, M Labopin, G Mufti, R Arnold, C Craddock, K Bilger, N Kroger, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4990715820261235051" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Azgs6IHzeyYC" class="gsc_a_at">Functional Characterization of CD4<sup>+</sup> T-Cells in Aplastic Anemia (AA)</a><div class="gs_gray">SY Kordasti, JCW Marsh, S Al-Khan, J Jiang, AE Smith, AM Mohamedali, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 1340-1340<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2826413667790276930" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ZqE1mSdD_DYC" class="gsc_a_at">Kings Health Partners 17 Gene Amplicon Panel for Next Generation Sequencing One Stop Mutational Assessment In Myeloid Malignancies</a><div class="gs_gray">NC Lea, A Abdallah, A Kizilors, AE Smith, SA Mian, AM Mohamedali, ...</div><div class="gs_gray">Blood 118 (21), 748<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14399154959556767538" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:zwpXiJ37cpgC" class="gsc_a_at">Pre-Emptive Donor Lymphocyte Infusions (DLI) Lead to High Cure Rates in T-Cell Depleted Allogeneic Haemopoietic Stem Cell Transplants for MDS/AML</a><div class="gs_gray">P Krishnamurthy, VT Potter, ZY Lim, AG Kulasekararaj, AY Ho, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 660-660<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13781045145113608315" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:unp9ATQDT5gC" class="gsc_a_at">Myelodysplasia (MDS) patients' Experiences with Blood Transfusions</a><div class="gs_gray">J Twiss, SP McKenna, SR Crawford, JN Wilburn, K Loth, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 5033-5033<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12891393625821434790" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:DrR-2ekChdkC" class="gsc_a_at"><i>TP53</i> Mutations Are Restricted Predominantly to 5q- Syndrome and Myelodysplastic Syndrome Patients with Complex Cytogenetics, and Correlate with Adverse&nbsp;…</a><div class="gs_gray">AG Kulasekararaj, AE Smith, SA Mian, P Krishnamurthy, AM Mohamedali, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 792-792<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1653332130822499561" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:cww_0JKUTDwC" class="gsc_a_at">Cytokine profile of patients with invasive aspergillosis: initial results from the first 100 patients recruited into the aspergillosis study; Great Britain: P1054</a><div class="gs_gray">M Ceesay, S Kordasti, L Berry, J Wade, M Smith, G Mufti, A Pagliuca</div><div class="gs_gray">Bone Marrow Transplantation 46<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5668525072462745567" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:mel-f30kHHgC" class="gsc_a_at">Retrospective analysis of 5-azacitidine as induction therapy prior to haematopoietic stem cell transplantation: P1172</a><div class="gs_gray">V Potter, V Tindell, L Jeyaraj-Nallathambi, M Doorga, L Reiff-Zall, A Ho, ...</div><div class="gs_gray">Bone Marrow Transplantation 46<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15997998873219946786" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:jSAVyFp_754C" class="gsc_a_at">The Myelodysplastic Syndromes (MDS) Foundation: A retrospective analysis of a nonprofit foundation</a><div class="gs_gray">JM Bennett, TJ Hamblin, GJ Mufti</div><div class="gs_gray">Leukemia research 35 (3), 283-285<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2822305731661823403" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:D_tqNUsBuKoC" class="gsc_a_at">JAK2V617F mutation and myeloproliferative disorders in splanchnic vein thrombosis: authors’ reply</a><div class="gs_gray">RH Westbrook, G Mufti, MA Heneghan</div><div class="gs_gray">Alimentary Pharmacology &amp; Therapeutics 33 (4), 496-497<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11209268009983105922" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-yGd096yOn8C" class="gsc_a_at">Occurrence of trisomy 8 (+ 8) in patients with Low-or Int-1-risk MDS with deletion 5q [del (5q)] treated with lenalidomide</a><div class="gs_gray">G Mufti, A Giagounidis, B Skikne, T Fu, B Schlegelberger, ...</div><div class="gs_gray">Leuk Res 35, S87<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8570054241540049745" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:hSRAE-fF4OAC" class="gsc_a_at">137 Standardization of flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group</a><div class="gs_gray">TM Westers, R Ireland, W Kern, C Alhan, JS Balleisen, MC Bene, ...</div><div class="gs_gray">Leukemia Research, S53<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7335162003290088476" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:sA9dB-pw3HoC" class="gsc_a_at">MDS as an autoimmune process</a><div class="gs_gray">W Ingram, Y Kordasti, GJ Mufti</div><div class="gs_gray">The Myelodysplastic Syndromes, 145-157<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4834386461998081253" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:dFKc6_kCK1wC" class="gsc_a_at">Low Level Residual Extravascular Haemolysis Is Commom Following Eculizumab Treatment In Paroxysmal Nocturnal Haemoglobinuria (PNH), but Does Not Affect Transfusion Requirement</a><div class="gs_gray">AG Kulasekararaj, D Odunsi, P Krishnamurthy, H Janet, I Momoh, GJ Mufti, ...</div><div class="gs_gray">Blood 116 (21), 4240<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11289867913925348693" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:eFf2swCANGcC" class="gsc_a_at">Microsatellite Instability (MSI) In High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML) Cells Promotes Frameshift Mutations In DNA Repair Genes&nbsp;…</a><div class="gs_gray">TJ Gaymes, A Mohamedali, AG Kulasekararaj, S Shall, GJ Mufti</div><div class="gs_gray">Blood 116 (21), 1194<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7803243624239471012" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:UmS_249rOGwC" class="gsc_a_at">Direct effect on the stroma by the conventional anti-multiple myeloma drug dexamethasone results in resistance of multiple myeloma plasma cells against therapy. Sensitisation&nbsp;…</a><div class="gs_gray">K Ramasamy, H Khatun, L Macpherson, GJ Mufti, S Schey, Y Calle</div><div class="gs_gray">Blood 116 (21), 1931<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5155891407870755321" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:TlpoogIpr_IC" class="gsc_a_at">OP26 Predicting thrombotic complications after liver transplantation in patients with Budd Chiari syndrome</a><div class="gs_gray">R Westbrook, D Orr, N Heaton, J O'Grady, R Patel, N Lea, A Quaglia, ...</div><div class="gs_gray">Gut 59 (Suppl 2), A11-A11<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1311751990038691486" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:KKBjqD86ppkC" class="gsc_a_at">PTU-070 Liver failure in association with hepatic amyloidosis and the role of liver transplantation: the King's College Hospital Experience</a><div class="gs_gray">AJ Stangou, M Rela, M Monaghan, CJ Mathias, G Mufti, N Heaton, ...</div><div class="gs_gray">Gut 59 (Suppl 1), A77-A77<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3430691371467401969" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:9VeumLvkZSQC" class="gsc_a_at">Umbilical cord blood transplantation in adults with haematological malignancies-UK single centre pilot study</a><div class="gs_gray">MM Ceesay, ZY Lim, S Querol, M Kenyon, A Ho, A Mijovic, S Devereux, ...</div><div class="gs_gray">Bone Marrow Transplantation 45, S161-S161<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13633403070864707414" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:SnGPuo6Feq8C" class="gsc_a_at">AN EVALUATION OF THE ASSOCIATION OF CDKN2B (P15) DNA METHYLATION WITH RESPONSE AND SURVIVAL IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES (MDS) TREATED IN THE AZA-001&nbsp;…</a><div class="gs_gray">J Herman, G Mufti, K MacBeth, J Seymour, P Fenaux, S Gore, V Santini, ...</div><div class="gs_gray">Haematologica 95, 124-124<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8331646167780330880" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:eAlLMO4JVmQC" class="gsc_a_at">Transfusion independence (TI) in patients with myelodysplastic syndromes (MDS) treated with azacitidine (AZA)</a><div class="gs_gray">L Silverman, P Fenaux, V Santini, J Seymour, G Mufti, ...</div><div class="gs_gray">Leukemia Research 33 (SUPPL. 1), S133-S134<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15254477771096702691" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Hck25ST_3aIC" class="gsc_a_at">Improvement in cytogenetic diagnosis and clinical prognostication using SNP-A karyotyping in combination with metaphase cytogenetics in MDS, MDS/MPD and secondary AML</a><div class="gs_gray">RV Tiu, LP Gondek, J Huh, C O'Keefe, MA Sekeres, GJ Mufti, MA McDevitt, ...</div><div class="gs_gray">Leukemia Research 33 (SUPPL. 1), S78-S79<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12268845418038173837" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:3_f9JqYsqVQC" class="gsc_a_at">Identification of a novel cancer-testis antigen as a target for the immunotherapy of acute myeloid leukaemia (AML): 46</a><div class="gs_gray">N Hardwick, W Ingram, F Farzaneh, G Mufti, B Guinn</div><div class="gs_gray">British Journal of Haematology 145, 19-20<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15034070344229111436" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:oXKBmVzQOggC" class="gsc_a_at">Quality-of-life assessment after haematopoietic stem cell transplant</a><div class="gs_gray">M Kenyon, G Mufti</div><div class="gs_gray">Bone Marrow Transplantation 43 (S1), S322-S322<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14697805265416965508" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:cF7EPgIk0B4C" class="gsc_a_at">NK Cell-Mediated Immunologic Responses Against Myeloma by B7-1 (CD80)/IL-2 Immune Gene Therapy</a><div class="gs_gray">H Guven, L Chan, D Darling, S Schey, G Mufti, F Farzaneh</div><div class="gs_gray">Clinical Lymphoma &amp; Myeloma 9, S135-S136<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=267486347343473188" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:8dzOF9BpDQoC" class="gsc_a_at">Poly ADP ribose polymerase (PARP) inhibitors induce apoptosis alone or synergistically with histone deacetylase inhibitors in primary acute myeloid leukemic patient cells</a><div class="gs_gray">TJ Gaymes, S Shall, F Farzaneh, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 2974-2974<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16454055010403171765" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:L_l9e5I586QC" class="gsc_a_at">High resolution molecular analysis of 5q-syndrome patients at diagnosis and following lenalidomide therapy</a><div class="gs_gray">AM Mohamedali, N Lea, N Twine, J Gaken, R Chelliah, N Westwood, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 225-225<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10360825489955098594" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:kJDgFkosVoMC" class="gsc_a_at">Array-Based Karyotyping and Genotyping Demonstrates a Non Random Selection of Allelic Variants of Genes in Clones with 5q31 Deletion Mutants.</a><div class="gs_gray">LP Gondek, H Ishwaran, AJ Dunbar, CL O’Keefe, MA McDevitt, D Batista, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 2057-2057<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8519273114512727631" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:kF1pexMAQbMC" class="gsc_a_at">Vascular Endothelial Cells Promote the Viability of CLL Cells Via the up-Regulation of Bcl-2 and Bcl-XL</a><div class="gs_gray">AGS Buggins, PEM Patten, SH Gohil, GJ Mufti, NSB Thomas, S Devereux</div><div class="gs_gray">Blood 112 (11), 357<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13753682326287132657" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:M_lZXyI38BkC" class="gsc_a_at">PRE-TRANSPLANT SERUM FERRITIN AS AN INDEPENDENT PROGNOSTIC FACTOR IN MDS PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING HSCT</a><div class="gs_gray">ZY Lim, VF Fiaccadori, SG Gandhi, M Kenyon, AYL Ho, AP Pagliuca, ...</div><div class="gs_gray">Haematologica 93, 95-95<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4760067384701610844" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:YlPif8NxrbYC" class="gsc_a_at">TREATMENT WITH VNP40101M (CLORETAZINE?) IN PATIENTS WITH HIGH RISK MYELODYSPLASTIC SYNDROMES (MDS): RESULTS OF A SUBSET POPULATION IN A PHASE II STUDY</a><div class="gs_gray">G Mufti, D Rizzieri, N Vey, D Hudak, J Karp, E Giles</div><div class="gs_gray">Haematologica 93, 94-95<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8013161646089820122" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:z6xuaG2dYH0C" class="gsc_a_at">Use of Intravenous Busulphan for Reduced Intensity Conditioning (RIC) Haematopoietic Stem Cell Transplantation (HSCT) Is Associated with Delayed T-Cell Full Donor Chimerism and&nbsp;…</a><div class="gs_gray">ZY Lim, M Thanigaikumar, S Gandhi, L Pearce, M Kenyon, AYL Ho, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 1994-1994<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12132111355689707626,1969066948220248541" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QUX0mv85b1cC" class="gsc_a_at">Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse after an initial allogeneic transplant</a><div class="gs_gray">B Shaw, G Mufti, S Mackinnon, J Cavenagh, K Towlson, R Pearce, ...</div><div class="gs_gray">Bone Marrow Transplantation 39<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=141622073595555441" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:UEFpDhwOD2kC" class="gsc_a_at">Value of transfusion-free living in MDS: results of health utility interviews with patients</a><div class="gs_gray">TF Goss, A Szende, C Schaefer, R Knight, K Heptinstall, M Lubbert, ...</div><div class="gs_gray">CLINICAL ADVANCES IN HEMATOLOGY AND ONCOLOGY 5 (7), 6<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6934215999504454239,18004495275463017227" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:6pF0wJmtdfAC" class="gsc_a_at">Inhibition of poly ADP ribose polymerase (PARP) induces cell death in leukaemic cell lines alone or synergistically with histone deacetylase inhibitors: potential for anti&nbsp;…</a><div class="gs_gray">TJ Gaymes, S Shall, F Farzaneh, GJ Mufti</div><div class="gs_gray">Leukemia Research 31, S61-S62<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7158020746413282006" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:CNPyR2KL9-0C" class="gsc_a_at">Value of transfusion-free living in myelodysplastic syndromes (MDS): results of health utility interviews with patients</a><div class="gs_gray">TF Goss, A Szende, C Schaefer, R Knight, K Heptinstall, M Lubbert, ...</div><div class="gs_gray">Leukemia Research 31, S105-S106<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15328641581634255742" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wE-fMHVdjMkC" class="gsc_a_at">P147 Management of haematological adverse events in MDS patients treated with lenalidomide</a><div class="gs_gray">A Giagounidis, M Cazzola, P Fenaux, G Mufti, P Muus, U Platzbecker, ...</div><div class="gs_gray">Leukemia Research, S121<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17870712334853261998" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:5rMqqAh47xYC" class="gsc_a_at">Inhibition of Poly ADP Ribose Polymerase (PARP) Activity Exerts Cytotoxic Effects on Chromosomal Instability Syndrome and Leukaemic Cell Lines: Potential for Anti-Leukaemia&nbsp;…</a><div class="gs_gray">TJ Gaymes, S Shall, F Farzaneh, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 108 (11), 2647-2647<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10603964281211104599" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:cSdaV2aYdYsC" class="gsc_a_at">IL-6 Production by B-CLL Cells Plays a Critical Role in the Inhibition of T Cell Activation and Proliferation and Promotes a Th2 Response in Normal T Lymphocytes.</a><div class="gs_gray">AGS Buggins, PEM Patten, J Richards, SJ Orr, GJ Mufti, NSB Thomas, ...</div><div class="gs_gray">Blood 108 (11), 2808<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7588662528740916249" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:KWzIFqRkAKkC" class="gsc_a_at">Combination chemotherapy with CHOP-daclizumab in HTLV-1 associated adult T-cell leukaemia/lymphoma.</a><div class="gs_gray">S Simpson, M Thanigaikumar, G Taylor, E Matutes, P Fields, S Devereux, ...</div><div class="gs_gray">Blood 108 (11), 778A-778A<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15156315224724737048" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:zGdJYJv2LkUC" class="gsc_a_at">IL-6 production by B-CLL cells plays a critical role in the inhibition of T cell activation and proliferation and promotes a Th2 response in normal T lymphocytes.</a><div class="gs_gray">AGS Bulagins, PEM Patten, J Richards, SJ Orr, GJ Mufti, NSB Thomas, ...</div><div class="gs_gray">Blood 108 (11), 795A-795A<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2905892851155384604" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:g5Ck-dwhA_QC" class="gsc_a_at">Poor risk assessment in the elderly receiving cloretazine induction for AML or MDS</a><div class="gs_gray">R Geller, D Rizzieri, N Vey, S O’Brien, B Johnson, J Karp, G Mufti, F Giles</div><div class="gs_gray">Journal of Clinical Oncology 24 (18_suppl), 18562-18562<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6816998527466543961" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:k_7cPK9k7w8C" class="gsc_a_at">Single agent cloretazine is an effective induction therapy in elderly patients (pts) with poor risk AML: 112</a><div class="gs_gray">F GILES, G Mufti, J Karp, M COOPER, S DAENEN, R GELLER, N VEY</div><div class="gs_gray">British Journal of Haematology 133<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3205809569934891042" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:AzKEL7Gb_04C" class="gsc_a_at">Early and sustained response to azacitidine occurs in high-risk MDS patients with monosomy 7: responses correlate with increased apoptosis not CDKN2B demethylation</a><div class="gs_gray">K Raj, A John, A Ho, NSB Thomas, GJ Mufti</div><div class="gs_gray">British Journal of Haematology 133, 61-62<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14150153486135006602" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:hvmnpdAuIbkC" class="gsc_a_at">Single HLA Allele Mismatches Are Well Tolerated in the Recipients of T Cell Depleted Reduced Intensity Conditioned Transplants from Unrelated Donors.</a><div class="gs_gray">BE Shaw, NH Russell, S Devereux, DG Emma, M Stephen, JA Madrigal, ...</div><div class="gs_gray">Blood 106 (11), 2895<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16607620695540054971" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:qE4H1tSSYIIC" class="gsc_a_at">The Outcome of Lymphoproliferative Disorder in Liver Transplant Recipients May Correlate with Age at Diagnosis and the Use of Chemotherapy: A Single Centre Report.</a><div class="gs_gray">CN Bagot, A Kulasekararaj, S Ramalingam, N Heaton, J O’Grady, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 1435-1435<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10311812012177987826" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:69ZgNCALVd0C" class="gsc_a_at">CLORETAZINE™(VNP40101M) Is Active in Elderly Untreated Poor Risk Patients with Acute Myelogenous Leukemia (AML) or High Risk Myelodysplasia (MDS).</a><div class="gs_gray">F Giles, S O’Brien, D Rizzieri, J Karp, M Cooper, G Mufti, B Johnson, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 2786-2786<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1153294200984993764" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:KaMxkj08jr0C" class="gsc_a_at">CLORETAZINE (TM)(VNP40101M) is active in elderly untreated poor risk patients with acute myelogenous leukemia (AML) or high risk myelodysplasia (MDS)</a><div class="gs_gray">F Giles, S O'Brien, D Rizzieri, J Karp, M Cooper, G Mufti, B Johnson, ...</div><div class="gs_gray">Blood 106 (11), 781A-781A<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15506477270188183869" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:CYCckWUYoCcC" class="gsc_a_at">The effect of interleukin-7 on the alloreactivity of human T cells depends on the timing of its administration in relation to the allostimulus</a><div class="gs_gray">RF Duarte, GJ Mufti, JA Madrigal</div><div class="gs_gray">Bone marrow transplantation 35 (7), 733-734<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5328481649749689657" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:silx2ntsSuwC" class="gsc_a_at">A novel approach to MRD monitoring in AML, real-time quantification of leukaemia associated antigens (WT1, PRAME and G250): 89</a><div class="gs_gray">G MORGAN, G NICKLESS, M Usai, G MUFTI, K Tobal</div><div class="gs_gray">British Journal of Haematology-Supplement 129, 28-29<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11177018939232384296" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:bCjgOgSFrM0C" class="gsc_a_at">Generalized eczematoid graft-versus-host disease: presentation, natural history, and treatment</a><div class="gs_gray">C Martyn-Simmons, G Osborne, D Creamer, A du Vivier, G Mufti, ...</div><div class="gs_gray">Journal of the American Academy of Dermatology 52 (3), AB8-AB8<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11768164115880264282" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:UuEBAcK4md4C" class="gsc_a_at">Lymphocytes, but not CD34+ or CD33+ myeloid cells, of MDS patients have a hypermethylated CDKN2B promoter</a><div class="gs_gray">AM John, K Raj, GJ Mufti, NSB Thomas</div><div class="gs_gray">British Journal of Haematology 129, 16<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3070943331555452429" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Cvh0bltMcLgC" class="gsc_a_at">Clonal gammopathies, immune cytopenias and autoimmune thyroid dysfunction following alemtuzumab containing reduced-intensity allogeneic hematopoietic stem cell transplantation.</a><div class="gs_gray">M Akhtari, K Raj, W Ingram, D Milojkovic, I El-Hemaidi, S Devereux, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 1839-1839<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10363785945478185266" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:2v_ZtQDX9iAC" class="gsc_a_at">Gemtuzumab ozogamicin with donor leucocyte infusions is safe and effective therapy for a subgroup of relapsed acute myeloid leukaemia and myelodysplastic syndrome following&nbsp;…</a><div class="gs_gray">K Raj, M Aldouri, A Ho, A Pagliuca, S Devereux, G Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 1806-1806<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6793630217979000646" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:8Xgff_V0N9gC" class="gsc_a_at">Immunohistochemical characterisation of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR in chronic myeloid leukaemia (CML) patients treated with&nbsp;…</a><div class="gs_gray">D Milojkovic, S Sahu, J Henderson, BH Czepulkowski, JR Salisbury, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 1999-1999<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6523769983515912699" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:JH5k92_tO-AC" class="gsc_a_at">Use of the galactomannan ELISA in the detection of invasive aspergillosis: a retrospective review and potential pitfalls in application</a><div class="gs_gray">Z Lim, A Pagliuca, J Wade, A Ho, S Devereux, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 125, 59-60<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4576247782475006826" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:FwTEoIZreccC" class="gsc_a_at">Increased incidence of granulomas in bone marrow trephines following alemtuzumab treatment</a><div class="gs_gray">S Chua, S Robinson, M Kenyan, A Pagliuca, S Devereux, J Salisbury, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7938737002800000269" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-c_eYhz9dBkC" class="gsc_a_at">Imatinib mesylate in myelofibrosis: sustained improvements in platelet counts and splenomegaly</a><div class="gs_gray">A Ho, S Lim, N Westwood, T Yang, K Fishlock, S Devereux, A Pagliuca, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6228777213186915303" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:1tZ8xJnm2c8C" class="gsc_a_at">Alemtuzumab containing reduced intensity conditioning regimen is safe and effective in myelofibrosis.</a><div class="gs_gray">WA Ingram, AYL Ho, M Kenyon, S Devereux, A Pagliuca, G Mufti</div><div class="gs_gray">Blood 102 (11), 5465<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8731512353724906928" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:6Zm5LS9gQ5UC" class="gsc_a_at">Reduced intensity allogeneic transplantation using BEAM-Campath in patients with lymphoproliferative disease-GVHD, toxicity and survival in 65 patients.</a><div class="gs_gray">RD Bainton, JL Byrne, C Craddock, P Mahendra, S Devereux, A Pagliuca, ...</div><div class="gs_gray">Blood 100 (11), 40A-40A<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14311043165566357842" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:XDrR66g3YHsC" class="gsc_a_at">Response criteria for myelodysplastic syndromes</a><div class="gs_gray">BD Cheson</div><div class="gs_gray">BASIC AND CLINICAL ONCOLOGY 27, 251-264<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11566024215045255055" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:qkm5LKljiV4C" class="gsc_a_at">Peripheral blood cells with the phenotype and function of myeloid dendritic cells express CD52 and are depleted during therapy with CAMPATH-1H</a><div class="gs_gray">A Buggins, K Fishlock, N Westwood, A Pagliuca, G Mufti, S Devereux</div><div class="gs_gray">British Journal of Haematology-Supplement 117<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18356428275095073301" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:eJD0kABLposC" class="gsc_a_at">Gemtuzumab ozogamicin: is not associated with an increased risk of veno-occlusive disease in relapsed or refactory AML, when used alone or in combination with flag chemotherapy</a><div class="gs_gray">K Raj, E Kelleher, O Fasan, S Devereux, A Pagliuca, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 117<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5746689711685251165" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:JP7YXuLIOvAC" class="gsc_a_at">Increased NHEJ activity in myeloid leukemias is associated with ongoing or induced DNA damage at sites that recruit key NHEJ proteins.</a><div class="gs_gray">N Brady, TJ Gaymes, M Cheung, GJ Mufti, FV Rassool</div><div class="gs_gray">Blood 100 (11), 4253<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14858997591939836418" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:dAp6zn-oMfAC" class="gsc_a_at">CAMPATH-1H reduces the risk of graft versus host disease following allogeneic hematopoietic stem cell transplantation and minimally myelosuppressive conditioning treatment with&nbsp;…</a><div class="gs_gray">S Devereux, JE Parker, T Shafi, A Pagliuca, E Macdonald, GJ Mufti</div><div class="gs_gray">Blood 98 (11), 355B-356B<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1213405549779121465" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:eO3_k5sD8BwC" class="gsc_a_at">Identification of HLA‐B* 0722</a><div class="gs_gray">AM Little, ST Cox, MA Hoddinott, H Ogilvie, EM Bohan, GJ Mufti, ...</div><div class="gs_gray">Tissue antigens 57 (2), 167-168<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15317003097951755362" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:G1UMdFYMoxkC" class="gsc_a_at">Management of the myelodysplastic syndromes</a><div class="gs_gray">JE Parker, GJ Mufti</div><div class="gs_gray">EDUCATIONAL BOOK, 87<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16800971598602430993" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:gI9wzKcniAoC" class="gsc_a_at">EFFECT OF LEUKEMIC CELLS ON THE DIFFERENTIATION OF NORMAL MONOCYTE-DERIVED DENDRITIC CELLS: A PHENOTYPIC AND FUNCTIONAL ANALYSIS.</a><div class="gs_gray">G Rigolin, A Buggins, N Lea, G Nickless, G Castoldi, G Mufti, W Hirst</div><div class="gs_gray">British Journal of Haematology-Supplement 108<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5348061056791992037" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:65Yg0jNCQDAC" class="gsc_a_at">Suppression of T cell proliferation by AML cells is an early event in G0 to G1 transition involving inhibition of pRB phosphorylation by cyclin D-cdk6/4.</a><div class="gs_gray">D Milojkovic, AGS Buggins, NC Lea, A Pagliuca, GJ Mufti, NSB Thomas, ...</div><div class="gs_gray">Blood 96 (11), 146B-146B<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3058019331525929296" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Xz60mAmATU4C" class="gsc_a_at">Non-myeloablative stem cell transplantation for congenital immunodeficiencies.</a><div class="gs_gray">PJ Amrolia, HB Gaspar, A Hassan, D Webb, A Pagliuca, G Mufti, G Davies, ...</div><div class="gs_gray">Blood 94 (10), 617A-617A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6368995773825379799" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:MpfHP-DdYjUC" class="gsc_a_at">The regulation of gene expression by methylation-Introduction</a><div class="gs_gray">SB Baylin</div><div class="gs_gray">SEMINARS IN CANCER BIOLOGY 9 (5), 327-328<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5135806570089954599" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-6RzNnnwWf8C" class="gsc_a_at">Effect of leukemia cell microenvironment on the differentiation of dendritic cells from normal monocytes: A phenotypic and functional analysis.</a><div class="gs_gray">GM Rigolin, AGS Buggins, N Lea, G Castoldi, A Pagliuca, GJ Mufti, ...</div><div class="gs_gray">Blood 94 (10), 70A-71A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12112007786966388844" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:isU91gLudPYC" class="gsc_a_at">Gene expression using adenoviral vectors in primary acute myeloid leukaemia cells.</a><div class="gs_gray">NC Lea, AGS Buggins, WJR Hirst, J Gaken, F Farzaneh, GJ Mufti, ...</div><div class="gs_gray">Blood 94 (10), 413B-413B<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10077106443176678364" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Xl6nMSl579sC" class="gsc_a_at">Soluble factors produced by primary acute myeloid leukemia cells inhibit Th1 cytokine production; potential role of c-AMP dependent pathways.</a><div class="gs_gray">A Buggins, W Hirst, A Pagliuca, GJ Mufti</div><div class="gs_gray">Blood 92 (10), 81A-81A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4426724325524790760" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:3A3nxV7CjKIC" class="gsc_a_at">Adult familial myelodysplastic syndromes (f-MDS): Towards the genetic basis of leukaemia</a><div class="gs_gray">A Mijovic, GJ Mufti</div><div class="gs_gray">British Journal of Haematology 102 (1-I)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4009773715963320124" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:YIdQ7BAI8VoC" class="gsc_a_at">Management of adult T-cell leukaemia/lymphoma</a><div class="gs_gray">GJ Mufti, R Pawson, A Pagliuca</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 100 (3), 453-458<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13947348289888978577" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QZWLLlSfqgYC" class="gsc_a_at">An atlas of malignant haematology: cytology, histology, and cytogenetics</a><div class="gs_gray">GJ Mufti, G Flandrin, HE Schaefer, AA Sandberg, EJ Kanfer, PA Bryon</div><div class="gs_gray">Hématologie 3 (5), 478-0<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4783470732161602940" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wvYxNZNCP7wC" class="gsc_a_at">Regulatory role of hematopoietic growth factors in abnormal localization of immature precursors (ALIP) formation in myelodysplastic syndrome.</a><div class="gs_gray">MH Mangi, AC Newland, GJ Mufti</div><div class="gs_gray">Blood 88 (10), 376-376<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2258509822507328651" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:IsPWOBWtZBwC" class="gsc_a_at">Flag/idarubicin for the treatment of poor risk myeloid malignancies.</a><div class="gs_gray">FN AlRefaie, D Milojkovic, THT Wong, A Pagliuca, R Grace, GJ Mufti</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 93, 76-76<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2686359326599895910" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:T_ojBgVMvoEC" class="gsc_a_at">Comparison of B7. 1 and interleukin-2 (IL-2) in the rejection of a murine myeloid leukaemia</a><div class="gs_gray">W Hirst, A Buggins, D Darling, S Hollingsworth, J Gaken, F Farzaneh, ...</div><div class="gs_gray">Blood 86 (10), 1644-1644<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11816357700128926252" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:NxmKEeNBbOMC" class="gsc_a_at">Single dose of filgrastim (rhG-CSF) to predict mobilisation of haemopoietic progenitors in patients with haematological malignancies.</a><div class="gs_gray">A Mijovic, GJ Mufti</div><div class="gs_gray">Bone marrow transplantation 15 (5), 813-814<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13724552287572220705" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:EsEWqaRxkBgC" class="gsc_a_at">VAPEC-B chemotherapy in the treatment of aggressive non-Hodgkin's lymphoma: A retrospective analysis of 45 patients</a><div class="gs_gray">JM Singer, A Mijovic, KW Pettingale, A Nethersell, HJ Dobbs, ...</div><div class="gs_gray">Clinical Oncology 7 (6), 366-370<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12931829901661245630" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LXmCCkuhhTsC" class="gsc_a_at">A randomized trial of hydroxyuea (HY) versus VP16 in advanced adult chronic myelomonocytic leukemia</a><div class="gs_gray">E Wattel, A Guerci, B Hecquet, T Economopoulos, A Copplestone, ...</div><div class="gs_gray">Leukemia Research 18, 21<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3720267150329448164" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:C33y2ycGS3YC" class="gsc_a_at">Warnings over cling film.</a><div class="gs_gray">A Pagliuca, GJ Mufti</div><div class="gs_gray">BMJ: British Medical Journal 302 (6776), 593<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10247056559679807874" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:oNZyr7d5Mn4C" class="gsc_a_at">Co-infection with HTLV-I/II and HIV-1</a><div class="gs_gray">JHC Tosswill, JN Weber, A Pagliuca, GJ Mufti</div><div class="gs_gray">The Lancet 336 (8711), 383<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2923786872758809316" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Wq2b2clWBLsC" class="gsc_a_at">MYELODYSPLASTIC SYNDROMES-DIAGNOSTIC AND PROGNOSTIC-SIGNIFICANCE OF IMMUNOHISTOCHEMICAL ASSESSMENT OF BONE-MARROW TREPHINES</a><div class="gs_gray">MH Mangi, JR Salisbury, GJ Mufti</div><div class="gs_gray">JOURNAL OF PATHOLOGY 161 (4), A344-A344<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10263413461891807248" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:RJOyoaXV5v8C" class="gsc_a_at">Relapse of lymphoma in the heart after a 10-year remission.</a><div class="gs_gray">AJ Bell, GJ Mufti, TJ Hamblin</div><div class="gs_gray">Postgraduate medical journal 60 (707), 607-610<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9373737652522060530" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:BMiRioqqltAC" class="gsc_a_at">Challenges in Liver Transplantation for Common Variable Immunodeficiency-related Liver Disease a Case Series and Systematic Review</a><div class="gs_gray">TH Tranah, Z Cargill, O Tavabie, G Mufti, V Aluvihare, A Sanchez-Fueyo, ...</div><div class="gs_gray">Journal of Liver Transplantation, 100038<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:MaiMEk8tZqMC" class="gsc_a_at">Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes (vol 94, pg&nbsp;…</a><div class="gs_gray">TJ Gaymes, S Shall, LJ Macpherson, NA Twine, NC Lea, F Farzaneh, ...</div><div class="gs_gray">HAEMATOLOGICA 106 (8), 2294-2294<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:npT69zEmqdIC" class="gsc_a_at">Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes</a><div class="gs_gray">TJ Gaymes, S Shall, LJ Macpherson, NA Twine, NC Lea, F Farzaneh, ...</div><div class="gs_gray">haematologica 106 (8), 2294<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:zDhyt2jClVkC" class="gsc_a_at">Bone marrow failure: causes and complications</a><div class="gs_gray">AG Kulasekararaj, GJ Mufti, JCW Marsh</div><div class="gs_gray">Medicine<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4p3FJGzxjgAC" class="gsc_a_at">A Retrospective Analysis From Patients Treated in The MEDALIST Study: Safety and Efficacy Of Luspatercept Treatment In Patients With Myelodysplastic Syndrome/Myeloproliferative&nbsp;…</a><div class="gs_gray">RS Komrokji, U Platzbecker, P Fenaux, G Garcia-Manero, GJ Mufti, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 193, 67-68<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:aK62MiYD7mUC" class="gsc_a_at">The clinical and histopathological spectrum of neutrophilic inflammatory disease encountered in the setting of myelodysplastic syndrome.</a><div class="gs_gray">CA Maguire, AG Kulasekararaj, JR Salisbury, SA Walsh, GJ Mufti, ...</div><div class="gs_gray">Clinical and Experimental Dermatology<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ECvNt0vk_34C" class="gsc_a_at">Functional reconstruction of human AML reveals stem cell origin and vulnerability of treatment-resistant MLL-rearranged leukemia</a><div class="gs_gray">BB Zeisig, TK Fung, M Zarowiecki, CT Tsai, H Luo, B Stanojevic, C Lynn, ...</div><div class="gs_gray">Science Translational Medicine 13 (582)<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:geVfx-PNG5EC" class="gsc_a_at">Early and late‐onset veno‐occlusive disease/sinusoidal syndrome post allogeneic stem cell transplantation–a real‐world UK experience</a><div class="gs_gray">V Mehra, S Tetlow, A Choy, H de Lavallade, A Kulasekararaj, ...</div><div class="gs_gray">American Journal of Transplantation 21 (2), 864-869<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:csTP5AdqY_wC" class="gsc_a_at">Matched platelet transfusions in alloimmunization</a><div class="gs_gray">JC Marsh, SJ Stanworth, LA Pankhurst, D Kallon, AZ Gilbertson, C Pigden, ...</div><div class="gs_gray">blood 137 (3)<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:t7izwRedFcYC" class="gsc_a_at">Human Erythroid Progenitors are Directly Infected by SARS-CoV-2: Implications for Hypoxia and Emerging Hematopoiesis/Erythropoiesis in COVID19</a><div class="gs_gray">HE Huerga, W Grey, MG Albornoz, H Wood, R Ulferts, IV Aramburu, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:tJ_1M1FLfZ0C" class="gsc_a_at">Differential Alemtuzumab Dosages in T-cell Deplete Allogeneic Haematopoietic Stem Cell Transplants for Myeloid Malignancies</a><div class="gs_gray">V Mehra, D Avenoso, XC Castellano, A Choy, S Widya, M Shah, S Inam, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 55 (SUPPL 1), 287-287<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:V8JMcbNWlSUC" class="gsc_a_at">Comparing Outcomes of Patients Having Mixed T Chimerism and Unrelated Donor Allografts for Acute Leukaemia/MDS to Patients with Complete Chimerism-Single Centre Retrospective Study</a><div class="gs_gray">V Sheth, V Potter, D McLornan, H Delavallade, S Gandhi, A Kulasekararaj, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 55 (SUPPL 1), 123-124<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:X41XOdD1uaEC" class="gsc_a_at">MDS-175: Assessment of Dose-Dependent Response to Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) with Ring Sideroblasts (RS) in the Phase 3&nbsp;…</a><div class="gs_gray">U Platzbecker, P Fenaux, GJ Mufti, G Garcia-Manero, RS Komrokji, ...</div><div class="gs_gray">Clinical Lymphoma Myeloma and Leukemia 20, S318<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:vkDViGfkvYEC" class="gsc_a_at">MDS-171: Effects of Luspatercept on Serum Ferritin in Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) with Ring Sideroblasts (RS) in the Phase 3 MEDALIST Trial</a><div class="gs_gray">P Fenaux, V Santini, GJ Mufti, M Diez-Campelo, C Finelli, MA Sekeres, ...</div><div class="gs_gray">Clinical Lymphoma Myeloma and Leukemia 20, S317<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:cAUKuAERoUMC" class="gsc_a_at">MDS-280: Longer-Term RBC Transfusion Reduction in the Phase 3 MEDALIST Study of Luspatercept in Patients with Lower-Risk MDS (LR-MDS) with Ring Sideroblasts (RS)</a><div class="gs_gray">RS Komrokji, MA Sekeres, AM Zeidan, P Fenaux, U Platzbecker, ...</div><div class="gs_gray">Clinical Lymphoma Myeloma and Leukemia 20, S322<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Sw8WaQuuSIgC" class="gsc_a_at">MDS-179: Clinical Benefit of Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) and High Transfusion Burden (HTB) in the Phase 3 MEDALIST Study</a><div class="gs_gray">AM Zeidan, G Garcia-Manero, AE DeZern, P Fenaux, PL Greenberg, ...</div><div class="gs_gray">Clinical Lymphoma Myeloma and Leukemia 20, S318-S319<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:0BSZZHtHo6cC" class="gsc_a_at">A study of Telomere length as a predictor for multi-system complications and outcomes in bone marrow failure disorders</a><div class="gs_gray">S Gandhi, J Jiang, S Mansour, A Kulasekararaj, H Wood, H Renshaw, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 189, 68-68<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:DGpvO1n63MYC" class="gsc_a_at">Why separate the inseparable? Integrating Mind and Body Care in haematology</a><div class="gs_gray">M Kenyon, G Mufti, C Williams, R Parker, G Shields</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 189, 47-48<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:96M4k3P_OWMC" class="gsc_a_at">Luspatercept significantly reduces red blood cell transfusion burden, regardless of gene mutation frequency, spectrum, and prognostic significance, among patients with lower&nbsp;…</a><div class="gs_gray">GJ Mufti, P Vyas, G Garcia-Manero, R Buckstein, V Santini, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 189, 149-150<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:kVKjLOQJbwAC" class="gsc_a_at">A review of a case series of post renal-transplantation erythrocytosis, a study of aetiological factors and outcomes</a><div class="gs_gray">A Da Silva, C Maharaj, H Wood, S Slade, M Gupta, J Large, J Marsh, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 189, 87-87<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:IwGqIHSOC8kC" class="gsc_a_at">Assessment of longer-term efficacy, safety, and haematological improvement in the phase 3, randomised, double-blind, placebo-controlled MEDALIST trial of luspatercept to treat&nbsp;…</a><div class="gs_gray">GJ Mufti, P Vyas, R Buckstein, V Santini, M Díez-Campelo, C Finelli, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 189, 140-140<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:AdGrMoNItN4C" class="gsc_a_at">Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome (MDS) Using Treosulfan Based Compared to Standard Reduced-Intensity or Myeloablative Conditioning&nbsp;…</a><div class="gs_gray">A Shimoni, M Robin, S Iacobelli, A van Biezen, DW Beelen, GJ Mufti, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 26 (3), S35<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Fx13dKtzC7kC" class="gsc_a_at">Differential Alemtuzumab Dosage Effects in T-Cell Deplete Allogeneic Haematopoietic Stem Cell Transplants for Myeloid Malignancies-King's College Hospital London Experience</a><div class="gs_gray">V Mehra, D Avenoso, XC Castellano, A Choy, S Widya, M Shah, S Inam, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:5o6HiIVP414C" class="gsc_a_at">Telomeric Length to Characterize and Prognosticate Bone Marrow Failure, Risk of Clonal Evolution and Multi-System Complications in Aplastic Anemia and Other Hypocellular&nbsp;…</a><div class="gs_gray">S Gandhi, J Jiang, S Slade, A Kulasekararaj, V Potter, V Mehra, P Muus, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:38eRAUXPO10C" class="gsc_a_at">Post-Transplant Flow Cytometry MRD Predicts Relapse in a Real World AML Cohort</a><div class="gs_gray">H Wood, K Sanchez, V Potter, A Kulasekararaj, H de Lavallade, D Yallop, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:H0nRGT7Dr7IC" class="gsc_a_at">Ibrutinib for Relapsed Mantle Cell Lymphoma after Standard First Line Therapy and ASCT Is Efficacious but Does Not Overcome the Impact of POD24-a Retrospective Study from the&nbsp;…</a><div class="gs_gray">C Burney, S Robinson, A Boumendil, H Finel, I Khvedelidze, H Hunter, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:00hq1xGbIBsC" class="gsc_a_at">Molecular, Epigenetic and Gene Expression Profiling of Triple Negative Essential Thrombocythaemia</a><div class="gs_gray">S Alimam, W Villiers, R Dillon, M Simpson, AE Smith, P Lavender, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QndmRo8phpgC" class="gsc_a_at">Reconstruction of Human AML Reveals Stem Cell Origin and Therapeutic Targets for Treatment Resistant CD34-/Lo MLL-Rearranged Leukemia</a><div class="gs_gray">TK Fung, B Zeisig, M Zarowiecki, H Luo, CT Tsai, B Stanojevic, C Lynn, ...</div><div class="gs_gray">Blood 134, 3203<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LLUdpdcEW3AC" class="gsc_a_at">Next Generation Sequencing and Microrna Assay in a Cohort of Patients Affected By Myelodysplastic Syndromes. an Analysis of Clinical and Genotypic Features</a><div class="gs_gray">D Avenoso, M Squillario, A Barla, A Verri, E Carminati, C Nurra, E Todisco, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wyCGhLAOp5UC" class="gsc_a_at">PROGNOSTIC AND PREDICTIVE IMPACT OF SMALL PNH CLONES IN A LARGE COHORT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND APLASTIC ANEMIA: A SINGLE-CENTER EXPERIENCE</a><div class="gs_gray">B Fattizzo, A Dunlop, G Levati, D Consonni, G Mufti, J Marsh, W Barcellini, ...</div><div class="gs_gray">HAEMATOLOGICA 104, 25-26<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Ef4XXjhdXvQC" class="gsc_a_at">Post-transplant cyclophosphamide-based GVHD prophylaxis compared to standard prophylaxis in patients with lymphoma receiving HLA identical transplantation: A retrospective&nbsp;…</a><div class="gs_gray">S Bramanti, A Boumendil, H Finel, I Khvedelidze, B Afanasyev, N Schmitz, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 54, 107-108<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:uqZYSrDi9MMC" class="gsc_a_at">early and late onset VOD prevalence and outcomes in a single centre retrospective study over 5 years: The King's BMT experience</a><div class="gs_gray">S Gandhi, S Tetlow, V Mehra, H deLavallade, A Kulasekararaj, ...</div><div class="gs_gray">Bone Marrow Transplantation 54, 271-271<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:3UHJKpZgG5wC" class="gsc_a_at">Adenoviral infections in adult T-cell depleted allogeneic stem cell transplants for myeloid disorders: Pre-emptive approach and impact on outcomes</a><div class="gs_gray">V Mehra, G Simini, E Barnwell, U Boczek, S Widya, A Choy, K Raj, ...</div><div class="gs_gray">Bone Marrow Transplantation 54, 424-425<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:XAEgxC7iu0MC" class="gsc_a_at">Outcomes of allogeneic stem cell transplantation (hsct) for older patients (&gt; 50 years) with severe aplastic anaemia using alemtuzumab-based ('FCC') regimen: King's college&nbsp;…</a><div class="gs_gray">V Sheth, I Shafqat, A Kulasekararaj, S Gandhi, H Delavallade, P Muus, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 54, 27-28<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:cG0OFEevkNgC" class="gsc_a_at">The case for upfront HLA-matched unrelated donor HCT as a curative option for adult acquired severe aplastic anemia: Upfront MUD HCT for adult severe aplastic anemia.</a><div class="gs_gray">JC Marsh, AM Risitano, GJ Mufti</div><div class="gs_gray">Biology of blood and marrow transplantation: journal of the American Society&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:SyxJh60XUSQC" class="gsc_a_at">EBV reactivation associated post-transplant lymphoproliferative disease, clonal gammopathy and outcomes in allogeneic T-cell depleted stem cell transplants for myeloid malignancies</a><div class="gs_gray">V Mehra, E Barnwell, U Boczek, A Bisquera, K Raj, D Mclornan, S Gandhi, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:FepLwMwnKBMC" class="gsc_a_at">Post-transplant flow cytometry MRD predicts relapse in AML and high risk MDS patients treated with allogeneic haematopoietic stem cell transplant</a><div class="gs_gray">H Wood, K Sanchez, V Potter, A Kulasekararaj, D Yallop, S Kassam, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 185, 153-154<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:IF0FbId8XVwC" class="gsc_a_at">Erythropoietic Stimulating Agents for Pure Red Cell Aplasia Following Major ABO Mismatch T-deplete Allogeneic Stem Cell Transplants</a><div class="gs_gray">V Mehra, O Pearse, R Walker, H de Lavallade, D McIornan, T Pagliuca, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 185, 153-153<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:hwlm9Y4obscC" class="gsc_a_at">Severe Aplastic Anaemia Working Party of the EBMT.(2019) Impact of T-cell depletion strategies on outcomes following hematopoietic stem cell transplantation for idiopathic&nbsp;…</a><div class="gs_gray">S Samarasinghe, K Clesham, S Iacobelli, G Sbianchi, C Knol, R Hamladji, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:8_tS2Vw13FcC" class="gsc_a_at">SNP-Array Genome Wide Association Study Meta-Analysis Identifies Innate Immune Susceptibility Loci Associated with Non-Del (5q) Myelodysplastic Syndromes Predisposition</a><div class="gs_gray">KL McGraw, CH Cheng, YA Chen, HA Hou, G Genovese, T Cluzeau, ...</div><div class="gs_gray">Blood 132, 107<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wUCFpcnEedwC" class="gsc_a_at">A Review of 1000 Molecular Investigations of Rare Inherited Anaemia and Related Conditions with the Red Cell Gene Panel</a><div class="gs_gray">R Mayhew, F Smith, L Steedman, N Parkin, EM Beiro, P Rushton, ...</div><div class="gs_gray">Blood 132, 3609<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Agc8PWtS8JkC" class="gsc_a_at">KINETICS OF EXPANSION AND PHENOTYPE OF UCART19 CELLS IN THE FIRST CLINICAL TRIAL OF A UNIVERSAL ALLOGENEIC CAR-T CELL PRODUCT</a><div class="gs_gray">A Jozwik, C Graham, A Dunlop, K Sanchez, D Yallop, P Patten, ...</div><div class="gs_gray">HUMAN GENE THERAPY 29 (11), A17-A17<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:OC7j4ufeY2cC" class="gsc_a_at">Importance of peripheral blood absolute lymphocyte counts (ALC) in predicting transplant outcomes in preparative regimens using anti-thymocyte globulin or alemtuzumab: an&nbsp;…</a><div class="gs_gray">V Sheth, V Kennedy, H de Lavallade, D Mclornan, V Potter, B Savani, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 53, 425-426<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-0tLmPFCw2kC" class="gsc_a_at">First-in-human study with UCART19, an allogeneic anti-CD19 CAR T-cell product, in high risk adult patients with CD19 (+) R/R B-cell ALL: Preliminary results of CALM study</a><div class="gs_gray">C Graham, D Yallop, A Jozwik, P Patten, A Dunlop, R Ellard, O Stewart, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 53, 21-22<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:YEBtnu9hOHUC" class="gsc_a_at">Comparison of sequential versus myeloablative, reduced intensity and non-myleoablative conditioning for patients with myelodysplastic syndrome: An analysis of the CMWP of the EBMT</a><div class="gs_gray">V Potter, J Wang, G Ehninger, F Auyk, L Koster, J Finke, D Beelen, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 53, 52-53<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:MUocvVTjX6cC" class="gsc_a_at">Outcome of Allogeneic Haematopoietic Stem Cell Transplantation in Myeloproliferative Neoplasms-Unclassified: A Retrospective Study by the Chronic Malignancies Working Party of&nbsp;…</a><div class="gs_gray">D McLornan, R Szydlo, M Robin, L Koster, G Stuhler, R Arnold, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 53, 246-247<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:MbTKqoTs-1EC" class="gsc_a_at">Allo-HSCT for Core Binding Factor AML (t (8; 21) or inv (16)/t (16; 16)) in Second Complete Remission: Report from the Acute Leukemia Working Party of the EBMT</a><div class="gs_gray">K Halaburda, M Labopin, A Mailhol, G Socie, C Craddock, M Aljurf, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 53, 28-29<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:C2yK8tfAHAgC" class="gsc_a_at">Trends in allogeneic stem cell transplantation outcomes for acute myeloid Leukemia patients. The experience of the Acute Leukemia Working Party of the EBMT</a><div class="gs_gray">J Canaani, E Beohou, M Labopidn, A Ghavamzadeh, D Beelen, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 53, 26-27<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:WsFh9Szeq2wC" class="gsc_a_at">Comparative study of complement components, regulators and receptors in healthy donors vs MDS patients</a><div class="gs_gray">ST Al-Shouli, SY Kordasti, GJ Mufti</div><div class="gs_gray">ALLERGY 73, 800-800<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:b8m_4JuPjscC" class="gsc_a_at">The role of the dermatologist in the haematology ward: our experience in a major haematopoietic stem cell transplant centre</a><div class="gs_gray">Z Willsmore, G Mufti, T Pagliuca, T Basu</div><div class="gs_gray">BRITISH JOURNAL OF DERMATOLOGY 179, 150-151<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:x8G803Bi31IC" class="gsc_a_at">OTU-005 Targeting expanded gut homing effector T cell lineages in GI-GVHD: a new therapeutic paradigm</a><div class="gs_gray">P Pavlidis, V Mehra, S Kottoor, E Alberts, JD Bell, TL Tsui, C Scotta, ...</div><div class="gs_gray">Gut 67 (Suppl 1), A54-A54<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4pF9x-cDGsoC" class="gsc_a_at">A case of Behcet disease-like mucocutaneous symptoms associated with myelodysplastic syndrome with trisomy 8</a><div class="gs_gray">F Tasker, AG Kulasekararaj, GJ Mufti, M Philippidou, T Basu</div><div class="gs_gray">BRITISH JOURNAL OF DERMATOLOGY 178 (4), E289-E290<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:MDQ-9Oe3GGUC" class="gsc_a_at">Prevalence of PNH clones and their clinical and prognostic significance in 3085 patients with cytopenia: a twenty-year single center experience</a><div class="gs_gray">B Fattizzo, A Dunlop, R Ireland, S Kassam, D Yallop, G Mufti, J Marsh, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 181, 22-22<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:5N-NJrZHaHcC" class="gsc_a_at">Randomised, Non-inferiority Trial of HLA Epitope Matched Platelet Transfusions for Alloimmunised Patients with Myeloid Bone Marrow Disorders</a><div class="gs_gray">J Marsh, L Pankhurst, D Kallon, C Brown, A Gilbertson, C Pigden, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 181, 33-33<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:YanO1q2l3soC" class="gsc_a_at">A single centre experience with Stenotrophomonas maltophilia infection within a UK teaching hospital haemato-oncology unit</a><div class="gs_gray">I Walker, S Moosai, S Babiker, V Potter, K Raj, D Mclornan, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 181, 50-50<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:1pC5hbHeJ6IC" class="gsc_a_at">Anti-type M phospholipase A2 receptor antibody-positive membranous nephropathy as a part of multi-system autoimmune syndrome post-allogeneic stem cell transplantation</a><div class="gs_gray">A Tedjaseputra, D McLornan, J McCormick, K Raj, H de Lavallade, ...</div><div class="gs_gray">Internal medicine journal 48 (4), 481-483<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:GUJN1xMjMHAC" class="gsc_a_at">Transplant-specific EBMT scoring system improves prognostic capability in myelodysplastic syndromes after allogeneic stem-stell transplantation</a><div class="gs_gray">N Gagelmann, DJ Eikema, D Beelen, M Stelljes, L Koster, G Mufti, ...</div><div class="gs_gray">Bone Marrow Transplantation 53, 117-118<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:tFyepMjQr3wC" class="gsc_a_at">Comparative outcomes for matched and mismatched (haplo) family donors for Myelodysplastic syndromes: Results from the EBMT Chronic Leukaemia Working Party</a><div class="gs_gray">K Raj, DJ Eikema, L Koster, MT Van Lint, D Blaise, A Nagler, D Beelen, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 53, 137-138<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:xyzrkeHX5M4C" class="gsc_a_at">REDUCED RELAPSE INCIDENCE WITH FLAMSA-TBI IN COMPARISON TO BU/FLU IN AML PATIENTS TRANSPLANTED IN CR1 OR CR2: ON BEHALF OF THE ALWP OF THE EBMT</a><div class="gs_gray">T Heinicke, M Labopiin, C Schmid, D Blaise, A Brecht, JY Cahn, Y Hicheri, ...</div><div class="gs_gray">Bone Marrow Transplant. 53, 289-291<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:n8FNryW2AHIC" class="gsc_a_at">In the Era of Chemoimmunotherapy, Relapse Post Autologous Stem Cell Transplantation for Follicular Lymphoma Is Associated with Prolonged Overall Survival. an Analysis By the&nbsp;…</a><div class="gs_gray">S Robinson, H Finel, A Boumendil, H Tilly, G Salles, P Corradini, R Cairoli, ...</div><div class="gs_gray">Blood 130, 3299<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:OKy9v0bssVUC" class="gsc_a_at">Optimized EBMT Transplant-Specific Risk Score of Patients with Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation</a><div class="gs_gray">N Gagelmann, M Stelljes, DW Beelen, DJ Eikema, NS Knelange, G Mufti, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 3325&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:INdAjOZKYREC" class="gsc_a_at">Low-Dose Second Generation TKI Is an Effective Approach to Reduce TKI Related Side Effects and Toxicity While Preserving Molecular Response in CML Patients with TKI Intolerance</a><div class="gs_gray">V Mehra, T Oyebamiji, S Widya, RM Ireland, AG Kulasekararaj, K Raj, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 5250&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:qQc65DSaYXMC" class="gsc_a_at">Transplant Outcome for Secondary Acute Myeloid Leukemia Based on Prior Hematological Disease or Solid Malignancy—on Behalf of the ALWP of the EBMT</a><div class="gs_gray">BN Savani, M Labopin, A Boumendil, J Finke, A Ganser, M Stelljes, ...</div><div class="gs_gray">Blood 130 (Supplement 1), 3320-3320<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Np1obAXpBq8C" class="gsc_a_at">Comparison of Outcome after Allogeneic Stem Cell Transplantation in AML Patients in First or Second Complete Remission Following Either Fludarabin/Busulfan, Flamsa-TBI or&nbsp;…</a><div class="gs_gray">T Heinicke, M Labopin, C Schmid, D Blaise, A Brecht, JY Cahn, Y Hicheri, ...</div><div class="gs_gray">Blood 130 (Supplement 1), 3242-3242<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:pZ2CosqRuhkC" class="gsc_a_at">Bone Marrow Stem Cells from Patients with Myelodysplastic Syndrome (MDS) Engraft and Migrate in-between the Humanized Niches in Immuno-Compromised Mouse Models</a><div class="gs_gray">SA Mian, K Rouault-Pierre, AE Smith, A Abarrategi, T Coats, D McLornan, ...</div><div class="gs_gray">Blood 130 (Supplement 1), 49-49<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:MtS25d97-7AC" class="gsc_a_at">Functional Characteristics of FAS-L Resistant and IL-2 Deprived Regulatory T Cells (Treg A) in Idiopathic Aplastic Anaemia</a><div class="gs_gray">B Costantini, SA Mian, SP Lim, F Toulza, S Orr, P Perez-Abellan, ...</div><div class="gs_gray">Blood 130 (Supplement 1), 2450-2450<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:KPAPMsW7zc0C" class="gsc_a_at">EBV Reactivation Incidence and Severity in Multiple Sclerosis Patients Treated with Autologous Haematopoietic Stem Cell Transplant and Comparing with Aplastic Anaemia Treated&nbsp;…</a><div class="gs_gray">V Mehra, E Rhone, S Widya, V Potter, K Raj, D McLornan, H De Lavallade, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 4535&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:qOpkhvVCMvUC" class="gsc_a_at">Favorable Long-Term Outcomes after Allogeneic Transplantation for Elderly Patients with Myelodysplastic Syndromes: A Report from the Chronic Malignancies Working Party of EBMT</a><div class="gs_gray">J Schetelig, LC de Wreede, M Van Gelder, L Koster, DW Beelen, G Mufti, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 4577&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wyM6WWKXmoIC" class="gsc_a_at">1: Rovira J, Cid J, Gutiérrez-García G, Pereira A, Fernández-Avilés F, Rosiñol L, Martínez C, Carreras E, Urbano A, Rovira M, Lozano M. Fatal immune hemolytic anemia following&nbsp;…</a><div class="gs_gray">F Moscardó, J de la Rubia, G Sanz, MA Sanz, S Devereux, GJ Mufti, ...</div><div class="gs_gray">Transfusion 57 (10), 2355-2358<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PuYkdpj8xa4C" class="gsc_a_at">Preclinical modeling of myelodysplastic syndromes</a><div class="gs_gray">S Mian, K Rouault-Pierre, M Goulard, P Fenaux, C Dosquet, G Mufti, ...</div><div class="gs_gray">Experimental Hematology 53, S78<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:DOLguN9Lh8sC" class="gsc_a_at">Long-term survival of patients with MDS after allogeneic transplantation: a report from the Chronic Malignancies Working Party of EBMT</a><div class="gs_gray">J Schetelig, L de Wreede, M van Gelder, L Koster, D Beelen, GJ Mufti, ...</div><div class="gs_gray">Bone Marrow Transplantation 52, S97-S98<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:n1qY4L4uFdgC" class="gsc_a_at">Thymoglobuline versus Campath in patients with myeloid disease receiving a reduced intensity conditioning regimen before allogeneic hematopoietic stem cell transplant (HSCT): P423</a><div class="gs_gray">M Robin, K Raj, S Chevret, J Gauthier, D Michonneau, D McLornan, ...</div><div class="gs_gray">Bone Marrow Transplantation 52<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LzOrNEA7mwcC" class="gsc_a_at">Effect of alemtuzumab dose de-escalation in reduced intensity conditioned unrelated donor haemataopoietic stem cell transplantation for myeloid malignancy: P405</a><div class="gs_gray">A Sarma, V Potter, L Floro, M DeCastro, K Raj, D McLornan, ...</div><div class="gs_gray">Bone Marrow Transplantation 52<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:HmWvvuJwtxYC" class="gsc_a_at">Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine as conditioning regimen for matched sibling and unrelated donor transplant in patients with acute myeloid&nbsp;…</a><div class="gs_gray">F Saraceni, M Labopin, RM Hamladji, G Mufti, G Socié, A Shimoni, ...</div><div class="gs_gray">Bone Marrow Transplantation 52<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:S_fw-_riRmcC" class="gsc_a_at">CLINICAL IMPLICATIONS OF CLONAL CD34+ CELLS IN STEM CELL HARVEST FROM PATIENTS WITH PLASMA CELL DYSCRASIAS</a><div class="gs_gray">S Chitre, F Stoelzel, K Cuthill, M Streetly, C Graham, M Bornhaeuser, ...</div><div class="gs_gray">HAEMATOLOGICA 102, 105-105<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:RZBefGmQYygC" class="gsc_a_at">PERIPHERAL BLOOD STEM CELL (PBSC) HAPLOIDENTICAL TRANSPLANTATION VERSUS MISMATCHED UNRELATED DONOR TRANSPLANTATION: A SINGLE UK CENTRE EXPERIENCE</a><div class="gs_gray">J O'Sullivan, K Parmesar, D McLornan, DL Hugues, V Potter, M Streetly, ...</div><div class="gs_gray">HAEMATOLOGICA 102, 631-631<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:6ScxedgR18sC" class="gsc_a_at">PHOSPHOPROTEOMICS AND MASS CYTOMETRY SIGNATURES OF PRIMARY AML CELL DIFFERENTIATION ARE ASSOCIATED WITH SENSITIVITY TO KINASE INHIBITORS</a><div class="gs_gray">P Casado-Izquierdo, EH Wilkes, F Miraki-Moud, MM Hadi, A Rio-Machin, ...</div><div class="gs_gray">HAEMATOLOGICA 102, 203-203<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ShjGdcaqzI0C" class="gsc_a_at">Relapse risk score after allogeneic stem cell transplantation for MDS patients. An EBMT study from the MDS subcommittee of Chronic Malignancies Working Party (CMWP)</a><div class="gs_gray">N Kröger, H Putter, L De Wreede, A van Biezen, D Ziagkos, L Volin, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 128 (22), 4701-4701<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:71d7Y1FijdoC" class="gsc_a_at">Spontaneous myonecrosis in chronic myeloid leukaemia</a><div class="gs_gray">H Renshaw, S Gandhi, A Shah, R Ireland, JC Marsh, GJ Mufti</div><div class="gs_gray">British journal of haematology 175 (2), 190-190<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:43B52WW2E64C" class="gsc_a_at">The phenotype, functions and cytokine properties of 5-Azacytidine (5AzaC) induced Treg-like FOXP3 (+) CD4 (+) T cells</a><div class="gs_gray">C Benfatto, T Seidl, PP Abellan, SS Chung, R Ellis, G Mufti, NSB Thomas, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF IMMUNOLOGY 46, 738-738<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:gnsKu8c89wgC" class="gsc_a_at">Identification of genetic polymorphisms associated with myelodysplastic syndromes by genome-wide association study</a><div class="gs_gray">K McGraw, CH Cheng, A Chen, G Genovese, T Cluzeau, HY Lin, ...</div><div class="gs_gray">Cancer Research 76 (14 Supplement), 2570-2570<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:j6V8Syvup0UC" class="gsc_a_at">Graft-versus-host disease or Stevens-Johnson syndrome? Diagnostic challenges in haematopoietic stem cell transplant recipients: BI11</a><div class="gs_gray">Z Shukur, H de Lavallade, V Potter, A Pagliuca, G Mufti, D Creamer, ...</div><div class="gs_gray">British Journal of Dermatology 175, 149-150<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:0Kh4an1R61UC" class="gsc_a_at">Severe and refractory psoriasis associated with myelodysplastic syndrome: BI10</a><div class="gs_gray">Z Laftah, A Kulasekararaj, G Mufti, A du Vivier, T Basu</div><div class="gs_gray">British Journal of Dermatology 175<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:7XUxBq3GufIC" class="gsc_a_at">TREATMENT-EMERGENT ADVERSE EVENTS IN LENALIDOMIDE-TREATED LOW/INT-1-RISK MYELODYSPLASTIC SYNDROMES PATIENTS WITHOUT DEL (5Q) INELIGIBLE FOR OR REFRACTORY TO ERYTHROPOIESIS&nbsp;…</a><div class="gs_gray">A Almeida, P Fenaux, G Garcia-Manero, A Giagounidis, S Goldberg, ...</div><div class="gs_gray">HAEMATOLOGICA 101, 502-502<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:2_BaaiyHPJIC" class="gsc_a_at">INTEGRATIVE GENOMICS IDENTIFIES THE MOLECULAR BASIS OF RESISTANCE TO AZACITIDINE THERAPY IN MYELODYSPLASTIC SYNDROMES</a><div class="gs_gray">A Unnikrishnan, E Papaemmanuil, D Beck, A Verma, A Kumari, P Woll, ...</div><div class="gs_gray">HAEMATOLOGICA 101, 157-158<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4uoR24qA-WYC" class="gsc_a_at">MIR-181C REGULATES BRK1, PART OF THE WAVE COMPLEX, AND IS INVOLVED IN T CELL FUNCTION</a><div class="gs_gray">SP Lim, G Mufti, J Gaken</div><div class="gs_gray">HAEMATOLOGICA 101, 577-578<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:b8wqy9DyMDUC" class="gsc_a_at">Targeted sequencing of 647 patients with myeloid malignancies, marrow failures and cytopenia: A prospective'real life'analysis</a><div class="gs_gray">N Igbineweka, S Best, A Kizilors, AS Riberio, N Igbineweka, T Chevassut, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 173, 13-14<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:WHBERAHVdrEC" class="gsc_a_at">Single UK centre outcomes of peripheral blood stem cell (PBSC) haploidentical transplantation</a><div class="gs_gray">JM O'Sullivan, A Pagliuca, M Streetly, H de Lavallade, V Potter, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 173, 15-15<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:uQVPmWFBlwUC" class="gsc_a_at">A comparison of PCR methods for the detection of MYD88 L265P mutations in a diagnostic setting</a><div class="gs_gray">J Anwar, A Kizilors, S Kassam, R Ireland, A Ribeiro, T Smith, D Yallop, ...</div><div class="gs_gray">British Journal of Haematology 173, 80-80<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:yCjxvIMm6_oC" class="gsc_a_at">T-cell depletion with anti-thymocyte globulin (ATG) favours superior overall survival and lowers rates of relapse and GVHD when compared to alemtuzumab in patients undergoing&nbsp;…</a><div class="gs_gray">S Alimam, Y Beauverd, D McLornan, M Ibrahim, C Saha, K Raj, ...</div><div class="gs_gray">British Journal of Haematology 173<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:yJjnfzR0HrkC" class="gsc_a_at">FLAG-lite regimen is effective bridging salvage chemotherapy for relapsed/refractory acute myeloid Leukaemia-a single centre experience: 336</a><div class="gs_gray">V Mehra, K Raj, V Potter, D Mclornan, H de Lavallade, J Hayden, G Ong, ...</div><div class="gs_gray">British Journal of Haematology 173<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:vVJNg6_NJEsC" class="gsc_a_at">Targeted sequencing of 647 patients with myeloid malignancies, marrow failures and cytopenia: A prospective ‘real life’analysis: 17</a><div class="gs_gray">A Kulasekararaj, S Best, A Kizilors, A Riberio, N Igbineweka, T Chevassut, ...</div><div class="gs_gray">British Journal of Haematology 173, 13-14<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:orDZ08hpP44C" class="gsc_a_at">Anti-phospholipase A2 receptor (Anti-PLA2R) antibody positive-nephrotic syndrome as a manifestation of multi-system, immunemediated complications post allogeneic stem cell&nbsp;…</a><div class="gs_gray">A Tedjaseputra, K Raj, H de Lavallade, D McLornan, V Potter, M Kenyon, ...</div><div class="gs_gray">British Journal of Haematology 173<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:OzeSX8-yOCQC" class="gsc_a_at">Germline mutations of hTERT in myelodysplastic syndromes are associated with shortened telomeres but are not associated with increased cytogenetic abnormalities</a><div class="gs_gray">SA Gandhi, K Thinzar, H Wood, K Majumder, G Ong, J Hayden, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 173, 122-122<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Ic1VZgkJnDsC" class="gsc_a_at">Dyskeratosis congenita: recognizing mucocutaneous manifestations of telomerase dysfunction: Poster 8</a><div class="gs_gray">X Du, J Marsh, A Kulasekararaj, A du Vivier, S Gandhi, G Mufti, T Basu</div><div class="gs_gray">British Journal of Dermatology 174 (4)<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:j8pvxH-kN2QC" class="gsc_a_at">Single Cell Mass Cytometry Identifies T-Regulatory Cell Subsets Associated with ECP Response in Chronic GVHD</a><div class="gs_gray">MH Jagasia, T Basu, BG Engelhardt, H Chen, W Clark, EK Waller, C Giver, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 22 (3), S400-S401<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:rFyVMFCKTwsC" class="gsc_a_at">Single centre outcomes from T cell deplete Allograft for MDS/MPDu: P366</a><div class="gs_gray">E Nuttall, L Floro, V Potter, H De Lavallade, D McLornan, A Pagliuca, ...</div><div class="gs_gray">Bone Marrow Transplantation 51<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:XUAslYVNQLQC" class="gsc_a_at">Towards the Potential Use of In Vitro Expanded Regulatory T-Cells (Tregs) in Aplastic Anemia (AA): Opportunities for Therapy</a><div class="gs_gray">B Costantini, S Kordasti, M Martinez-Llordella, G Povoleri, JCW Marsh, ...</div><div class="gs_gray">Blood 128 (22), 2673<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:C5mqfHIFIucC" class="gsc_a_at">P53 Protein Expression Correlates with Adverse Outcome in Low-Risk Myelodysplastic Syndromes</a><div class="gs_gray">F Donatelli, AG Kulasekararaj, A e Smith, J Salisbury, SA Mian, ...</div><div class="gs_gray">Blood 128 (22), 5505<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:5p9vMBpPSXYC" class="gsc_a_at">Comparable Outcomes after Allogeneic Stem-Cell Transplantation with Intravenous Busulfan or Treosulfan-Based Reduced-Intensity and Reduced Toxicity Regimens in Acute Myeloid&nbsp;…</a><div class="gs_gray">A Shimoni, M Labopin, BN Savani, RM Hamladji, DW Beelen, GJ Mufti, ...</div><div class="gs_gray">Blood 128 (22), 2280<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:HoDPlbN_d1QC" class="gsc_a_at">Donor Lymphocyte Infusions Correct Deficiency of Naive T Cells and Improve T-Cell Competence after Allogeneic Haematopoietic Stem Cell Transplantation with Lymphocyte Depletion</a><div class="gs_gray">M Al Rukhayes, VT Potter, P Perez-Abellan, J Feliu, L Floro, ...</div><div class="gs_gray">Blood 128 (22), 2233<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:w-fwKiQwpQAC" class="gsc_a_at">Heterozygous RTEL1 Variants Are Associated with Bone Marrow Failure and Abnormal Clinical Phenotype</a><div class="gs_gray">S Gandhi, J Jiang, M Ibanez, I Callebaut, JCW Marsh, GJ Mufti</div><div class="gs_gray">Blood 128 (22), 1043<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:MnogvFdIBdwC" class="gsc_a_at">Targeted Sequencing of 647 Patients with Myeloid Malignancies, Marrow Failures and Cytopenia: A Prospective Analysis</a><div class="gs_gray">AG Kulasekararaj, S Best, A Kizilors, S Gandhi, VT Potter, JCW Marsh, ...</div><div class="gs_gray">Blood 128 (22), 1981<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:3BvdIg-l-ZAC" class="gsc_a_at">Abstract B124: Immunotherapy of acute myeloid leukemia using Vg9Vd2 T-cells</a><div class="gs_gray">AC Parente-Pereira, LM Whilding, P Krishnamurthy, R Beatson, ...</div><div class="gs_gray">Cancer Immunology Research 4 (1 Supplement), B124-B124<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Og1tA8FjbJAC" class="gsc_a_at">Comparison of outcome after haplo-identical, HLA-mismatched unrelated donor and unrelated cord blood transplantation in patients with myelodysplastic syndrome (MDS) and&nbsp;…</a><div class="gs_gray">M Robin, R Porcher, MT Van Lint, F Ciceri, J Tisher, J Sanz, U Platzbecker, ...</div><div class="gs_gray">Bone Marrow Transplantation, S73-S73<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:IExZWSxeYXUC" class="gsc_a_at">Autologous <i>Ex-Vivo</i> Regulatory T Cells(Tregs) Expansion in Aplastic Anemia for Potential Clinical Use</a><div class="gs_gray">B Costantini, S Kordasti, S Thomas, S Alexander, M Syed, A Kizilors, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 3617-3617<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:IvSMUa3B7yYC" class="gsc_a_at">Zinc Finger Nuclease (ZFN) Targeted Homologous Recombination Assay Detects Elevated Inter Homologous Recombination Activity and Copy Neutral Loss of Heterozygosity (CN-LOH) in&nbsp;…</a><div class="gs_gray">TJ Gaymes, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 1219-1219<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:RJNGbXJAtMsC" class="gsc_a_at">An Integrative Genomics Approach Uncovers the Basis of Resistance to AZA Therapy in MDS and CMML</a><div class="gs_gray">A Unnikrishnan, E Papaemmanuil, D Beck, A Verma, A Kumari, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 710-710<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Ul_CLA4dPeMC" class="gsc_a_at">Mutations in Histone Modulators Are Associated with Prolonged Survival during Azacitidine Therapy</a><div class="gs_gray">M Tobiasson, D McLornan, M Karimi, M Dimitriou, M Jansson, ...</div><div class="gs_gray">57th ASH Annual Meeting and Exposition<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:gmHTDCtJMcoC" class="gsc_a_at">Age Distribution and Pattern of Myeloid Marrow Mutations in Patients (pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS) after Failure of Hypomethylating Agents (HMAs)</a><div class="gs_gray">GJ Mufti, LR Silverman, S Best, S Fructman, N Azarnia, ME Petrone, ...</div><div class="gs_gray">Blood 126 (23), 5257<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Vztgr1qGG8IC" class="gsc_a_at">Telomere Length and Telomerase Assay Assist in Identifying Novel Telomere Gene Complex Mutations in a Cohort of Patients with Aplastic Anemia</a><div class="gs_gray">S Gandhi, J Jiang, N Benson-Quarm, H Renshaw, SA Mian, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 667-667<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:hHIA4WEVY-EC" class="gsc_a_at">Immunological Profile of Patients after HSCT Using the FCC Conditioning Regimen for Treatment of Severe Aplastic Anemia Shows Sustained Mixed T-Cell Chimerism Is Due to&nbsp;…</a><div class="gs_gray">F Grimaldi, P Perez-Abellan, S Best, N Lea, J Veluchamy, M Atif, R Grain, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 3129-3129<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:h168fVGZblEC" class="gsc_a_at">Prevalence and Impact on Outcomes of Additional Karyotypic Abnormalities in Patients (Pts) with Myelodysplastic Syndromes (MDS) and Del (5q) from the MDS-003 and MDS-004 Studies</a><div class="gs_gray">A Giagounidis, AF List, E Hellström-Lindberg, GJ Mufti, B Schlegelberger, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 1680-1680<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:xyvS_IvSCKsC" class="gsc_a_at">Dendritic Cell Subsets in Bone Marrow and Peripheral Blood of Patients with Myelodysplastic Syndromes Display Numeric and Functional Defects</a><div class="gs_gray">N van Leeuwen-Kerkhoff, TM Westers, HJ Bontkes, S Kordasti, GJ Mufti, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 4109-4109<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:jmjb1lOE9QIC" class="gsc_a_at">Allogeneic Hematopoietic Cell Transplantation (HCT) for Advanced Mycosis Fungoides and Sezary Syndrome (MF/SS): Impact of Increasing the Use of Unrelated Donors (UD)-the EBMT&nbsp;…</a><div class="gs_gray">RF Duarte, A Boumendil, F Onida, H Finel, IH Gabriel, W Arcese, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 4403-4403<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:5F1dSjz1ScoC" class="gsc_a_at">IMMUNOLOGICAL PROFILE OF PATIENTS AFTER ALEMTUZUMAB-BASED HSCT FOR SEVERE APLASTIC ANEMIA INDICATES POTENTIAL BASIS FOR TOLERANCE WITH MIXED T-CELL CHIMERISM AND EXTREMELY LOW&nbsp;…</a><div class="gs_gray">F Grimaldi, R Grain, P Perez-Abellan, S Best, N Lea, JP Veluchamy, M Atif, ...</div><div class="gs_gray">HAEMATOLOGICA 100, 24-24<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:dhpJJ7xvgBgC" class="gsc_a_at">Impact of Mutation Variant Allele Frequency on Phenotype, Outcomes, and Patient Management in Myelodysplastic Syndromes</a><div class="gs_gray">D Sallman, R Komrokji, C Vaupel, T Cluzeau, KL McGraw, NH Al Ali, ...</div><div class="gs_gray">Clinical Lymphoma, Myeloma and Leukemia 15, S43-S44<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:0urtJCGzaFQC" class="gsc_a_at">RETROSPECTIVE ANALYSIS OF OPTIA® GRANULOCYTE COLLECTION EFFICIENCY OVER A TWO YEAR PERIOD IN KING'S COLLEGE HOSPITAL, LONDON: P-251A</a><div class="gs_gray">W Perera, D Hess, D Kuruppu, A Herath, C Haili, D McLornan, A Pagliuca, ...</div><div class="gs_gray">Vox Sanguinis 109<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:J6OZcwVsj5AC" class="gsc_a_at">OC-031 Rectogismoid biopsies are sufficient to confirm intestinal involvement in symptomatic patients with acute or chronic graft versus host disease: a retrospective&nbsp;…</a><div class="gs_gray">P Pavlidis, L Floro, K Raj, D McLornan, H DeLavallade, T Pagliuca, ...</div><div class="gs_gray">Gut 64 (Suppl 1), A16-A16<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:hEXC_dOfxuUC" class="gsc_a_at">PTU-079 Non-invasive testing is diagnostic and prognostic in intestinal graft versus host disease</a><div class="gs_gray">B Hayee, P Pavlidis, L Floro, V Potter, G Mufti</div><div class="gs_gray">Gut 64 (Suppl 1), A95-A95<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:yY3RG6sOEgwC" class="gsc_a_at">A novel zinc finger gene, <i>ZNF465</i>, is inappropriately expressed in acute myeloid leukaemia cells</a><div class="gs_gray">JF Collin, JW Wells, B Czepulkowski, L Lyne, PJ Duriez, AH Banham, ...</div><div class="gs_gray">Genes, Chromosomes and Cancer 54 (5), 288-302<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:xlVdBZVQT58C" class="gsc_a_at">Donor lymphocyte infusion-a retrospective single centre audit: 13</a><div class="gs_gray">C Saha, J Feliu, V Potter, J Clay, L Floro, K Raj, H De Lavallade, ...</div><div class="gs_gray">British Journal of Haematology 169<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:lK9BDNCuzFgC" class="gsc_a_at">Immunological profile of patients after HSCT using the FCC conditioning regimen for treatment of severe aplastic anemia indicates potential basis for tolerance with mixed T&nbsp;…</a><div class="gs_gray">F Grimaldi, R Grain, P Perez-Abellan, S Best, N Lea, J Veluchamy, M Atif, ...</div><div class="gs_gray">British Journal of Haematology 169<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:X5YyAB84Iw4C" class="gsc_a_at">Role of allogeneic SCT in low risk MDS: A Retrospective Study on Behalf of the CMWP of the EBMT</a><div class="gs_gray">M Robin, R Porcher, W Zinke, A Van Biezen, L Volin, G Mufti, C Craddock, ...</div><div class="gs_gray">Bone Marrow Transplantation 50, S109-S110<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LiF7i2gyBHwC" class="gsc_a_at">Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI)</a><div class="gs_gray">J Feliu, V Potter, J Clay, L Floro, C Saha, L Barber, G Orti, AA Alnagar, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 50, S125-S126<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:MDX3w3dAD3YC" class="gsc_a_at">BACK TO WORK AFTER ALLOGENEIC TRANSPLANT: EXPLORING EMPLOYMENT RATES IN THE LONG-TERM FOLLOW-UP CLINIC</a><div class="gs_gray">M Kenyon, J Clay, C Wykes, A Pagliuca, G Mufti, K Raj</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 50, S507-S507<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LpHykl0McycC" class="gsc_a_at">A novel zinc finger gene, ZNF465, is inappropriately expressed in presentation acute myeloid leukaemia cells</a><div class="gs_gray">JF Collin, JW Wells, B Czepulkowski, L Lyne, PJ Duriez, AH Banham, ...</div><div class="gs_gray">Wiley<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:xIusEVNJREcC" class="gsc_a_at">117 A PHASE 3 STUDY OF LENALIDOMIDE VERSUS PLACEBO IN RBC TRANSFUSION-DEPENDENT (TD) PATIENTS WITH LOWER-RISK MDS WITHOUT DEL (5Q) UNRESPONSIVE OR REFRACTORY TO ERYTHROPOIESIS&nbsp;…</a><div class="gs_gray">V Santini, A Almeida, A Giagounidis, S Gröpper, A Jonasova, N Vey, ...</div><div class="gs_gray">Leukemia Research, S60-S61<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:anDooRL1HQEC" class="gsc_a_at">111 MUTATIONAL PROFILE AND KARYOTYPIC ABNORMALITIES OF CLINICAL TRIAL PATIENTS WITH HIGHER-RISK MDS FOLLOWING FAILURE OF HYPOMETHYLATING AGENTS (HMAS): IMPACT ON RESPONSE TO&nbsp;…</a><div class="gs_gray">GJ Mufti, S Best, N Lea, E Hellstrom-Lindberg, LR Silverman, ...</div><div class="gs_gray">Leukemia Research, S57<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:e3CVSTJ63dQC" class="gsc_a_at">Fludarabine and Treosulfan Conditioning is Associated with a More Favorable Outcome after Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome. A Survey on Behalf&nbsp;…</a><div class="gs_gray">A Shimoni, A Nagler, S Iacobelli, A van Biezen, D Beelen, G Mufti, F Ciceri, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:HKviVsUxM5wC" class="gsc_a_at">57 A PHASE 2 MULTICENTER STUDY OF CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) WHO FAIL TO ACHIEVE RESPONSE WITH INJECTABLE AZACITIDINE OR DECITABINE</a><div class="gs_gray">G Garcia-Manero, LR Silverman, RS Komrokji, GJ Mufti, JF Seymour, ...</div><div class="gs_gray">Leukemia Research, S28<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Zbx7W2Xs4QsC" class="gsc_a_at">Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome (MDS) Patients at Lower Risk According to International Prognostic Scoring System (IPSS): A&nbsp;…</a><div class="gs_gray">M Robin, P Raphael, A van Biezen, L Volin, GJ Mufti, C Craddock, J Finke, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 2530-2530<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:h9G0ZmjYpDoC" class="gsc_a_at">Mutational Profile and Karyotypic Abnormalities of a Cohort of Clinical Trial Patients with Higher-Risk Myelodysplastic Syndromes (MDS) Following Failure of Hypomethylating&nbsp;…</a><div class="gs_gray">GJ Mufti, S Best, N Lea, LR Silverman, G Garcia-Manero, N Azarnia, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 3258-3258<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:JdL-Xu2nR38C" class="gsc_a_at">Telomere Gene Complex Mutations Are Frequently Found with Shortened Telomeres in Bone Marrow Failure Syndromes and Idiopathic Pulmonary Fibrosis; Correlation with&nbsp;…</a><div class="gs_gray">SA Gandhi, J Jiang, N Benson-Quarm, SA Mian, S Best, A Kulasekararaj, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 2935-2935<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:KqnX2w3egDsC" class="gsc_a_at">Increased Mortality in Patients with Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation</a><div class="gs_gray">M Wang, W Wang, A Abeywardane, M Adikarama, D McLornan, K Raj, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 2512-2512<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:L7vk9XBBNxgC" class="gsc_a_at">King’s College Hospital FCC Conditioning for Severe Aplastic Anemia Induces Tolerance with Mixed T-Cell Chimerism and Extremely Low Incidence of Gvhd</a><div class="gs_gray">F Grimaldi, LD Barber, P Perez-Abellan, R Grain, VT Potter, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 1594-1594<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:GJVTs2krol4C" class="gsc_a_at">Mutation and Expression Analysis of Jumonji Genes in Myelodysplastic Syndrome &amp; Acute Myeloid Leukaemia</a><div class="gs_gray">S Shinde, AM Mohamedali, G Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 3555-3555<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PVqtIyvKoSUC" class="gsc_a_at">Autologous Stem Cell Transplantation Achieves Long-Term Survival in a Selected CNS Lymphoma Population</a><div class="gs_gray">AB Khan, AA Hunt, VT Potter, S Kassam, D Yallop, PEM Patten, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 1197-1197<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:yIeBiWEAh44C" class="gsc_a_at">Busulfan-Dose Escalation in Reduced Intensity Stem Cell Transplantation (RIC-HSCT) Results in Good Outcomes for Patients with MDS and AML without Increased Toxicity</a><div class="gs_gray">A Sarma, VT Potter, J Clay, D McLornan, H de Lavallade, K Raj, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 1236-1236<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:yTLRzDEmwhEC" class="gsc_a_at">Identification of a Prognostic Gene Expression Signature for AZA Response in MDS and CMML Patients</a><div class="gs_gray">A Unnikrishnan, D Beck, A Verma, LA Richards, JAI Thoms, A Kumari, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 4601-4601<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ymY9cBF3mdcC" class="gsc_a_at">Multi-Center Study on Myelodysplastic Syndromes with Isolated Partial or Total Loss of Chromosome 7</a><div class="gs_gray">E Crisà, E Such, S Best, A Kulasekararaj, J Cervera, V Adema, N Lea, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 4662-4662<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:NMlhSUseqAsC" class="gsc_a_at">RPL27A Is a Target for Mir-595 and Contributes to Myelodysplastic Phenotype through Ribosomal Dysgenesis</a><div class="gs_gray">HA Alkhatabi, J Gaken, A Kulasekararaj, S Tan, F Malik, AJ Warren, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 1895-1895<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:p-HGrieyzrAC" class="gsc_a_at">Internal Tandem Duplication Mutation of FLT3 (FLT3/ITD) Significantly Increases Inter Chromosomal Homologous Recombination Providing a Direct Link Between Constitutive FLT3-ITD&nbsp;…</a><div class="gs_gray">TJ Gaymes, AM Mohamedali, GJ Mufti</div><div class="gs_gray">Blood 124 (21), 2185<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:aNch6Af-aFkC" class="gsc_a_at">Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome; A More Favorable Outcome after Fludarabine and Treosulfan Conditioning. a Survey on Behalf of the Chronic&nbsp;…</a><div class="gs_gray">A Shimoni, A Nagler, S Iacobelli, A van Biezen, D Beelen, GJ Mufti, ...</div><div class="gs_gray">Blood 124 (21), 1216<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:xii_ZKWM4-0C" class="gsc_a_at">Cutaneous adverse reactions to tyrosine kinase inhibitors in a cohort of patients treated for chronic myeloid leukaemia: P74</a><div class="gs_gray">A Sears, E Orrin, J Salisbury, G Mufti, H Lavallade, T Basu</div><div class="gs_gray">British Journal of Dermatology 171<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:X4-KO54GjGYC" class="gsc_a_at">Early clinical and pathological cutaneous features of chronic graft-versus-host disease: P43</a><div class="gs_gray">M Lynch, A Pagliuca, G Mufti, J Salisbury, T Basu</div><div class="gs_gray">British Journal of Dermatology 171<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:jtI9f0ekYq0C" class="gsc_a_at">ISOLATED TOTAL MONOSOMY 7 IS ASSOCIATED WITH BETTER PROGNOSIS IN A LARGE COHORT OF MDS PATIENTS COMPARED WITH OTHER ABNORMALITIES OF CHROMOSOME 7-A SINGLE INSTITUTE EXPERIENCE</a><div class="gs_gray">E Crisa, A Kulasekararaj, V Potter, K Raj, R Ireland, H De Lavallade, ...</div><div class="gs_gray">HAEMATOLOGICA 99, 500-501<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:g30IDTdgJMgC" class="gsc_a_at">Single centre experience of low dose cytarabine (LDAraC) treatment outcomes in myeloproliferative neoplasms (MPN), high risk myelodysplasia (MDS) and acute myeloid leukaemia&nbsp;…</a><div class="gs_gray">M Young, A Arasaretnam, D McLornan, H De Lavallade, T Pagliuca, ...</div><div class="gs_gray">British Journal of Haematology 165<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:yZoBfgUKqwcC" class="gsc_a_at">Application of HLAMatchmaker computer programme to select HLA epitope matched platelets for alloimmunised thrombocytopenic patients with aplastic anaemia, MDS and acute myeloid&nbsp;…</a><div class="gs_gray">J Marsh, D Kallon, C Brown, C Pigden, A Deary, K Harding, L Choo, ...</div><div class="gs_gray">British Journal of Haematology 165, 95-96<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:RMgMIBzvq-4C" class="gsc_a_at">Genetic analysis of PRC2 and Jumonji genes in MDS: 174</a><div class="gs_gray">S Shinde, A Mohamedali, S Mian, G Mufti</div><div class="gs_gray">British Journal of Haematology 165<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PQ6BjWB6CiEC" class="gsc_a_at">A case of vegetative oral herpes simplex 1 infection resistant to first-line treatment: Poster 8</a><div class="gs_gray">E Corden, M Zuckerman, K Raj, D McLornan, G Mufti, T Basu</div><div class="gs_gray">British Journal of Dermatology 170 (3)<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:vkuYBMKU6wEC" class="gsc_a_at">EBV REACTIVATION AND PTLD IN PATIENTS RECEIVING HSCT FOR APLASTIC ANAEMIA: PH-AB075</a><div class="gs_gray">P César, V Potter, M Zuckerman, J Clay, A Kulasekararaj, M Kenyon, ...</div><div class="gs_gray">Bone Marrow Transplantation 49<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:UKB2i6g6GNMC" class="gsc_a_at">SECOND ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) IN PATIENTS WITH RELAPSED LYMPHOMA AFTER FIRST ALLO-SCT. A RETROSPECTIVE STUDY OF THE EBMT LYMPHOMA WORKING PARTY.: PH-P139</a><div class="gs_gray">K Horstmann, A Boumendil, H Finel, J Apperley, F Ciceri, J Finke, ...</div><div class="gs_gray">Bone Marrow Transplantation 49<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:DPO9WFcz7UcC" class="gsc_a_at">RETROSPECTIVE COMPARISON OF HPC-A COLLECTION EFFICIENCY BETWEEN SPECTRA OPTIA® AND COBE SPECTRA® CELL SEPARATORS IN A LARGE TERTIARY COLLECTION FACILITY.: PH-AB200</a><div class="gs_gray">K Majumder, D Hess, D McLornan, A Mijovic, N Besson, E Tatam, ...</div><div class="gs_gray">Bone Marrow Transplantation 49<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:IT1MJ6E3JesC" class="gsc_a_at">NON MYELOABLATIVE HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH POST GRAFT HIGH DOSE CYCLOPHOSPHAMIDE FOR REFRACTORY SAA OR AFTER FAILED UNRELATED OR CORD BLOOD TRANSPLANT: PH-P044</a><div class="gs_gray">A Kulasekararaj, V Potter, J Clay, D Mclornan, K Raj, H De Lavallade, ...</div><div class="gs_gray">Bone Marrow Transplantation 49<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:oursBaop5wYC" class="gsc_a_at">PREDICTING FACTORS FOR INPATIENT MORTALITY AND LONG TERM SURVIVAL IN ALLOGENEIC STEM CELL TRANSPLANTATION RECIPIENTS ADMITTED TO INTENSIVE CARE UNIT: PH-P317</a><div class="gs_gray">L Floro, H de Lavallade, R Szydlo, J Clay, D McLornan, K Raj, M Kenyon, ...</div><div class="gs_gray">Bone Marrow Transplantation 49<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:c59VksA5Vz4C" class="gsc_a_at">ALLOGENEIC STEM CELL TRANSPLANTATION FOR HYPOPLASTIC MDS IS COMPLICATED BY INCREASED REJECTION, WHEREAS DISEASE RELAPSE IS THE PREDOMINANT CAUSE OF TREATMENT FAILURE IN&nbsp;…</a><div class="gs_gray">J Clay, K Raj, D McLornan, De lavallade, H., V Potter, A Kulasekararaj, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 49, S185-S186<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:JTtNqH-x4gYC" class="gsc_a_at">Myeloid Derived Suppressor Cell Expansion Correlates With Increased regulatory T Cells In Myelodysplastic Syndrome</a><div class="gs_gray">AO Kittang, S Kordasti, KE Sand, P Perezabellan, T Seidl, KP Rye, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 2766-2766<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:8RAEygVn5_EC" class="gsc_a_at">Characteristics and Outcome Of Acute Myeloid Leukemia Following Breast Cancer: Analysis Of 408 Cases and Controls</a><div class="gs_gray">M Gilabert, JB Micol, AG Kulasekararaj, S de Botton, C Chahine, B Esterni, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 1408-1408<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:a2necdfpwlEC" class="gsc_a_at">Second Allogeneic Stem Cell Transplantation (AlloSCT) In Patients With Relapsed Lymphoma After First Allosct. A Retrospective Study Of The EBMT Lymphoma Working Party</a><div class="gs_gray">K Horstmann, A Boumendil, H Finel, JF Apperley, F Ciceri, J Finke, ...</div><div class="gs_gray">Blood 122 (21), 4632<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:1l3MdapXzAoC" class="gsc_a_at">Cover Figure</a><div class="gs_gray">PM Kluin, G Hess, RG Meyer, A Nencioni, M Cea, F Montecucco, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:rUnQDpM0TEQC" class="gsc_a_at">PARP inhibitor sensitivity in high risk MDS and acute myeloid leukaemia is associated with microsatellite instability dependent frameshift mutations in DNA repair genes</a><div class="gs_gray">TJ Gaymes, AM Mohamedali, M Patterson, N Matto, A Smith, ...</div><div class="gs_gray">Haematologica 98 (9), 1397-1406<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:aVq8r21TQD4C" class="gsc_a_at">Cover Figure</a><div class="gs_gray">ES Jaffe, A Engert, AM Carella, S Branford, M Deininger, FX Mahon, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:rwEhk56xNqMC" class="gsc_a_at">HIGHER LEVELS OF CIRCULATING MYELOID DERIVED SUPPRESSOR CELLS (MDSC) IN MYELOID DYSPLASTIC SYNDROMES (MDS)</a><div class="gs_gray">A Kittang, S Kordasti, O Bruserud, G Mufti</div><div class="gs_gray">HAEMATOLOGICA 98, 78-78<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ocbgtyEEUOwC" class="gsc_a_at">P53 PROTEIN EXPRESSION PREDICTS OUTCOME AND CYTOGENETIC RESPONSE IN PATIENTS WITH LOW-/INT-1 RISK MYELODYSPLASTIC SYNDROMES TREATED WITH LENALIDOMIDE: RESULTS FROM THE MDS004&nbsp;…</a><div class="gs_gray">L Saft, M Karimi, M Ghaderi, A Matolscy, P Fenaux, G Mufti, A Giagounidis, ...</div><div class="gs_gray">HAEMATOLOGICA 98, 483-483<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:0d9pApVQ-n0C" class="gsc_a_at">T-CELL AND MONOCYTE PROFILING SHOWS MARKED DIFFERENCES IN FRESH TISSUE GENE EXPRESSION BETWEEN POSITIVELY SELECTED TUMOUR INFILTRATING AND PERIPHERAL BLOOD CELLS IN FOLLICULAR&nbsp;…</a><div class="gs_gray">S Rassam, F Malik, A Mohamedali, B Przychodzen, J Schofield, H Ali, ...</div><div class="gs_gray">Hematological Oncology 31<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:RgznTc0nqo4C" class="gsc_a_at">Early cytomegalovirus reactivation is associated with a poorer outcome after an alemtuzumab-based reducedintensity conditioning allogeneic stem cell transplant: P920</a><div class="gs_gray">V Noriega, T Cutino-Moguel, M Zuckerman, V Potter, L Barabino, K Raj, ...</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:2Q0AJrNhS-QC" class="gsc_a_at">Peptide vaccination using combined adjuvants for synergistic activation of cellular immunity (CASAC) promotes potent WT1-specific immune responses in anin vivomouse model: 38</a><div class="gs_gray">P Krishnamurthy, G Tye, L Barber, A Noble, G Mufti, F Farzaneh</div><div class="gs_gray">British Journal of Haematology 161<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:KS-xo-ZNxMsC" class="gsc_a_at">No difference between ATG and alemtuzumab when used for T-cell depletion in reduced intensity conditioned haematopoietic stem cell transplantation for MDS and AML: P768</a><div class="gs_gray">L Floro, V Potter, V Noriega, M Kenyon, J Marsh, K Raj, H De Lavallade, ...</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:_AeoHAGD03cC" class="gsc_a_at">Heterogeneity of inherited bone marrow failure syndromes and delay in diagnosis: 64</a><div class="gs_gray">S Gandhi, F Sillito, J Large, N Benson-Quarm, A Kulasekararaj, J Marsh, ...</div><div class="gs_gray">British Journal of Haematology 161, 28-29<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:idthP5jqfYAC" class="gsc_a_at">Cancer survivorship: A pilot study exploring responses of Bone Marrow Transplant survivors to a life-coaching intervention</a><div class="gs_gray">M Kenyon, F Young, G Mufti, A Pagliuca, Z Lim, E Ream</div><div class="gs_gray">PSYCHO-ONCOLOGY 22, 13-14<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:U0iAMwwPxtsC" class="gsc_a_at">P-098 p53 protein expression predicts outcome and cytogenetic response in patients with low-/INT-1-risk myelodysplastic syndromes treated with lenalidomide</a><div class="gs_gray">L Saft, M Karimi, M Ghaderi, A Matolscy, P Fenaux, G Mufti, A Giagounidis, ...</div><div class="gs_gray">Leukemia Research, S66<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:09LM3QYkMKUC" class="gsc_a_at">Expansion of CD141<sup>int</sup> Dendritic Cells in Myelodysplastic Syndrome (MDS)</a><div class="gs_gray">N Kerkhoff, S Kordasti, T Seidl, AA Van de Loosdrecht, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 3856-3856<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:9CGX2owmTHMC" class="gsc_a_at">Utility of Peripheral Blood for Cytogenetic and Mutation Analysis in Myelodysplastic Syndrome</a><div class="gs_gray">HA Alkhatabi, AM Mohamedali, AG Kulasekararaj, S Shinde, J Gaken, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 1707-1707<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Oj-SLI0tZTcC" class="gsc_a_at">Bone Marrow Hypocellularity Does Not Impair the Tolerability or Efficacy of Azacitidine (AZA) in Patients with Higher-Risk Myelodysplastic Syndromes Treated in the AZA-001 Study</a><div class="gs_gray">JF Seymour, JM Bennett, AF List, GJ Mufti, SD Gore, P Fenaux, V Santini, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 3808-3808<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:vofGIMt6cyEC" class="gsc_a_at">Adverse Effect of Very Poor Cytogenetics and Monosomal Karyotype On Outcomes Following T-Deplete Reduced Intensity Conditioned Stem Cell Transplant for MDS and AML.</a><div class="gs_gray">P Krishnamurthy, VT Potter, AG Kulasekararaj, V Noriega, H de Lavallade, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 3141-3141<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:BCdnXsLIVDwC" class="gsc_a_at">Demethylating Agents As a Salvage Treatment in Relapsed Myeloid Diseases Following Allogeneic Bone Marrow Transplantation</a><div class="gs_gray">S Atwal, AB Khan, V Noriega, Y Jethava, M Kenyon, H de Lavallade, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 4216-4216<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:K4-iKlO5MD4C" class="gsc_a_at">Allogeneic Stem Cell Transplantation for Accelerated/Blastic Phase Philadelphia-Chromosome Negative MPN</a><div class="gs_gray">AB Khan, D McLornan, Y Jethava, K Raj, VT Potter, H de Lavallade, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 4532-4532<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:DQNrXyjhriIC" class="gsc_a_at">T-Cell Profiling Shows Marked Differences in Gene Expression Between Tumour Infiltrating (TIL) and Peripheral Blood (PB) Antibody-Bead Selected T-Cells From Fresh Lymph Node&nbsp;…</a><div class="gs_gray">SMB Rassam, F Malik, J Schofield, H Ali, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 683-683<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:lbI08cpqPnQC" class="gsc_a_at">Outcome of BEAM-Autologous and BEAM-Alemtuzumab Allogeneic Transplantation in Relapsed Advanced Stage Follicular Lymphoma</a><div class="gs_gray">V Noriega, AB Khan, S Devereux, RE Marcus, M Kenyon, VT Potter, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 2022-2022<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:C-Rn0OCouf8C" class="gsc_a_at">A lentiviral vector manufactured under GMP for a Phase I study in Acute Myeloid Leukaemia-manufacture summary, safety testing, application and post-administration safety-monitoring</a><div class="gs_gray">L Chan, YQ Ma, P Krishnamurthy, D Darling, G Giunti, M Audit, J Bhalla, ...</div><div class="gs_gray">HUMAN GENE THERAPY 23 (5), A16-A16<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PuOEWVtPfzwC" class="gsc_a_at">British Society for Gene Therapy 2012 March 9, 2012 UCL Institute of Child Health, London</a><div class="gs_gray">SH Cheng, N Smart, N Cartier, I Pizzitola, F Anjos-Afonso, V Marin, ...</div><div class="gs_gray">Human Gene Therapy 23 (5), A1-A22<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:zTJoPluU4X4C" class="gsc_a_at">Impact of alemtuzumab versus anti-thymocyte globulin after unrelated allogeneic stem cell transplantation with reduced-intensity conditioning as treatment for AML in CR1: a&nbsp;…</a><div class="gs_gray">F Baron, M Labopin, G Mufti, R Arnold, C Craddock, K Bilger, N Kroger, ...</div><div class="gs_gray">Bone Marrow Transplantation 47<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:RVqaWcrwK10C" class="gsc_a_at">Plerixaforex vivomobilization of placental-derived haematopoietic stem cells: P814</a><div class="gs_gray">M Ceesay, S Tulpule, S Querol, L Barber, T Duffy, B Shaw, J Madrigal, ...</div><div class="gs_gray">Bone Marrow Transplantation 47<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:v_xunPV0uK0C" class="gsc_a_at">A UK single centre experience of 5-azacitidine in patients with myeloid malignancies, prior to NICE approval-a retrospective evaluation of 113 patients</a><div class="gs_gray">AG Kulasekararaj, S Patel, M Skwarski, P Krishnamurthy, RI Ireland, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 157, 65-65<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:cB__R-XWw9UC" class="gsc_a_at">MicroRNAs expression on MDS with− 7/7q deletion: 145</a><div class="gs_gray">H Alkhatabi, A Kulasekararaj, F Malik, G Mufti, J Gaken</div><div class="gs_gray">British Journal of Haematology 157, 56-57<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:l6Q3WhenKVUC" class="gsc_a_at">A comprehensive diagnostic approach improves the diagnostic accuracy of invasive fungal disease (IFD) in adult haemato-oncology patients undergoing HSCT or high dose&nbsp;…</a><div class="gs_gray">MM Ceesay, L Berry, SR Desai, J Cleverly, CC Kibbler, J Wade, M Smith, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 157, 2-3<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:cBPnxVikjH8C" class="gsc_a_at">Sweets syndrome and its association with myelodysplastic syndrome (MDS)-a single centre retrospective analysis of 27 cases: 167</a><div class="gs_gray">A Kulasekararaj, M Skwarski, S Patel, J Salisbury, A du Vivier, G Mufti</div><div class="gs_gray">British Journal of Haematology 157<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:u_mOZUIutIEC" class="gsc_a_at">Defining the Topography of Deletion 5q Using SNP-A Identifies Patients with More Aggressive Disease and Correlates with Additional Lesions</a><div class="gs_gray">A Jerez, AM Jankowska, H Makishima, LP Gondek, RV Tiu, LOK Christine, ...</div><div class="gs_gray">Blood 118 (21), 2795<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:cdwqcPQS8ssC" class="gsc_a_at">Clinical and Genomic Characterization of Chromosome 7 Lesions in Myeloid Malignancies</a><div class="gs_gray">A Jerez, Y Sugimoto, H Makishima, A Verma, LOK Christine, RV Tiu, ...</div><div class="gs_gray">Blood 118 (21), 3549<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:txeM2kYbVNMC" class="gsc_a_at">Long-Term Outcomes of Reduced Intensity Conditioning Haematopoietic Stem Cell Transplantation (RIC-HSCT) for AML with Myelodysplasia-Related Changes</a><div class="gs_gray">VT Potter, P Krishnamurthy, ZY Lim, VJ Tindell, S Devereux, RE Marcus, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 3079-3079<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:g8uWPOAv7ggC" class="gsc_a_at">Microsatellite Instability Induced Mutation in DNA Repair Genes, <i>CTiP</i> and <i>Mre11</i> Confer Hypersensitivity to PARP Inhibitors in Myeloid Malignancies</a><div class="gs_gray">TJ Gaymes, R Chelliah, AG Kulasekararaj, AM Mohamedali, S Shall, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 276-276<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QsKbpXNoaWkC" class="gsc_a_at">Single Nucleotide Polymorphism Array (SNP-A) Karyotype Is the Best Predictor of Prognosis In Normal Cytogenetics Acute Myeloid Leukaemia (AML)</a><div class="gs_gray">AM Mohamedali, RK Hills, EE Nasser, A Abdallah, S Shinde, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 411-411<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:BOlwja0KXvYC" class="gsc_a_at">Plerixafor <i>Ex Vivo</i> Mobilization of Placental Derived Haematopoietic Stem Cells</a><div class="gs_gray">MM Ceesay, S Tulpule, S Querol, L Barber, T Duffy, BE Shaw, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 4790-4790<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:jq04SsiGh3QC" class="gsc_a_at">Development of therapeutic vaccines for cancer and chronic infections: from AML to HBV</a><div class="gs_gray">F Farzaneh, P Krishnamurthy, GJ Tye, E Amofah, L Barber, L Chan, ...</div><div class="gs_gray">Human Gene Therapy 22 (10), A3-A3<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:uoRD4RTSUPoC" class="gsc_a_at">European Society of Gene and Cell Therapy British Society for Gene Therapy Collaborative Congress 2011 October 27–31, 2011 The Brighton Centre, Brighton United Kingdom</a><div class="gs_gray">LW Seymour, M Antoniou, DRP Harbottle, C Denning, R Hajjar, S Ferber, ...</div><div class="gs_gray">Human Gene Therapy 22 (10), A1-A138<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:60iIaj97TE0C" class="gsc_a_at">The pMHC array demonstrates that untouched T cell populations from Acute Myeloid Leukaemia patients can recognize tumour antigens</a><div class="gs_gray">S Brooks, S Bonney, E Smits, C Lee, D Sigurdardottir, H Rammensee, ...</div><div class="gs_gray">HUMAN GENE THERAPY 22 (10), A39-A39<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:_IsBomjs8bsC" class="gsc_a_at">Allogeneic stem-cell transplantation in chronic myelomonocytic leukemia (CMML): Factors affecting transplantation outcome. A study of the CLWP of the EBMT</a><div class="gs_gray">A Symeonidis, A van Bietsen, G Mufti, J Finke, D Beelen, M Bornhaeuser, ...</div><div class="gs_gray">Abstracts of the 11th International Symposium on Myelodysplastic Syndromes (MDS)<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QAOzB4mb83kC" class="gsc_a_at">Therapy related myelodysplastic syndrome and acute myeloid leukaemia (tMDS/tAML) in patients treated with purine analogues (PA) for lymphoproliferative disorders (LPD); an&nbsp;…</a><div class="gs_gray">S Rassam, N Heeney, S Bowcock, P Kalkur, E Dimitriadou, G Mufti</div><div class="gs_gray">British Journal of Haematology 153, 55-56<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:9tXw7Op4-u0C" class="gsc_a_at">Video-assisted thoracoscopic biopsy is feasible and safe in adult haemato-oncology patients undergoing stem cell transplantation or high-dose chemotherapy: P775</a><div class="gs_gray">M Ceesay, L Berry, S Desai, M Marrinan, R Deshpande, D Whitaker, ...</div><div class="gs_gray">Bone Marrow Transplantation 46<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:lRPiJ3GhvscC" class="gsc_a_at">Video-assisted thoracoscopic (VATS) biopsy is feasible and safe in adult haemato-oncology patients undergoing stem cell transplantation or high dose chemotherapy: 35</a><div class="gs_gray">M Ceesay, L Berry, S Desai, M Marrinan, R Deshpande, D Whitaker, ...</div><div class="gs_gray">British Journal of Haematology 153<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:1EqfMoDn7-AC" class="gsc_a_at">A rare case of inherited cytopenias with dysplastic features: 131</a><div class="gs_gray">V Tindell, V Potter, A Foggo, J Jiang, Z Lim, G Mufti, R Ireland</div><div class="gs_gray">British Journal of Haematology 153<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Gpwnp1kGG20C" class="gsc_a_at">The pMHC array demonstrates that untouched T cell populations from presentation myeloid leukaemia patients can recognize multiple tumour antigens: 163</a><div class="gs_gray">S Brooks, S Bonney, C Lee, D Sigurdardottir, HG Rammensee, G Mufti, ...</div><div class="gs_gray">British Journal of Haematology 153<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:G36d5HCDkJYC" class="gsc_a_at">Fanconi's anaemia like clinical syndrome without increased chromosomal breakages: 88</a><div class="gs_gray">L Chia, A Arasaretnam, S Gupta, C Wykes, A Ho, G Mufti, S Rassam</div><div class="gs_gray">British Journal of Haematology 153<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:YTuZlYwrTOUC" class="gsc_a_at">Survivorship following bone marrow transplant: a pilot study exploring responses to a life-coaching intervention</a><div class="gs_gray">M Kenyon, F Young, G Mufti, A Pagliuca, Z Lim, E Ream</div><div class="gs_gray">Bone Marrow Transplantation 46, S407-S408<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4n0clTBhZ78C" class="gsc_a_at">Alemtuzumab vs ATG for T-Cell Depletion in Sibling Donor Reduced Intensity Haematopoietic Stem Cell Transplantation (RIC HSCT) for the Treatment of Acute Myeloid Leukaemia and&nbsp;…</a><div class="gs_gray">VT Potter, VJ Tindell, L Reiff-Zall, A Ho, M Kenyon, J Marsh, A Pagliuca, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 17 (2), S289<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:8rLWgkbgOXQC" class="gsc_a_at">63 Long-term outcomes following RIC HSCT for MDS with fludarabine, busulphan and alemtuzumab</a><div class="gs_gray">V Potter, Z Lim, P Krishnamurthy, R Pinto, M Kenyon, J Marsh, R Ireland, ...</div><div class="gs_gray">Leukemia Research, S23<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:nroGzMJTTpEC" class="gsc_a_at">332 Outcomes of reduced intensity conditioning HSCT for lower-risk MDS: King's college hospital experience</a><div class="gs_gray">R Pinto, V Potter, V Tindell, P Krishnamurthy, J Marsh, R Ireland, ...</div><div class="gs_gray">Leukemia Research, S133<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PZE8UkGerEcC" class="gsc_a_at">The Myelodysplastic Overlap Syndromes</a><div class="gs_gray">W Ingram, GJ Mufti</div><div class="gs_gray">The Myelodysplastic Syndromes, 159-173<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:17ZO-CJnx_8C" class="gsc_a_at">Separation of cell cycle and growth cycle programmes in primary human T cells</a><div class="gs_gray">SJ Orr, DR Boutz, GJ Mufti, EM Marcotte, NSB Thomas</div><div class="gs_gray">British Journal of Haematology 153, 19-20<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:CMvovTBb2okC" class="gsc_a_at">225 Retrospective review of treatment of patients with concurrent t-large granular lymphocytosis and myelodysplastic syndrome</a><div class="gs_gray">V Tindell, V Pottter, J Hayden, G Mufti, Z Lim, R Ireland</div><div class="gs_gray">Leukemia Research, S88-S89<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:lPDSu1ZU3VAC" class="gsc_a_at">Re-Evaluation of the Efficacy of Azacitidine (AZA) In Patients From the AZA-001 Study with Higher-Risk Myelodysplastic Syndromes (MDS) Classified by WHO Criteria and WPSS Risk</a><div class="gs_gray">N Gattermann, GF Sanz, A Giagounidis, JF Seymour, P Fenaux, V Santini, ...</div><div class="gs_gray">Blood 116 (21), 4031<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:JqN3CTdJtl0C" class="gsc_a_at">Low Level Residual Extravascular Haemolysis Is Common Following Eculizumab Treatment In Paroxysmal Nocturnal Haemoglobinuria (PNH), but Does Not Affect Transfusion Requirement</a><div class="gs_gray">AG Kulasekararaj, D Odunsi, P Krishnamurthy, H Janet, I Momoh, GJ Mufti, ...</div><div class="gs_gray">BLOOD 116 (21), 1721-1722<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:tFzHCjejgA0C" class="gsc_a_at">Dysfunctional Tregs with Absence of Cytokine-Secreting CD4+ T-Cell Subsets and Marked Expansion of Th1 Cells Is a Hallmark of Idiopathic Aplastic Anaemia (AA)</a><div class="gs_gray">S Kordasti, JCW Marsh, PP Abellan, S Alkhan, J Hayden, C Veen, J Jiang, ...</div><div class="gs_gray">Blood 116 (21), 2233<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:SgM-ki2adj0C" class="gsc_a_at">Alemtuzumab-Based RIC HSCT with Pre-Emptive DLI as An Effective Strategy to Achieve Long-Term Disease Remission In Patients with High Risk Myelodysplastic Syndrome (MDS) and&nbsp;…</a><div class="gs_gray">SA Gandhi, VT Potter, VJ Tindell, R Kesse-Adu, L Reiff-Zall, M Kenyon, ...</div><div class="gs_gray">Blood 116 (21), 1304<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:5bfplxN71z4C" class="gsc_a_at">Cytokine Profile of Patients with Invasive Apsergillosis-Preliminary Results.</a><div class="gs_gray">MM Ceesay, S Kordasti, L Berry, M Smith, J Wade, GJ Mufti, A Pagliuca</div><div class="gs_gray">Blood 116 (21), 1500<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-vzq6BoH5oUC" class="gsc_a_at">Comparative Analysis of An Azacytidine Versus Azacytidine-HSCT Approach for the Treatment of Older Patients with AML/MDS</a><div class="gs_gray">VT Potter, VJ Tindell, R Kesse-Adu, J Hayden, P Pasipanodya, L Reiff-Zall, ...</div><div class="gs_gray">Blood 116 (21), 2375<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:XtJa11BXPS4C" class="gsc_a_at">The JAK2 46/1 Haplotype Analysis In Essential Thrombocythaemia and Polycythaemia Rubra Vera Reveals That CC Genotype Is Associated with a Higher JAK2V617F and c-MPL W515 Allele&nbsp;…</a><div class="gs_gray">S Mahmood, L Mellish, N Lea, AG Kulasekararaj, A Abdallah, S Srirangan, ...</div><div class="gs_gray">Blood 116 (21), 1977<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:HqhvjgTjE9cC" class="gsc_a_at">Prognostic Significance of Cryptic Genomic Aberrations In AML with Normal Karyotype</a><div class="gs_gray">A Mohamedali, R Hills, EE Nasser, A Abdallah, AG Kulasekararaj, ...</div><div class="gs_gray">Blood 116 (21), 2729<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:zdX0sdgBH_kC" class="gsc_a_at">Reduction of Tregs with Expansion of Th1 Cells and Lack of IFN-γ Secretion by GPI Negative T-Cells In PNH</a><div class="gs_gray">S Kordasti, M Elebute, PP Abellan, AG Kulasekararaj, J Hayden, ...</div><div class="gs_gray">Blood 116 (21), 2240<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:sJK75vZXtG0C" class="gsc_a_at">Serum Ferritin and Cardiac/Liver Magnetic Resonance Imaging In Evaluating Iron Overload for Patients with Bone Marrow Failure Conditions Undergoing Non-Myeloablative HSCT</a><div class="gs_gray">VJ Tindell, VT Potter, R Kesse-Adu, L Reiff-Zall, AY Ho, GJ Mufti, ...</div><div class="gs_gray">Blood 116 (21), 1331<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:cRMvf6lLvU8C" class="gsc_a_at">A Functional Assay for MicroRNA Target Identification and Validation</a><div class="gs_gray">J Gaken, A Mohamedali, J Jiang, F Malik, AG Kulasekararaj, F Farzaneh, ...</div><div class="gs_gray">Blood 116 (21), 3874<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4e5Qn2KL_jwC" class="gsc_a_at">Apoptin Induced Tumour Specific Killing Via Protein Kinase C Isoforms: A Potential Therapeutic Strategy In Plasma Cell Dyscrasias</a><div class="gs_gray">J Jiang, D Cole Sr, N Westwood, L Macpherson, F Farzaneh, GJ Mufti, ...</div><div class="gs_gray">Blood 116 (21), 5039<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:c_xDhezhKKUC" class="gsc_a_at">Pre-Surgical Methylene-Blue “targeting” of Small Intrapulmonary Nodules In Patients with Haematological Malignancies: Preliminary Experience.</a><div class="gs_gray">MM Ceesay, O Jaffer, PFC Lung, MT Marrinan, R Deshpande, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 116 (21), 4551-4551<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:1xBWf43XMUgC" class="gsc_a_at">P94 Prevalence and clinical significance of heparin induced thrombocytopaenia in patients transplanted for Budd Chiari syndrome</a><div class="gs_gray">R Westbrook, D Orr, N Heaton, J Wendon, W Bernal, G Auzinger, ...</div><div class="gs_gray">Gut 59 (Suppl 2), A49-A49<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:dHRcJqc9SEQC" class="gsc_a_at">Reducing MCM levels in human primary T cells during the [G. sub. 0][right arrow][G. sub. 1] transition causes genomic instability during the first cell cycle</a><div class="gs_gray">SJ Orr, T Gaymes, D Ladon, C Chronis, B Czepulkowski, R Wang, ...</div><div class="gs_gray">Oncogene, 3803-3815<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ifOnle78iJkC" class="gsc_a_at">Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C.(vol 149, pg 244, 2010)</a><div class="gs_gray">P Fenaux, N Gattermann, JF Seymour, E Hellstrom-Lindberg, GJ Mufti, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 149 (6), 919-919<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:R22Rs3tN8aoC" class="gsc_a_at">INTERIM ANALYSIS OF THE USE OF 5-AZACYTIDINE FOR TREATMENT OF MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKAEMIA WITH CHROMOSOME 7 OR COMPLEX CYTOGENETIC ABNORMALITIES</a><div class="gs_gray">R Yiu, ZY Lim, AY Ho, R Ireland, J Marsh, P Pasipanodya, J Hayden, ...</div><div class="gs_gray">HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 95, 130-130<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:cNe27ouKFcQC" class="gsc_a_at">Gene methylation and cytogenetic abnormalities in patients (pts) with higher-risk myelodysplastic syndromes.</a><div class="gs_gray">GJ Mufti, JG Herman, S Gore, JF Seymour, V Santini, AM Hagemeijer, ...</div><div class="gs_gray">Journal of Clinical Oncology 28 (15_suppl), 6606-6606<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:oH8HCDhqVGsC" class="gsc_a_at">Impact of cytogenetics on outcomes of patients with secondary acute myeloid leukaemia undergoing allogeneic stem cell transplantation</a><div class="gs_gray">ZY Lim, R Brand, A Biezen, DW Beelen, A Devergie, E Alessandrino, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 45, S63-S63<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:IyxfXMz2bNAC" class="gsc_a_at">Fludarabine, cyclophosphamide and alemtuzumab for stem cell transplantation in acquired aplastic anaemia is associated with a low risk of graft-versus-host disease and&nbsp;…</a><div class="gs_gray">J Marsh, V Gupta, ZY Lim, D Marks, E Gordon-Smith, G Mufti</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 45, S166-S167<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:lYAcb2jw7qUC" class="gsc_a_at">Outcomes of sibling and unrelated donor reduced intensity conditioning allogeneic hsct for patients with MDS RCMD</a><div class="gs_gray">P Krishnamurthy, ZY Lim, A Ho, M Kenyon, MM Ceesay, J Hayden, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 45, S180-S180<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:WGv8Og3F3KgC" class="gsc_a_at">Development of a novel DNA vaccine encorporating a PASD1 analogue peptide which can enhance anti-leukaemia T cell responses in vitro and in vivo</a><div class="gs_gray">NR Hardwick, S Buchan, W Ingram, J Rice, GJ Mufti, FK Stevenson, ...</div><div class="gs_gray">British Journal of Haematology 149, 73-73<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:IHkkN1K1AlAC" class="gsc_a_at">Prevalence and Clinical Significance of Heparin Induced Thrombocytopenia in Patients Transplanted for Budd Chiari Syndrome</a><div class="gs_gray">R Westbrook, D Orr, N Heaton, J Wendon, W Bernal, G Auzinger, ...</div><div class="gs_gray">Liver Transplantation 16 (6), S85-S85<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:i91s68tWr-MC" class="gsc_a_at">Evidence for a macromolecular complex in poor prognostic chronic lymphocytic leukaemia (CLL) that contains CD38, CD49d, CD44, MMP-9 And ZAP-70</a><div class="gs_gray">A Levi, AGS Buggins, S Gohil, K Fishlock, PEM Patten, D Yallop, G Mufti, ...</div><div class="gs_gray">British Journal of Haematology 149, 91-91<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Nufq_to8ts0C" class="gsc_a_at">Immune Gene Therapy for Acute Myeloid Leukaemia</a><div class="gs_gray">F Farzaneh, L Chan, N Hardwick, W Ingram, G Mufti, M Aloysius, A Robins, ...</div><div class="gs_gray">Human Gene Therapy 21 (9), 1177-1178<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Y9VhQm-5nPIC" class="gsc_a_at">Mobilized peripheral blood stem cells compared with bone marrow for related reduced-intensity transplantation in acute myeloid leukaemia in complete remission: a retrospective&nbsp;…</a><div class="gs_gray">A Nagler, M Labopin, A Shimoni, G Mufti, JJ Cornelissen, D Blaise, ...</div><div class="gs_gray">Bone Marrow Transplantation 45, S21-S22<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:xGWFX6Gbr9MC" class="gsc_a_at">DETECTION OF TP53 MUTATIONS IN LOW-RISK MYELODYSPLASTIC SYNDROMES WITH DEL (5Q) IS ASSOCIATED WITH DISEASE PROGRESSION</a><div class="gs_gray">M Jadersten, L Saft, A Smith, A Kulasekararaj, S Pomplun, R Hast, ...</div><div class="gs_gray">Haematologica 95, 126-126<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:I8rxH6phXEkC" class="gsc_a_at">Simultaneous analysis of specific T cell populations in acute leukaemia patients using the pMHC array</a><div class="gs_gray">S Brooks, CH Lee, D Sigurdardottir, C Wang, HG Rammensee, GJ Mufti, ...</div><div class="gs_gray">British Journal of Haematology 149, 73-74<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:mgoTDWlsYNUC" class="gsc_a_at">A Decade of Reduced-Intensity Conditioned Allogeneic Haematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes Following Conditioning with Fludarabine, Busulphan&nbsp;…</a><div class="gs_gray">AYL Ho, P Krishnamurthy, ZY Lim, M Kenyon, A Mijovic, S Devereux, ...</div><div class="gs_gray">Blood 114 (22), 2266<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:qCaWouos7ogC" class="gsc_a_at">Alemtuzumab Used with Fludarabine and Cyclophosphamide (FCC) for Stem Cell Transplantation in Acquired Aplastic Anemia Is Associated with a Low Risk of Graft Versus Host&nbsp;…</a><div class="gs_gray">JCW Marsh, V Gupta, ZY Lim, D Marks, EC Gordon-Smith, GJ Mufti</div><div class="gs_gray">Blood 114 (22), 1084<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:jRIwE-1ttnoC" class="gsc_a_at">Acquired Somatic Uniparental Disomy is a Chromosomal Defect Important in Predicting Treatment Responses and Survival Outcomes in MDS, MDS/MPN and Secondary AML.</a><div class="gs_gray">RV Tiu, C O'Keefe, LP Gondek, AM Mohamedali, BP Przychodzen, ...</div><div class="gs_gray">Blood 114 (22), 2630<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-38epGy1wY0C" class="gsc_a_at">Deep Sequencing the Tet2 Gene in 360 Patients with Myeloid Neoplasms Provides a Comprehensive and Quantitative Mutation Map and Reveals Low Level Mutant Clones.</a><div class="gs_gray">AE Smith, AM Mohamedali, S a Mian, NC Lea, N Westwood, ...</div><div class="gs_gray">Blood 114 (22), 733<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:s1ouQE5r0WUC" class="gsc_a_at">Therapy Related Myelodysplastic Syndrome and Acute Myeloid Leukaemia (tMDS/tAML) in Patients Treated with Purine Analogues (PA) for Lymphoproliferative Disorders (LPD); An&nbsp;…</a><div class="gs_gray">P Kalkur, SJ Bowcock, A Sharma, E Dimitriadou, GJ Mufti, SMB Rassam</div><div class="gs_gray">Blood 114 (22), 3828<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:NnTm98qLMbgC" class="gsc_a_at">Evidence for A Macromolecular Complex in Poor Prognostic CLL That Contains CD38, CD49d, CD44, MMP-9 and ZAP-70.</a><div class="gs_gray">AGS Buggins, A Levi, S Gohil, K Fishlock, PEM Patten, D Yallop, GJ Mufti, ...</div><div class="gs_gray">Blood 114 (22), 2334<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:vD2iS2Kej30C" class="gsc_a_at">Inborn Genomic Variation as Predisposing Factors to Myeloid Malignancies.</a><div class="gs_gray">C O'Keefe, BP Przychodzen, AM Mohamedali, GJ Mufti, M McDevitt, ...</div><div class="gs_gray">Blood 114 (22), 1590<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:aDl3D7KC1E4C" class="gsc_a_at">Recurrent Novel Regions of Uniparental Disomy and Homozygous Deletions in Mycosis Fungoides Identified Using High Resolution Single Nucleotide Polymorphism Analysis.</a><div class="gs_gray">AM Mohamedali, TJ Mitchell, S Ferreira, BA Guinn, RM Ireland, ...</div><div class="gs_gray">Blood 114 (22), 2644<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:aEW5N-EHWIMC" class="gsc_a_at">Mobilized Peripheral Blood Stem Cells (PBSC) Compared with Bone Marrow (BM) as the Stem Cell Source for Unrelated Donor Allogeneic Transplantation with Reduced Intensity&nbsp;…</a><div class="gs_gray">A Nagler, M Labopin, A Shimoni, D Niederwieser, N Basara, GJ Mufti, ...</div><div class="gs_gray">Blood 114 (22), 527<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:pYKElYtJMmwC" class="gsc_a_at">Late Relapses Following Reduced Intensity Conditioning Allogeneic Haematopoietic Stem Cell Transplantation for Myeloid Malignancies Can Be Effectively Salvaged with Intensive&nbsp;…</a><div class="gs_gray">AG Kulasekararaj, Z Lim, P Krishnamurthy, MM Ceesay, M Kenyon, ...</div><div class="gs_gray">Blood 114 (22), 2265<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:sJPMR1oEGYQC" class="gsc_a_at">Comparative Analysis of Sibling Donor Reduced Intensity Conditioning Regimen for High Risk AML/MDS Using Anti-Thymocyte Globulin Versus Alemtuzumab for T-Cell Depletion.</a><div class="gs_gray">ZY Lim, S Bennett, AYL Ho, AG Kulasekararaj, S Gupta, M Kenyon, ...</div><div class="gs_gray">Blood 114 (22), 3362<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:hQUaER0FWQ4C" class="gsc_a_at">Dual Src/Abl Kinase Targeted Inhibition in Myeloma Microenvironment Promotes Myeloma Cell Apoptosis Both in Vitro and In Vivo.</a><div class="gs_gray">K Ramasamy, L Macpherson, GJ Mufti, S Schey, Y Calle</div><div class="gs_gray">Blood 114 (22), 2813<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:SxCCDk4iOpsC" class="gsc_a_at">Prevalence of 46/1 JAK2 Haplotype in Patients with Budd-Chiari Syndrome with and without JAK2V617F and TET2 Mutations.</a><div class="gs_gray">NC Lea, LN Roberts, RK Patel, R Westbrook, MA Heneghan, ...</div><div class="gs_gray">Blood 114 (22), 434<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:w2UhwfzvF0QC" class="gsc_a_at">Rates of infection and bleeding are not increased in patients (Pts) with MDS treated with azacitidine (AZA) compared with best supportive care (BSC)</a><div class="gs_gray">V Santini, L Silverman, J Seymour, P Fenaux, G Mufti, ...</div><div class="gs_gray">Leukemia Research 33 (SUPPL. 1), S133-S133<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:8uzoZH4hB9AC" class="gsc_a_at">Azacitidine delivers dramatic results in patients with high-risk myelodysplastic syndromes</a><div class="gs_gray">P Fenaux, GJ Mufti, E Hellstrom-Lindberg</div><div class="gs_gray">EXPERT REVIEW OF ANTICANCER THERAPY 9 (4), 395-395<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:RXiHnyRawswC" class="gsc_a_at">Audit of ABVD chemotherapy for Hodgkins lymphoma patients regardless of the absolute neutrophil count and without G-CSF; no treatment delays and optimal dose intensity: 217</a><div class="gs_gray">R Stewart, J Allan, M Drummond, R Soutar</div><div class="gs_gray">British Journal of Haematology 145<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:0sTkTiv_uMkC" class="gsc_a_at">pMHC arrays: analysis of T cell populations in myeloid leukaemia patients during treatment: 45</a><div class="gs_gray">S Brooks, C Lee, D Sigurdardottir, M Arno, HG Rammensee, G Mufti, ...</div><div class="gs_gray">British Journal of Haematology 145<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:MqTxh1vmwXEC" class="gsc_a_at">Changing landscapes in haematopoietic stem cell transplantation for haematological malignancy</a><div class="gs_gray">M Kenyon, G Mufti</div><div class="gs_gray">Bone Marrow Transplantation 43 (S1), S348-S348<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:8cBNEdFwSQkC" class="gsc_a_at">Chronic Myeloid Leukemia-A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line&nbsp;…</a><div class="gs_gray">T Ernst, FX Gruber, O Pelz-Ackermann, J Maier, M Pfirrmann, MC Muller, ...</div><div class="gs_gray">Haematologica 94 (9), 1227<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:cxS_fjKIGZMC" class="gsc_a_at">Myelodysplastic Syndromes-Inhibitors of poly-ADP-ribose polymerase (PARD) induce apoptosis of myeloid leukemic cells: Potential for therapy of myeloid leukemia and&nbsp;…</a><div class="gs_gray">TJ Gaymes, S Shall, LJ MacPherson, NA Twine, NC Lea, F Farzaneh, ...</div><div class="gs_gray">Haematologica 94 (5), 638<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:HAmI6pRF5skC" class="gsc_a_at">Myelodysplastic Syndromes-Ectopic expression of C/EBP# 945 and ID1 is sufficient to restore defective neutrophil development in low-risk myelodysplasia-Although a number of&nbsp;…</a><div class="gs_gray">CR Geest, M Buiteillits, E Vellenga, PJ Coffer</div><div class="gs_gray">Haematologica 94 (8), 1075<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:3x-KLxxGyuUC" class="gsc_a_at">Acute myeloid leukemia 25 Alan K Burnett and Steven Knapper Chapter 4 Chronic myeloid leukemia 35 John M Goldman and Tariq I Mughal Chapter 5 Acute lymphoblastic leukemia in&nbsp;…</a><div class="gs_gray">N Gdkbuget, D Hoelzer, K Baird, AS Wayne, ZY Lim, GJ Mufti, F van Rhee, ...</div><div class="gs_gray">Hematopoietic Stem Cell Transplantation: In Clinical Practice<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:KIRwYnRZzWQC" class="gsc_a_at">Cutaneous graft-versus-host disease: the increasing trend of the eczematoid subtype: P-79</a><div class="gs_gray">E Craythorne, E Benton, G Mufti, A du Vivier</div><div class="gs_gray">British Journal of Dermatology 161<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ufKn5pxu7C0C" class="gsc_a_at">Decision Making and Problem Solving-Platelet Disorders-Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H&nbsp;…</a><div class="gs_gray">DM Arnold, A Bernotas, I Nazi, R Stasi, M Kuwana, Y Liu, JG Kelton, ...</div><div class="gs_gray">Haematologica 94 (6), 850<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:RfUwGJFMQ-0C" class="gsc_a_at">Stem Cell Transplantation-Imbalance of effector and regulatory CD4 T cells is associated with graft versus host disease after hematopoietic stem cell transplantation using a&nbsp;…</a><div class="gs_gray">K Matthews, ZY Lim, B Afzali, L Pearce, A Abdallah, S Kordasti, ...</div><div class="gs_gray">Haematologica 94 (7), 956<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wUn16MOA3RoC" class="gsc_a_at">Treatment of pemphigus vulgaris with rituximab: P-4</a><div class="gs_gray">E Craythorne, S Warnakulasuriya, G Mufti, A du Vivier</div><div class="gs_gray">British Journal of Dermatology 161, 22-23<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:m4fbC6XIj1kC" class="gsc_a_at">ABT 737 BCL-2 INHIBITOR TARGETS LEUKEMIC STEM CELLS IN MOUSE MODELS OF MYELOID (PRE) LEUKAEMIA</a><div class="gs_gray">RA Padua, S Beurlet, M Saeed, N Omidvar, P Krief, D Auboeuf, ...</div><div class="gs_gray">Haematologica 94, 99-99<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:t-hv7AR41mYC" class="gsc_a_at">Dasatinib and Dexamethasone Combination Therapy Targets Myeloma and the Tumor Microenvironment</a><div class="gs_gray">KA Ramasamy, L Macpherson, G Mufti, S Schey, Y Calle</div><div class="gs_gray">Clinical Lymphoma &amp; Myeloma 9, S116-S117<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Oo_WeVVXg5wC" class="gsc_a_at">SNP-Array Based Karyotyping Complements Routine Cytogenetics in Diagnosis and Risk Stratification Schemes of MDS</a><div class="gs_gray">RV Tiu, LP Gondek, J Huh, C O’Keefe, MA Sekeres, GJ Mufti, MA McDevitt, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 639-639<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:jKT558fuBk8C" class="gsc_a_at">In-Vitro Culture of Human CD80/IL2 Lentivirus Transduced Acute Myeloid Leukemia Cells (AML) Promote NK Cell Activation and Cytolytic Activity</a><div class="gs_gray">W Ingram, L Chan, H Guven, S Kordasti, L Barber, N Hardwick, D Darling, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 2969-2969<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:pxXbYLTb8EgC" class="gsc_a_at">Increased number of IL-17 producing CD4+ T cells in low risk myelodysplastic syndrome (MDS)</a><div class="gs_gray">SY Kordasti, B Afzali, Z Lim, W Ingram, J Hayden, L Barber, G Lombardi, ...</div><div class="gs_gray">Blood 112 (11), 637<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:DIubQTN3OvUC" class="gsc_a_at">RFUSIN2-a Clinical Grade Lentiviral Vector Co-Expressing CD80/IL-2 Manufactured Under GMP for a Phase I Clinical Trial Study of Immune Gene Therapy for Poor Prognosis Acute&nbsp;…</a><div class="gs_gray">L Chan, W Ingram, N Hardwick, D Darling, J Bhalla, A Kizilors, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 4630-4630<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:R-LXmdHK_14C" class="gsc_a_at">High Resolution Genomic Mapping of Breast Cancer Derived T-MDS/TAML</a><div class="gs_gray">AM Mohamedali, N Twine, J Gaken, N Westwood, N Lea, R Chelliah, ...</div><div class="gs_gray">Blood 112 (11), 2692<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:7xtfDMUJqJkC" class="gsc_a_at">The myelodysplastic syndromes</a><div class="gs_gray">ZY Lim, GJ Mufti</div><div class="gs_gray">Hematopoietic Stem Cell Transplantation in Clinical Practice 15, 19<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:mJbmKSuM8toC" class="gsc_a_at">Cord Blood Transplants in Adults with Leukaemia: The value of Genetic Testing in determining Engraftment</a><div class="gs_gray">L Brown, S Chehade, H Gilbert, B Czepulkowski, M Kenyon, GJ Mufti</div><div class="gs_gray">JOURNAL OF MEDICAL GENETICS 45, S50-S50<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:N5XbD978G_MC" class="gsc_a_at">Outcomes of MDS patients with chromosome 7 abnormalities treated with 5-azacytidine: 157</a><div class="gs_gray">Z Lim, A Ho, K Raj, B Czepulkowski, J Samuels, J Hayden, ...</div><div class="gs_gray">British Journal of Haematology 141<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:WMtz-WDmgKQC" class="gsc_a_at">Pre-transplant serum ferritin as an independent prognostic factor in MDS patients undergoing reduced intensity conditioning HSCT: 146</a><div class="gs_gray">V Fiaccadori, Z Lim, M Kenyon, M Ceesay, J Hayden, A Ho, G Mufti, ...</div><div class="gs_gray">British Journal of Haematology 141<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:hKjooKYXoHIC" class="gsc_a_at">Outcomes of MDS patients with chromosome 7 abnormalities treated with 5-azacytidine</a><div class="gs_gray">ZY Lim, AYL Ho, K Raj, B Czepulkowski, J Samuels, J Hayden, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 141, 57-57<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:S2WlVNSe3u4C" class="gsc_a_at">Single centre experience of allogeneic haematopoietic stem cell transplantation for chronic myelomonocytic leukaemia: 153</a><div class="gs_gray">P Krishnamurthy, W Nagi, Z Lim, M Kenyon, A Ho, G Mufti, A Pagliuca</div><div class="gs_gray">British Journal of Haematology 141, 55-56<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:rbGdIwl2e6cC" class="gsc_a_at">Reduced intensity transplantation for myelofibrosis: a single centre experience 155</a><div class="gs_gray">W Nagi, P Krishnamurthy, Z Lim, M Kenyon, G Mufti, A Ho, A Pagliuca</div><div class="gs_gray">British Journal of Haematology 141<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:J3LtWjKFLicC" class="gsc_a_at">Epigenetic analyses of T cells during the G0 to G1 transition: 78</a><div class="gs_gray">A Smith, C Chronis, M Christodoulakis, A Bhinge, N Twine, N Lea, G Mufti, ...</div><div class="gs_gray">British Journal of Haematology 141<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:kQqwFFzsCTwC" class="gsc_a_at">The use of rituximab as a single therapy for the treatment of severe recalcitrant pemphigus</a><div class="gs_gray">SI Goolamali, G Mufti, S Warnakulasuriya, AWP Du Vivier</div><div class="gs_gray">British Journal of Dermatology 159, 28-28<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Pqt4MY__2vwC" class="gsc_a_at">Results of a BSBMT phase I/II-study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following reduced intensity allogeneic stem&nbsp;…</a><div class="gs_gray">Z Lim, G Cook, P Johnson, A Parker, M Zuckerman, D Marks, H Wiltshire, ...</div><div class="gs_gray">British Journal of Haematology 141, 154<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:FQ36aI_S1AEC" class="gsc_a_at">MOBILISATION FAILURE IS PREDICTIVE OF POOR OVERALL SURVIVAL AFTER AUTOLOGOUS TRANSPLANTATION</a><div class="gs_gray">K Ramasamy, S Mahmood, ZY Lim, A Mijovic, S Devereux, A Pagliuca, ...</div><div class="gs_gray">Haematologica 93, 261-261<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:rpSJNIKeXWsC" class="gsc_a_at">Cytogenetic characterisation in a patient with concomitant multiple myeloma and CLL</a><div class="gs_gray">D Ladon, T Kontou, S Devereux, S Schey, B Czepulkowski, GJ Mufti</div><div class="gs_gray">Journal of Medical Genetics 45, S96-S96<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:8p8iYwVyaVcC" class="gsc_a_at">EFFECT OF AZACITIDINE (AZA) vs LOW-DOSE ARA-C (LDAC) ON OVERALL SURVIVAL (OS), HEMATOLOGIC RESPONSE, TRANSFUSION INDEPENDENCE, AND SAFETY IN PATIENTS (PTS) WITH HIGHER-RISK&nbsp;…</a><div class="gs_gray">P Fenaux, N Gattermann, J Seymour, E Hellstrom-Lindberg, GJ Mufti, ...</div><div class="gs_gray">Haematologica 93, 90-90<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:iKswqCX-FLkC" class="gsc_a_at">SINGLE UK CENTRE EXPERIENCE OF ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHRONIC MYELOMONOCYTIC LEUKEMIA</a><div class="gs_gray">ZY Lim, PK Krishnamurthy, W Nagi, M Kenyon, AYL Ho, GJ Mufti, ...</div><div class="gs_gray">Haematologica 93, 134-135<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:TesyEGJKHF4C" class="gsc_a_at">Poly ADP Whose Polymerase (PARP) Inhibitors Induce Apoptosis Alone or Synergistically with Histone Deacetylase Inhibitors in Primary Acute Myeloid Leukemic Patient Cells.</a><div class="gs_gray">TJ Gaymes, S Shall, F Farzaneh, GJ Mufti</div><div class="gs_gray">Blood 112 (11), 1022-1022<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:37UQlXuwjP4C" class="gsc_a_at">OUTCOMES OF PATIENTS RELAPSING FOLLOWING T-CELL DEPLETED REDUCED INTENSITY CONDITIONING ALLOGENEIC TRANSPLANTATION FOR MDS OR AML</a><div class="gs_gray">ZY Lim, T Munir, SG Gandhi, M Kenyon, AYL Ho, AP Pagliuca, GJ Mufti</div><div class="gs_gray">Haematologica 93, 137-137<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:U4n9YNQMCAIC" class="gsc_a_at">Decision Making and Problem Solving-Myelodysplastic Syndromes-Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of&nbsp;…</a><div class="gs_gray">GJ Mufti, JM Bennett, J Goasguen, BJ Bain, I Baumann, R Brunning, ...</div><div class="gs_gray">Haematologica 93 (11), 1712<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:CC3C2HR4nz8C" class="gsc_a_at">Increased Effector CD4<sup>+</sup> T-Cells Early Post Hematopoietic Stem Cell Transplantation Using an Alemtuzumab-Based Reduced Intensity Conditioning Regimen&nbsp;…</a><div class="gs_gray">K Matthews, ZY Lim, L Pearce, K Tobal, A Madrigal, GJ Mufti, LD Barber</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 4999-4999<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:9o6PfxSMcEIC" class="gsc_a_at">The ΔN Isoform of the p73 Gene Is Induced during the G<sub>0</sub>→G<sub>1</sub> Transition in Primary Human T Cells.</a><div class="gs_gray">C Chronis, AE Smith, SJ Orr, K Raj, GJ Mufti, NSB Thomas</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 3353-3353<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:koF6b02d8EEC" class="gsc_a_at">Systems Biology Analysis of Human Primary T Cells Identifies SAP145 as Rate Limiting for the G<sub>1</sub>→S Phase Transition.</a><div class="gs_gray">SJ Orr, R Wang, NC Lea, C Chronis, AK Ramani, GJ Mufti, EM Marcotte, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 3350-3350<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:U5uP8zs9lfgC" class="gsc_a_at">Progression Free Survival (PFS) in Alemtuzumab Based RIC Allogeneic Transplantation for Myeloma Is Improved with Use of Pre-Emptive DLI (pDLI).</a><div class="gs_gray">K Ramasamy, S Mahmood, L Pearce, ZY Lim, D Ladon, A Pagliuca, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 3034-3034<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:oAywNP-vUhwC" class="gsc_a_at">Fanconi-Like Syndrome with Negative Chromosomal Breakages Test and High Incidence of Myelodysplasia.</a><div class="gs_gray">S Gupta, SMB Rassam, M Riyali, AYL Ho, G Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 1681-1681<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4QKQTXcH0q8C" class="gsc_a_at">In-Situ Proliferation May Explain the Persistence of Host Derived Langerhans Cells Following Allogeneic Hematopoietic Stem Cell Transplantation with Reduced Intensity Conditioning.</a><div class="gs_gray">J Richards, L Pearce, PEM Patten, AGS Buggins, AY Ho, A Pagliuca, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 1196-1196<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:M0j1y4EgrScC" class="gsc_a_at">Long Term Outcomes of Adults Undergoing Alemtuzumab-Based Reduced Intensity Conditioning Haematopoietic Stem Cell Transplantation.</a><div class="gs_gray">MM Ceesay, ZY Lim, M Kenyon, AYL Ho, S Devereux, S Schey, A Mijovic, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 1665-1665<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:WIXB4To3Tx4C" class="gsc_a_at">CD4<sup>+</sup>CD25<sup>high</sup> Foxp3<sup>+</sup> Regulatory T-Cells Are Correlated with Different Risk Factors in Myelodysplastic Syndrome (MDS).</a><div class="gs_gray">SY Kordasti, W Ingram, J Hayden, D Darling, L Barber, F Farzaneh, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 2445-2445<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:u3T1itk59dMC" class="gsc_a_at">Results of a phase I/II-Study on PCR-based pre-emptive therapy with vallganciclovir or ganciclovir for active CMV infection following reduced intensity allogeneic stem cell&nbsp;…</a><div class="gs_gray">ZY Lim, G Cook, PR Johnson, A Parker, M Zuckerman, GJ Mufti, D Marks, ...</div><div class="gs_gray">BLOOD 110 (11), 331B-332B<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:e84hm74t-eoC" class="gsc_a_at">Fanconi-like syndrome with negative chromosomal breakages test and high incidence ofmyelodysplasia.</a><div class="gs_gray">S Gupta, S Rassam, M Riyali, AYL Ho, G Mufti</div><div class="gs_gray">BLOOD 110 (11), 501A-501A<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:BJtnxTr0fRcC" class="gsc_a_at">Reducing MCM Loading Causes Chromosomal Aneuploidy.</a><div class="gs_gray">SJ Orr, T Gaymes, R Wang, B Czepulkowski, D Ladon, C Chronis, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 3349-3349<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:WWeOtg8bX_EC" class="gsc_a_at">Results of a Phase I/II-Study on PCR-Based Pre-Emptive Therapy with Valganciclovir or Ganciclovir for Active CMV Infection Following Reduced Intensity Allogeneic Stem Cell&nbsp;…</a><div class="gs_gray">ZY Lim, G Cook, PR Johnson, A Parker, M Zuckerman, GJ Mufti, D Marks, ...</div><div class="gs_gray">Blood 110 (11), 5011<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:BmWJbWwHJAwC" class="gsc_a_at">Hepatocyte Growth Factor Expression in Bone Marrow Microenvironment Is Critical for Progression of MGUS to Myeloma.</a><div class="gs_gray">K Ramasamy, S Schey, GJ Mufti, F Farzaneh, Y Calle</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 4766-4766<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Xxrp-jDxsD4C" class="gsc_a_at">Value of transfusion-free living in MDS: Results of health utility interviews with MDS patients</a><div class="gs_gray">TF Goss, A Szende, C Schaefer, R Knight, K Heptinstall, M Luebbert, ...</div><div class="gs_gray">VALUE IN HEALTH 10 (6), A285-A286<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:y7JhAc_VBLgC" class="gsc_a_at">VALUE OF TRANSFUSION-FREE LIVING IN MDS: RESULTS OF HEALTH UTILITY INTERVIEWS WITH MDS PATIENTS PHM20</a><div class="gs_gray">F GossT, A Szende, C Schaefer, R Knight, K Heptinstall, M Lübbert, ...</div><div class="gs_gray">Value in Health 10 (6)<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:DoBzxrgsGIIC" class="gsc_a_at">Corrigendum to “Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantation”[Journal of Infection 54 (2007) e83–e86]</a><div class="gs_gray">ZY Lim, B Baker, M Zuckerman, JJ Wade, M Ceesay, AYL Ho, S Devereux, ...</div><div class="gs_gray">Journal of Infection 55 (1), e11<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:n3vGvpFsckwC" class="gsc_a_at">The role of IL-6 in the immune dysfunction of B-CLL</a><div class="gs_gray">GS Buggins, PEM Patten, J Richards, NSB Thomas, GJ Mufti, S Devereux</div><div class="gs_gray">HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 92, 38-38<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:WM2K3OHRCGMC" class="gsc_a_at">C012 Prevalence and prognostic significance of allelic imbalance by single nucleotide polymorphism analysis in low risk myelodysplastic syndromes</a><div class="gs_gray">A Mohamedali, J Gaken, N Twine, W Ingram, N Westwood, N Lea, ...</div><div class="gs_gray">Leukemia Research 31, S29<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Tfl4UtY-dJUC" class="gsc_a_at">Allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndromes 50 years or older. A retrospective survey from the European Group for Blood and&nbsp;…</a><div class="gs_gray">ZY Lim, R Brand, R Martino, S Iacobelli, T Jansen, A van Biezen, J Finke, ...</div><div class="gs_gray">LEUKEMIA RESEARCH 31, S39-S40<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LGlY6t8CeOMC" class="gsc_a_at">Polyclonal CD4 (+) CD25 (high) Foxp (3+) regulatory T-cells are significantly increased in high risk myelodysplastic syndromes (MDS)</a><div class="gs_gray">S Kordasti, W Ingram, J Hayden, D Darling, L Barber, B Afzali, G Lombardi, ...</div><div class="gs_gray">Leukemia Research 31 (S1), S68-S68<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:qYOp8iumCsAC" class="gsc_a_at">Engraftment of donor langerhans cells following allogeneic stem cell transplantation with reduced intensity conditioning (RIC) is delayed compared to other myeloid lineages: 112</a><div class="gs_gray">J Richards, L Pearce, P Patten, A Ho, A Paliuca, G Mufti, S Devereux</div><div class="gs_gray">British Journal of Haematology 137<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:zUl2_INMlC4C" class="gsc_a_at">121 HAEMOPHAGOCYTIC SYNDROME COMPLICATING LIVER TRANSPLANT CARRIES A POOR PROGNOSIS</a><div class="gs_gray">AT Barnardo, W Bernal, N Heaton, M Heneghan, J O’Grady, G Mufti, ...</div><div class="gs_gray">Gut 56<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:nqdriD65xNoC" class="gsc_a_at">Laser capture microscopy as a tool for the assessment of lineage‐specific chimaerism from archived blood and bone marrow films</a><div class="gs_gray">J Richards, G Yvonne Morgan, L Pearce, PEM Patten, GJ Mufti, ...</div><div class="gs_gray">British journal of haematology 136 (4), 677-678<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:TiLqlu47W2oC" class="gsc_a_at">Practical recommendations on the management of non-haematological adverse events in MDS patients treated with lenalidomide</a><div class="gs_gray">A Giagounidis, M Cazzola, P Fenaux, G Mufti, P Muus, U Platzbecker, ...</div><div class="gs_gray">Haematologica 92, 0229<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:qt-6tCTBDsQC" class="gsc_a_at">Low IPSS score and bone marrow hypocellularity in MDS patients predict haematological responses to anti-thymocyte globulin</a><div class="gs_gray">ZY Lim, S Killick, U Germing, J Cavenagh, D Culligan, A Bacigalupo, ...</div><div class="gs_gray">Leukemia Research 31, S36-S37<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:sfsSB7lKuh0C" class="gsc_a_at">C031 Allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndromes 50 years or older. A retrospective survey from the European Group for Blood&nbsp;…</a><div class="gs_gray">ZY Lim, R Brand, R Martino, S Iacobelli, T Jansen, A van Biezen, J Finke, ...</div><div class="gs_gray">Leukemia Research, S39-S40<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:uWy0R8PweswC" class="gsc_a_at">Allogeneic stem cell transplantation for patients with refractory anaemia: delayed SCT (&gt; 12 months) results in worse outcome</a><div class="gs_gray">T De Witte, R Brand, A van Biezen, GJ Mufti, T Ruutu, J Finke, ...</div><div class="gs_gray">Bone Marrow Transplantation 39<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:qbqt7gslDFUC" class="gsc_a_at">A new approach to MRD monitoring in AML, real-time quantification of multiple AML-upregulated genes</a><div class="gs_gray">K Tobal, GJ Mufti</div><div class="gs_gray">Haematologica 92, 0926<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:J4E9jCG1tHUC" class="gsc_a_at">Cytogenetics of myelodysplastic syndromes and detection of del 5q</a><div class="gs_gray">G Mufti</div><div class="gs_gray">Leukemia Research 31, S8-S9<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:urP0JZOBBUsC" class="gsc_a_at">Investigation of disease kinetics in CML patients with b3a2 and b2a2 BCR-ABL fusion transcripts undergoing Imatinib treatment</a><div class="gs_gray">GE Nickless, GY Morgan, A Ho, GJ Mufti, K Tobal</div><div class="gs_gray">Haematologica 92, 1023<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:eAUscmXIlQ8C" class="gsc_a_at">The effect of the B-CLL microenvironment on CD38 expression by the malignant clone</a><div class="gs_gray">PEM Patten, ASG Buggins, J Richards, A Wotherspoon, J Salisbury, ...</div><div class="gs_gray">Haematologica 92, 0521<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Nnq8S6OXqDYC" class="gsc_a_at">Practical recommendations on the management of haematological adverse events in MDS patients treated with lenalidomide</a><div class="gs_gray">A Giagounidis, M Cazzola, P Fenaux, G Mufti, P Muus, U Platzbecker, ...</div><div class="gs_gray">Haematologica 92, 0227<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QKtdBID3u5MC" class="gsc_a_at">Budd Chiari Syndrome in children: A single centre experience in the United Kingdom</a><div class="gs_gray">R Vara, NJ Bab, J Karani, GJ Mufti, N Heaton, G Mieli-Vergani, A Dhawan</div><div class="gs_gray">Hepatology 46 (4), 1105<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:pRWBApOjXDcC" class="gsc_a_at">B-CLL cells secrete factors including IL-6 which inhibit T cell proliferation and activation and promote Th2 polarisation</a><div class="gs_gray">AGS Buggins, PEM Patten, J Richards, NSB Thomas, GJ Mufti, ...</div><div class="gs_gray">British Journal of Haematology 137, 65<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:NU-BerS4NX4C" class="gsc_a_at">Systems biology analysis of the G0-G1 cell cycle transition of human primary T cells</a><div class="gs_gray">SJ Orr, R Wang, NC Lea, C Chronis, AK Ramani, GJ Mufti, EM Marcotte, ...</div><div class="gs_gray">British Journal of Haematology 137, 238<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:9LpHyFPp1DQC" class="gsc_a_at">Use of quantitative PCR approaches to predict relapse and direct molecularly targeted therapy with arsenic trioxide (ATO) in acute promyelocytic leukaemia (APL)</a><div class="gs_gray">D Grimwade, JV Jovanovic, D Diverio, E Nugent, AY Ho, GJ Mufti, ...</div><div class="gs_gray">British Journal of Haematology 137, 39-39<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Nw_I7GeUguwC" class="gsc_a_at">B-Cell Lymphoma, Leg Type: Clinicopathologic Features and Prognostic Analysis in 60 Cases Florent Grange, MD, PhD</a><div class="gs_gray">M Beylot-Barry, P Courville, JA Taverna, A Lerner, L Goldberg, S Werth, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:inmFHauC9wsC" class="gsc_a_at">'Excess' MCM proteins maintain genomic stability in human cells</a><div class="gs_gray">SJ Orr, T Gaymes, R Wang, B Czepulkowski, D Ladon, C Chronis, ...</div><div class="gs_gray">British Journal of Haematology 137, 131<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Oo1CbQkBAzEC" class="gsc_a_at">Use of autologous bone marrow harvests in patients undergoing volunteer unrelated donor stem cell transplantation: a single-centre experience</a><div class="gs_gray">PS Junagade, S Simpson, A Ho, S Devereux, A Pagliuca, A Mijovic, ...</div><div class="gs_gray">Bone Marrow Transplantation 39 (S1), S129-S129<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:SrKkpNFED5gC" class="gsc_a_at">Persistence of recipient langerhans cells following allogeneic haemopoietic stem cell transplants with reduced intensity conditioning</a><div class="gs_gray">J Richards, L Pearce, PEM Patten, AY Ho, A Pagliuca, GJ Mufti, ...</div><div class="gs_gray">Haematologica 92, 0590<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:0ngZmJvimKcC" class="gsc_a_at">Genetic instability as an area of potential therapeutic intervention</a><div class="gs_gray">F Rassool, T Gaymes, N Omidvar, N Brady, M Pla, M Reboul, N Lea, ...</div><div class="gs_gray">MEDICINA-BUENOS AIRES- 67, 20<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:WzTVkKNmPSkC" class="gsc_a_at">Adenovirus infections following allogeneic HSCT. A single UK centre experience</a><div class="gs_gray">L Green, C Bagot, S Ramalingam, Z Lim, M Sudhanva, S Devereux, A Ho, ...</div><div class="gs_gray">Bone Marrow Transplantation 39, S168-S168<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:uUvzmPk0f8oC" class="gsc_a_at">C025 Low IPSS score and bone marrow hypocellularity in MDS patients predict haematological responses to anti-thymocyte globulin</a><div class="gs_gray">ZY Lim, S Killick, U Germing, J Cavenagh, D Culligan, A Bacigalupo, ...</div><div class="gs_gray">Leukemia Research, S36-S37<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:KI9T_ytC6pkC" class="gsc_a_at">Management of Haematological Adverse Events in MDS Patients Treated With Lenalidomide and Management of Non-haematological Adverse Events in MDS Patients Treated With Lenalidomide</a><div class="gs_gray">AAN Giagounidis, M Cazzola, P Fenaux, GJ Mufti, P Muus, U Platzbecker, ...</div><div class="gs_gray">CLINICAL ADVANCES IN HEMATOLOGY AND ONCOLOGY 5 (7), 12<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:W2uZP3ddy8sC" class="gsc_a_at">The deltaN isoform of the TP73 gene is produced by cell cycle-dependent splicing during the G0-G1 transition in primary human T cells to regulate gene expression</a><div class="gs_gray">C Chronis, K Raj, AE Smith, SJ Orr, GJ Mufti, NSB Thomas</div><div class="gs_gray">British Journal of Haematology 137, 130<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:7Frjd3zlGBUC" class="gsc_a_at">Failure to mobilise is not a poor prognostic factor in myeloma</a><div class="gs_gray">K Ramasamy, K Phekoo, A Pagliuca, A Mijovic, GJ Mufti, S Schey</div><div class="gs_gray">Haematologica 92 (6), 196-196<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:DXE8ND7PrJAC" class="gsc_a_at">David Galton, myelodysplasia and little me!</a><div class="gs_gray">G Mufti</div><div class="gs_gray">Leukemia &amp; lymphoma 48 (12), 2286-2287<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:jlhcAiayVhoC" class="gsc_a_at">Genomic profiling of CD34+ and CD61+ cells in 5q-syndrome</a><div class="gs_gray">NC Lea, A Mohamedali, N Twine, J Gaken, N Westwood, W Ingram, ...</div><div class="gs_gray">Leukemia Research 31, S79-S79<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wSy_KLzO7YEC" class="gsc_a_at">CD38 expression in B-CLL is dynamic and influenced by cell contact in the leukaemic microenvironment</a><div class="gs_gray">PEM Patten, AGS Buggins, J Richards, A Wotherspoon, T Hamblin, ...</div><div class="gs_gray">British Journal of Haematology 137, 64<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ijdKiLOsEJMC" class="gsc_a_at">Impact of non-myeloablative conditioning on the frequency of second donation: what should donors be told?</a><div class="gs_gray">K Ramasamy, M Kenyon, Z Lim, A Ho, S Devereux, A Pagliuca, GJ Mufti</div><div class="gs_gray">Bone Marrow Transplantation 39, S138-S138<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:z8nqeaKD1nsC" class="gsc_a_at">CLINICAL TRIALS AND OBSERVATIONS-A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate-to high-risk myelodysplastic syndrome</a><div class="gs_gray">P Fenaux, A Raza, GJ Mufti, C Aul, U Germing, H Kantarjian, L Cripe, ...</div><div class="gs_gray">Blood 109 (10), 4158-4163<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:oPLKW5k6eA4C" class="gsc_a_at">A highly sensitive method for detection of haemopoietic chimerism in allogeneic haemopoietic stem cell transplant recipients</a><div class="gs_gray">A Abdallah, L Pearce, A Mijovic, G Mufti, K Tobal</div><div class="gs_gray">Haematologica 92, 0575<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:3WNXLiBY60kC" class="gsc_a_at">The JAK2 V617F Mutation Identifies Specific Subgroups of Myelodysplastic Syndrome (MDS).</a><div class="gs_gray">MM Ceesay, N Lea, WC Ingram, J Cervera, U Germing, P Fenaux, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 108 (11), 2610-2610<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LWqeokA2EBkC" class="gsc_a_at">The Pattern of T-Cell Donor Chimerism Is a Key Predictor of Outcome Following Alemtuzumab Based Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for MDS&nbsp;…</a><div class="gs_gray">ZY Lim, L Pearce, AYL Ho, L Barber, W Ingram, M Usai, S Devereux, ...</div><div class="gs_gray">Blood 108 (11), 42<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:bXQfdp6S9ecC" class="gsc_a_at">Allogeneic SCT with Matched Related and Unrelated Donors for Patients (pts) with Refractory Anemia (RA): Improved Survival after Introduction of Reduced Intensity Conditioning&nbsp;…</a><div class="gs_gray">TM de Witte, R Brand, A van Biezen, G Mufti, T Ruutu, J Finke, ...</div><div class="gs_gray">Blood 108 (11), 519<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:6ZzL7HXColQC" class="gsc_a_at">Reduced-intensity transplants-Red cell antigens, antibodies, and blood product usage.</a><div class="gs_gray">A Mijovic, AM Abdallah, GJ Mufti</div><div class="gs_gray">Blood 108 (11), 2986<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PlWzFYVEG4EC" class="gsc_a_at">Outcome of second allogeneic transplants using reduced intensity conditioning following relapse after an initial allogeneic transplant.</a><div class="gs_gray">BE Shaw, GJ Mufti, S Mackinnon, J Cavenagh, K Towlson, R Pearce, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 108 (11), 3660-3660<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:rCNdntzdTkkC" class="gsc_a_at">An Unusual Expression: The Tumour Antigen SSX2IP Is Preferentially Expressed on the Surface of Acute Myeloid Leukaemia Cells during Early Mitosis.</a><div class="gs_gray">FAK Denniss, NR Hardwick, GJ Mufti, BA Guinn</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 108 (11), 4305-4305<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:x21FZCSn4ZoC" class="gsc_a_at">TAT-Apoptin Mediated Induction of Apoptosis in Leukaemic Cells.</a><div class="gs_gray">J Gaken, L Pericleous, F Farzaneh, GJ Mufti, M Tavassoli</div><div class="gs_gray">Blood 108 (11), 1900<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LK8CI43ZvvMC" class="gsc_a_at">Expansion of Polyclonal CD4+ CD25high Foxp3+ Regulatory T-Cells in High Risk Myelodysplastic Syndromes (MDS).</a><div class="gs_gray">SY Kordasti, W Ingram, J Hayden, D Darling, L Barber, F Farzaneh, ...</div><div class="gs_gray">Blood 108 (11), 2641<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:j5aT6aphRxQC" class="gsc_a_at">ACTIVATING JAK2 TYROSINE KINASE MUTATION PREDICTS RECURRENT BUDD-CHIARI SYNDROME POST LIVER TRANSPLANT: 12</a><div class="gs_gray">D Orr, R Patel, N Lea, A Quaglia, N Heaton, M Rela, J O'Grady, G Mufti, ...</div><div class="gs_gray">Hepatology 44<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:rOcdG6UcVlcC" class="gsc_a_at">PREVALENCE OF THE ACTIVATING JAK2 TYROSINE KINASE MUTATION IN CHRONIC PORTO-SPLENOMESENTERIC VENOUS THROMBOSIS: 77</a><div class="gs_gray">D Orr, R Patel, N Lea, P Harrison, N Heaton, J O'Grady, A Pagliuca, ...</div><div class="gs_gray">Hepatology 44<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:hefNtdE4IMkC" class="gsc_a_at">Myelodysplastic Syndrome with Deletion 5q Abnormality and Its Treatment</a><div class="gs_gray">W Ingram, GJ Mufti</div><div class="gs_gray">Clinical Leukemia 1 (1), 28-33<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:e0LTWoPxLYMC" class="gsc_a_at">CLINICAL SIGNIFICANCE OF BONE MARROW MICROMETASTASES IN PATIENTS UNDERGOING LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA (HCC): YIP 3.06</a><div class="gs_gray">N Battula, R Sutcliffe, D Maguire, B Portmann, M Rela, G O'Sullivan, ...</div><div class="gs_gray">The Official Journal of The International Hepato Pancreato Biliary Association 8<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:SWgZeABleR0C" class="gsc_a_at">Toxic erythema in the haemato-oncology patient: clinical patterns, triggers and natural history in a series of 16 cases P-3</a><div class="gs_gray">K Watson, G Mufti, J Salisbury, D Creamer</div><div class="gs_gray">British Journal of Dermatology 155<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:i_7YvbSbtFEC" class="gsc_a_at">ROS, DNA damage and error-prone repair: A model for genomic instability in mice with myeloid leukaemia disease progression</a><div class="gs_gray">FV Rassool, TJ Gaymes, N Omidvar, M Pla, M Reboul, C Chomienne, ...</div><div class="gs_gray">Cancer Research 66 (8 Supplement), 599-599<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:aCwMkEyfDy8C" class="gsc_a_at">Improved disease free survival following non-myeloablative allogeneic stem cell transplantation compared with autologous transplantation in poor risk follicular lymphoma: 288</a><div class="gs_gray">W Ingram, S Devereux, J Gonzalez, A Ho, G MUFTI, A Pagliuca</div><div class="gs_gray">British Journal of Haematology 133, 110-111<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Lo8V22OuN40C" class="gsc_a_at">Association of sarcoidosis with haematological malignancies and secondary dysplastic features. A single centre experience: 198</a><div class="gs_gray">L GOONERATNE, Z LIM, K Raj, A Pagliuca, A HO, S Devereux, G MUFTI</div><div class="gs_gray">British Journal of Haematology 133<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:bbjcffOLshcC" class="gsc_a_at">High incidence of therapy-related myelodysplasia and acute myeloid leukaemia (tMDS/tAML) following treatment with fludarabine and cyclophosphamide for low grade&nbsp;…</a><div class="gs_gray">S BOWCOCK, S RASSAM, Z LIM, S WARD, G MUFTI</div><div class="gs_gray">British Journal of Haematology 133<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:GUYAmugLYisC" class="gsc_a_at">Use of autologous bone marrow harvests (BMH) in patients undergoing volunteer unrelated donor stem cell transplantation: a single centre experience 130</a><div class="gs_gray">P JUNAGADE, S Simpson, Z LIM, M Kenyon, A HO, S Devereux, ...</div><div class="gs_gray">British Journal of Haematology 133<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:TeJ9juy8vcMC" class="gsc_a_at">Improved outcome following reduced intensity conditioned allogeneic haematopoietic stem cell transplantation compared with myeloablative conditioning for acute myeloid&nbsp;…</a><div class="gs_gray">W Ingram, Z LIM, A Pagliuca, M Kenyon, S Devereux, A Ho, G MUFTI</div><div class="gs_gray">British Journal of Haematology 133<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:5VjbC5aozO0C" class="gsc_a_at">Haemophagocytic lymphohistiocytosis (HLH) following orthotopic liver transplantation: a single centre report of 37 cases 32</a><div class="gs_gray">A Barnardo, Z LIM, K Ramasamy, S Devereux, A HO, N Heaton, ...</div><div class="gs_gray">British Journal of Haematology 133<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:eH23hyXCXa4C" class="gsc_a_at">HIV associated Hodgkin's Lymphoma: improved outcome within a single centre 105</a><div class="gs_gray">P JUNAGADE, F Chen, S Simpson, S Devereux, C Taylor, P Easterbrook, ...</div><div class="gs_gray">British Journal of Haematology 133, 59-60<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:m92CDrhVnKEC" class="gsc_a_at">Acute myeloid leukaemia presenting with mediastinal myeloid sarcoma: a single institution experience 120</a><div class="gs_gray">K Ramasamy, Z LIM, A Pagliuca, A HO, S Devereux, G MUFTI</div><div class="gs_gray">British Journal of Haematology 133<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:1Aeql8wG3wEC" class="gsc_a_at">Second reduced-intensity transplants are effective and well tolerated in older patients with relapsed myeloid malignancies</a><div class="gs_gray">F Chen, H Ahmad, P Junagade, Z Lim, S Devereux, A Pagliuca, A Ho, ...</div><div class="gs_gray">Bone Marrow Transplantation 37<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:dMpQl7XwOw4C" class="gsc_a_at">Incidence and management of veno-occlusive disease following reduced-intensity conditioning haematopoietic stem cell transplantation</a><div class="gs_gray">K Ramasamy, Z Lim, R Grundy, A Pagliuca, A Ho, S Devereux, G Mufti</div><div class="gs_gray">Bone Marrow Transplantation 37<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:rp474-M6Y4oC" class="gsc_a_at">Mobilization of hematopoietic progenitors in low-grade myelodysplastic syndromes</a><div class="gs_gray">A Mijovic, M Delforge, M Sekhavat, B Czepulkowski, GJ Mufti</div><div class="gs_gray">haematologica 91 (4), 572-573<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:T_0gP6tLVL0C" class="gsc_a_at">Cytomegalovirus monitoring in allogeneic haemopoietic stem cell transplant recipients</a><div class="gs_gray">S Ramalingam, Z Lim, P Junagade, M Sudhanva, A Pagliuca, S Devereux, ...</div><div class="gs_gray">Journal of Clinical Virology 36, S45<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:w0odbtu79TwC" class="gsc_a_at">CLINICAL TRIALS AND OBSERVATIONS-Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell&nbsp;…</a><div class="gs_gray">R Martino, S Iacobelli, R Brand, T Jansen, A Biezen, J Finke, ...</div><div class="gs_gray">Blood 108 (3), 836-846<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:oynPyU19kbsC" class="gsc_a_at">Five serum biomarkers distinguish Ph plus CML from normal and reactive neutrophilia</a><div class="gs_gray">AM Mohamedali, S Sahu, BA Guinn, NSB Thomas, GJ Mufti</div><div class="gs_gray">British Journal of Haematology 133, 108-108<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:hfzGNhXhx5MC" class="gsc_a_at">Minimal criteria for diagnosis of MDS</a><div class="gs_gray">J Bennett, G Mufti</div><div class="gs_gray">Leukemia Research, S8<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:LlXTz_FrCmAC" class="gsc_a_at">Clonal Gammopathies Following Reduced Intensity Conditioning Transplantation with Fludarabine, Busulphan and Alemtuzumab for Myeloid Malignancies Predict Improved Overall Survival.</a><div class="gs_gray">ZY Lim, A Pagliuca, W Ingram, D Milojkovic, M Akthari, A Ho, S Devereux, ...</div><div class="gs_gray">Blood 106 (11), 1410<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QtA78RmWg5MC" class="gsc_a_at">Improved disease free survival following reduced intensity conditioned allogeneic stem cell transplantation incorporating alemtuzumab compared with autologous stem cell&nbsp;…</a><div class="gs_gray">W Ingram, S Devereux, J Gonzalez, A Ho, G Mufti, A Pagliuca</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 1144-1144<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:tBlTYpvFGQIC" class="gsc_a_at">Use of pre-emptive donor lymphocyte infusions to achieve durable remission following alemtuzumab based reduced intensity conditioning (RIC) transplantation for AML or MDS.</a><div class="gs_gray">ZY Lim, L Pearce, W Ingram, R Duarte, S Devereux, A Pagliuca, A Ho, ...</div><div class="gs_gray">Blood 106 (11), 1124<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ukw-9cB-YDkC" class="gsc_a_at">Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation Is as Effective in Poor Risk as Standard Risk Acute Myeloid Leukaemia (AML).</a><div class="gs_gray">W Ingram, Z Lim, A Pagliuca, S Devereux, A Ho, G Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 2901-2901<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:V_vSwabWVtYC" class="gsc_a_at">Matched pair analysis of intravenous vs oral busulphan as part of fludarabine-busulphan-campath (alemtuzumab) reduced intensity conditioning (RIC) haematopoietic stem cell&nbsp;…</a><div class="gs_gray">ZY Lim, D Milojkovic, L Pearce, M Kenyon, A Ho, S Devereux, A Pagliuca, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 1762-1762<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:H7nrzBkawXsC" class="gsc_a_at">Second Reduced Intensity Transplants Are Effective and Well Tolerated in Older Patients with Relapsed Myeloid Malignancies. A Single Centre Report.</a><div class="gs_gray">FE Chen, HN Ahmad, P Junagade, Z Lim, S Devereux, A Pagliuca, A Ho, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 5406-5406<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:L24QuVWYgZ0C" class="gsc_a_at">Serum Protein Profiling Distinguishes BCR-ABL+ CML from Normal and Neutrophilia Cases.</a><div class="gs_gray">AM Mohamedali, S Sahu, NSB Thomas, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 4871-4871<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:XAp-VaTZjjwC" class="gsc_a_at">Tumor supernatant from myeloid malignancies inhibits T-cell apoptosis and cell cycle entry independently</a><div class="gs_gray">D Milojkovic, AGS Buggins, S Devereux, NSB Thomas, GJ Mufti</div><div class="gs_gray">Leukemia 19 (9), 1699-1702<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:KsTgnNRry18C" class="gsc_a_at">Generalized eczematoid graft-vs.-host disease: presentation and natural history CPC-17</a><div class="gs_gray">C MARTYN-SIMMONS, G Osborne, G Mufti, S Devereux, J Salisbury, ...</div><div class="gs_gray">British Journal of Dermatology, Supplement 153<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:VnuxuLaQPLMC" class="gsc_a_at">Sweet's syndrome associated with myeloid malignancies and administration of granulocyte colony-stimulating factor: CPC-12</a><div class="gs_gray">J WHITE, G MUFTI, J SALISBURY, A DU VIVIER</div><div class="gs_gray">British Journal of Dermatology, Supplement 153<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:OkrdTXRNpVkC" class="gsc_a_at">1130. A Single-Component CD40-Targeted Adenoviral Vector for Efficient Transduction and Activation of Cutaneous Dendritic Cells</a><div class="gs_gray">L Chan, N Hardwich, D Darling, J Gäken, J Galea-Lauri, S Devereux, ...</div><div class="gs_gray">Molecular Therapy 11, 1<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:BAanoTsO0WEC" class="gsc_a_at">Development of a whole cell vaccine for acute myeloid leukaemia: a comparison of B7-1, B7-2 and 4-1BBL</a><div class="gs_gray">AT Cheuk, L Chan, SA Berger, H Yagita, K Okumura, F Farzaneh, GJ Mufti, ...</div><div class="gs_gray">Cancer Research 65 (9 Supplement), 1217-1218<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QhqSGEHatosC" class="gsc_a_at">Liver function abnormalities following alemtuzumab (Campath-1H): A previously unrecognised first dose effect 244</a><div class="gs_gray">Z LIM, C BRITTEN, J CHAPPELL, A HO, R DUARTE, A PAGLIUCA, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 129<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:6fxomyk5x4cC" class="gsc_a_at">Optimising the use of arsenic trioxide in ‘high risk’acute promyelocytic leukaemia (APL): The UK experience 87</a><div class="gs_gray">A BURNETT, E NUGENT, A LENNARD, A HO, G MUFTI, N MIR, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 129<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-fu4zM_6qcIC" class="gsc_a_at">Development of a semi-quantitative method for obtaining chimerism data from tissue and archived material: 9</a><div class="gs_gray">J Richards, G MORGAN, L Pearce, G MUFTI, S Devereux</div><div class="gs_gray">British Journal of Haematology-Supplement 129<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:e9bUPLv0EjcC" class="gsc_a_at">Retrospective review of prophylaxis for toxoplasmosis following allogeneic bone marrow transplantation</a><div class="gs_gray">ZY Lim, B Baker, M Kenyon, R Duarte, A Ho, J Wade, M Zukermann, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 129, 76-76<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ujxm2eEBZHIC" class="gsc_a_at">Retrospective review of patients with high risk of HBV disease undergoing reduced intensity conditioned (RIC) allogeneic BMT: 110</a><div class="gs_gray">S Moses, Z LIM, M Sudhanva, M Kenyon, R Duarte, A HO, M Zuckermann, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 129<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:q1zXlPLtbUIC" class="gsc_a_at">Patterns of engraftment of T-cells, granulocytes, B-cells, NK cells and dendritic cells (BDCA1 and BDCA4) following RIC Allo HSCT: 241</a><div class="gs_gray">L Pearce, R PADUA, A Ho, N Greenwood, M Usai, G MUFTI</div><div class="gs_gray">British Journal of Haematology-Supplement 129<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:X0DADzN9RKwC" class="gsc_a_at">Liver function abnormalities following alemtuzumab (Campath-1H): A previously unrecognised first dose effect</a><div class="gs_gray">D Milojkovic, ZY Lim, C Britten, J Chappell, A Ho, R Duarte, A Pagliuca, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 129, 79-79<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:8JTMrWI6FdcC" class="gsc_a_at">CDKN1A promoter methylation occurs in lymphocytes of MDS patients</a><div class="gs_gray">AM John, K Raj, GJ Mufti, NSB Thomas</div><div class="gs_gray">British Journal of Haematology 129, 205<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Mx5hWS9ctUkC" class="gsc_a_at">Immunoregulatory properties of B-CLL cells</a><div class="gs_gray">AGS Buggins, J Richards, PEM Patten, GJ Mufti, S Devereux</div><div class="gs_gray">British Journal of Haematology 129, 71<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:j2GSQqY3pL0C" class="gsc_a_at">P-56 CDKN2B (Pl5INK4B) and CDKN1A (P21CIP1) promoter hypermethylation occurs in lymphocytes and not in CD34+ or CD33+ myeloid cells of MDS patients</a><div class="gs_gray">A John, R Kavita, NS Thomas, G Mufti</div><div class="gs_gray">Leukemia Research, S45<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:VjBpw8Hezy4C" class="gsc_a_at">P-55 5 Azacytidine in myelodysplasticsyndromes: Correlation between clinical responses and CDKN2B promoter methylation</a><div class="gs_gray">K Rai, A John, A Ho, NS Thomas, G Mufti</div><div class="gs_gray">Leukemia Research, S45<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:CCeGMaHljPEC" class="gsc_a_at">Optimising the use of arsenic trioxide in'high risk'acute promyelocytic leukaemia (APL): The UK experience.</a><div class="gs_gray">D Grimwade, AK Burnett, E Nugent, AL Lennard, AY Ho, GJ Mufti, N Mir, ...</div><div class="gs_gray">British Journal of Haematology 129, 28-28<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wGzT3bKASkAC" class="gsc_a_at">Results of an international phase 2study of the oral farnesyl transferase inhibitor (FTI) tipifarnib (ZARNESTRA®) in patients with high-risk myelodysplastic syndrome (MDS)</a><div class="gs_gray">P Fenaux, P De Porre, A Raza, G Mufti, C Aul, U Germing, H Kantarjian, ...</div><div class="gs_gray">Leukemia Research 29, S71-S71<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:pQTOvowfQioC" class="gsc_a_at">1131. Generation of Whole Cell Vaccines for Acute Myeloid Leukaemia by Lentivirus Mediated IL-2/CD80 Transduction</a><div class="gs_gray">L Chan, N Hardwich, D Darling, J Gäken, J Galea-Lauri, S Devereux, ...</div><div class="gs_gray">Molecular Therapy, 436<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:TaaCk18tZOkC" class="gsc_a_at">Porphyria in association with myelodysplastic syndrome</a><div class="gs_gray">C Martyn-Simmons, AWP Du Vivier, GJ Mufti, AY Ho</div><div class="gs_gray">Journal of the American Academy of Dermatology 52 (3), 56-56<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:onKP9CxGSkIC" class="gsc_a_at">Invasive pulmonary aspergillosis is not a contraindication to reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation (RIC allo-HSCT).</a><div class="gs_gray">AYL Ho, SR Desai, IDP Stanton, SJ Copley, AU Wells, A Pagliuca, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 1831-1831<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:1_W9tMSvGuwC" class="gsc_a_at">Single centre experience of patients with haematological malignancies admitted to intensive care unit: A comparative review of allogenic bone marrow transplant data.</a><div class="gs_gray">ZY Lim, J Graham, S Simpson, S Devereux, A Pagliuca, A Ho, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 1830-1830<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:MGPUR4WVBMEC" class="gsc_a_at">Haemophagocytic lymphohistiocytosis post liver transplantation.</a><div class="gs_gray">A Barnardo, ZY Lim, M Foxton, K Ramasamy, G Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 3822-3822<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:tz746QTLzJkC" class="gsc_a_at">IL-2/B7. 1 Fusagene Transduction of AML Blasts by a Self-Inactivating Lentiviral Vector Stimulates T Cell Responses in Vitro: A Strategy To Generate Whole Cell Vaccines for AML.</a><div class="gs_gray">L Chan, N Hardwick, D Darling, J Galea-Lauri, J Gäken, S Devereux, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 5275-5275<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:BJrgspguQaEC" class="gsc_a_at">The Acquired CD40L Deficiency in B-CLL Is Reversible and Due To Contact Dependant and Independent Factors.</a><div class="gs_gray">AGS Buggins, J Richards, PEM Patten, GJ Mufti, S Devereux</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 2813-2813<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:YB4bud6kWLwC" class="gsc_a_at">Spectrum of clinical presentation, histology, treatment and prognosis in a series of eight patients with leukaemia cutis</a><div class="gs_gray">K WATSON, G Mufti, J SALISBURY, A DU VIVIER, D Creamer</div><div class="gs_gray">British Journal of Dermatology, Supplement 151<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:sYWwZaPVD1oC" class="gsc_a_at">Histone deacetylase inhibitors mimic the double strand break DNA repair response to irradiation in vitro</a><div class="gs_gray">TJ Gaymes, GJ Mufti, FV Rassool</div><div class="gs_gray">Cancer Research 64 (7 Supplement), 330-330<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:hB2aVRuWZNwC" class="gsc_a_at">The Werners syndrome protein plays a complex role in NHEJ-related genomic instability.</a><div class="gs_gray">N Brady, TJ Gaymes, GJ Mufti, FV Rassool</div><div class="gs_gray">Cancer Research 64 (7 Supplement), 526-526<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Gb6Hms-Uo9kC" class="gsc_a_at">Humoral detection of presentation acute myeloid leukaemia antigens in a testes cDNA library</a><div class="gs_gray">BA Guinn, EA Bland, U Lodi, AH Banham, GJ Mufti</div><div class="gs_gray">Cancer Research 64 (7 Supplement), 1258-1259<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:d4tt_xEv1X8C" class="gsc_a_at">A single centre experience of reduced intensity conditioned HSCT using BEAM-campath for low-grade lymphoid malignancies</a><div class="gs_gray">M Lissack, W Ingram, M Lamacchia, A Ho, N Greenwood, G Mufti, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 125<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:3lUAU8Oskd0C" class="gsc_a_at">Identification of presentation acute myeloid leukaemia antigens in a testes cDNA library</a><div class="gs_gray">B Guinn, E Bland, J Collin, U Lodi, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 125<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:rLGzs9wiiwIC" class="gsc_a_at">cDNA microarray analysis of tumour antigen expression in presentation acute myeloid leukaemia</a><div class="gs_gray">BA Guinn, AF Gilkes, GJ Mufti, DC Linch, AK Burnett, KI Mills</div><div class="gs_gray">Cancer Research 64 (7 Supplement), 1261-1261<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:1r-w4gtu6w8C" class="gsc_a_at">Use of cDNA microarray analysis to identify cancer testes antigen expression in presentation acute myeloid leukaemia</a><div class="gs_gray">B Guinn, A Gilkes, G Mufti, D Linch, A Burnett, K Mills</div><div class="gs_gray">British Journal of Haematology-Supplement 125, 16-17<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:qPeb-qHga9sC" class="gsc_a_at">Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors: T-cell depletion and reduced-intensity regimens are&nbsp;…</a><div class="gs_gray">T de Witte, R Brand, A van Biezen, P Guardiola, J Cornelissen, ...</div><div class="gs_gray">Bone Marrow Transplantation 33<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ji7lAbPyDbYC" class="gsc_a_at">Retrospective analysis of the use of valganciclovir in the prevention of cytomegalovirus following stem cell transplantation</a><div class="gs_gray">J Subedi, J Chappell, W Ingram, M Zuckerman, S Devereux, A Ho, G Mufti, ...</div><div class="gs_gray">Bone Marrow Transplantation 33<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:v6PuF9mNY3oC" class="gsc_a_at">Prevalence and impact of adenovirus viraemia in adult stem-cell transplant recipients treated with Campath-1H</a><div class="gs_gray">A Geretti, E Nieto, S Ramalingam, A Ho, M Smith, G Mufti, S Devereux, ...</div><div class="gs_gray">Clinical Microbiology &amp; Infection Supplement 10, 83-84<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:s2G-WRnXBicC" class="gsc_a_at">The acquired CD40 ligand deficiency observed in patients with B-CLL is reversible and due to soluble leukaemia derived factor (s)</a><div class="gs_gray">AGS Buggins, J Richards, GJ Mufti, S Devereux</div><div class="gs_gray">British Journal of Haematology 125, 25<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:1paMEeroeoQC" class="gsc_a_at">CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS-Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid&nbsp;…</a><div class="gs_gray">AYL Ho, A Pagliuca, M Kenyon, JE Parker, A Mijovic, S Devereux, ...</div><div class="gs_gray">Blood 104 (6), 1616-1623<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:htyGaKyDgHMC" class="gsc_a_at">Monocistronic high titre vectors for targeted expression of multiple therapeutic genes</a><div class="gs_gray">D Darling, J Gaken, D Nesbeth, L Chan, N Hardwick, T Mackey, ...</div><div class="gs_gray">Cancer Gene Therapy 11 (12), 843-843<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:5LPo_wSKItgC" class="gsc_a_at">High titre vectors for targeted expression of multiple genes</a><div class="gs_gray">D Darling, J Gaken, D Nesbeth, L Chan, N Hardwick, T Mackey, ...</div><div class="gs_gray">JOURNAL OF GENE MEDICINE 6 (9), 71<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:sbeIDTyQOFgC" class="gsc_a_at">CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS-BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD&nbsp;…</a><div class="gs_gray">RD Faulkner, C Craddock, JL Byrne, P Mahendra, AP Haynes, ...</div><div class="gs_gray">Blood 103 (2), 428-434<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PkcyUWeTMh0C" class="gsc_a_at">Erythema following imatinib mesylate</a><div class="gs_gray">E Duncan, K Raj, G Mufti</div><div class="gs_gray">British journal of haematology 122 (1), 1<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Qy-rCirNo-8C" class="gsc_a_at">Secretion of factor (s) that inhibit T cell activation in B cell chronic lymphocytic leukaemia (B-CLL) is associated with clinically aggressive disease and lack of mutation in&nbsp;…</a><div class="gs_gray">A Buggins, J Richards, B Vadher, A Pagliuca, G Mufti, S Devereux</div><div class="gs_gray">British Journal of Haematology-Supplement 121, 28-29<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:GdZ7R06HQM4C" class="gsc_a_at">Marrow cellularity is predictive of CD34+ bone marrow harvest yield</a><div class="gs_gray">O Fasan, A Mijovic, V Day, S Devereux, A Pagliuca, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:AkvegQHRDQ8C" class="gsc_a_at">Antibacterial resistance in Gram-negative bacteria recovered from haemato-oncology patients</a><div class="gs_gray">O Fasan, S Devereux, A Pagliuca, G Mufti, J Wade</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:TY5xIG7f_2sC" class="gsc_a_at">DNA microarray analysis with small numbers of haematopoietic cells: validation of small-scale labelling protocol</a><div class="gs_gray">M Arno, N Westwood, N Thomas, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:G7txJ4jiatkC" class="gsc_a_at">Tumour supernatant (TSN) derived from myeloblasts inhibits the apoptosis of haematopoietic cells</a><div class="gs_gray">D Milojkovic, A Buggins, S Devereux, N Thomas, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 121, 74-75<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:beqBT5984LEC" class="gsc_a_at">Outcome of patients with haematological malignancy transferred to intensive care unit</a><div class="gs_gray">S Simpson, Z Lim, S Devereux, A Pagliuca, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Amrzk_ktLr0C" class="gsc_a_at">T cell effector functions can be induced in G0 and do not require entry into the cell cycle</a><div class="gs_gray">N Lea, S Orr, K Stoeber, G Williams, E Lam, M Ibrahim, G Mufti, N Thomas</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:djft3U1LymYC" class="gsc_a_at">Cyclin D2 controls B cell progenitor numbers</a><div class="gs_gray">N Lea, G Mohamedali, I Soeiro, J Glassford, L Banerji, G Mufti, E Lam, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 121, 49-50<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:V63Ir2N1OTwC" class="gsc_a_at">Protein delivery into primary haemopoietic cells</a><div class="gs_gray">A John, G Mufti, N Thomas</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:SEKBqlyTJecC" class="gsc_a_at">Mono-and biclonal gammopathies following conditioning regimens incorporating alemtuzumab for haemopoietic stem cell transplantation (SCT)</a><div class="gs_gray">W Ingram, D Milojkovic, M Kenyon, J Chappell, A Ho, E Davies, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 121, 85-86<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:CKf5m1HYVjMC" class="gsc_a_at">The inhibitory effect of tumour-derived soluble factors on T-cell activation and proliferation is dependant on disease stage</a><div class="gs_gray">D Milojkovic, A Buggins, N Thomas, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 121, 32-33<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:gL9scSG3K_gC" class="gsc_a_at">Reduced-intensity allogeneic transplantation using BEAM-Campath in patients with lymphoproliferative diseases–GVHD, toxicity and survival in 65 patients</a><div class="gs_gray">R Faulkner, J Byrne, C Craddock, P Mahendra, S Devereux, A Pagliuca, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:J-ba04ztB30C" class="gsc_a_at">Identification of a commitment point that controls entry into the cell cycle from a quiescent (G0) state</a><div class="gs_gray">N Lea, S Orr, K Stoeber, G Williams, E Lam, M Ibrahim, G Mufti, N Thomas</div><div class="gs_gray">British Journal of Haematology-Supplement 121, 2-3<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:I2jIoRS3jIgC" class="gsc_a_at">Response to Peggs et al.</a><div class="gs_gray">AYL Ho, S Devereux, A Pagliuca, GJ Mufti</div><div class="gs_gray">Bone Marrow Transplantation 31 (8), 727-727<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:zmHQPunddckC" class="gsc_a_at">An unusual case of pneumonia.</a><div class="gs_gray">AA Mangoni, SR Desai, H Shaikh, RD Barker, GJ Mufti, SH Jackson</div><div class="gs_gray">International journal of clinical practice 57 (2), 153-154<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wgKq3sYidysC" class="gsc_a_at">Bullous graft-versus-host disease in a patient with acute myeloid leukaemia</a><div class="gs_gray">KMT Watson, G Mufti, D Creamer</div><div class="gs_gray">British Journal of Dermatology 149, 18-18<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4tNoA7Af41QC" class="gsc_a_at">Increased incidence of autoimmune cytopenia and paraproteinemia following allogeneic bone marrow transplants conditioned with Alemtuzumab.</a><div class="gs_gray">K Raj, W Ingram, A Ho, D Milojkovic, S Devereaux, A Pagliuca, G Mufti</div><div class="gs_gray">Blood 102 (11), 3603<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:GHsHDPAyICYC" class="gsc_a_at">Defining quiescence and the G (0)-&gt; G (1) commitment point by gene expression analysis.</a><div class="gs_gray">NC Lea, SJ Orr, GJ Mufti, SN Thomas</div><div class="gs_gray">Blood 102 (11), 1285<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:tgTmbKTkO1IC" class="gsc_a_at">RAS and BCL-2 co-operate in a mouse model of myelodysplasia (MDS).</a><div class="gs_gray">RA Padua, C Chomienne, S Kogan, TH Phan, M Robledo, S Muszlak, ...</div><div class="gs_gray">Blood 102 (11), 499<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:nWoA1JPTheMC" class="gsc_a_at">Reduced-intensity allogeneic haematopoietic stem cell transplantation (HSCT) with fludarabine, busulphan and alemtuzumab (CAMPATH-1H) conditioning: Patterns of CD3 and CD15&nbsp;…</a><div class="gs_gray">AYL Ho, L Pearce, N Westwood, R Padua, M Kenyon, S Devereux, ...</div><div class="gs_gray">Blood 102 (11), 5459<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:q0uBw5dMOAkC" class="gsc_a_at">Cdc2 (cdk1) is aberrantly expressed in CML.</a><div class="gs_gray">SJ Orr, NC Lea, GJ Mufti, SN Thomas</div><div class="gs_gray">Blood 102 (11), 4494<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:9NZAP19TdFAC" class="gsc_a_at">Immunocytochemical detection of hepatocellular carcinoma micrometastases using Hep Par-1 monoclonal antibody in patients undergoing liver transplantation.</a><div class="gs_gray">RP Sutcliffe, DD Maguire, B Portmann, M Rela, GC O'Sullivan, GJ Mufti, ...</div><div class="gs_gray">Hepatology 38 (4), 1244<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:AZju0d2GQJ0C" class="gsc_a_at">Late events in reduced-intensity allogeneic haematopoietic stem cell transplantation (HSCT) with alemtuzumab (CAMPATH-1H) containing regimens impact on outcome compared with&nbsp;…</a><div class="gs_gray">AYL Ho, M Kenyon, JE Parker, I El-Hemaidi, M Zuckerman, S Devereux, ...</div><div class="gs_gray">BLOOD 100 (11), 414A-414A<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:10A3hb2jUxYC" class="gsc_a_at">Cutaneous side-effects of STI571, a novel therapy for chronic myeloid leukaemia</a><div class="gs_gray">K Short, D Milojkovic, D Creamer, G Mufti, A Vivier</div><div class="gs_gray">British Journal of Dermatology, Supplement 147, 34-35<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QI7uKX5mnFEC" class="gsc_a_at">Increased infidelity of non homologous end-joining (NHEJ) in Bloom's syndrome and myeloid leukaemias: evidence that Ku70 and/or 86 are required for increased frequency and size&nbsp;…</a><div class="gs_gray">T Gaymes, N Brady, P North, I Hickson, G Mufti, F Rassool</div><div class="gs_gray">British Journal of Haematology-Supplement 117<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Weau3kkTRIMC" class="gsc_a_at">Allogeneic stem-cell transplantation (allo-SCT) following reduced-intensity conditioning in MDS: 4.5 years follow-up</a><div class="gs_gray">J Parker, I El-Hemaidi, A Pagliuca, S Devereux, J Yin, M Potter, H Prentice, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 117<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:bxPAEoiBajcC" class="gsc_a_at">Reduced-intensity Rituximab-BEAM-CAMPATH allogeneic haematopoietic stem cell transplantation (HSCT) for follicular lymphoma with quantitative monitoring of minimal residual disease</a><div class="gs_gray">A Ho, S Devereux, G Mufti, A Pagliuca</div><div class="gs_gray">British Journal of Haematology-Supplement 117, 37-38<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:tL5YfqkXb3gC" class="gsc_a_at">Tumour supernatant (TSN) from primary AML is anti-apoptotic and its effect is mediated by the maintenance of BCL-2 and BCL-XL levels</a><div class="gs_gray">D Milojkovic, A Buggins, N Lea, N Thomas, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 117<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4Wrxgq2JVp0C" class="gsc_a_at">Reduced intensity conditioning (RIC) containing CAMPATH-1H, a comparison of sibling versus voluntary unrelated donor (VUD) haemopoietic stem cell transplantation (HSCT)</a><div class="gs_gray">A Ho, I El-Hemaidi, A Pagliuca, A Mijovic, S Devereux, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 117, 39-40<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:RgMnzfD6kpIC" class="gsc_a_at">Differentially expressed genes in familial myelodysplastic syndromes (MDS) as identified by microarray analysis</a><div class="gs_gray">A Pradhan, G Mufti, F Rassool</div><div class="gs_gray">British Journal of Haematology-Supplement 117<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:w9ZB08sdvuUC" class="gsc_a_at">Reduced intensity conditioned (RIC) voluntary unrelated donor transplantation (VUD) in poor risk MDS and myeloid leukaemia using Fludarabine, Busulphan and CAMPATH-1H (FBC)</a><div class="gs_gray">I El-Hemiadi, J Parker, M Kenyon, A Ho, S Devereux, A Pagliuca, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 117<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:NKlx0PmyA3cC" class="gsc_a_at">Dose limiting dermatological toxicity secondary to imatinib mesylate (STI-571) in chronic myeloid leukaemia (CML)</a><div class="gs_gray">D Milojkovic, K Short, A du Vivier, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 117, 16-17<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:mo9XK3BEATIC" class="gsc_a_at">Liver failure in systemic primary (AL) and hereditary forms of amyloidosis; The role of liver transplantation.</a><div class="gs_gray">AJ Stangou, PN Hawkins, G Mufti, JG O'Grady</div><div class="gs_gray">Hepatology 36 (4), 81<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:bkKuixW_xMkC" class="gsc_a_at">The inhibitory effects of multiple tumor derived soluble factors on apoptosis and T cell function in the leukemic microenvironment.</a><div class="gs_gray">D Milojkovic, AGS Buggins, S Devereux, NSB Thomas, GJ Mufti</div><div class="gs_gray">Blood 100 (11), 2184<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:rJyh6hJnyfgC" class="gsc_a_at">POST-TRANSPLANT COMPLICATIONS-Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated&nbsp;…</a><div class="gs_gray">AYL Ho, S Adams, H Shaikh, A Pagliuca, S Devereux, GJ Mufti</div><div class="gs_gray">Bone Marrow Transplantation 29 (10), 867-870<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:gFrPXmx1TSsC" class="gsc_a_at">Depletion of dendritic cells (DCs) from the blood and skin of patients undergoing allogeneic hematopoietic stem cell transplants (allo-HSCT) by alemtuzumab containing regimens.</a><div class="gs_gray">G Osborne, AGS Buggins, D Creamer, K Fishlock, A Pagliuca, GJ Mufti, ...</div><div class="gs_gray">Blood 100 (11), 1586<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ehoypfNsBj8C" class="gsc_a_at">18FDG-PET positron emission tomography (PET) is highly predictive of outcome following autograft for relapsed lymphoma. A retrospective study of 41 patients.</a><div class="gs_gray">P Fields, T Nunnan, S Devereaux, P Patten, A Ho, A Pagliuca, E Wegner, ...</div><div class="gs_gray">Blood 100 (11), 3042<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:pbQCAAeKvsAC" class="gsc_a_at">Systemic AL amyloidosis related liver failure; the role of liver transplantation.</a><div class="gs_gray">AJ Stangou, ND Heaton, M Rela, JR Bradley, GJ Mufti, PN Hawkins</div><div class="gs_gray">BLOOD 98 (11), 312B-312B<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:6IBXqrN-DEwC" class="gsc_a_at">Allogeneic bone marrow transplantation in chronic lymphocytic leukaemia (CLL) and prolymphocytic leukaemia (PLL) using BEAM-Campath reduced intensity conditioning.</a><div class="gs_gray">RJ Lush, S Devereux, JL Byrne, AP Haynes, AY Ho, GJ Mufti, A Pagliuca, ...</div><div class="gs_gray">BLOOD 98 (11), 378B-378B<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:-w1eE4La9_EC" class="gsc_a_at">A SOLUBLE FACTOR SECRETED BY PRIMARY AML CELLS BLOCKS T CELL CYCLE ENTRY AND PREVENTS T CELL APOPTOSIS</a><div class="gs_gray">D Milojković, A Buggins, G Mufti, N Thomas, W Hirst</div><div class="gs_gray">British Journal of Haematology-Supplement 113<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:xm1hsP5ya-EC" class="gsc_a_at">THE IMPLICATIONS &amp; CHARACTERISATION OF A SOLUBLE PROTEIN SECRETED BY PRIMARY AML CELLS THAT INHIBITS T CELL ACTIVATION.</a><div class="gs_gray">A Buggins, M Arno, D Milojković, N Lea, G Mufti, N Thomas, W Hirst</div><div class="gs_gray">British Journal of Haematology-Supplement 113<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:yaBp1wUtcLsC" class="gsc_a_at">UPDATED RESULTS OF NON-MYELOABLATIVE ALLOGRAFTING WITH BEAM-CAMPATH CONDITIONING IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASE.</a><div class="gs_gray">R Lush, A Haynes, J Byrne, A Pagliuca, J Parker, G Mufti, P Mahendra, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 113<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:JhbybO29vGQC" class="gsc_a_at">EXPRESSION OF TUMOUR-ASSOCIATED ANTIGENS IN PRESENTATION MYELOID LEUKAEMIAS.</a><div class="gs_gray">S Adams, B Guinn, A Mijovic, B Czepulkowski, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 113<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:qSd0DAb9jMoC" class="gsc_a_at">Reactive haemophagocytic lymphohistiocytosis: a frequent finding in immunosuppressed patients with multiple organ failure</a><div class="gs_gray">G Auzinger, J Devlin, PG O'Callaghan, ND Heaton, GJ Mufti, JA Wendon</div><div class="gs_gray">Critical Care 5 (1), 1-1<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:SpPTWFSNUtQC" class="gsc_a_at">Results of allogeneic transplantation using BEAM (+/-Fludarabine) with in vivo pre-transplant campath combined with Donor Leucocyte Infusion (DLI) in patients with&nbsp;…</a><div class="gs_gray">RJ Lush, AP Haynes, JL Byrne, A Pagliuca, JE Parker, P Mahendra, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 27, S278-S278<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:VHM5RxzNINsC" class="gsc_a_at">Liver transplantation for liver failure in association with AL amyloidosis.</a><div class="gs_gray">AJ Stangou, ND Heaton, M Rela, J O'Grady, D Westaby, GJ Alexander, ...</div><div class="gs_gray">Hepatology 34 (4), 205A-205A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Sf6vrWCRp3YC" class="gsc_a_at">Liver transplantation for end stage hepatic amyloidosis</a><div class="gs_gray">AJ Stangou, N Heaton, M Rela, G Mufti, GJ Alexander, D Gillmore, ...</div><div class="gs_gray">AMYLOID 8, 152-152<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:eIKNFFVQvJAC" class="gsc_a_at">Increased activity and infidelity of non homologous end-joining (NHEJ) DNA repair in Bloom's syndrome and myeloid leukemias (MDS/AML).</a><div class="gs_gray">TJ Gaymes, PS North, ID Hickson, A Pagliuca, GJ Mufti, FV Rassool</div><div class="gs_gray">Blood 98 (11), 455A-455A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:I858iXPj1OkC" class="gsc_a_at">Primary AML cell supernatant inhibits T cell and neutrophil apoptosis.</a><div class="gs_gray">D Milojkovic, AGS Buggins, NC Lea, A Pagliuca, GJ Mufti, NSB Thomas</div><div class="gs_gray">Blood 98 (11), 324A-324A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:E8ajGqO0XoUC" class="gsc_a_at">Chemotherapy-induced dermatoses in the haemato-oncology patient</a><div class="gs_gray">K Harman, J Mellerio, L Whittam, D Creamer, C Fuller, E Higgins, ...</div><div class="gs_gray">British Journal of Dermatology, Supplement 143, 65-66<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:h-xndbdg2koC" class="gsc_a_at">ALLOGENEIC STEM CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROMES (MDS): A SINGLE CENTRE EXPERIENCE.</a><div class="gs_gray">J Parker, M Kenyon, A Mijovic, S Devereux, A Pagliuca, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 108<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:vkz5F8TaVKkC" class="gsc_a_at">IMMUNOTHERAPY OF LEUKAEMIA USING MEMBRANE-ANCHORED GM-CSF.</a><div class="gs_gray">M Arno, P Towner, D Darling, W Hirst, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 108<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:3pYxbvHKFu8C" class="gsc_a_at">ANALYSIS OF THE INHIBITORY EFFECT OF LEUKAEMIC CELLS ON T CELL ACTIVATION.</a><div class="gs_gray">A Buggins, N Lea, M Arno, N Thomas, G Mufti, W Hirst</div><div class="gs_gray">British Journal of Haematology-Supplement 108<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:0paDrhnEFY0C" class="gsc_a_at">GENE EXPRESSION USING ADENOVIRAL VECTORS IN PRIMARY ACUTE LEUKAEMIA CELLS.</a><div class="gs_gray">N Lea, A Buggins, W Hirst, J Gaken, F Farzaneh, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 108<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:TiIbgCYny7sC" class="gsc_a_at">Bristol Cup Poster Presentations: Summaries of Papers-Chemotherapy-induced dermatoses in the haemato-oncology patient</a><div class="gs_gray">K Harman, J Mellerio, L Whittam, D Creamer, C Fuller, E Higgins, ...</div><div class="gs_gray">British Journal of Dermatology-Supplement, 65-65<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:AFmTUeZ1pmEC" class="gsc_a_at">Increased non homologous and joining (NHEJ) efficiency and infidelity in myeloid leukaemia: A possible mechanism for chromosomal deletions in cancer.</a><div class="gs_gray">TJ Gaymes, GJ Mufti, FV Rassool</div><div class="gs_gray">Blood 96 (11), 158B-159B<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:3vbIHxFL9FgC" class="gsc_a_at">Non-Myeloablative Preparative Regimen in Children with Severe Organ Dysfunction Undergoing Bone Marrow Transplantation</a><div class="gs_gray">PA Veys, EG Davies, D Webb, A Jones, A Hassan, A Pagliuca, GJ Mufti, ...</div><div class="gs_gray">Pediatric Research 45 (5), 768-768<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Iq19BMNozs4C" class="gsc_a_at">British Society for Haematology Slide Session Annual Scientific Meeting of BSH, Glasgow, 1998</a><div class="gs_gray">B Bain, G Mufti, T Hamblin, G Lucas, Z Mughal, M Bhavnani, B Wilkins, ...</div><div class="gs_gray">CLINICAL AND LABORATORY HAEMATOLOGY 21 (2), 149-153<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:xa5BkEQK8BgC" class="gsc_a_at">THE ROLE OF CD34+ CELL PROLIFERATION, APOPTOSIS AND AMIFOSTINE IN THE MYELODYSPLASTIC SYNDROMES (MDS) AND AML SECONDARY TO MDS</a><div class="gs_gray">JE Parker, KL Fishlock, B Czepulkowski, A Pagliuca, GJ Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 105 (1S)<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:I9gX6wnfuA8C" class="gsc_a_at">MODULATION OF T CELL ACTIVATION BY ACUTE MYELOID LEUKAEMIA (AML) DERIVED SOLUBLE FACTORS</a><div class="gs_gray">AGS Buggins, GJ Mufti, WJR Hirst</div><div class="gs_gray">British Journal of Haematology-Supplement 105 (1S)<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:natZJ_-F0IUC" class="gsc_a_at">REJECTION BY MHC-UNRESTRICTED EFFECTORS MAY PREVENT THE GENERATION OF ANTI-LEUKAEMIC IMMUNITY</a><div class="gs_gray">WJR Hirst, AGS Buggins, D Darling, J Gaken, F Farzaneh, GJ Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 105 (1S)<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PklR0melJeUC" class="gsc_a_at">The'G-CSF test': Response to a single dose of rhGCSF predicts mobilisation of haemopoietic progenitors in patients with haematological malignancies.</a><div class="gs_gray">A Mijovic, A Pagliuca, GJ Mufti</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 23, S217-S217<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:In6cVmBjs0IC" class="gsc_a_at">Patients with myelodysplastic syndromes (MDS) often mobilise abnormal haemopoietic progenitors.</a><div class="gs_gray">A Mijovic, J Howard, B Czepulkowski, A Pagliuca, GJ Mufti</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 23, S153-S153<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:x2hKVfJWtf0C" class="gsc_a_at">Non-myeloablative preparative regimen in children with severe organ dysfunction undergoing unrelated related donor BMT.</a><div class="gs_gray">P Vevs, G Davies, D Webb, A Jones, A Hassan, A Pagliuca, GJ Mufti, ...</div><div class="gs_gray">BRIT J HAEMATOL 105, 66-66<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:adHtZc2wMuEC" class="gsc_a_at">INFECTIONS POST-TRANSPLANT-Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: A randomised, double-blind, placebo-controlled study</a><div class="gs_gray">SM Kelsey, JM Goldman, S McCann, AC Newland, JH Scarffe, ...</div><div class="gs_gray">Bone Marrow Transplantation 23 (2), 163-168<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:qsWQJNntlusC" class="gsc_a_at">Haematological malignancy-RESEARCH PAPERS-Phenotypic and functional characteristics of monocyte-derived dendritic cells from patients with myelodysplastic syndromes</a><div class="gs_gray">G Matteo Rigolin, J Howard, A Buggins, C Sneddon, G Castoldi, ...</div><div class="gs_gray">British Journal of Haematology 107 (4), 844-850<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Kqc1aDSOPooC" class="gsc_a_at">In myelodysplastic syndromes (MDS) dendritic cells are phenotypically and functionally different from those obtained in healthy subjects.</a><div class="gs_gray">GM Rigolin, J Howard, AGS Buggins, C Sneddon, G Castoldi, A Pagliuca, ...</div><div class="gs_gray">Blood 94 (10), 389A-389A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:bVQMTfhMCi4C" class="gsc_a_at">Rejection by MHC-unrestricted effectors prevents the generation of anti-leukemic immunity.</a><div class="gs_gray">W Hirst, A Buggins, D Darling, J Gaken, A Pagliuca, F Farzaneh, GJ Mufti</div><div class="gs_gray">BLOOD 92 (10), 616A-617A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Dmoar05iI2YC" class="gsc_a_at">Neutrophilic eccrine hidradenitis in 2 neutrophilic patients</a><div class="gs_gray">F Keane, S Munn, D Hopster, G Mufti, A du Vivier</div><div class="gs_gray">British Journal of Dermatology, Supplement 139<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:svGagg1hbZMC" class="gsc_a_at">ABSENCE OF COSTIMULATION AND SECRETION OF TH1 CYTOKINE INHIBITORS CONTRIBUTE TO EVASION OF ANTI-LEUKAEMIC IMMUNITY</a><div class="gs_gray">A Buggins, W Hirst, D Darling, J Gaken, A Pagliuca, F Farzaneh, GJ Mufti</div><div class="gs_gray">British Journal of Haematology 102 (1-I)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:uAPFzskPt0AC" class="gsc_a_at">INDUCTION OF T-CELL DYSFUNCTION BY LEUKAEMIA-DERIVED FACTOR (S): DIRECT AND INDIRECT MECHANISMS</a><div class="gs_gray">W Hirst, A Buggins, A Pagliuca, G Mufti</div><div class="gs_gray">British Journal of Haematology 102 (1-I), 82-83<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:DUFsPKDdMi0C" class="gsc_a_at">Cyclophosphamide, cytosine arabinoside, idarubicin and methylprednisolone (CAIP) as a debulking regimen prior to stem cell mobilisation in relapsed/refractory lymphomas.</a><div class="gs_gray">AYL Ho, A Mijovic, A Pagliuca, GJ Mufti</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 101, 42-42<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:uPCvBZYD9qUC" class="gsc_a_at">CENTRAL ROLE OF SOLUBLE IMMUNOSUPPRESSIVE FACTORS IN THE DEVELOPMENT OF LEUKAEMIA-ASSOCIATED IMMUNE DYSFUNCTION</a><div class="gs_gray">WJR Hirst, AGS Buggins, A Pagliuca, GJ Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 101 (1S)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:feST4K8J0scC" class="gsc_a_at">Refractory anaemia with isolated del (16)(q22q24)</a><div class="gs_gray">GM Crotty, B Czepulkowski, D Milojkovic, A Pagliuca, GJ Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 101 (1S)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:_9Xh93LWpsYC" class="gsc_a_at">DETECTION OF 11Q23 TRANSLOCATIONS BY NESTED RT-PCR-MRD ANALYSIS USING HOT PCR SHOWS INCREASED SENSITIVITY</a><div class="gs_gray">SAB Jabbar, Z Stone, B Czepulkowski, G Nickless, GJ Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 101 (1S)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:vnF2_uLGgtgC" class="gsc_a_at">'LOW RISK'MYELODYSPLASTIC SYNDROME (MDS) IS ASSOCIATED WITH EXCESSIVE APOPTOSIS AND AN INCREASED RATIO OF PROVERSUS ANTI-APOPTOTIC BCL-2 RELATED PROTEINS</a><div class="gs_gray">JE Parker, KL Fishlock, A Mijovic, A Pagliuca, GJ Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 101 (1S)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:sfnaS5RM6jYC" class="gsc_a_at">SUBVERSION OF CELL-MEDIATED IMMUNITY BY LEUKAEMIC CELLS: LESSONS FOR CLINICAL IMMUNOTHERAPY</a><div class="gs_gray">AGS Buggins, WJR Hirst, D Darling, J Gaken, A Pagliuca, F Farzaneh, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 101 (1S)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:i8eIfGGcn98C" class="gsc_a_at">The Scope of Viral Vectors for the Transduction of Haemopoietic Cells</a><div class="gs_gray">N Lea, GJ Mufti</div><div class="gs_gray">Hematology 3 (1), 37-53<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:EaFouW7jFu4C" class="gsc_a_at">Haematological malignancy-RESEARCH PAPERS-'Low-risk'myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro-versus anti-apoptotic bcl-2&nbsp;…</a><div class="gs_gray">JE Parker, KL Fishlock, A Mijovic, B Czepulkowski, A Pagliuca, GJ Mufti</div><div class="gs_gray">British Journal of Haematology 103 (4), 1075-1082<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:WwIwg2wKZ0QC" class="gsc_a_at">Megakaryocyte dysplasia in bone marrow transplant (BMT) patients</a><div class="gs_gray">K Skordilis, GM Crotty, GJ Mufti, JR Salisbury</div><div class="gs_gray">JOURNAL OF PATHOLOGY 184, 34A-34A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:f2PrUAIjnKUC" class="gsc_a_at">Provision of costimulatory molecules on myeloid leukemic cells enhances T-cell proliferation but fails to induce cytokine production.</a><div class="gs_gray">A Buggins, W Hirst, A Pagliuca, GJ Mufti</div><div class="gs_gray">BLOOD 90 (10), 1231-1231<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:v_tt_AnqfNMC" class="gsc_a_at">Mechanisms of T-cell dysfunction in acute leukemia: Intrinsic T-cell defect or soluble inhibitory factor.</a><div class="gs_gray">W Hirst, A Buggins, A Pagliuca, GJ Mufti</div><div class="gs_gray">BLOOD 90 (10), 84-84<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:eI34FqJmdUoC" class="gsc_a_at">137 Clinical potential of mutant ras</a><div class="gs_gray">GJ Mufti</div><div class="gs_gray">Leukemia Research 21 (1), S35<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:OqYjx1B7R3oC" class="gsc_a_at">Prospects for immune gene therapy of myeloid leukaemia</a><div class="gs_gray">W Hirst, J Gäken, D Darling, J Gaiea-Lauri, A Buggins, M Kuiper, ...</div><div class="gs_gray">Transfusion Medicine 7<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:RJujIP1NYNUC" class="gsc_a_at">149 Treatment strategies in MDS: Who and how should be treated?</a><div class="gs_gray">GJ Mufti</div><div class="gs_gray">Leukemia Research 1 (21), S39<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:EsrhoZGmrkoC" class="gsc_a_at">Induction of tumour rejection by B7. 1 and IL-2 expressing tumour cells</a><div class="gs_gray">J Gaken, W Hirst, D Darling, J GaleaLauri, A Buggins, M Kuiper, ...</div><div class="gs_gray">CANCER GENE THERAPY 4 (5)<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:KqW5X_olkfQC" class="gsc_a_at">Recent developments in the prognostic classification for MDS: results of the international risk analysis workshop</a><div class="gs_gray">P Greenberg, C Cox, M LeBeau, P Fenaux, P Morel, G Sanz, M Sanz, ...</div><div class="gs_gray">Leukemia Research 21 (S1), S13-S13<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wBLCggQE-ToC" class="gsc_a_at">Idarubicin, fludarabine, cytarabine and G-CSF (FLAG-Ida) for the treatment of high risk MDS or AML</a><div class="gs_gray">JE Parker, J Cullis, A Mijovic, A Pagliuca, S Rassam, I Samaratunga, ...</div><div class="gs_gray">Leukemia Research 21 (S1), S45-S45<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:R6EwkKsDylYC" class="gsc_a_at">Post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation: The role of combination chemotherapy.</a><div class="gs_gray">JO Cullis, M McCarthy, N Heaton, R Williams, R JanMohamed, A Pagliuca, ...</div><div class="gs_gray">BLOOD 88 (10), 359-359<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:fF_gHTpLxhAC" class="gsc_a_at">Autologous blood or bone marrow transplantation for relapsed and partially responding low-grade non-Hodgkin lymphoma (NHL).</a><div class="gs_gray">A Mijovic, J Parker, J Salisbury, A Pagliuca, GJ Mufti</div><div class="gs_gray">BLOOD 88 (10), 3866-3866<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:GtqhT-R7ZnwC" class="gsc_a_at">Loss of CD3-zeta expression is a late event in the development of T-cell dysfunction in a murine leukaemic model.</a><div class="gs_gray">WJR Hirst, AGS Buggins, D Darling, J Gaken, P Towner, F Farzaneh, ...</div><div class="gs_gray">BLOOD 88 (10), 3420-3420<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:6VlyvFCUEfcC" class="gsc_a_at">CD3-zeta expression in NK and T-cells from patients with myeloid malignancies.</a><div class="gs_gray">AGS Buggins, WJR Hirst, A Pagliuca, GJ Mufti</div><div class="gs_gray">BLOOD 88 (10), 2326-2326<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:vjZqxyZ7hS4C" class="gsc_a_at">Induction of tumour rejection by autologous and allogeneic tumour cells expressing B7. 1 and IL-2.</a><div class="gs_gray">W Hirst, D Darling, J Gaken, A Buggins, A Barnard, J GaleaLauri, ...</div><div class="gs_gray">IMMUNOLOGY 89<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:JIEWM9yDoCIC" class="gsc_a_at">INDUCTION OF HUMAN T CELL RESPONSES TO TUMOUR-ASSOCIATED NEOANTIGENS AND VIRUS ANTIGENS USING CULTURED DENDRITIC CELLS.: OJ98</a><div class="gs_gray">J Li, G Bowen, J Murphy, H Davies, S Hollingsworth, G Mufti</div><div class="gs_gray">Immunology-Supplement 89<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:jPVjDSAV6m0C" class="gsc_a_at">AN ANALYSIS OF FACTORS AFFECTING POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION (OLT)</a><div class="gs_gray">M McCarthy, J Ramage, E Gar, B Portmann, M Rela, N Heaton, ...</div><div class="gs_gray">Journal of Gastroenterology &amp; Hepatology 11 (10)<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:f-E_jMG6T4AC" class="gsc_a_at">The Haemopoietic Colony—Stimulating Factors</a><div class="gs_gray">GJ Mufti, P Towner</div><div class="gs_gray">Journal of the Royal College of Physicians of London 30 (4), 391<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:8VtEwCQfWZkC" class="gsc_a_at">A randomized trial of hydroxyurea (HY) versus VP16 in advanced adult chronic myelomonocytic leukemia (CMML)</a><div class="gs_gray">E Wattel, A Guerci, B Hecquet, T Economopoulos, A Copplestone, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 93, 590-590<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:gkldIfsazJcC" class="gsc_a_at">Transfusion-associated graft-versus-host disease in immunocompromised patients: A single centre experience.</a><div class="gs_gray">JO Cullis, R JanMohamed, CB Taylor, N Heaton, R Williams, A Pagliuca, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 93, 176-176<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ovGv7akYl-cC" class="gsc_a_at">Bone marrow stem cell transplantation in myelodysplastic syndromes</a><div class="gs_gray">D Milojkovic, A Pagliuca, A Mijovic, B Czepulkowski, GJ Mufti</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 93, 73-73<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:w7CBUyPWg-0C" class="gsc_a_at">Enhanced immune costimulatory activity of primary human AML blasts following gene transfer of B7. 1 (CC80).</a><div class="gs_gray">A Buggins, W Hirst, D Darling, J Gaken, S Hollingsworth, F Farzaneh, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 93, 260-260<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:za7pDTvVV8kC" class="gsc_a_at">Chemotherapy can offer a long term remission in post transplant lymphoproliferative disorder (PTLD) following orthotopic liver transplantation (OLT).</a><div class="gs_gray">M McCarthy, J Ramage, E Gane, B Portmann, M Rela, N Heaton, ...</div><div class="gs_gray">GASTROENTEROLOGY 110 (4), A1264-A1264<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:3MwzVuqRcA0C" class="gsc_a_at">Autologous stem cell transplantation (ASCT) for relapsed low-grade non-Hodgkin lymphoma (NHL): A single centre study.</a><div class="gs_gray">A Mijovic, J Parker, A Pagliuca, J Salisbury, GJ Mufti</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 93, 165-165<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:QaSi33NTfwYC" class="gsc_a_at">The role of B7. 1 (CD80) and IL-2 in a murine myeloid leukaemia model.</a><div class="gs_gray">W Hirst, A Buggins, D Darling, J Gaken, S Hollingsworth, F Farzaneh, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 93, 207-207<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PQEM9vzQD9gC" class="gsc_a_at">Post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation: A single centre experience.</a><div class="gs_gray">JO Cullis, M McCarthy, N Heaton, R Williams, R JanMohamed, A Pagliuca, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 93, 213-213<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:naSTrk-c4S8C" class="gsc_a_at">B7. 1/IL-2 gene-modified leukaemic cells may act as antigen-presenting cells (APCs).</a><div class="gs_gray">W Hirst, A Buggins, D Darling, J Gaken, S Hollingsworth, F Farzaneh, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 93, 259-259<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PazO6pb-sMwC" class="gsc_a_at">HTLV-1 STATUS IN MYCOSIS FUNGOIDES</a><div class="gs_gray">D Bryan, L Fuller, F Child, E Higgins, A du Vivier, G Mufti</div><div class="gs_gray">Journal of Cutaneous Pathology 23 (1)<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:r56sNq9gaawC" class="gsc_a_at">Therapy at adult T-cell leukaemia/lymphoma: Experience of two London hospitals</a><div class="gs_gray">DS Richardson, R Pawson, SM Kelsey, A Pagliuca, S Hoque, J Breuer, ...</div><div class="gs_gray">BRIT J HAEMATOL 93, 1169-1169<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:U3qCfcK-7lkC" class="gsc_a_at">Clinical and laboratory features of myelodysplastic syndrome.</a><div class="gs_gray">GJ Mufti</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4E1Y8I9HL1wC" class="gsc_a_at">Adult T-cell leukaemia/lymphoma in London: Clinical experience of 21 cases.</a><div class="gs_gray">R Pawson, D Richardson, A Pagliuca, S Kelsey, S Hoque, J Breuer, ...</div><div class="gs_gray">BRIT J HAEMATOL 93, 285-285<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:I-2NeQpV75MC" class="gsc_a_at">Retrovirus-mediated gene transfer of B7. 1 (CD80) into primary acute myeloid leukaemia (AML) cells enhances their immune costimulatory activity.</a><div class="gs_gray">A Buggins, W Hirst, D Darling, J Gaken, F Farzaneh, GJ Mufti</div><div class="gs_gray">BLOOD 86 (10), 1642-1642<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:NZNkWSpQBv0C" class="gsc_a_at">A randomized trial of hydroxyurea (HY) versus VP16 in advanced adult chronic myelomonocytic leukemia (CMML)</a><div class="gs_gray">E Wattel, A Guerci, B Hecquet, T Economopoulos, A Copplestone, ...</div><div class="gs_gray">BLOOD 86 (10), 195-195<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:qwOXE0mbtu4C" class="gsc_a_at">Immunoglobulin genes Immunoglobulin genes, 1989</a><div class="gs_gray">R PITERA, JE PITERA, GJ MUFTI, JR SALISBURY</div><div class="gs_gray">Pathology, research and practice 191 (5), 444-455<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:M7C5BM2v8n8C" class="gsc_a_at">A Practical Guide to Molecular Cloning A Practical Guide to Molecular Cloning, 1988</a><div class="gs_gray">R PITERA, JE PITERA, GJ MUFTI, JR SALISBURY</div><div class="gs_gray">Pathology, research and practice 191 (5), 444-455<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:CmbFvBriOyMC" class="gsc_a_at">Immunologic Approaches to the Classification and Management of Lymphomas and Leukemias Immunologic Approaches to the Classification and Management of Lymphomas and Leukemias, 1988</a><div class="gs_gray">R PITERA, JE PITERA, GJ MUFTI, JR SALISBURY</div><div class="gs_gray">Pathology, research and practice 191 (5), 444-455<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:lSLsV1MU4ZUC" class="gsc_a_at">COMBINED EXPRESSION OF B7-1 AND IL-2-SYNERGY IN TUMOR REJECTION</a><div class="gs_gray">J GAKEN, D DARLING, S HOLLINGSWORTH, W HIRST, M KUIPER, ...</div><div class="gs_gray">JOURNAL OF CELLULAR BIOCHEMISTRY, 421-421<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:C-SEpTPhZ1wC" class="gsc_a_at">Self‐assessment in clinical haematology. Jon A Homes, Sally Kinsey, Christopher Ludlam, David Webb and John Whittaker. Price:£ 18.95</a><div class="gs_gray">GJ Mufti</div><div class="gs_gray">Hematological Oncology 13 (2), 107-107<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:F9HO9s0W2bwC" class="gsc_a_at">RETROVIRUS-MEDIATED GENE-TRANSFER OF B7. 1 INTO PRIMARY ACUTE MYELOID-LEUKEMIA BLASTS</a><div class="gs_gray">AS BUGGINS, D DARLING, J GAKEN, SJ HOLLINGSWORTH, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF CANCER 31, 47-47<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:vxA22ZmNLkoC" class="gsc_a_at">Retrovirus-mediated gene transfer of B7. 1 into primary acute myeloid leukaemia blasts</a><div class="gs_gray">AS Buggins, D Darling, J Gäken, SJ Hollingsworth, F Farzaneh, GJ Mufti</div><div class="gs_gray">European Journal of Cancer, S26<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:g_UdREhPGEoC" class="gsc_a_at">Bone marrow transplantation and imaging</a><div class="gs_gray">AC Jeanes, AR Perry, M Firth, GJ Mufti</div><div class="gs_gray">IMAGING-OXFORD- 7, 178-178<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:TGkaJS32XoUC" class="gsc_a_at">The molecular pathogenesis of myelodysplasia: a long way to go</a><div class="gs_gray">J Stephenson, RA Padua, GJ Mufti</div><div class="gs_gray">EXCERPTA MEDICA INTERNATIONAL CONGRESS SERIES 1080 (1), 219-219<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1200&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:xm0LlTxljI0C" class="gsc_a_at">Immune reconstitution of severe combined immune deficient (SCID) mice: A potential model for testing immune gene therapy for acute myeloid leukaemia</a><div class="gs_gray">SJ Hollingsworth, W Hirst, S Humphreys, A Buggins, F Farzaneh, GJ Mufti</div><div class="gs_gray">European Journal of Cancer, S26<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:JTqpx9DYBaYC" class="gsc_a_at">COMPARISON OF 4 CATEGORIZED RISK SCORING SYSTEMS FOR ANALYZING OUTCOME IN GCSF-TREATED AND OBSERVED PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROME (MDS)</a><div class="gs_gray">P GREENBERG, K TAYLOR, R LARSON, P KOEFFLER, R NEGRIN, ...</div><div class="gs_gray">BLOOD 84 (10), A25-A25<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:_AkkBXT-jcoC" class="gsc_a_at">Comparison of four prognostic scores for survival and transformation in MDS</a><div class="gs_gray">GJ Mufti, A Mijovic, A Mijovic</div><div class="gs_gray">Leukemia Research 18, 6<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:nPTYJWkExTIC" class="gsc_a_at">Microdeletion at the acetylcholinesterase locus at 7q22 associated with myelodysplasia and acute myeloid leukaemia</a><div class="gs_gray">J Stephenson, B Czepulkowski, W Hirst, GJ Mufti</div><div class="gs_gray">Leukemia Research 18, 13<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:T8_be82Iz5gC" class="gsc_a_at">THE PROGNOSTIC-SIGNIFICANCE OF CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES (MDS) FOLLOWING G-CSF</a><div class="gs_gray">M LEBEAU, K TAYLOR, R LARSON, P KOEFFLER, R NEGRIN, H SABA, ...</div><div class="gs_gray">BLOOD 82 (10), A375-A375<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:YPNY0knpFBYC" class="gsc_a_at">LONG-TERM CULTURE OF PERIPHERAL-BLOOD STEM-CELLS (PBSC)</a><div class="gs_gray">RS KACZMARSKI, A MIJOVIC, A PAGLIUCA, GJ MUFTI</div><div class="gs_gray">BLOOD 82 (10), A485-A485<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:cx97FdCJQX8C" class="gsc_a_at">ADULT T-CELL LEUKEMIA-LYMPHOMA IN SOUTH LONDON-CLINICAL-EXPERIENCE OVER 10 YEARS</a><div class="gs_gray">A PAGLIUCA, GJ MUFTI</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 84, 40-40<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:k8to_Y4Q4_EC" class="gsc_a_at">QUANTIFICATION OF HIV BY PCR IN MONOCYTES AND LYMPHOCYTES OF PATIENTS ON GMCSF</a><div class="gs_gray">F DAVISON, R KACZMARSKI, GJ MUFTI, S SUTHERLAND</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 84, 48-48<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ZqLB7dQ1iF4C" class="gsc_a_at">RADIOLOGICAL INSERTION OF HICKMAN CATHETERS-NEW TECHNICAL MODIFICATIONS AND COMPLICATIONS</a><div class="gs_gray">P GISHEN, O CHAN, GJ MUFTI</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 84, 32-32<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:pUxgyZctzPYC" class="gsc_a_at">THE EFFECT OF TRILINEAGE DYSPLASIA ON ENGRAFTMENT IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PRIMARY ACUTE MYELOID-LEUKEMIA</a><div class="gs_gray">W HIRST, S AGRAWAL, PM PARIKH, S ALLARD, J MEHTA, R POWLES, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 84, 27-27<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:E7VqQtBCVmcC" class="gsc_a_at">THE INTERVAL FROM DIAGNOSIS TO TREATMENT AND BLAST PERCENTAGE INFLUENCES THE OUTCOME OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS) AND TRILINEAGE DYSPLASIA ACUTE&nbsp;…</a><div class="gs_gray">W HIRST, GJ MUFTI</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 84, 34-34<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:lg2tdxc6qMwC" class="gsc_a_at">BONE-MARROW BIOPSIES IN ADVANCED HIV-INFECTION</a><div class="gs_gray">RS KACZMARSKI, J SALISBURY, GJ MUFTI</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 84, 49-49<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4Yq6kJLCcecC" class="gsc_a_at">THE USE OF LOW-DOSE HEMATOPOIETIC GROWTH-FACTORS IN THE TREATMENT OF CHRONIC NEUTROPENIA</a><div class="gs_gray">RS KACZMARSKI, A POZNIAK, GJ MUFTI</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 84, 22-22<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:BPS1z4jHU5cC" class="gsc_a_at">Therapeutic Implications of Understanding Pathogenesis: Clinical Relevance of Prognostic Factors</a><div class="gs_gray">GJ Mufti</div><div class="gs_gray">Myelodysplastic Syndromes, 235-239<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Ej9njvOgR2oC" class="gsc_a_at">Cross-lineage rearrangement of antigen receptor genes in atypical chronic myeloid leukemia.</a><div class="gs_gray">MH Mangi, DM Layton, K Tobal, GJ Mufti</div><div class="gs_gray">Leukemia 5 (3), 210-213<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:CMPXdcK5v8EC" class="gsc_a_at">IMMUNOHISTOCHEMICAL ASSESSMENT OF BONE-MARROW BIOPSIES-DIAGNOSTIC AND PROGNOSTIC-SIGNIFICANCE IN MDS</a><div class="gs_gray">MH MANGI, JR SALISBURY, GJ MUFTI</div><div class="gs_gray">LEUKEMIA 5 (2), 177-177<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:37Fl7vPTsUIC" class="gsc_a_at">Direct sequencing of c-fms in myelodysplastic syndrome and AML.</a><div class="gs_gray">A Pagliuca, MG Thomas, K Tobal, F Farzaneh, GJ Mufti</div><div class="gs_gray">Leukemia research 15, 7-<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:o9ULDYDKYbIC" class="gsc_a_at">(C3) Chromosomal deletions in haematological malignancies</a><div class="gs_gray">WJR Hirst, B Czepulkowski, GJ Mufti</div><div class="gs_gray">Leukemia Research 15, 6<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:MNNNGtAgD4EC" class="gsc_a_at">The reactivities of bone marrow cells with K167, bromodeoxyuridine and GM-CSF MoAbs in childhood MDS</a><div class="gs_gray">AM Tunčcer, G Hiçaönmez, GJ Mufti</div><div class="gs_gray">Leukemia Research 15, 28<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:4oJvMfeQlr8C" class="gsc_a_at">Radiologically guided insertion of chronic indwelling central venous catheters</a><div class="gs_gray">O Chan, D Hughes, S Khan, P Gishen, GJ Mufti</div><div class="gs_gray">Seventy seventh assembly and annual meeting of the Radiological Society of&nbsp;…<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:u0Mu_IsstPMC" class="gsc_a_at">Leukeml'a Research</a><div class="gs_gray">T HAMBLIN, P REIZENSTEIN, J BERNARD, J WALDENSTROM, G MUFTI, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Y0-TYkg6YM4C" class="gsc_a_at">(B9) Childhood MDS in Turkey—clinical experience in 25 cases</a><div class="gs_gray">AM Tuncer, A Pagliuca, G Hicsonmez, GJ Mufti</div><div class="gs_gray">Leukemia Research 15, 5<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wLxue7F8ec0C" class="gsc_a_at">BRODN1EWICZ-PROBA, Z., 245 BRUNAT-MENTIGNY, M., 90</a><div class="gs_gray">A BYBEE, S DEVEREUX, WR MAYR, J MORGAN, GJ MUFTI, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:2vr6o8x5NLkC" class="gsc_a_at">First international symposium on myelodysplastic syndrome</a><div class="gs_gray">H Zwierzina, GJ Mufti, F Schmalzl</div><div class="gs_gray">Journal of Cancer Research and Clinical Oncology 115 (3), 300-307<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:8O4vDxvErlEC" class="gsc_a_at">MYELOFIBROSIS IN PRIMARY MYELODYSPLASTIC SYNDROMES-A CLINICOMORPHOLOGICAL STUDY OF 10 CASES</a><div class="gs_gray">A PAGLIUCA, DM LAYTON, RM IRELAND, A MANOHARAN, S GORDON, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 69 (1), 122-122<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:UarirCmVI0EC" class="gsc_a_at">THE DIAGNOSTIC-VALUE OF BONE-MARROW MORPHOLOGY IN PEDIATRIC LIVER-DISEASE</a><div class="gs_gray">RM IRELAND, G MIELIVERGANI, GJ MUFTI, AP MOWAT, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 69 (1), 111-111<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:DquSII9TDu4C" class="gsc_a_at">RAS MUTATION IN MYELODYSPLASTIC SYNDROMES-EVIDENCE FOR INVOLVEMENT OF A MULTIPOTENT STEM-CELL</a><div class="gs_gray">DM LAYTON, J LYONS, JWG JANSSEN, CR BARTRAM, GJ MUFTI</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 69 (1), 121-121<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:NtCmTCuxid4C" class="gsc_a_at">PLATELET ASSOCIATED IMMUNOPROTEINS IN PRIMARY MYELODYSPLASTIC SYNDROMES</a><div class="gs_gray">DK KNIGHT, A AMOS, DM LAYTON, GJ MUFTI, UM HEGDE</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 69 (1), 145-145<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:KTwcwpFFj4wC" class="gsc_a_at">Treatment for myelodysplastic syndromes</a><div class="gs_gray">A Pagliuca, DM Layton, GJ Mufti</div><div class="gs_gray">The Lancet 330 (8567), 1095<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:3AIi9tQMIrsC" class="gsc_a_at">The Myelodysplastic Syndromes</a><div class="gs_gray">EG Sims</div><div class="gs_gray">Journal of the National Medical Association 79 (7), 781<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:iyewoVqAXLQC" class="gsc_a_at">TREATMENT OF NON-HODGKIN LYMPHOMA WITH UNIVALENT MONOCLONAL ANTIIDIOTYPIC ANTIBODY</a><div class="gs_gray">A WORSLEY, TJ HAMBLIN, M GLENNIE, GJ MUFTI, J SMITH, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 64 (4), 820-820<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:1wZ_wKGpLuwC" class="gsc_a_at">COEXISTENT MYELODYSPLASIA IN LYMPHOPROLIFERATIVE DISORDERS</a><div class="gs_gray">JA COPPLESTONE, GJ MUFTI, DG OSCIER, TJ HAMBLIN</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 61 (3), 557-557<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Vno172sVVMwC" class="gsc_a_at">SYNERGISTIC INTERACTIONS OF DIFFERENTIATION INDUCERS AND DNA-SYNTHESIS INHIBITORS-INVITRO STUDIES AND CLINICAL-TRIAL IN MYELODYSPLASIA AND REFRACTORY AML</a><div class="gs_gray">GE FRANCIS, GJ MUFTI, JET GUIMARAES, TJ HAMBLIN</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 61 (3), 570-570<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:yeL6HyUMUGUC" class="gsc_a_at">INTERACTIONS OF DIFFERENTIATION INDUCING AGENTS INVITRO PROVIDE INSIGHT INTO MOLECULAR MECHANISMS OF DIFFERENTIATION AND IDENTIFY SYNERGISTIC COMBINATIONS EFFECTIVE INVIVO</a><div class="gs_gray">GE FRANCIS, GJ MUFTI, JET GUIMARAES, JJ BERNEY</div><div class="gs_gray">EXPERIMENTAL HEMATOLOGY 13 (5), 321-321<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ndLnGcHYRF0C" class="gsc_a_at">AJM BOULTON, WD ARMSTRONG, J. H. B. SCARPELLO AND JD WARD. 556 Fractures of the pelvis</a><div class="gs_gray">S HATTY, GJ MUFTI, TJ HAMBLIN</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1982</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:mzRTpvMFn3IC" class="gsc_a_at">King’s Research Portal</a><div class="gs_gray">HA Alkhatabi, DP McLornan, AG Kulasekararaj, F Malik, T Seidl, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:j33aPA1ap8EC" class="gsc_a_at">Human Erythroid Progenitors are Directly Infected by SARS-CoV-2: Implications for Hypoxia and Emerging Hematopoiesis/Erythropoiesis in COVID19</a><div class="gs_gray">H Encabo Huerga, W Grey, M Garcia Albornoz, H Wood, R Ulferts, ...</div><div class="gs_gray">Erythropoiesis in COVID19<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:SNyOjmPOlygC" class="gsc_a_at">Longer-term red blood cell transfusion reduction in the phase 3 MEDALIST study of luspatercept in patients with lower-risk myelodysplastic syndromes with ring sideroblasts</a><div class="gs_gray">RS Komrokji, MA Sekeres, AM Zeidan, P Fenaux, AF List, AE DeZern, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:5uu-MYFt2EcC" class="gsc_a_at">Tuesday, March 28th</a><div class="gs_gray">F Saraceni, M Labopin, RM Hamladji, G Mufti, G Socié, A Shimoni, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:pk6FPx6l9xIC" class="gsc_a_at">Luspatercept Significantly Reduces Red Blood Cell Transfusion Burden, Regardless of Gene Mutation Frequency, Spectrum, and Prognostic Significance, Among Patients With Lower&nbsp;…</a><div class="gs_gray">U Platzbecker, D Dunshee, RS Komrokji, GJ Mufti, G Garcia-Manero, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:IX653JsL2_EC" class="gsc_a_at">About novoseek</a><div class="gs_gray">A Giagounidis, P Fenaux, GJ Mufti, P Muus, U Platzbecker, G Sanz, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ey9_mCyZ-VYC" class="gsc_a_at">abnormal karyotype</a><div class="gs_gray">GJ MUFTI, TJ HAMBLIN, M SEABRIGHT</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:TuM7UPshZo8C" class="gsc_a_at">Mutations of FLT3 and JAK2 promote inter chromosomal homologous recombination and the potential for copy neutral loss of heterozygosity (CN-LOH) in acute myeloid leukemia</a><div class="gs_gray">TJ Gaymes, A Mohamedali, AL Eiliazadeh, D Darling, G Mufti</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:z-B63o8J19IC" class="gsc_a_at">Columnistas Destacados Terapia con Rituximab (terapia de anticuerpos monoclonales) para el Sindrome de Resistencia a la insulina severo tipo B</a><div class="gs_gray">AP Coll, S Thomas, GJ Mufti, FRC Path</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:yeKNu01O_4gC" class="gsc_a_at">Development of a novel DNA vaccine encorporating a PASD1 analogue peptide which can enhance anti-leukaemia T cell responses in vitro and in vivo. Nicola Hardwick1, Sarah Buchan2</a><div class="gs_gray">W Ingram, J Rice, GJ Mufti, F Stevenson, BA Guinn</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:PcT55Ow6fAIC" class="gsc_a_at">Development of a DNA vaccine targeting PASD1: a cancer-testis antigen expressed in acute myeloid leukaemia (AML).</a><div class="gs_gray">N Hardwick, S Buchan, W Ingram, G Vittess, J Rice, G Mufti, F Farzaneh, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:7nQzp1YiEc4C" class="gsc_a_at">VASCULOPATIA RETINIANA BILATERAL ASSOCIADA A DISQUERATOSE CONGÉNITA AUTOSSÓMICA DOMINANTE</a><div class="gs_gray">S Vaz-Pereira, PA Pacheco, S Gandhi, AG Kulasekararaj, JC Marsh, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:zfsRRabFVBUC" class="gsc_a_at">Safety of Lenalidomide 10 mg in non-del (5q) Versus del (5q) in the Treatment of Patients With Lower-Risk Myelodysplastic Syndromes (MDS): Pooled Analysis of Treatment-Emergent&nbsp;…</a><div class="gs_gray">A Almeida, V Santini, S Gröpper, A Jonasova, N Vey, A Giagounidis, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:ZOYfmFL0FrgC" class="gsc_a_at">King's College Hospital, Department of Haematology, London, United Kingdom;* University Hospital Leuven, Department of Hematology, Leuven, Belgium</a><div class="gs_gray">A Mijovic, M Delforge, M Sekhavat, B Czepulkowski, GJ Mufti</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:tSVUDDkujAIC" class="gsc_a_at">WP 8-MDS</a><div class="gs_gray">M Jädersten, L Saft, A Smith, A Kulasekararaj, S Pomplun, A Hedlund, ...</div><div class="gs_gray">INFORMATION leTTeR Nº8 FebRuARy 2012, 4<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:wlzmIqt2EaEC" class="gsc_a_at">Do patients with low-grade myelodysplastic syndromes (MDS) mobilise normal haemopoietic progenitors7 A. Mjovic, M. Delforge, M. Sekhavat, B, Czepolkowski</a><div class="gs_gray">GJ Mufti</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:h1pkognVyKwC" class="gsc_a_at">Volume Contents: Volume 21 (2007)</a><div class="gs_gray">J Delaunay, AT Nurden, P Nurden, GJ Kato, MT Gladwin, MH Steinberg, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:nOiSByfp82kC" class="gsc_a_at">BEAM-Campath reduced intensity allogeneic stem cell transplantation</a><div class="gs_gray">G Mufti, JL Yin, NH Russell, G Prentice, M Potter, A Pagliuca, A Ho, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:nU66GSXDKhoC" class="gsc_a_at">Low doses of cytarabine in the treat-ment of myelodysplastic syndrome</a><div class="gs_gray">GJ Mufti, DG Oscier, TJ Hamblin</div><div class="gs_gray">The Indian Journal of Pediatrics 192, 15<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:It0W0vAlS5QC" class="gsc_a_at">265 Why have Pneumocystis carinii trophozoites been ignored? JMW Chatterton, AW L Joss, MM Davidson, D 0 Ho-Yen</a><div class="gs_gray">A Pagliuca, GJ Mufti, AN Baldwin, AJ Wallis, GE Wilson, A Curry, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:7VEv-pLvLSsC" class="gsc_a_at">Guidelines for the diagnosis and therapy of</a><div class="gs_gray">D Bowen, D Culligan, S Jowitt, S Kelsey, G Mufti, D Oscier, J Parker</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:c1AJUTjuCtUC" class="gsc_a_at">Accademia Nazionale di Medicina Editors: Robin Foà, A. Victor Hoffbrand</a><div class="gs_gray">GJ Mufti</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:sgsej9ZJWHMC" class="gsc_a_at">Quality of life assessment after Haematopoietic Stem Cell Transplant (HSCT)</a><div class="gs_gray">M Kenyon, A Pagliuca, Z Lim, J Hayden, GJ Mufti</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:kUhpeDhEZMUC" class="gsc_a_at">Romano M, Dri P, Dadalt L, Patriarca P, Baralle FE. Biochemical and molecular characterization of hereditary myeloperoxidase deficiency. Blood. 1997; 90 (10): 4126-4134.</a><div class="gs_gray">MB Treppendahl, X Qiu, A Søgaard</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=gZU2Ie8AAAAJ&amp;cstart=1300&amp;pagesize=100&amp;citation_for_view=gZU2Ie8AAAAJ:Vr2j17o0sqMC" class="gsc_a_at">Diagnosis and treatment of primary myelodysplastic syndromes in adults</a><div class="gs_gray">RS Skov-Holm, A Symeonidis, AA van de Loosdrecht, T de Witte, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–1359</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>